<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd"><key id="d13" for="edge" attr.name="truncate" attr.type="string"/>
<key id="d12" for="edge" attr.name="created_at" attr.type="long"/>
<key id="d11" for="edge" attr.name="file_path" attr.type="string"/>
<key id="d10" for="edge" attr.name="source_id" attr.type="string"/>
<key id="d9" for="edge" attr.name="keywords" attr.type="string"/>
<key id="d8" for="edge" attr.name="description" attr.type="string"/>
<key id="d7" for="edge" attr.name="weight" attr.type="double"/>
<key id="d6" for="node" attr.name="truncate" attr.type="string"/>
<key id="d5" for="node" attr.name="created_at" attr.type="long"/>
<key id="d4" for="node" attr.name="file_path" attr.type="string"/>
<key id="d3" for="node" attr.name="source_id" attr.type="string"/>
<key id="d2" for="node" attr.name="description" attr.type="string"/>
<key id="d1" for="node" attr.name="entity_type" attr.type="string"/>
<key id="d0" for="node" attr.name="entity_id" attr.type="string"/>
<graph edgedefault="undirected"><node id="Ovarian Cancer">
  <data key="d0">Ovarian Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Ovarian cancer most often starts in the epithelium surrounding the ovaries or in the fallopian tubes near the ovary.&lt;SEP&gt;Ovarian cancer is a type of cancer that can cause symptoms like bloating, pelvic pain, and urinary urgency, and its likelihood increases if symptoms are recent, frequent, and worsening.&lt;SEP&gt;Ovarian cancer is a disease diagnosed through various tests and procedures; its symptoms include bloating, pelvic pain, and difficulty eating, and it can be hereditary or non-hereditary.&lt;SEP&gt;Ovarian cancer is a disease that can spread to nearby tissues, the omentum, lymph nodes, and the abdominal cavity, requiring surgical and chemotherapeutic treatment.&lt;SEP&gt;Ovarian cancer is a type of cancer that originates in the ovaries and is treated with surgery and chemotherapy.&lt;SEP&gt;Ovarian cancer is a disease with symptoms including bloating, pelvic or abdominal pain, difficulty eating, and feeling full quickly, which can impact nutrition and treatment outcomes.&lt;SEP&gt;Ovarian cancer is a disease with stages from I to IV, subdivided into substages, used to describe the extent of the cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249496</data>
  <data key="d6"></data>
</node>
<node id="FIGO Stages">
  <data key="d0">FIGO Stages</data>
  <data key="d1">concept</data>
  <data key="d2">FIGO stages are a system for describing the extent of ovarian cancer, detailed across stages 1A to 4B.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249496</data>
  <data key="d6"></data>
</node>
<node id="Stage 1A">
  <data key="d0">Stage 1A</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 1A ovarian cancer is confined to one ovary with an intact capsule, no surface cancer, and no cancer cells in ascites or washings.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249500</data>
  <data key="d6"></data>
</node>
<node id="Stage 1B">
  <data key="d0">Stage 1B</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 1B ovarian cancer is in both ovaries with intact capsules, no surface cancer, and no cancer cells in ascites or washings.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249502</data>
  <data key="d6"></data>
</node>
<node id="Stage 1C">
  <data key="d0">Stage 1C</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 1C ovarian cancer is in one or both ovaries with additional criteria: surgical spill (1C1), pre-surgical capsule rupture or surface cancer (1C2), or cancer cells in ascites/washings (1C3).</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249502</data>
  <data key="d6"></data>
</node>
<node id="Stage 2A">
  <data key="d0">Stage 2A</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 2A ovarian cancer involves one or both ovaries and has grown into or spread to the uterus and/or fallopian tubes.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249502</data>
  <data key="d6"></data>
</node>
<node id="Stage 2B">
  <data key="d0">Stage 2B</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 2B ovarian cancer involves one or both ovaries and has grown into or spread to other pelvic organs like the bladder, colon, or rectum.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249503</data>
  <data key="d6"></data>
</node>
<node id="Stage 3A1">
  <data key="d0">Stage 3A1</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 3A1 ovarian cancer involves one or both ovaries and has spread to retroperitoneal lymph nodes, with sub-stages based on tumor size in the nodes.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249504</data>
  <data key="d6"></data>
</node>
<node id="Stage 3A2">
  <data key="d0">Stage 3A2</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 3A2 ovarian cancer has microscopic spread to the abdominal lining and may involve retroperitoneal lymph nodes.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249505</data>
  <data key="d6"></data>
</node>
<node id="Stage 3B">
  <data key="d0">Stage 3B</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 3B ovarian cancer has visible cancer on the abdominal lining smaller than 2 cm and may involve retroperitoneal lymph nodes.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249507</data>
  <data key="d6"></data>
</node>
<node id="Stage 3C">
  <data key="d0">Stage 3C</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 3C ovarian cancer has visible cancer on the abdominal lining larger than 2 cm and may involve retroperitoneal lymph nodes or the outer surface of the liver or spleen.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249507</data>
  <data key="d6"></data>
</node>
<node id="Stage 4">
  <data key="d0">Stage 4</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 4 ovarian cancer has spread to other parts of the body, subdivided into Stage 4A (malignant pleural effusion) and Stage 4B (spread to liver/spleen interior, distant lymph nodes, or organs outside the abdomen).</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249508</data>
  <data key="d6"></data>
</node>
<node id="Platinum-Based Chemotherapy">
  <data key="d0">Platinum-Based Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">A recommended systemic therapy option for use with radiation therapy in the treatment of CSCC.&lt;SEP&gt;Platinum-based chemotherapy is a recommended systemic therapy option to be used with radiation for CSCC treatment.&lt;SEP&gt;Platinum-based chemotherapy is a specific type of systemic therapy preferred for use with radiation therapy in certain treatment plans.&lt;SEP&gt;Platinum-based chemotherapy, using drugs like carboplatin, cisplatin, or oxaliplatin, is recommended for ovarian cancer, often combined with a taxane.&lt;SEP&gt;Platinum-based chemotherapy is a treatment using drugs like carboplatin and cisplatin, which defines cancer as platinum-sensitive or platinum-resistant based on response.&lt;SEP&gt;Platinum-based chemotherapy is a type of initial treatment to which ovarian cancer may respond well, making maintenance therapy an option.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249513</data>
  <data key="d6"></data>
</node>
<node id="Taxane">
  <data key="d0">Taxane</data>
  <data key="d1">method</data>
  <data key="d2">Taxanes, such as paclitaxel and docetaxel, are a type of chemotherapy drug often given with platinum-based drugs for ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249513</data>
  <data key="d6"></data>
</node>
<node id="Paclitaxel">
  <data key="d0">Paclitaxel</data>
  <data key="d1">artifact</data>
  <data key="d2">Paclitaxel is a chemotherapy drug used in preferred regimens for treating ovarian cancer, often combined with carboplatin and bevacizumab.&lt;SEP&gt;Paclitaxel is a taxane chemotherapy drug that can cause peripheral neuropathy and is part of the preferred regimen for ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249516</data>
  <data key="d6"></data>
</node>
<node id="Carboplatin">
  <data key="d0">Carboplatin</data>
  <data key="d1">artifact</data>
  <data key="d2">A platinum-based chemotherapy drug used to treat squamous cell skin cancer and other cancers.&lt;SEP&gt;Carboplatin is a platinum chemotherapy drug used to treat squamous cell skin cancer and other cancers.&lt;SEP&gt;Carboplatin is a chemotherapy drug used in preferred regimens for treating ovarian cancer, often combined with paclitaxel and bevacizumab.&lt;SEP&gt;Carboplatin is a platinum-based chemotherapy drug used in the preferred regimen for ovarian cancer, often combined with paclitaxel.&lt;SEP&gt;Carboplatin is a platinum-based chemotherapy drug associated with an increased risk of hypersensitivity reactions upon repeat use.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249516</data>
  <data key="d6"></data>
</node>
<node id="Bevacizumab (Avastin)">
  <data key="d0">Bevacizumab (Avastin)</data>
  <data key="d1">artifact</data>
  <data key="d2">Bevacizumab is a drug that may be added to chemotherapy to stop tumor blood vessel growth and is considered for maintenance therapy.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249518</data>
  <data key="d6"></data>
</node>
<node id="Peripheral Neuropathy">
  <data key="d0">Peripheral Neuropathy</data>
  <data key="d1">concept</data>
  <data key="d2">Peripheral neuropathy is a common side effect of paclitaxel, causing pain, tingling, and numbness, often in the hands and feet.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249520</data>
  <data key="d6"></data>
</node>
<node id="Maintenance Therapy">
  <data key="d0">Maintenance Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Maintenance therapy is a treatment approach guided by BRCA status after initial successful treatment for ovarian cancer.&lt;SEP&gt;Maintenance therapy may follow once ovarian cancer is in remission, after surgery and additional chemotherapy.&lt;SEP&gt;Maintenance therapy may be an option for advanced ovarian cancers if initial treatment works well.&lt;SEP&gt;Maintenance therapy is treatment given after initial therapy; decisions about it are guided by the tumor's BRCA and HRD status.&lt;SEP&gt;Maintenance therapy is a potential next step after successful chemotherapy for ovarian cancer.&lt;SEP&gt;Maintenance therapy is the use of systemic therapy after successful initial treatment to reduce the risk of cancer returning or to extend the time until it returns.&lt;SEP&gt;Maintenance therapy is a treatment given after initial cancer therapy to prevent recurrence, which is stopped if cancer grows or side effects become severe.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249522</data>
  <data key="d6"></data>
</node>
<node id="Intravenous Chemotherapy">
  <data key="d0">Intravenous Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Intravenous chemotherapy is administered directly into the bloodstream through a vein, often via a port, for ovarian cancer treatment.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249524</data>
  <data key="d6"></data>
</node>
<node id="Stage 1">
  <data key="d0">Stage 1</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 1 is a category of ovarian cancer encompassing substages 1A, 1B, and 1C, generally indicating cancer confined to the ovaries.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249524</data>
  <data key="d6"></data>
</node>
<node id="Stage 2">
  <data key="d0">Stage 2</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 2 is a category of ovarian cancer encompassing substages 2A and 2B, indicating cancer that has spread within the pelvis.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249525</data>
  <data key="d6"></data>
</node>
<node id="Stage 3">
  <data key="d0">Stage 3</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 3 is a category of ovarian cancer encompassing substages 3A1, 3A2, 3B, and 3C, indicating cancer that has spread to the abdominal lining or lymph nodes.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249526</data>
  <data key="d6"></data>
</node>
<node id="Stage 4A">
  <data key="d0">Stage 4A</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 4A ovarian cancer is characterized by the presence of cancer cells in the fluid around the lungs, known as a malignant pleural effusion.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249526</data>
  <data key="d6"></data>
</node>
<node id="Stage 4B">
  <data key="d0">Stage 4B</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 4B ovarian cancer is characterized by spread to the inside of the liver or spleen, distant lymph nodes, or other organs outside the abdomen.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249526</data>
  <data key="d6"></data>
</node>
<node id="Neoadjuvant Therapy">
  <data key="d0">Neoadjuvant Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Neoadjuvant therapy is chemotherapy given before surgery to treat ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249529</data>
  <data key="d6"></data>
</node>
<node id="Adjuvant Chemotherapy">
  <data key="d0">Adjuvant Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Adjuvant chemotherapy, also called primary chemotherapy, is chemotherapy given after surgery to treat ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249529</data>
  <data key="d6"></data>
</node>
<node id="Cisplatin">
  <data key="d0">Cisplatin</data>
  <data key="d1">artifact</data>
  <data key="d2">A platinum-based chemotherapy drug used to treat squamous cell skin cancer and other cancers.&lt;SEP&gt;Cisplatin is a platinum chemotherapy drug used to treat squamous cell skin cancer and other cancers.&lt;SEP&gt;Cisplatin is a platinum-based chemotherapy drug used for ovarian cancer.&lt;SEP&gt;Cisplatin is a platinum-based chemotherapy drug associated with an increased risk of hypersensitivity reactions upon repeat use.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249529</data>
  <data key="d6"></data>
</node>
<node id="Oxaliplatin">
  <data key="d0">Oxaliplatin</data>
  <data key="d1">artifact</data>
  <data key="d2">Oxaliplatin is a platinum-based chemotherapy drug used for ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249530</data>
  <data key="d6"></data>
</node>
<node id="Docetaxel">
  <data key="d0">Docetaxel</data>
  <data key="d1">artifact</data>
  <data key="d2">Docetaxel is a taxane chemotherapy drug used for ovarian cancer.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249531</data>
  <data key="d6"></data>
</node>
<node id="Port">
  <data key="d0">Port</data>
  <data key="d1">artifact</data>
  <data key="d2">A port is a small disc placed in the chest to deliver systemic therapy, fluids, and blood products during AML treatment.&lt;SEP&gt;A port is a small, round disc placed under the skin, typically in the upper chest, to facilitate the delivery of chemotherapy and can be removed after treatment.&lt;SEP&gt;A port is a small, round disc placed under the skin to facilitate the intravenous administration of chemotherapy.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249532</data>
  <data key="d6"></data>
</node>
<node id="5-Fluorouracil">
  <data key="d0">5-Fluorouracil</data>
  <data key="d1">method</data>
  <data key="d2">5-Fluorouracil is a prescription chemotherapy cream applied directly to the skin to treat early squamous cell skin cancer and actinic keratoses.&lt;SEP&gt;5-Fluorouracil is a topical chemotherapy cream used to treat actinic keratosis, applied directly to the skin.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249532</data>
  <data key="d6"></data>
</node>
<node id="Chemotherapy">
  <data key="d0">Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Chemotherapy is a systemic cancer treatment that uses drugs to kill fast-growing or fast-dividing cancer cells throughout the body. It is a standard of care for many cancers, including acute myeloid leukemia (AML) and ovarian cancer, and is typically prescribed by medical oncologists. The treatment is administered in cycles via various methods, such as orally, by injection, intravenously, or, for ovarian cancer, intraperitoneally.

Common chemotherapeutic agents include platinum-based drugs like cisplatin and carboplatin, as well as regimens such as Paclitaxel combined with carboplatin. Its application can be neoadjuvant (given before surgery to shrink tumors, particularly when cancer is too advanced for immediate removal) or adjuvant (given after surgery). A biopsy is often required before initiating neoadjuvant chemotherapy. Furthermore, chemotherapy may be combined with other treatments, such as immune checkpoint inhibitor therapy for certain PD-L1 positive cancers.

A significant side effect of chemotherapy is its potential impact on a patient's fertility, as the drugs can affect healthy, rapidly dividing cells in addition to cancerous ones.</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249534</data>
  <data key="d6"></data>
</node>
<node id="Calcipotriene">
  <data key="d0">Calcipotriene</data>
  <data key="d1">method</data>
  <data key="d2">Calcipotriene is a cream, a form of vitamin D, often used with 5-fluorouracil to treat actinic keratosis by activating the skin's immune system.&lt;SEP&gt;Calcipotriene is a topical cream, a form of vitamin D, often used with 5-fluorouracil to treat actinic keratosis by activating the skin's immune system.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249535</data>
  <data key="d6"></data>
</node>
<node id="Imiquimod">
  <data key="d0">Imiquimod</data>
  <data key="d1">method</data>
  <data key="d2">Imiquimod is a prescription cream used to treat early squamous cell skin cancer and actinic keratoses.&lt;SEP&gt;Imiquimod is a topical cream and an immune response modifier used to treat actinic keratosis by activating the immune system to damage abnormal skin cells.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249540</data>
  <data key="d6"></data>
</node>
<node id="Tirbanibulin">
  <data key="d0">Tirbanibulin</data>
  <data key="d1">method</data>
  <data key="d2">Tirbanibulin is a topical microtubule inhibitor used to treat actinic keratosis by killing fast-growing abnormal cells, applied once daily for five consecutive days.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249541</data>
  <data key="d6"></data>
</node>
<node id="Hyperkeratosis">
  <data key="d0">Hyperkeratosis</data>
  <data key="d1">concept</data>
  <data key="d2">Hyperkeratosis is the thickening of the outer layer of skin, a condition that may require softening before treatment for actinic keratosis.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249541</data>
  <data key="d6"></data>
</node>
<node id="Cryotherapy">
  <data key="d0">Cryotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Cryotherapy, or cryosurgery, is a treatment that freezes and destroys precancerous and cancerous cells using a very cold substance like liquid nitrogen, causing a blister and scab to form.&lt;SEP&gt;Cryotherapy is a treatment that freezes and destroys cancer cells using a very cold liquid or tool.&lt;SEP&gt;Cryotherapy is a treatment option for actinic keratoses, which are pre-cancerous lesions.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249542</data>
  <data key="d6"></data>
</node>
<node id="Topical Tazarotene">
  <data key="d0">Topical Tazarotene</data>
  <data key="d1">method</data>
  <data key="d2">Topical tazarotene is a retinoid product related to vitamin A used to treat hyperkeratotic actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249545</data>
  <data key="d6"></data>
</node>
<node id="Curettage">
  <data key="d0">Curettage</data>
  <data key="d1">method</data>
  <data key="d2">Curettage is a surgical method that involves scraping away skin with a spoon-shaped tool.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249545</data>
  <data key="d6"></data>
</node>
<node id="Topical Keratolytics">
  <data key="d0">Topical Keratolytics</data>
  <data key="d1">method</data>
  <data key="d2">Topical keratolytics, such as urea, lactic acid, or salicylic acid, are used to treat hyperkeratotic actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249546</data>
  <data key="d6"></data>
</node>
<node id="Topical Diclofenac">
  <data key="d0">Topical Diclofenac</data>
  <data key="d1">method</data>
  <data key="d2">Topical diclofenac is a therapy sometimes used for actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249546</data>
  <data key="d6"></data>
</node>
<node id="Chemical Peels">
  <data key="d0">Chemical Peels</data>
  <data key="d1">method</data>
  <data key="d2">Chemical peels, using agents like trichloroacetic acid, are a therapy sometimes used for actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249546</data>
  <data key="d6"></data>
</node>
<node id="Resurfacing Techniques">
  <data key="d0">Resurfacing Techniques</data>
  <data key="d1">method</data>
  <data key="d2">Resurfacing techniques, such as laser or dermabrasion, are therapies sometimes used for actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249548</data>
  <data key="d6"></data>
</node>
<node id="Mohs Surgery">
  <data key="d0">Mohs Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Mohs surgery is a form of PDEMA and a recommended surgical procedure for CSCC that allows for immediate microscopic examination of tissue margins to ensure complete cancer removal.&lt;SEP&gt;A form of PDEMA and a recommended surgical option for local, high-risk, or very high-risk CSCC.&lt;SEP&gt;Mohs surgery is a recommended surgical treatment for low-risk CSCC and is the preferred option for very high-risk CSCC that has not spread to lymph nodes.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249549</data>
  <data key="d6"></data>
</node>
<node id="Curettage And Electrodesiccation">
  <data key="d0">Curettage And Electrodesiccation</data>
  <data key="d1">method</data>
  <data key="d2">Curettage and electrodesiccation is a two-step surgical method involving scraping off a tumor and then cauterizing the wound, recommended for early CSCC.&lt;SEP&gt;A recommended surgical option for local, low-risk CSCC.&lt;SEP&gt;Curettage and electrodesiccation is a surgical treatment option recommended for low-risk, local cutaneous squamous cell carcinoma.&lt;SEP&gt;Curettage and electrodesiccation is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249555</data>
  <data key="d6"></data>
</node>
<node id="PDEMA">
  <data key="d0">PDEMA</data>
  <data key="d1">method</data>
  <data key="d2">Peripheral and deep en face margin assessment is a type of surgery used for treating cancers in sensitive areas, allowing for complete testing of tissue edges.&lt;SEP&gt;A category of surgical methods, including Mohs surgery, used for treating cutaneous squamous cell carcinoma.&lt;SEP&gt;PDEMA is a form of surgery, similar to Mohs surgery, recommended for treating low-risk and very high-risk cutaneous squamous cell carcinoma.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249555</data>
  <data key="d6"></data>
</node>
<node id="Standard Surgical Excision">
  <data key="d0">Standard Surgical Excision</data>
  <data key="d1">method</data>
  <data key="d2">Standard surgical excision is a surgical option for treating squamous cell skin cancer that involves removing the tumor and a margin of normal tissue.&lt;SEP&gt;A recommended treatment option for high-risk or very high-risk local CSCC involving removal of a wider margin of normal tissue around the lesion.&lt;SEP&gt;Standard surgical excision is a recommended surgical treatment for low-risk, local CSCC, and also for high-risk or very high-risk cases with wider margins.&lt;SEP&gt;Standard surgical excision is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249557</data>
  <data key="d6"></data>
</node>
<node id="Lymph Node Dissection">
  <data key="d0">Lymph Node Dissection</data>
  <data key="d1">method</data>
  <data key="d2">Lymph node dissection is an extensive surgery to remove multiple lymph nodes if a biopsy shows cancer spread, performed under general anesthesia.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249559</data>
  <data key="d6"></data>
</node>
<node id="Sentinel Lymph Node Biopsy">
  <data key="d0">Sentinel Lymph Node Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">Sentinel lymph node biopsy is a surgery that removes and examines the first lymph nodes to which cancer cells are likely to spread from a primary tumor.&lt;SEP&gt;A surgical procedure that removes tissue samples from sentinel lymph nodes to check for cancer cells, used for cancer staging and treatment planning.&lt;SEP&gt;A sentinel lymph node biopsy is a procedure used to identify the first lymph nodes where cancer might have spread, often considered before or during PDEMA.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249560</data>
  <data key="d6"></data>
</node>
<node id="Actinic Keratosis">
  <data key="d0">Actinic Keratosis</data>
  <data key="d1">concept</data>
  <data key="d2">Actinic keratosis is an area of scaly or rough skin caused by sun exposure that may develop into Squamous Cell Carcinoma.&lt;SEP&gt;An area of scaly or rough skin that has a higher chance of becoming squamous cell skin cancer.&lt;SEP&gt;Actinic keratosis is a skin condition characterized by abnormal skin growths, treated with various topical and surgical therapies.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249561</data>
  <data key="d6"></data>
</node>
<node id="Squamous Cell Skin Cancer">
  <data key="d0">Squamous Cell Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">The second most common type of skin cancer, highly treatable and often curable, also known as cutaneous squamous cell carcinoma (CSCC).&lt;SEP&gt;Squamous cell skin cancer is a type of skin cancer that can form in old wounds, burns, or scars, known as Marjolin's ulcer, and may require various diagnostic tests and treatments.&lt;SEP&gt;Squamous cell skin cancer is a type of skin cancer treated with various surgical methods, including excision and lymph node procedures.&lt;SEP&gt;Squamous cell skin cancer is a type of cancer treated with systemic therapies like chemotherapy, targeted therapy, and immunotherapy.&lt;SEP&gt;Squamous cell skin cancer is a type of cancer diagnosed via skin biopsy, with certain rare subtypes more likely to return after treatment.&lt;SEP&gt;Squamous cell skin cancer is a type of cancer with local and systemic forms, treated with surgery, radiation, or systemic therapy.&lt;SEP&gt;Squamous cell skin cancer is the specific type of cancer discussed, which can be local, regional, or metastatic.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249564</data>
  <data key="d6"></data>
</node>
<node id="CSCC">
  <data key="d0">CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">CSCC refers to cutaneous squamous cell carcinoma, a type of skin cancer for which specific surgical procedures like Mohs surgery are recommended.&lt;SEP&gt;CSCC is an abbreviation for cutaneous squamous cell carcinoma, a type of skin cancer treated with systemic therapies.&lt;SEP&gt;CSCC is an abbreviation for cutaneous squamous cell carcinoma, a type of skin cancer discussed in the text regarding its risk factors and treatments.&lt;SEP&gt;CSCC is an abbreviation for cutaneous squamous cell carcinoma, the specific skin cancer being treated.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249568</data>
  <data key="d6"></data>
</node>
<node id="Sorilux">
  <data key="d0">Sorilux</data>
  <data key="d1">artifact</data>
  <data key="d2">Sorilux is a brand name for a calcipotriene cream used in the treatment of actinic keratosis.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249568</data>
  <data key="d6"></data>
</node>
<node id="Dovonex">
  <data key="d0">Dovonex</data>
  <data key="d1">artifact</data>
  <data key="d2">Dovonex is a brand name for a calcipotriene cream used in the treatment of actinic keratosis.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249570</data>
  <data key="d6"></data>
</node>
<node id="Klisyri">
  <data key="d0">Klisyri</data>
  <data key="d1">artifact</data>
  <data key="d2">Klisyri is a brand name for the topical therapy tirbanibulin used to treat actinic keratosis.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249570</data>
  <data key="d6"></data>
</node>
<node id="Trichloroacetic Acid">
  <data key="d0">Trichloroacetic Acid</data>
  <data key="d1">method</data>
  <data key="d2">Trichloroacetic acid is a chemical agent used in chemical peels for the treatment of actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249570</data>
  <data key="d6"></data>
</node>
<node id="Laser">
  <data key="d0">Laser</data>
  <data key="d1">method</data>
  <data key="d2">Laser is a resurfacing technique used as a therapy for actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249572</data>
  <data key="d6"></data>
</node>
<node id="Dermabrasion">
  <data key="d0">Dermabrasion</data>
  <data key="d1">method</data>
  <data key="d2">Dermabrasion is a resurfacing technique used as a therapy for actinic keratoses.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249573</data>
  <data key="d6"></data>
</node>
<node id="Scalpel">
  <data key="d0">Scalpel</data>
  <data key="d1">artifact</data>
  <data key="d2">A scalpel is a surgical tool used in procedures like Mohs surgery and standard surgical excision to remove tumors.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249574</data>
  <data key="d6"></data>
</node>
<node id="Microscope">
  <data key="d0">Microscope</data>
  <data key="d1">artifact</data>
  <data key="d2">A microscope is used by surgeons and pathologists to examine tissue margins and lymph nodes for cancer cells.&lt;SEP&gt;A microscope is used to study cells after a chemical marker is added in the Immunohistochemistry (IHC) staining process.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249574</data>
  <data key="d6"></data>
</node>
<node id="Dermatologic Surgeon">
  <data key="d0">Dermatologic Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A dermatologic surgeon is a specialist who performs Mohs surgery, requiring special training and experience.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249579</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Gland Cancer">
  <data key="d0">Adrenal Gland Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A very rare cancer affecting approximately 1 to 2 people per million, which can begin in the adrenal cortex.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249579</data>
  <data key="d6"></data>
</node>
<node id="Adrenocortical Carcinoma">
  <data key="d0">Adrenocortical Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Adrenocortical carcinoma is a rare, malignant cancer that begins in the adrenal cortex and can be a functioning or nonfunctioning tumor.&lt;SEP&gt;A type of adrenal cancer that starts in the adrenal cortex, can be functioning or nonfunctioning, and can occur at any age but is most common in children under 5 and adults in their 40s and 50s.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249580</data>
  <data key="d6"></data>
</node>
<node id="Surgery">
  <data key="d0">Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Surgery is a broad category of medical procedures involving the physical removal or manipulation of tissue. It serves as a fundamental diagnostic and treatment modality across numerous cancer types. As a primary treatment, surgery aims to completely excise cancerous tissue from the body. This is commonly the first-line approach for early-stage or locally advanced cancers, including basal cell skin cancer, squamous cell skin cancer (CSCC), non-small cell lung cancer (NSCLC), and ovarian cancer.

The specific surgical approach is highly dependent on the cancer type, stage, and patient factors. For skin cancers like basal cell and cutaneous squamous cell carcinoma (CSCC), surgery typically involves the excision of the tumor itself. In cases of CSCC or other cancers where lymph node involvement is suspected, surgery may also extend to the removal of nearby lymph nodes, with the extent determined by their number, location, and size. For ovarian cancer, initial surgery (debulking) is performed to remove as much of the tumor as possible and to accurately determine the cancer's spread through biopsy and staging. However, its feasibility depends on tumor characteristics and the patient's overall health, and it may sometimes be delayed in favor of initial chemotherapy.

Beyond treatment, surgery plays a critical diagnostic role. Tissue removed during a procedure is examined pathologically to determine the exact type, grade, and stage of the cancer, which guides further management. A significant consideration for patients undergoing any surgical procedure is that behaviors like smoking and vaping are strongly discouraged, as they greatly increase the risk of postoperative side effects and complications.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249582</data>
  <data key="d6"></data>
</node>
<node id="Neuroblastoma">
  <data key="d0">Neuroblastoma</data>
  <data key="d1">concept</data>
  <data key="d2">Neuroblastoma is a rare, cancerous type of adrenal tumor that primarily affects children aged 5 and under, most often infants, and can spread to other parts of the body.&lt;SEP&gt;A rare, cancerous adrenal tumor that affects children ages 5 and under, most often infants, and can spread to other parts of the body like bones.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249582</data>
  <data key="d6"></data>
</node>
<node id="Pheochromocytoma">
  <data key="d0">Pheochromocytoma</data>
  <data key="d1">concept</data>
  <data key="d2">A type of tumor that begins in the adrenal medulla, characterized by symptoms like high blood pressure, headache, rapid heartbeat, and sweating; most are benign but can be cancerous.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249588</data>
  <data key="d6"></data>
</node>
<node id="Adenoma">
  <data key="d0">Adenoma</data>
  <data key="d1">concept</data>
  <data key="d2">The most common type of adrenal gland tumor, also called adrenocortical adenoma; it is noncancerous and can be functioning or nonfunctioning.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249588</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Glands">
  <data key="d0">Adrenal Glands</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Adrenal glands are small, yellow, triangle-shaped glands located on top of each kidney that produce hormones affecting metabolism, stress response, and other bodily functions.&lt;SEP&gt;Small, yellow glands that are part of the body's endocrine system, producing hormones.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249590</data>
  <data key="d6"></data>
</node>
<node id="Endocrine System">
  <data key="d0">Endocrine System</data>
  <data key="d1">concept</data>
  <data key="d2">The endocrine system is made up of tissues and organs, including the adrenal glands, that produce hormones to regulate bodily functions.&lt;SEP&gt;A system made up of tissues and organs that produce hormones, which are chemical substances carried through the bloodstream to control how organs or cells work.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249590</data>
  <data key="d6"></data>
</node>
<node id="Hormones">
  <data key="d0">Hormones</data>
  <data key="d1">concept</data>
  <data key="d2">Chemical substances made in one part of the body and carried through the bloodstream to other parts to control organ or cell function.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249591</data>
  <data key="d6"></data>
</node>
<node id="Beckwith-Wiedemann Syndrome">
  <data key="d0">Beckwith-Wiedemann Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249593</data>
  <data key="d6"></data>
</node>
<node id="Carney Complex">
  <data key="d0">Carney Complex</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249593</data>
  <data key="d6"></data>
</node>
<node id="Familial Adenomatous Polyposis">
  <data key="d0">Familial Adenomatous Polyposis</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as FAP, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249593</data>
  <data key="d6"></data>
</node>
<node id="Hereditary Paraganglioma-Pheochromocytoma Syndrome">
  <data key="d0">Hereditary Paraganglioma-Pheochromocytoma Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as PGL/PCC, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249594</data>
  <data key="d6"></data>
</node>
<node id="Li-Fraumeni Syndrome">
  <data key="d0">Li-Fraumeni Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249595</data>
  <data key="d6"></data>
</node>
<node id="Lynch Syndrome">
  <data key="d0">Lynch Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition that can increase the risk of developing an adrenal tumor.&lt;SEP&gt;Lynch syndrome is a hereditary condition that commonly causes colon and uterine cancers but can also cause ovarian and other cancers.&lt;SEP&gt;Lynch syndrome is a hereditary condition that increases the risk for ovarian and other cancers.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249596</data>
  <data key="d6"></data>
</node>
<node id="Multiple Endocrine Neoplasia Type 1">
  <data key="d0">Multiple Endocrine Neoplasia Type 1</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as MEN 1, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249597</data>
  <data key="d6"></data>
</node>
<node id="Multiple Endocrine Neoplasia Type 2">
  <data key="d0">Multiple Endocrine Neoplasia Type 2</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as MEN 2, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249598</data>
  <data key="d6"></data>
</node>
<node id="Neurofibromatosis Type 1">
  <data key="d0">Neurofibromatosis Type 1</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as NF1, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249599</data>
  <data key="d6"></data>
</node>
<node id="Von Hippel-Lindau Syndrome">
  <data key="d0">Von Hippel-Lindau Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A hereditary genetic condition, abbreviated as VHL, that can increase the risk of developing an adrenal tumor.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249600</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines For Patients: Kidney Cancer">
  <data key="d0">NCCN Guidelines For Patients: Kidney Cancer</data>
  <data key="d1">content</data>
  <data key="d2">A set of patient guidelines available at NCCN.org/patientguidelines, providing information on conditions that can also increase the risk for kidney tumors.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249600</data>
  <data key="d6"></data>
</node>
<node id="Testing">
  <data key="d0">Testing</data>
  <data key="d1">method</data>
  <data key="d2">A process used to diagnose and plan treatment for adrenal tumors, involving various tests like imaging, blood tests, genetic tests, and biopsy.&lt;SEP&gt;Testing, including blood tests and biopsies, is the initial step in treatment planning for CML, used to diagnose the disease and determine a treatment plan.&lt;SEP&gt;Testing for mouth cancer includes imaging studies, biopsy, biomarker testing, and general health tests to determine the cancer stage and treatment plan.&lt;SEP&gt;Testing is conducted when ovarian cancer is suspected to determine the clinical stage and to assess if surgery is the best first treatment.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249601</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Cortex">
  <data key="d0">Adrenal Cortex</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The adrenal cortex is the outer part of the adrenal gland that produces hormones like cortisol, aldosterone, and DHEA to control metabolism, blood pressure, and body features.&lt;SEP&gt;The outer layer of the adrenal gland where adrenocortical carcinoma begins.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249608</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Medulla">
  <data key="d0">Adrenal Medulla</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The adrenal medulla is the inner part of the adrenal gland that produces hormones like epinephrine, norepinephrine, and dopamine to control the body's stress response.&lt;SEP&gt;The inner part of the adrenal gland where pheochromocytoma begins.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249609</data>
  <data key="d6"></data>
</node>
<node id="Pathologist">
  <data key="d0">Pathologist</data>
  <data key="d1">person</data>
  <data key="d2">A pathologist is a physician and medical expert specializing in the laboratory analysis of cells and tissues to diagnose disease. Their primary role involves examining samples obtained from biopsies, surgical resections, and bodily fluids under a microscope. A core function is the diagnosis of cancer, which includes confirming its presence, identifying the specific type and subtype (such as ovarian cancer), and determining the tumor's grade. Pathologists also play a critical role in cancer staging by analyzing features like tumor margins and checking lymph nodes or bone marrow for the spread of cancer cells. Their examination notes detailed cellular characteristics, including appearance, size, and shape. Beyond diagnosis, pathologists provide essential biomarker information that guides treatment decisions. While frequently associated with oncology, their expertise in cellular and tissue analysis is fundamental to the diagnosis of a wide range of medical conditions.</data>
  <data key="d3">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249609</data>
  <data key="d6"></data>
</node>
<node id="Functioning Tumor">
  <data key="d0">Functioning Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A type of adrenal tumor that produces excess hormones.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249610</data>
  <data key="d6"></data>
</node>
<node id="Nonfunctioning Tumor">
  <data key="d0">Nonfunctioning Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A type of adrenal tumor that does not produce excess hormones.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249613</data>
  <data key="d6"></data>
</node>
<node id="Benign Tumor">
  <data key="d0">Benign Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A noncancerous tumor, such as most pheochromocytomas and all adenomas.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249614</data>
  <data key="d6"></data>
</node>
<node id="Cancerous Tumor">
  <data key="d0">Cancerous Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A malignant tumor, such as adrenocortical carcinoma, neuroblastoma, and some pheochromocytomas.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249614</data>
  <data key="d6"></data>
</node>
<node id="Kidney Tumor">
  <data key="d0">Kidney Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A tumor in the kidney; some hereditary conditions that increase adrenal tumor risk can also increase kidney tumor risk.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249614</data>
  <data key="d6"></data>
</node>
<node id="General Health Tests">
  <data key="d0">General Health Tests</data>
  <data key="d1">method</data>
  <data key="d2">General health tests are part of the initial testing process for diagnosing basal cell skin cancer.&lt;SEP&gt;A category of tests used as part of the diagnostic process for adrenal tumors.&lt;SEP&gt;General health tests are part of the diagnostic process for esophageal cancer.&lt;SEP&gt;General health tests include medical history, family history, and physical exams, which help determine the best treatment.&lt;SEP&gt;General health tests are part of the testing process for throat cancer.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249616</data>
  <data key="d6"></data>
</node>
<node id="Genetic Tests">
  <data key="d0">Genetic Tests</data>
  <data key="d1">method</data>
  <data key="d2">Tests used to identify hereditary conditions that may increase the risk of adrenal tumors.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249622</data>
  <data key="d6"></data>
</node>
<node id="Medical Binder">
  <data key="d0">Medical Binder</data>
  <data key="d1">artifact</data>
  <data key="d2">A binder or notebook used to organize medical records, including test results, reports, and insurance information, for personal reference and second opinions.&lt;SEP&gt;A notebook or binder used by patients to organize medical records, test results, and care team contact information.&lt;SEP&gt;A medical binder or notebook is a tool recommended for patients to organize their health information.&lt;SEP&gt;A notebook or binder used to organize medical records, including test results, reports, insurance forms, and notes for appointments.&lt;SEP&gt;A medical binder is a notebook used to organize medical records, including blood tests, imaging results, and cancer reports, which is helpful for obtaining second opinions.&lt;SEP&gt;A medical binder is an organizational tool for storing copies of medical records, test results, and notes for appointments and second opinions.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249630</data>
  <data key="d6"></data>
</node>
<node id="Abdominal Exam">
  <data key="d0">Abdominal Exam</data>
  <data key="d1">method</data>
  <data key="d2">An abdominal exam is a physical examination where a provider feels the belly to check organ size, texture, tenderness, and for signs of fluid buildup.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249630</data>
  <data key="d6"></data>
</node>
<node id="Care Team">
  <data key="d0">Care Team</data>
  <data key="d1">organization</data>
  <data key="d2">A care team is the multidisciplinary group of healthcare professionals responsible for a patient's diagnosis, treatment, and ongoing management. It typically includes doctors, radiologists, nurses, nurse practitioners, physician assistants, and other specialists such as social workers, genetic counselors, and mind-body therapists. The team's specific composition can vary depending on the condition, such as cancer types like Follicular Lymphoma, AML (Acute Myeloid Leukemia), or ovarian cancer, where it may also incorporate sexual health experts.

The core functions of the care team are comprehensive. They conduct diagnostic testing, including evaluating suspicious lymph nodes and analyzing bone marrow samples, to determine the extent of disease and plan treatment. They prescribe treatments, manage the course of care, and work with the patient to manage side effects. A key responsibility is facilitating shared decision-making; patients are encouraged to get to know their team, ask questions, discuss treatment preferences, imaging results, and make their wishes known.

Effective operation requires the care team to be fully informed. They rely on a patient's complete medical history, list of medications and supplements, physical exam findings, and allergy information, such as to contrast material. Patients are advised to maintain their team's contact information and report symptoms promptly. Beyond medical treatment, the team's role extends to providing counseling, support for distress, and aiding in lifestyle changes like smoking cessation.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249632</data>
  <data key="d6"></data>
</node>
<node id="Pelvic Exam">
  <data key="d0">Pelvic Exam</data>
  <data key="d1">method</data>
  <data key="d2">A pelvic exam is a physical examination to check the ovaries, cervix, and uterus for abnormal changes in size, shape, or position, often using a speculum.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249633</data>
  <data key="d6"></data>
</node>
<node id="Pap Test">
  <data key="d0">Pap Test</data>
  <data key="d1">method</data>
  <data key="d2">A Pap test involves removing a sample of cervical cells to detect cervical cancer or pre-cancer; it is not used to detect ovarian cancer.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249638</data>
  <data key="d6"></data>
</node>
<node id="Endometrial Biopsy">
  <data key="d0">Endometrial Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">An endometrial biopsy is a test that samples the uterine lining, performed during a pelvic exam to rule out uterine cancer.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249639</data>
  <data key="d6"></data>
</node>
<node id="Rectovaginal Exam">
  <data key="d0">Rectovaginal Exam</data>
  <data key="d1">method</data>
  <data key="d2">A rectovaginal exam is a physical examination of the rectum and vagina together to check for cancer in the space between them.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249639</data>
  <data key="d6"></data>
</node>
<node id="Ultrasound">
  <data key="d0">Ultrasound</data>
  <data key="d1">method</data>
  <data key="d2">Ultrasound uses high-energy sound waves to create images of the body, is painless, and does not involve radiation.&lt;SEP&gt;An ultrasound is an imaging technique that might be used to guide a lymph node biopsy.&lt;SEP&gt;Ultrasound is a type of test, and an echocardiogram is a specific form of it.&lt;SEP&gt;Ultrasound is an imaging test using sound waves to create pictures of internal organs; it is often the first test used to look for ovarian cancer.&lt;SEP&gt;Ultrasound is an imaging test often used first for suspected ovarian cancer.&lt;SEP&gt;Ultrasound is an imaging test often used as the first imaging test for ovarian cancer.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249640</data>
  <data key="d6"></data>
</node>
<node id="Transabdominal Ultrasound">
  <data key="d0">Transabdominal Ultrasound</data>
  <data key="d1">method</data>
  <data key="d2">A transabdominal ultrasound involves spreading gel on the abdomen and pelvis and moving a probe on the skin to create images.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249641</data>
  <data key="d6"></data>
</node>
<node id="Transvaginal Ultrasound">
  <data key="d0">Transvaginal Ultrasound</data>
  <data key="d1">method</data>
  <data key="d2">A transvaginal ultrasound involves inserting a probe into the vagina to obtain clearer images of the ovaries.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249644</data>
  <data key="d6"></data>
</node>
<node id="CT Scan">
  <data key="d0">CT Scan</data>
  <data key="d1">method</data>
  <data key="d2">A computed tomography scan that uses x-rays and computer technology to create detailed 3D pictures of the inside of the body, often using contrast.&lt;SEP&gt;A medical imaging method used to determine the location of cancer cells, often combined with PET scans for greater accuracy.&lt;SEP&gt;A CT scan is an imaging test used to look for signs of cancer in lymph nodes or other body parts in patients with regional CSCC.&lt;SEP&gt;A CT scan uses X-rays and computer technology to create detailed cross-sectional images of the body, often using contrast material.&lt;SEP&gt;A CT scan is an imaging technique that might be used to guide a lymph node biopsy.&lt;SEP&gt;A CT scan is a detailed imaging test using X-rays and contrast agents to create 3-D pictures, used to check if ovarian cancer has spread.&lt;SEP&gt;A CT scan is a detailed type of X-ray that takes multiple images from different angles to create 3-D pictures of the body.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249644</data>
  <data key="d6"></data>
</node>
<node id="MRI">
  <data key="d0">MRI</data>
  <data key="d1">method</data>
  <data key="d2">MRI is an imaging test using radio waves and magnets, without radiation, to take pictures of the body, used when ultrasound images are unclear.&lt;SEP&gt;MRI is a medical imaging method sometimes combined with PET scans for diagnostic purposes.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249644</data>
  <data key="d6"></data>
</node>
<node id="PET Scan">
  <data key="d0">PET Scan</data>
  <data key="d1">method</data>
  <data key="d2">Positron emission tomography that uses an injected radioactive tracer to help locate cancer cells, often combined with CT or MRI for accuracy.&lt;SEP&gt;A PET scan uses a radioactive tracer to detect cancer cells by their sugar consumption, showing them as bright spots on the scan.&lt;SEP&gt;A positron emission tomography scan that uses a radioactive tracer to show where cancer cells are in the body and how fast they are growing.&lt;SEP&gt;A PET scan shows how cells use sugar and is sometimes combined with CT or MRI to provide more detailed information.&lt;SEP&gt;A PET scan shows how cells use a form of sugar (radiotracer) to help identify cancer, as cancer cells use sugar faster and appear brighter.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249647</data>
  <data key="d6"></data>
</node>
<node id="Imaging Tests">
  <data key="d0">Imaging Tests</data>
  <data key="d1">method</data>
  <data key="d2">Imaging tests are diagnostic procedures that create pictures of the inside of the body. Their primary purpose is to locate tumors, check for the spread of cancer, and identify other abnormalities such as areas of infection or bleeding. These tests are a fundamental component of the diagnostic and treatment planning process for a wide variety of cancers and conditions.

Specifically, imaging tests are used in the diagnosis and management of adrenal tumors, esophageal cancer, follicular lymphoma, acute myeloid leukemia (AML), ovarian cancer, and throat cancer. In the context of leukemia, they are particularly valuable for detecting disease outside the bone marrow. As a broad category encompassing scans and other techniques, imaging tests are routinely mentioned in the overview of diagnostic testing for these and other diseases.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249648</data>
  <data key="d6"></data>
</node>
<node id="Clinical Stage">
  <data key="d0">Clinical Stage</data>
  <data key="d1">concept</data>
  <data key="d2">Clinical stage (c) is the cancer stage rating given before any treatment, based on physical exam, biopsy, and imaging tests.&lt;SEP&gt;The clinical stage is a pre-treatment assessment that provides a best guess of how far ovarian cancer has spread, determined through testing.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249648</data>
  <data key="d6"></data>
</node>
<node id="Contrast Agent">
  <data key="d0">Contrast Agent</data>
  <data key="d1">artifact</data>
  <data key="d2">A contrast agent is a substance used in imaging tests like CT and MRI to make pictures clearer; it can be injected or ingested.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249655</data>
  <data key="d6"></data>
</node>
<node id="Blood Tests">
  <data key="d0">Blood Tests</data>
  <data key="d1">method</data>
  <data key="d2">Blood tests are a broad category of diagnostic procedures performed on blood samples to analyze various health indicators, assess organ function, and check for signs of disease. They are a fundamental component of the diagnostic process for numerous conditions, including adrenal tumors, chronic myeloid leukemia (CML), esophageal cancer, follicular lymphoma, and ovarian cancer. For adrenal tumors, specific blood tests can detect abnormal hormone secretion and are used to monitor treatment response. In the context of ovarian cancer, common blood tests include a complete blood count (CBC), blood chemistry profile, liver function tests, and tumor marker tests (such as CA-125); these are used to assess a patient's general health and signal potential problems, but are not used alone to make a definitive diagnosis. Furthermore, blood tests are critical in managing cancer treatment, as they are ordered during chemotherapy to monitor a patient's overall health and their specific response to the therapy, thereby helping to determine and adjust treatment plans for conditions like CML and follicular lymphoma.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249655</data>
  <data key="d6"></data>
</node>
<node id="Biopsy">
  <data key="d0">Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A biopsy is a fundamental medical diagnostic procedure involving the removal of a small sample of tissue or fluid from the body for microscopic examination. It is a primary method used to confirm or rule out diseases, most notably various forms of cancer. The procedure is critical for definitive diagnosis, determining the specific type and stage of cancer, and informing subsequent treatment plans.

The application of biopsy is broad and is utilized in the diagnosis and management of numerous conditions. Specific examples include basal cell skin cancer, adrenal tumors, chronic myeloid leukemia (CML), lung nodules, follicular lymphoma, ovarian cancer, and throat cancer. For ovarian cancer, it is often performed during initial surgery or via methods such as fine-needle aspiration (FNA), core biopsy, or paracentesis. A biopsy is considered essential before initiating treatments like chemotherapy.

The procedure can be performed in various ways, sometimes guided by imaging technologies such as ultrasound or CT scans to accurately target the area of concern. The overarching purpose remains consistent: to obtain a tissue sample for laboratory analysis, thereby providing a definitive diagnosis and guiding clinical decision-making.</data>
  <data key="d3">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249659</data>
  <data key="d6"></data>
</node>
<node id="Speculum">
  <data key="d0">Speculum</data>
  <data key="d1">artifact</data>
  <data key="d2">A speculum is a widening instrument used during a pelvic exam to view the vagina and cervix.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249659</data>
  <data key="d6"></data>
</node>
<node id="Ultrasound Probe">
  <data key="d0">Ultrasound Probe</data>
  <data key="d1">artifact</data>
  <data key="d2">An ultrasound probe is a hand-held device used in ultrasound exams to generate sound waves and create images.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249662</data>
  <data key="d6"></data>
</node>
<node id="CT Scanner">
  <data key="d0">CT Scanner</data>
  <data key="d1">artifact</data>
  <data key="d2">A CT scanner is a large machine with a tunnel that rotates an X-ray beam to take pictures from many angles for a CT scan.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249662</data>
  <data key="d6"></data>
</node>
<node id="MRI Machine">
  <data key="d0">MRI Machine</data>
  <data key="d1">artifact</data>
  <data key="d2">An MRI machine is a scanning device that uses radio waves and powerful magnets to create images; it is more enclosed than a CT scanner.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249663</data>
  <data key="d6"></data>
</node>
<node id="Sedative">
  <data key="d0">Sedative</data>
  <data key="d1">artifact</data>
  <data key="d2">A sedative is a type of medicine that may be given to help a patient relax during an MRI scan if they are nervous in enclosed spaces.&lt;SEP&gt;A sedative is a type of medicine given to help a patient relax, particularly if they get nervous in enclosed spaces like during a scan.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249664</data>
  <data key="d6"></data>
</node>
<node id="Symptoms Of Ovarian Cancer">
  <data key="d0">Symptoms Of Ovarian Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Symptoms of ovarian cancer include bloating, heartburn, pelvic pain, trouble eating, urinary urgency, and pain during sex, which may become more severe over time.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249666</data>
  <data key="d6"></data>
</node>
<node id="Ascites">
  <data key="d0">Ascites</data>
  <data key="d1">concept</data>
  <data key="d2">Ascites is a fluid buildup in the belly area that a provider checks for during an abdominal exam as a potential sign of ovarian cancer.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249666</data>
  <data key="d6"></data>
</node>
<node id="Oral Contrast">
  <data key="d0">Oral Contrast</data>
  <data key="d1">artifact</data>
  <data key="d2">Oral contrast is a substance a patient drinks before a CT scan to help make the internal pictures clearer.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249667</data>
  <data key="d6"></data>
</node>
<node id="PET CT">
  <data key="d0">PET CT</data>
  <data key="d1">method</data>
  <data key="d2">PET CT is a combined imaging technique that uses positron emission tomography with computed tomography to provide detailed metabolic and anatomical information.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249671</data>
  <data key="d6"></data>
</node>
<node id="Airways Of The Lungs">
  <data key="d0">Airways Of The Lungs</data>
  <data key="d1">concept</data>
  <data key="d2">The system of passages through which air moves during breathing, including the throat, windpipe, bronchi, and bronchioli.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249672</data>
  <data key="d6"></data>
</node>
<node id="Trachea">
  <data key="d0">Trachea</data>
  <data key="d1">concept</data>
  <data key="d2">Also known as the windpipe, it is the airway that splits into two bronchi.&lt;SEP&gt;The trachea, or windpipe, is the airway that carries air from the throat and splits into the bronchi.&lt;SEP&gt;The windpipe, which splits into two bronchi that connect to the lungs.&lt;SEP&gt;The windpipe, which splits into two bronchi to carry air into the lungs.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249673</data>
  <data key="d6"></data>
</node>
<node id="Bronchi">
  <data key="d0">Bronchi</data>
  <data key="d1">concept</data>
  <data key="d2">The two airways that branch from the trachea and lead into the lungs.&lt;SEP&gt;The bronchi are the two main airways that split from the windpipe and lead into the lungs.&lt;SEP&gt;Two large breathing tubes that connect the windpipe (trachea) to the lungs, one for each lung.&lt;SEP&gt;The two main airways that branch from the trachea into the lungs.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249673</data>
  <data key="d6"></data>
</node>
<node id="Bronchioli">
  <data key="d0">Bronchioli</data>
  <data key="d1">concept</data>
  <data key="d2">The smaller airways inside the lung that branch from the bronchi.&lt;SEP&gt;Bronchioli are smaller airways inside the lungs that branch off from the bronchi.&lt;SEP&gt;Smaller airways that branch from the bronchi inside the lungs.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249676</data>
  <data key="d6"></data>
</node>
<node id="Alveoli">
  <data key="d0">Alveoli</data>
  <data key="d1">concept</data>
  <data key="d2">Sacs at the end of the bronchioli where oxygen is transferred from air into the blood.&lt;SEP&gt;Alveoli are sacs at the end of the bronchioli where oxygen is transferred from air into the blood.&lt;SEP&gt;Small air sacs at the end of the bronchioles where oxygen is transferred into the blood.&lt;SEP&gt;Alveoli are part of the airways of the lungs where lung cancer can start.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249676</data>
  <data key="d6"></data>
</node>
<node id="Non-Small Cell Lung Cancer">
  <data key="d0">Non-Small Cell Lung Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A type of lung cancer that forms from lung cells and includes subtypes like adenocarcinoma, large cell carcinoma, and squamous cell carcinoma.&lt;SEP&gt;The most common type of lung cancer, which includes subtypes like adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.&lt;SEP&gt;Non-small cell lung cancer is the most common type of lung cancer, with subtypes including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249679</data>
  <data key="d6"></data>
</node>
<node id="Adenocarcinoma">
  <data key="d0">Adenocarcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">A common type of NSCLC that often forms from cells lining the alveoli that make mucus.&lt;SEP&gt;A subtype of non-small cell lung cancer that starts in mucus-making cells lining the alveoli; the most common type in non-smokers.&lt;SEP&gt;Adenocarcinoma is a subtype of non-small cell lung cancer.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249679</data>
  <data key="d6"></data>
</node>
<node id="Large Cell Carcinoma">
  <data key="d0">Large Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">A type of NSCLC that forms from large cells found throughout the airways.&lt;SEP&gt;A subtype of non-small cell lung cancer that starts in large cells and can grow anywhere in the lungs.&lt;SEP&gt;Large cell carcinoma is an undifferentiated type of non-small cell lung cancer that can grow anywhere in the lungs, accounting for 5 out of 10 NSCLCs.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249681</data>
  <data key="d6"></data>
</node>
<node id="Squamous Cell Carcinoma">
  <data key="d0">Squamous Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous Cell Carcinoma (CSCC) is a type of skin cancer that can form in scars, chronic wounds, or from actinic keratoses, and is more difficult to treat in damaged skin.&lt;SEP&gt;A type of NSCLC that forms from cells that line the bronchi.&lt;SEP&gt;A subtype of non-small cell lung cancer that starts in flat cells lining the inside of the bronchi.&lt;SEP&gt;Squamous cell carcinoma is a subtype of non-small cell lung cancer, accounting for about 3 out of 10 lung cancers.&lt;SEP&gt;Squamous Cell Carcinoma (SCC) is the most common type of mouth cancer, originating in the thin, flat squamous cells that form the surface lining of the mouth.&lt;SEP&gt;Squamous cell carcinoma is the most common type of mouth cancer, forming in the thin, flat cells of the mucous membranes of the mouth.&lt;SEP&gt;Squamous cell carcinoma (SCC) is a type of cancer that starts in the squamous cells of the epithelium, specifically mentioned in the context of mouth cancer.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249683</data>
  <data key="d6"></data>
</node>
<node id="Early And Locally Advanced NSCLC">
  <data key="d0">Early And Locally Advanced NSCLC</data>
  <data key="d1">concept</data>
  <data key="d2">Lung cancers that have not spread to the tissue lining around the lung or to other organs, encompassing stages 1, 2, and 3.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249683</data>
  <data key="d6"></data>
</node>
<node id="Cancer Stage">
  <data key="d0">Cancer Stage</data>
  <data key="d1">concept</data>
  <data key="d2">A description of the extent of lung cancer in the body, typically written with Roman numerals I, II, III, and IV.&lt;SEP&gt;Cancer stage is a classification determined from test results, such as imaging and biopsy, which directly informs the treatment plan.&lt;SEP&gt;Cancer stage describes categories of where the cancer has or hasn't spread from the ovary.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249687</data>
  <data key="d6"></data>
</node>
<node id="Stage 1 Cancer">
  <data key="d0">Stage 1 Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Early NSCLC where cancer has grown from the airway into lung tissue.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249687</data>
  <data key="d6"></data>
</node>
<node id="Stage 2 Cancer">
  <data key="d0">Stage 2 Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Locally advanced NSCLC where cancer has grown and may have spread to nearby lymph nodes.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249689</data>
  <data key="d6"></data>
</node>
<node id="Lymph Nodes">
  <data key="d0">Lymph Nodes</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Lymph nodes are small, bean-shaped structures that are a key component of the immune and lymphatic systems. Their primary function is to filter lymphatic fluid, trapping foreign particles, infectious agents, and harmful cells such as cancer cells. They contain high concentrations of disease-fighting cells, particularly lymphocytes, to combat infection and disease.

These structures are distributed throughout the body but are found in high concentrations in specific regions, including the neck, underarms (armpits), groin, and within the head and neck. Clinically, lymph nodes are assessed for signs of disease through physical examination, where enlargement may be detected, and via imaging studies like CT scans. Enlargement often indicates an immune response or the spread of disease.

In the context of cancer, lymph nodes are critical sites for regional metastasis. Their involvement is a major factor in cancer staging and influences treatment decisions. Specific cancers noted to spread to lymph nodes include squamous cell skin cancer, non-small cell lung cancer (NSCLC), esophageal cancer, throat cancer, ovarian cancer, and leukemia (which can spread outside the bloodstream to nodes). During cancer surgery, such as for ovarian cancer, lymph nodes are sometimes removed for therapeutic or diagnostic purposes.</data>
  <data key="d3">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249689</data>
  <data key="d6"></data>
</node>
<node id="Stage 3 Cancer">
  <data key="d0">Stage 3 Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Locally advanced NSCLC where cancer has grown and may have spread to nearby lymph nodes.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249689</data>
  <data key="d6"></data>
</node>
<node id="Metastatic Cancer">
  <data key="d0">Metastatic Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer that has spread to the tissue lining around the lung or to other organs, referred to as stage 4 at diagnosis.&lt;SEP&gt;Metastatic cancer refers to esophageal cancer that has spread to distant body parts like the liver, lungs, or brain.&lt;SEP&gt;Metastatic cancer is a type of cancer that has spread from its original site to other parts of the body, such as the lung and distant lymph nodes, and may be referred to as very advanced disease.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249689</data>
  <data key="d6"></data>
</node>
<node id="Treatment For NSCLC">
  <data key="d0">Treatment For NSCLC</data>
  <data key="d1">concept</data>
  <data key="d2">The therapeutic approach for NSCLC, which varies per individual and can include surgery, radiation therapy, or chemoradiation.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249695</data>
  <data key="d6"></data>
</node>
<node id="Chemoradiation">
  <data key="d0">Chemoradiation</data>
  <data key="d1">method</data>
  <data key="d2">A cancer treatment combining two types of therapies, discussed in a dedicated chapter.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249699</data>
  <data key="d6"></data>
</node>
<node id="Supportive Care">
  <data key="d0">Supportive Care</data>
  <data key="d1">concept</data>
  <data key="d2">Care that addresses the challenges of cancer, shown to extend and enhance life for people with lung cancer.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249699</data>
  <data key="d6"></data>
</node>
<node id="Clinical Trials">
  <data key="d0">Clinical Trials</data>
  <data key="d1">event</data>
  <data key="d2">A type of health research that tests new ways of fighting cancer, offering hope to people with lung cancer.&lt;SEP&gt;Clinical trials study the safety and effectiveness of investigational treatments and are an option in ovarian cancer treatment plans.&lt;SEP&gt;Clinical trials are research studies that patients may join based on the results of biomarker testing.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249701</data>
  <data key="d6"></data>
</node>
<node id="Lung Nodules">
  <data key="d0">Lung Nodules</data>
  <data key="d1">concept</data>
  <data key="d2">Small masses of tissue in the lungs that may be found by chance and can be caused by cancer, infections, or scar tissue.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249701</data>
  <data key="d6"></data>
</node>
<node id="Pulmonologist">
  <data key="d0">Pulmonologist</data>
  <data key="d1">person</data>
  <data key="d2">A board-certified doctor who is an expert in lung diseases.&lt;SEP&gt;A doctor who is an expert in lung diseases and is part of a patient's care team.&lt;SEP&gt;A board-certified expert specializing in lung diseases, part of a cancer assessment team.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249703</data>
  <data key="d6"></data>
</node>
<node id="Thoracic Radiologist">
  <data key="d0">Thoracic Radiologist</data>
  <data key="d1">person</data>
  <data key="d2">A board-certified doctor who is an expert in imaging of the chest.&lt;SEP&gt;A doctor who is an expert in imaging of the chest, which involves taking pictures of the inside of the body.&lt;SEP&gt;A board-certified expert specializing in imaging of the chest, part of a cancer assessment team.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249703</data>
  <data key="d6"></data>
</node>
<node id="Thoracic Surgeon">
  <data key="d0">Thoracic Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A board-certified doctor who is an expert in operations within the chest.&lt;SEP&gt;A doctor who is an expert in operations within the chest.&lt;SEP&gt;A board-certified expert who performs surgery on chest organs, part of a cancer assessment team.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249704</data>
  <data key="d6"></data>
</node>
<node id="NCCN.org/patientguidelines">
  <data key="d0">NCCN.org/patientguidelines</data>
  <data key="d1">content</data>
  <data key="d2">NCCN.org/patientguidelines is a website providing information on side effects of immune checkpoint inhibitors and managing nausea.&lt;SEP&gt;A website providing patient guidelines for cancer, including information on NSCLC.&lt;SEP&gt;A website providing information on lung cancer screening and patient guidelines.&lt;SEP&gt;NCCN.org/patientguidelines is a website where information on lung neuroendocrine tumors can be found.&lt;SEP&gt;NCCN.org/patientguidelines is a website providing information on Hodgkin lymphoma in children and adolescents.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249705</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines For Patients Early And Locally Advanced Non-Small Cell Lung Cancer 2024">
  <data key="d0">NCCN Guidelines For Patients Early And Locally Advanced Non-Small Cell Lung Cancer 2024</data>
  <data key="d1">content</data>
  <data key="d2">A specific set of patient guidelines for early and locally advanced non-small cell lung cancer published in 2024.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249712</data>
  <data key="d6"></data>
</node>
<node id="Stomach Cancer">
  <data key="d0">Stomach Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">An example of a cancer that, if it spreads to the lungs, is not considered lung cancer.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249712</data>
  <data key="d6"></data>
</node>
<node id="Imaging">
  <data key="d0">Imaging</data>
  <data key="d1">method</data>
  <data key="d2">Imaging refers to tests like CT or MRI scans used to diagnose conditions, including finding adrenal tumors incidentally or as part of cancer staging.&lt;SEP&gt;A method that takes pictures of the inside of the body, used by thoracic radiologists.&lt;SEP&gt;Imaging tests are ordered as needed during chemotherapy to monitor how well the treatment is working.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249712</data>
  <data key="d6"></data>
</node>
<node id="Radiation Therapy">
  <data key="d0">Radiation Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Radiation therapy is a cancer treatment that uses beams of intense energy, such as electrons, photons, or protons, to kill cancer cells. It is a standard treatment option for various skin cancers, including basal cell carcinoma and cutaneous squamous cell carcinoma (CSCC). Its primary use is in cases where surgery is not possible, for patients who are not surgical candidates, or as an adjuvant follow-up treatment after surgery to eliminate any remaining cancer cells and decrease the chance of tumor recurrence.

The treatment is typically administered in daily sessions over a period of several weeks. For advanced CSCC that cannot be surgically removed, radiation therapy may be combined with systemic therapy. It is also a recommended option for early-stage cancers. A notable specific application is radiation therapy to the head and neck region, which can have side effects affecting endocrine glands and hearing.

Paradoxically, while it is a treatment, radiation therapy itself is also identified as a risk factor for developing certain cancers, particularly basal cell carcinoma, especially when received at a young age.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249713</data>
  <data key="d6"></data>
</node>
<node id="General Anesthesia">
  <data key="d0">General Anesthesia</data>
  <data key="d1">method</data>
  <data key="d2">A state of deep sleep induced for medical procedures, such as extensive skin surgery or sentinel lymph node biopsy.&lt;SEP&gt;General anesthesia is medicine given to put a patient into a deep sleep so they won't feel pain during surgery.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249713</data>
  <data key="d6"></data>
</node>
<node id="Surgeon">
  <data key="d0">Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A doctor who performs surgical procedures, such as injecting substances to locate sentinel lymph nodes and removing them.&lt;SEP&gt;A surgeon is a medical professional who performs procedures like sentinel lymph node biopsy and various excisions to treat CSCC.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249714</data>
  <data key="d6"></data>
</node>
<node id="Secondary Intention Healing">
  <data key="d0">Secondary Intention Healing</data>
  <data key="d1">method</data>
  <data key="d2">A wound healing process where the wound is left open to fill in and close naturally, often requiring regular dressings for several weeks.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249719</data>
  <data key="d6"></data>
</node>
<node id="Linear Closure">
  <data key="d0">Linear Closure</data>
  <data key="d1">method</data>
  <data key="d2">A wound healing technique where a surgeon reshapes a circular wound into a fusiform (oval) shape to stitch it together in a line.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249720</data>
  <data key="d6"></data>
</node>
<node id="Skin Graft">
  <data key="d0">Skin Graft</data>
  <data key="d1">method</data>
  <data key="d2">A surgical procedure where a patch of skin is removed from one area of the body and transplanted to another to aid wound healing and reduce scarring.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249721</data>
  <data key="d6"></data>
</node>
<node id="Radiation Oncologist">
  <data key="d0">Radiation Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">A radiation oncologist is a doctor trained to use different types of radiation therapy to treat cancer.&lt;SEP&gt;A doctor who is an expert in administering radiation treatment for cancer.&lt;SEP&gt;A board-certified expert specializing in cancer treatment with radiation, part of a cancer assessment team.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249721</data>
  <data key="d6"></data>
</node>
<node id="External Beam Radiation Therapy">
  <data key="d0">External Beam Radiation Therapy</data>
  <data key="d1">method</data>
  <data key="d2">A type of radiation therapy where a beam of radiation is directed at a tumor from a machine, commonly using electrons for superficial tumors or photons for deeper tumors.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249721</data>
  <data key="d6"></data>
</node>
<node id="Brachytherapy">
  <data key="d0">Brachytherapy</data>
  <data key="d1">method</data>
  <data key="d2">A type of radiation therapy where a radiation source is placed close to or in direct contact with a tumor for a short period.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249722</data>
  <data key="d6"></data>
</node>
<node id="Adjuvant Therapy">
  <data key="d0">Adjuvant Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Treatment given after primary cancer therapy to lower the risk of cancer recurrence, such as radiation used after surgery.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249723</data>
  <data key="d6"></data>
</node>
<node id="Basal Cell Nevus Syndrome">
  <data key="d0">Basal Cell Nevus Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">A genetic condition that puts individuals at a higher risk of skin cancer caused by radiation, making radiation therapy unsuitable.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249728</data>
  <data key="d6"></data>
</node>
<node id="Xeroderma Pigmentosum">
  <data key="d0">Xeroderma Pigmentosum</data>
  <data key="d1">concept</data>
  <data key="d2">Xeroderma Pigmentosum (XP) is a genetic condition where the body cannot repair DNA damage from sunlight, leading to a high risk of skin cancer.&lt;SEP&gt;A genetic condition that increases the risk of skin cancer from radiation, contraindicating the use of radiation therapy.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249728</data>
  <data key="d6"></data>
</node>
<node id="NCCN Patient Guides For Cancer App">
  <data key="d0">NCCN Patient Guides For Cancer App</data>
  <data key="d1">artifact</data>
  <data key="d2">The NCCN Patient Guides for Cancer App is a mobile application and digital platform that provides patient guidelines for a wide variety of cancers. It offers comprehensive information based on clinical guidelines, covering numerous specific cancer types and related topics. These include non-small cell lung cancer (NSCLC), lung cancer screening, and Hodgkin lymphoma in children and adolescents. The app also addresses supportive care subjects, such as fertility preservation for cancer patients. Its primary function is to serve as a centralized, accessible resource for patients seeking reliable, guideline-based information on cancer diagnosis, treatment, and management.</data>
  <data key="d3">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249728</data>
  <data key="d6"></data>
</node>
<node id="Lupus">
  <data key="d0">Lupus</data>
  <data key="d1">concept</data>
  <data key="d2">A connective tissue disease for which radiation therapy may not be an appropriate treatment option.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249729</data>
  <data key="d6"></data>
</node>
<node id="Scleroderma">
  <data key="d0">Scleroderma</data>
  <data key="d1">concept</data>
  <data key="d2">A connective tissue disease that may make radiation therapy an inappropriate treatment choice.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249729</data>
  <data key="d6"></data>
</node>
<node id="Cutaneous Squamous Cell Carcinoma">
  <data key="d0">Cutaneous Squamous Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">An alternative name for squamous cell skin cancer, specifically referring to cancer that starts in squamous cells of the skin.&lt;SEP&gt;A type of skin cancer for which treatments like surgery, radiation therapy, and systemic therapy are discussed.&lt;SEP&gt;Cutaneous squamous cell carcinoma of the vermilion lip is a type of skin cancer at the junction of the skin and lip, not included in the primary discussion of mouth cancer.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249729</data>
  <data key="d6"></data>
</node>
<node id="Sentinel Lymph Node">
  <data key="d0">Sentinel Lymph Node</data>
  <data key="d1">concept</data>
  <data key="d2">The first lymph node to which cancer cells most likely spread from a primary tumor; sometimes there is more than one.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249732</data>
  <data key="d6"></data>
</node>
<node id="Wound">
  <data key="d0">Wound</data>
  <data key="d1">concept</data>
  <data key="d2">An injury to the skin created by surgery, which can heal by secondary intention, linear closure, or require skin grafts.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249735</data>
  <data key="d6"></data>
</node>
<node id="Scar">
  <data key="d0">Scar</data>
  <data key="d1">concept</data>
  <data key="d2">A mark left on the skin after a wound has healed; scar treatment and aftercare are often recommended post-surgery.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249735</data>
  <data key="d6"></data>
</node>
<node id="Electrons">
  <data key="d0">Electrons</data>
  <data key="d1">concept</data>
  <data key="d2">A type of radiation beam used in External Beam Radiation Therapy to treat superficial tumors.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249735</data>
  <data key="d6"></data>
</node>
<node id="Photons">
  <data key="d0">Photons</data>
  <data key="d1">concept</data>
  <data key="d2">A type of radiation beam (high-energy x-rays) used in External Beam Radiation Therapy to treat deeper, more invasive tumors.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249736</data>
  <data key="d6"></data>
</node>
<node id="Protons">
  <data key="d0">Protons</data>
  <data key="d1">concept</data>
  <data key="d2">Charged particles that can be used as a beam of intense energy in Radiation Therapy to kill cancer cells.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249736</data>
  <data key="d6"></data>
</node>
<node id="Recurrence">
  <data key="d0">Recurrence</data>
  <data key="d1">concept</data>
  <data key="d2">Recurrence refers to basal cell skin cancer returning to its original location or metastasizing to lymph nodes or distant body parts.&lt;SEP&gt;The return of cancer after treatment; adjuvant therapy aims to lower the risk of recurrence.&lt;SEP&gt;Recurrence is the return of cancer after treatment, also known as a relapse, which may present with specific symptoms.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249736</data>
  <data key="d6"></data>
</node>
<node id="Skin Redness">
  <data key="d0">Skin Redness</data>
  <data key="d1">concept</data>
  <data key="d2">A common short-term side effect of Radiation Therapy.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249737</data>
  <data key="d6"></data>
</node>
<node id="Non-Healing Ulcer">
  <data key="d0">Non-Healing Ulcer</data>
  <data key="d1">concept</data>
  <data key="d2">A potential serious long-term side effect of Radiation Therapy.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249739</data>
  <data key="d6"></data>
</node>
<node id="Second Cancer">
  <data key="d0">Second Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A rare potential long-term risk of Radiation Therapy where a new cancer develops in the treated area.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249740</data>
  <data key="d6"></data>
</node>
<node id="PET/MRI">
  <data key="d0">PET/MRI</data>
  <data key="d1">method</data>
  <data key="d2">A combined medical imaging method considered more accurate than individual scans for locating cancer cells.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249740</data>
  <data key="d6"></data>
</node>
<node id="FDG-PET Scan">
  <data key="d0">FDG-PET Scan</data>
  <data key="d1">method</data>
  <data key="d2">A type of PET scan that uses a radioactive sugar tracer to identify active cancer cells based on their faster sugar consumption.&lt;SEP&gt;A type of PET scan using a radioactive sugar tracer to identify active cancer cells, which appear brighter in images.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249741</data>
  <data key="d6"></data>
</node>
<node id="SSTR-PET Scan">
  <data key="d0">SSTR-PET Scan</data>
  <data key="d1">method</data>
  <data key="d2">A type of PET scan using a tracer that binds to somatostatin receptors on cells, helpful for imaging certain tumors.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249741</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Tumor">
  <data key="d0">Adrenal Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A tumor located in the adrenal glands, which may not be fast-growing and can be evaluated with specific PET scans.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249742</data>
  <data key="d6"></data>
</node>
<node id="Neuroendocrine Tumor">
  <data key="d0">Neuroendocrine Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A type of tumor that can become more aggressive, assessed using FDG-PET scans.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249742</data>
  <data key="d6"></data>
</node>
<node id="Somatostatin Receptor">
  <data key="d0">Somatostatin Receptor</data>
  <data key="d1">concept</data>
  <data key="d2">A protein on cell surfaces that binds to the hormone somatostatin, targeted by SSTR-PET scan tracers.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249742</data>
  <data key="d6"></data>
</node>
<node id="Biochemical Tests">
  <data key="d0">Biochemical Tests</data>
  <data key="d1">method</data>
  <data key="d2">Tests measuring hormones in blood, urine, or saliva to diagnose adrenal tumors or related syndromes.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249743</data>
  <data key="d6"></data>
</node>
<node id="Systemic Therapy">
  <data key="d0">Systemic Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Systemic therapy is a broad category of medical treatment, primarily for cancer, that involves medications which travel through the bloodstream to affect cells throughout the entire body. It is administered intravenously or orally, often by oncology nurses. This approach is distinct from localized treatments like surgery or radiation.

The primary forms of systemic therapy are chemotherapy, targeted therapy, and immunotherapy. Its use is indicated in several scenarios: when cancer has spread (metastasized), when surgery cannot remove all of the cancer, or when surgery and radiation are not viable options. It is frequently used in combination with other treatments; for example, it can be employed alongside or after radiation therapy, particularly in high-risk cases following surgery.

Systemic therapy is applied to a wide range of cancers. Specific examples from the descriptions include basal cell skin cancer, cutaneous squamous cell carcinoma (CSCC), and acute myeloid leukemia (AML). For CSCC, it may involve immunotherapy or chemotherapy, either with radiation or alone when surgery is insufficient.</data>
  <data key="d3">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249743</data>
  <data key="d6"></data>
</node>
<node id="Basal Cell Carcinoma">
  <data key="d0">Basal Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">The most common type of skin cancer, often grouped with squamous cell skin cancers as nonmelanoma skin cancers.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249744</data>
  <data key="d6"></data>
</node>
<node id="Melanoma">
  <data key="d0">Melanoma</data>
  <data key="d1">concept</data>
  <data key="d2">A less common but more aggressive type of skin cancer, distinct from nonmelanoma skin cancers.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249747</data>
  <data key="d6"></data>
</node>
<node id="Keratinocyte Carcinoma">
  <data key="d0">Keratinocyte Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">An alternative term for nonmelanoma skin cancers, including basal cell and squamous cell skin cancers.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249747</data>
  <data key="d6"></data>
</node>
<node id="Epidermis">
  <data key="d0">Epidermis</data>
  <data key="d1">concept</data>
  <data key="d2">The epidermis is the top layer of skin, providing a waterproof barrier and creating skin color; it contains basal cells, squamous cells, and melanocytes, and is where most skin cancers form.&lt;SEP&gt;The outermost layer of skin, containing squamous cells, basal cells, and melanocytes, where skin cancers often form.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249747</data>
  <data key="d6"></data>
</node>
<node id="Squamous Cells">
  <data key="d0">Squamous Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cells are flat cells found in the upper part of the epidermis.&lt;SEP&gt;Thin, flat cells in the epidermis that form the skin's surface and can become cancerous.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249749</data>
  <data key="d6"></data>
</node>
<node id="Basal Cells">
  <data key="d0">Basal Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Basal cells are found in the lower part of the epidermis and constantly divide to form new cells that replace squamous cells on the skin's surface; they can become abnormal and cause basal cell skin cancer.&lt;SEP&gt;Cells in the lower epidermis that divide to replace squamous cells and can lead to basal cell carcinoma.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249749</data>
  <data key="d6"></data>
</node>
<node id="Melanocytes">
  <data key="d0">Melanocytes</data>
  <data key="d1">concept</data>
  <data key="d2">Melanocytes are cells located in the lower part of the epidermis that produce melanin, which gives color to hair, skin, and eyes and protects skin from UV rays.&lt;SEP&gt;Cells in the epidermis that produce melanin, providing skin color and protection from UV rays.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249751</data>
  <data key="d6"></data>
</node>
<node id="Ultraviolet Rays">
  <data key="d0">Ultraviolet Rays</data>
  <data key="d1">concept</data>
  <data key="d2">Harmful rays from the sun that can damage skin and increase the risk of skin cancer.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249751</data>
  <data key="d6"></data>
</node>
<node id="Indoor Tanning">
  <data key="d0">Indoor Tanning</data>
  <data key="d1">concept</data>
  <data key="d2">The use of tanning machines, a major risk factor for developing squamous cell skin cancer.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249752</data>
  <data key="d6"></data>
</node>
<node id="Environmental Toxins">
  <data key="d0">Environmental Toxins</data>
  <data key="d1">concept</data>
  <data key="d2">Pollutants like tobacco smoke, vehicle exhaust, and arsenic that can cause skin damage leading to squamous cell carcinoma.&lt;SEP&gt;Environmental toxins are pollutants like tobacco smoke, vehicle exhaust, and arsenic that can cause skin damage leading to Squamous Cell Carcinoma.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249752</data>
  <data key="d6"></data>
</node>
<node id="Marjolin Ulcer">
  <data key="d0">Marjolin Ulcer</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell carcinoma that forms in scars or chronic wounds such as ulcers and burns.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249752</data>
  <data key="d6"></data>
</node>
<node id="Dermis">
  <data key="d0">Dermis</data>
  <data key="d1">concept</data>
  <data key="d2">The dermis is the middle layer of skin, containing connective tissue, blood vessels, oil and sweat glands, nerves, and hair follicles.&lt;SEP&gt;The middle layer of skin containing connective tissue, hair follicles, and sweat glands.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249753</data>
  <data key="d6"></data>
</node>
<node id="Hypodermis">
  <data key="d0">Hypodermis</data>
  <data key="d1">concept</data>
  <data key="d2">The hypodermis is the deepest tissue layer of the skin, made up of fat and connective tissue.&lt;SEP&gt;The deepest layer of skin, made up of fat and connective tissue, also known as the subcutis.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249754</data>
  <data key="d6"></data>
</node>
<node id="Melanin">
  <data key="d0">Melanin</data>
  <data key="d1">concept</data>
  <data key="d2">Melanin is a pigment produced by melanocytes that is responsible for hair, skin, and eye color and protects skin from harmful ultraviolet (UV) rays.&lt;SEP&gt;A pigment produced by melanocytes responsible for skin, hair, and eye color, and which protects skin from UV rays.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249754</data>
  <data key="d6"></data>
</node>
<node id="18-Fluorodeoxyglucose">
  <data key="d0">18-Fluorodeoxyglucose</data>
  <data key="d1">concept</data>
  <data key="d2">A radioactive type of sugar used as the tracer in an FDG-PET scan.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249755</data>
  <data key="d6"></data>
</node>
<node id="Somatostatin">
  <data key="d0">Somatostatin</data>
  <data key="d1">concept</data>
  <data key="d2">A hormone that helps control other hormones in the body and binds to somatostatin receptors.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249755</data>
  <data key="d6"></data>
</node>
<node id="Guide 1 Biochemical Tests">
  <data key="d0">Guide 1 Biochemical Tests</data>
  <data key="d1">content</data>
  <data key="d2">A reference guide providing more information on biochemical tests for adrenal tumors.</data>
  <data key="d3">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249756</data>
  <data key="d6"></data>
</node>
<node id="Esophagus">
  <data key="d0">Esophagus</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The esophagus is a muscular tube connecting the throat to the stomach, composed of striated and smooth muscle layers.&lt;SEP&gt;A long, muscular tube that transports food from the throat to the stomach, part of the digestive system.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249756</data>
  <data key="d6"></data>
</node>
<node id="Tunica Adventitia">
  <data key="d0">Tunica Adventitia</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The tunica adventitia is the outermost connective tissue layer of the esophagus wall.&lt;SEP&gt;The outermost layer of the esophagus wall, made of connective tissue.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249758</data>
  <data key="d6"></data>
</node>
<node id="Striated Muscle">
  <data key="d0">Striated Muscle</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Striated muscle is a type of muscle found in the upper esophagus that generates force and is under voluntary control.&lt;SEP&gt;Voluntary muscle that generates force, found in the upper part of the esophagus.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249758</data>
  <data key="d6"></data>
</node>
<node id="Smooth Muscle">
  <data key="d0">Smooth Muscle</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Smooth muscle is a type of involuntary muscle found in the lower esophagus and parts of the middle esophagus.&lt;SEP&gt;Involuntary muscle, found in the lower part of the esophagus and mixed in the middle.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249759</data>
  <data key="d6"></data>
</node>
<node id="Esophagogastric Junction">
  <data key="d0">Esophagogastric Junction</data>
  <data key="d1">location</data>
  <data key="d2">The esophagogastric junction is the anatomical location where the esophagus meets the stomach, situated beneath the diaphragm.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249759</data>
  <data key="d6"></data>
</node>
<node id="Esophageal Cancer">
  <data key="d0">Esophageal Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Esophageal cancer is a disease where cells in the esophageal epithelium grow uncontrollably, with main types being squamous cell carcinoma and adenocarcinoma.&lt;SEP&gt;Cancer that starts when abnormal cells grow out of control in the inner lining of the esophagus.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249760</data>
  <data key="d6"></data>
</node>
<node id="Esophageal Squamous Cell Carcinoma">
  <data key="d0">Esophageal Squamous Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Esophageal squamous cell carcinoma is a type of cancer that starts in the squamous cells lining the inner esophagus, common in the upper and middle regions.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249760</data>
  <data key="d6"></data>
</node>
<node id="Esophageal Adenocarcinoma">
  <data key="d0">Esophageal Adenocarcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Esophageal adenocarcinoma is a type of cancer that starts in the mucus-making cells of the esophageal lining, often found in the lower esophagus.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249761</data>
  <data key="d6"></data>
</node>
<node id="Barrett Esophagus">
  <data key="d0">Barrett Esophagus</data>
  <data key="d1">concept</data>
  <data key="d2">Barrett esophagus is a condition where squamous cells in the lower esophagus are replaced by abnormal cells due to chronic reflux, increasing adenocarcinoma risk.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249761</data>
  <data key="d6"></data>
</node>
<node id="Mucosa">
  <data key="d0">Mucosa</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The mucosa is the innermost layer of the esophagus wall where cancer typically begins.&lt;SEP&gt;The inner membrane layer of the esophagus wall that is in contact with food.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249762</data>
  <data key="d6"></data>
</node>
<node id="Submucosa">
  <data key="d0">Submucosa</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The submucosa is a layer of the esophagus wall located beneath the mucosa.&lt;SEP&gt;A layer of connective tissue below the mucosa containing blood vessels, nerves, and lymphatic vessels.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249762</data>
  <data key="d6"></data>
</node>
<node id="Muscularis Propria">
  <data key="d0">Muscularis Propria</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The muscularis propria is a muscle layer within the esophagus wall.&lt;SEP&gt;A thick layer of muscle under the submucosa that contracts to push food down the esophagus.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249763</data>
  <data key="d6"></data>
</node>
<node id="Early-Stage Cancer">
  <data key="d0">Early-Stage Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Early-stage esophageal cancer is confined to the inner esophagus, often small and not involving lymph nodes.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249763</data>
  <data key="d6"></data>
</node>
<node id="Locoregional Cancer">
  <data key="d0">Locoregional Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Locoregional or locally advanced esophageal cancer has invaded the esophageal wall and/or spread to nearby lymph nodes or organs.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249764</data>
  <data key="d6"></data>
</node>
<node id="Siewert Types">
  <data key="d0">Siewert Types</data>
  <data key="d1">concept</data>
  <data key="d2">Siewert types are a classification system used in cancer staging to describe tumor location relative to the esophagus and stomach.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249764</data>
  <data key="d6"></data>
</node>
<node id="Endoscopy">
  <data key="d0">Endoscopy</data>
  <data key="d1">method</data>
  <data key="d2">Endoscopy is a diagnostic procedure used to examine the esophagus and obtain tissue samples.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249765</data>
  <data key="d6"></data>
</node>
<node id="Gastroesophageal Junction">
  <data key="d0">Gastroesophageal Junction</data>
  <data key="d1">location</data>
  <data key="d2">The gastroesophageal junction is an alternative name for the esophagogastric junction, where the esophagus meets the stomach.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249766</data>
  <data key="d6"></data>
</node>
<node id="Diaphragm">
  <data key="d0">Diaphragm</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The diaphragm is a muscle located just above the esophagogastric junction.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249766</data>
  <data key="d6"></data>
</node>
<node id="North America">
  <data key="d0">North America</data>
  <data key="d1">location</data>
  <data key="d2">North America is a region where adenocarcinoma is the most common type of esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249767</data>
  <data key="d6"></data>
</node>
<node id="Western Europe">
  <data key="d0">Western Europe</data>
  <data key="d1">location</data>
  <data key="d2">Western Europe is a region where adenocarcinoma is the most common type of esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249767</data>
  <data key="d6"></data>
</node>
<node id="Eastern Europe">
  <data key="d0">Eastern Europe</data>
  <data key="d1">location</data>
  <data key="d2">Eastern Europe is a region where squamous cell carcinoma is a more common type of esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249768</data>
  <data key="d6"></data>
</node>
<node id="Asia">
  <data key="d0">Asia</data>
  <data key="d1">location</data>
  <data key="d2">Asia is a region where squamous cell carcinoma is a more common type of esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249768</data>
  <data key="d6"></data>
</node>
<node id="Africa">
  <data key="d0">Africa</data>
  <data key="d1">location</data>
  <data key="d2">Africa is a region where squamous cell carcinoma is a more common type of esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249769</data>
  <data key="d6"></data>
</node>
<node id="Liver">
  <data key="d0">Liver</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The liver is an organ to which esophageal cancer can spread.&lt;SEP&gt;An organ that is part of the digestive system.&lt;SEP&gt;An organ that makes or processes chemicals; its health is assessed by measuring these chemicals, with abnormal levels indicating poor function or blocked bile ducts.&lt;SEP&gt;The liver is a site where leukemia can spread outside the bloodstream.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249769</data>
  <data key="d6"></data>
</node>
<node id="Pancreas">
  <data key="d0">Pancreas</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The pancreas is an organ to which esophageal cancer can spread.&lt;SEP&gt;An organ that is part of the digestive system.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249769</data>
  <data key="d6"></data>
</node>
<node id="Lung">
  <data key="d0">Lung</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The lung is an organ to which esophageal cancer can spread.&lt;SEP&gt;The lung is an organ and a potential area of the body to which cancer can spread (metastasize).</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249770</data>
  <data key="d6"></data>
</node>
<node id="Spleen">
  <data key="d0">Spleen</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The Spleen is the largest organ of the lymphatic system, about 4 inches long, which makes lymphocytes and plays a role in blood filtration and storage.&lt;SEP&gt;The spleen is an organ to which esophageal cancer can spread.&lt;SEP&gt;The spleen is a site where leukemia can spread outside the bloodstream.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249770</data>
  <data key="d6"></data>
</node>
<node id="Bone">
  <data key="d0">Bone</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Bone is a tissue to which metastatic esophageal cancer can spread.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249772</data>
  <data key="d6"></data>
</node>
<node id="Brain">
  <data key="d0">Brain</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The brain is an organ to which metastatic esophageal cancer can spread.&lt;SEP&gt;The brain is an organ that can be scanned by CT or MRI and is rarely a site for leukemia spread.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249772</data>
  <data key="d6"></data>
</node>
<node id="Metric System">
  <data key="d0">Metric System</data>
  <data key="d1">concept</data>
  <data key="d2">The metric system is a measurement system used by healthcare teams to measure aspects of cancer treatment.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249773</data>
  <data key="d6"></data>
</node>
<node id="Nutritional Assessment">
  <data key="d0">Nutritional Assessment</data>
  <data key="d1">method</data>
  <data key="d2">Nutritional assessment is part of the diagnostic process for esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249773</data>
  <data key="d6"></data>
</node>
<node id="Genetic Risk Testing">
  <data key="d0">Genetic Risk Testing</data>
  <data key="d1">method</data>
  <data key="d2">Genetic risk testing is part of the diagnostic process for esophageal cancer.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249773</data>
  <data key="d6"></data>
</node>
<node id="Performance Status">
  <data key="d0">Performance Status</data>
  <data key="d1">concept</data>
  <data key="d2">Performance status is an assessment of a patient's general well-being and ability to carry out activities, used in cancer care.&lt;SEP&gt;Performance status is a measure of a person's general fitness and ability to perform daily self-care tasks, often rated using the ECOG scale, and is considered when choosing a treatment plan.&lt;SEP&gt;A person's general level of fitness and ability to perform daily tasks, rated using scales like ECOG or KPS to help choose a treatment plan.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249774</data>
  <data key="d6"></data>
</node>
<node id="Online Patient Portals">
  <data key="d0">Online Patient Portals</data>
  <data key="d1">method</data>
  <data key="d2">Digital platforms used by patients to view, download, or print their medical test results and other health records.&lt;SEP&gt;Digital platforms used to view test results and medical records, which can be downloaded or printed for a medical binder.&lt;SEP&gt;Online patient portals are a method for patients to access their test results.&lt;SEP&gt;Online patient portals are digital platforms that allow patients to access their medical information and communicate with their care team.&lt;SEP&gt;Online patient portals are digital tools that allow patients to access their medical test results.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249774</data>
  <data key="d6"></data>
</node>
<node id="Ovaries">
  <data key="d0">Ovaries</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The ovaries are part of the female reproductive system, producing eggs for sexual reproduction and connected to the fallopian tubes, uterus, cervix, and vagina.&lt;SEP&gt;The ovaries are a pair of grape-sized organs in the female reproductive system that produce eggs and hormones affecting breast growth, body shape, and the menstrual cycle.&lt;SEP&gt;The ovaries are the primary site of ovarian cancer and are removed during surgery for the disease.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249777</data>
  <data key="d6"></data>
</node>
<node id="Epithelium">
  <data key="d0">Epithelium</data>
  <data key="d1">concept</data>
  <data key="d2">The innermost lining of the mucosa, normally made of squamous cells.&lt;SEP&gt;The epithelium is the surface layer of the oral mucosa containing stratified squamous cells, which are thin, flat cells.&lt;SEP&gt;The epithelium is the surface layer of cells, such as the squamous cell layer that lines the inside of the mouth, where certain cancers originate.&lt;SEP&gt;The epithelium is the surface layer of tissue surrounding the ovaries, where most ovarian cancers are found.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249777</data>
  <data key="d6"></data>
</node>
<node id="Fallopian Tube">
  <data key="d0">Fallopian Tube</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The fallopian tube is a long, thin tube surrounding each ovary that catches and transports eggs to the uterus; ovarian cancer can also start here.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249779</data>
  <data key="d6"></data>
</node>
<node id="Biomarker Testing">
  <data key="d0">Biomarker Testing</data>
  <data key="d1">method</data>
  <data key="d2">Biomarker testing is a diagnostic method used in oncology to identify specific molecules, genes, proteins, or mutations associated with a patient's cancer. It analyzes tumor features, such as DNA mutations, to provide critical information for treatment planning. The primary purpose of this testing is to guide therapeutic decisions by identifying mutations that suggest specific treatment options, determine a patient's eligibility for clinical trials, and identify beneficial maintenance therapies.

While fundamentally applied across cancer types, biomarker testing is explicitly noted as part of the diagnostic and testing process for specific cancers, including ovarian cancer and throat cancer. For throat cancer, specific tests like p16 (HPV) testing are utilized. Overall, biomarker testing is a key procedure in personalized medicine, enabling treatment strategies tailored to the unique molecular characteristics of an individual's tumor.</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249780</data>
  <data key="d6"></data>
</node>
<node id="Uterus">
  <data key="d0">Uterus</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The uterus is part of the female reproductive system.&lt;SEP&gt;The uterus is an organ in the female reproductive system where a fetus grows during pregnancy and where unfertilized eggs lead to menstruation.&lt;SEP&gt;The uterus is an organ that is removed along with the ovaries and fallopian tubes during surgery for ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249780</data>
  <data key="d6"></data>
</node>
<node id="Cervix">
  <data key="d0">Cervix</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The cervix is part of the female reproductive system.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249780</data>
  <data key="d6"></data>
</node>
<node id="Vagina">
  <data key="d0">Vagina</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The vagina is part of the female reproductive system.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249783</data>
  <data key="d6"></data>
</node>
<node id="High-Grade Serous Carcinoma (HGSC)">
  <data key="d0">High-Grade Serous Carcinoma (HGSC)</data>
  <data key="d1">concept</data>
  <data key="d2">High-grade serous carcinoma is one of the most common forms of epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249783</data>
  <data key="d6"></data>
</node>
<node id="High-Grade Endometrioid Carcinoma">
  <data key="d0">High-Grade Endometrioid Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">High-grade endometrioid carcinoma is one of the most common forms of epithelial ovarian cancer.&lt;SEP&gt;High-grade endometrioid carcinoma is one of the most common types of ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249784</data>
  <data key="d6"></data>
</node>
<node id="Less Common Ovarian Cancers (LCOCs)">
  <data key="d0">Less Common Ovarian Cancers (LCOCs)</data>
  <data key="d1">concept</data>
  <data key="d2">Less common ovarian cancers are rare types that can start in the epithelium, supporting tissues, or reproductive cells of the ovary.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249784</data>
  <data key="d6"></data>
</node>
<node id="Low-Grade Serous Carcinoma">
  <data key="d0">Low-Grade Serous Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Low-grade serous carcinoma is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249785</data>
  <data key="d6"></data>
</node>
<node id="Low-Grade Endometrioid Carcinoma">
  <data key="d0">Low-Grade Endometrioid Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Low-grade endometrioid carcinoma is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249785</data>
  <data key="d6"></data>
</node>
<node id="Carcinosarcoma">
  <data key="d0">Carcinosarcoma</data>
  <data key="d1">concept</data>
  <data key="d2">Carcinosarcoma, also called malignant mixed Mullerian tumors, is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249785</data>
  <data key="d6"></data>
</node>
<node id="Clear Cell Carcinoma">
  <data key="d0">Clear Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Clear cell carcinoma is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249785</data>
  <data key="d6"></data>
</node>
<node id="Mucinous Carcinoma">
  <data key="d0">Mucinous Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Mucinous carcinoma is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249787</data>
  <data key="d6"></data>
</node>
<node id="Borderline Epithelial Tumor">
  <data key="d0">Borderline Epithelial Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">Borderline epithelial tumor, also called low malignant potential tumors, is a type of less common epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249787</data>
  <data key="d6"></data>
</node>
<node id="Malignant Sex-Cord Stromal Tumors">
  <data key="d0">Malignant Sex-Cord Stromal Tumors</data>
  <data key="d1">concept</data>
  <data key="d2">Malignant sex-cord stromal tumors are a type of less common non-epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249787</data>
  <data key="d6"></data>
</node>
<node id="Malignant Germ Cell Tumors">
  <data key="d0">Malignant Germ Cell Tumors</data>
  <data key="d1">concept</data>
  <data key="d2">Malignant germ cell tumors are a type of less common non-epithelial ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249787</data>
  <data key="d6"></data>
</node>
<node id="Primary Peritoneal Cancer">
  <data key="d0">Primary Peritoneal Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Primary peritoneal cancer forms in the tissue lining the abdominal wall and covering abdominal organs; treatment information for ovarian cancer applies to it.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249788</data>
  <data key="d6"></data>
</node>
<node id="Fallopian Tube Cancer">
  <data key="d0">Fallopian Tube Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Fallopian tube cancer is a type of cancer; treatment information for ovarian cancer applies to it.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249789</data>
  <data key="d6"></data>
</node>
<node id="Cancer Grade">
  <data key="d0">Cancer Grade</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer grade is a rating of how abnormal cancer cells look under a microscope, indicating how quickly the cancer grows and spreads.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249789</data>
  <data key="d6"></data>
</node>
<node id="Gynecologic Oncologist">
  <data key="d0">Gynecologic Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">A gynecologic oncologist is a doctor expert in surgery and chemotherapy for gynecologic cancers and should perform the initial surgery for ovarian cancer.&lt;SEP&gt;A gynecologic oncologist is a surgeon expert in cancers of the female reproductive organs who performs ovarian cancer surgery.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249789</data>
  <data key="d6"></data>
</node>
<node id="Medical Oncologist">
  <data key="d0">Medical Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">A medical oncologist is a doctor who specializes in prescribing cancer-treatment drugs, such as chemotherapy, administered orally, by injection, or intravenously.&lt;SEP&gt;A board-certified expert specializing in cancer treatment with medication, part of a cancer assessment team.&lt;SEP&gt;A medical oncologist treats cancer using systemic drug therapy.&lt;SEP&gt;A medical oncologist is a doctor expert in treating cancer with chemotherapy and other medicines.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249791</data>
  <data key="d6"></data>
</node>
<node id="Treatment Plan">
  <data key="d0">Treatment Plan</data>
  <data key="d1">concept</data>
  <data key="d2">A treatment plan is developed based on the diagnosis of basal cell skin cancer and determines the course of medical care.&lt;SEP&gt;A treatment plan is a structured course of action designed to manage a patient's health condition.&lt;SEP&gt;The treatment plan is developed based on test results, including imaging studies and biopsy findings, and is specific to the cancer stage and tumor location.&lt;SEP&gt;A treatment plan is a course of action for cancer care that may be determined by results from imaging studies and biopsy.&lt;SEP&gt;A treatment plan for ovarian cancer is agreed upon by the patient and care team, noting the chosen treatment and possible side effects, and may change based on new information.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249791</data>
  <data key="d6"></data>
</node>
<node id="Abdominal And Pelvic Exam">
  <data key="d0">Abdominal And Pelvic Exam</data>
  <data key="d1">method</data>
  <data key="d2">An abdominal and pelvic exam is a testing method used to learn more about suspected ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249794</data>
  <data key="d6"></data>
</node>
<node id="Family History And Genetic Testing">
  <data key="d0">Family History And Genetic Testing</data>
  <data key="d1">method</data>
  <data key="d2">Family history and genetic testing are part of the testing process for ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249794</data>
  <data key="d6"></data>
</node>
<node id="Nutritional And Digestive Tract Health Assessment">
  <data key="d0">Nutritional And Digestive Tract Health Assessment</data>
  <data key="d1">method</data>
  <data key="d2">Assessment of nutritional and digestive tract health is part of the testing process for ovarian cancer.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249795</data>
  <data key="d6"></data>
</node>
<node id="Female Reproductive System">
  <data key="d0">Female Reproductive System</data>
  <data key="d1">concept</data>
  <data key="d2">The female reproductive system is a biological system that includes the ovaries, fallopian tubes, uterus, cervix, and vagina, responsible for reproduction.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249795</data>
  <data key="d6"></data>
</node>
<node id="Cancer Type">
  <data key="d0">Cancer Type</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer type refers to the specific classification of ovarian cancer, such as epithelial or non-epithelial, determined by a pathologist.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249795</data>
  <data key="d6"></data>
</node>
<node id="Primary Care Provider">
  <data key="d0">Primary Care Provider</data>
  <data key="d1">person</data>
  <data key="d2">A health professional who may be the first to suspect a patient has lung cancer.&lt;SEP&gt;A primary care provider is a doctor who helps manage a patient's other health conditions that may be affected by cancer treatment.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249795</data>
  <data key="d6"></data>
</node>
<node id="Symptoms">
  <data key="d0">Symptoms</data>
  <data key="d1">concept</data>
  <data key="d2">Symptoms are changes in the body caused by ovarian cancer, such as bloating, pelvic pain, and trouble eating, which may not appear until the tumor is large.</data>
  <data key="d3">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249796</data>
  <data key="d6"></data>
</node>
<node id="Cancer">
  <data key="d0">Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer refers to the disease being treated, specifically squamous cell skin cancer that can spread to lymph nodes and other body areas.&lt;SEP&gt;Cancer is a disease characterized by abnormal cell growth, with specific types including cancer in the base of the skull or carotid artery, and metastatic cancer that spreads to other body parts.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249796</data>
  <data key="d6"></data>
</node>
<node id="Tumor">
  <data key="d0">Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A tumor is a mass of tissue formed by cancer cells, with characteristics like location, size, shape, and grade used to assess risk.&lt;SEP&gt;A tumor is a mass of cancer cells that can be removed via surgery or targeted with other therapies.&lt;SEP&gt;A tumor is a mass of tissue formed by cancer cells that grow uncontrollably, do not die appropriately, and can invade other body parts.&lt;SEP&gt;Tumor refers to the primary cancer mass, which can be measured and is categorized by size and spread in cancer staging.&lt;SEP&gt;A tumor is an abnormal mass of tissue that can grow into nearby structures, with size measured in centimeters or millimeters and depth of invasion (DOI) indicating how deep it has grown.&lt;SEP&gt;A tumor is an abnormal growth of tissue, a sample of which may be tested for DNA mutations, protein levels, or other molecular features.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249798</data>
  <data key="d6"></data>
</node>
<node id="Extracapsular Extension">
  <data key="d0">Extracapsular Extension</data>
  <data key="d1">concept</data>
  <data key="d2">A condition where cancer has grown through the protective outer layer of a lymph node, also known as extranodal extension.&lt;SEP&gt;Extracapsular extension is a condition where cancer has grown through the protective outer layer of a lymph node, influencing treatment recommendations.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249798</data>
  <data key="d6"></data>
</node>
<node id="Cancer Doctors">
  <data key="d0">Cancer Doctors</data>
  <data key="d1">organization</data>
  <data key="d2">A group of medical professionals specializing in cancer treatment, consulted to determine next steps after surgery.&lt;SEP&gt;Cancer doctors are medical professionals whose discussion is recommended to consider treatment options, especially in complex cases.&lt;SEP&gt;Cancer doctors are medical specialists who are consulted to determine next treatment steps when concerning features are noted during or after CSCC surgery.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249800</data>
  <data key="d6"></data>
</node>
<node id="Immunotherapy">
  <data key="d0">Immunotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Immunotherapy stimulates the immune system to find and destroy cancer cells, using agents like PD-1 inhibitors.&lt;SEP&gt;A type of systemic therapy, specifically with immune checkpoint inhibitors, recommended for eligible patients.&lt;SEP&gt;Immunotherapy, specifically with an immune checkpoint inhibitor, is the preferred systemic therapy for CSCC when used alone.&lt;SEP&gt;Immunotherapy is a systemic treatment method, specifically involving immune checkpoint inhibitors, preferred for eligible patients.&lt;SEP&gt;Immunotherapy is a type of systemic therapy that works throughout the body to treat cancer.&lt;SEP&gt;Immunotherapy is a treatment option for ovarian cancer based on specific biomarkers, with side effects managed per NCCN guidelines.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249801</data>
  <data key="d6"></data>
</node>
<node id="Clinical Trial">
  <data key="d0">Clinical Trial</data>
  <data key="d1">event</data>
  <data key="d2">A clinical trial is a medical research study testing new cancer treatments for safety and effectiveness before FDA approval.&lt;SEP&gt;An option for systemic therapy involving experimental treatments like chemotherapy, targeted therapy, or immunotherapy.&lt;SEP&gt;Enrolling in a clinical trial for systemic therapy is presented as a potential treatment option for CSCC.&lt;SEP&gt;A clinical trial is a research study for new treatments, with specific eligibility requirements and no enrollment fee, though it may involve indirect costs.&lt;SEP&gt;A clinical trial is a research study that may involve treatment with chemotherapy, targeted therapy, or immunotherapy, and is an option for patients.&lt;SEP&gt;A research study on preventing lung cancer that patients can ask their care team about joining.&lt;SEP&gt;A clinical trial is a research study that everyone with persistent or recurrent ovarian cancer is encouraged to consider for treatment.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249801</data>
  <data key="d6"></data>
</node>
<node id="Targeted Therapy">
  <data key="d0">Targeted Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Targeted therapies are medicines that target specific receptors on cancer cells, such as EGFR inhibitors.&lt;SEP&gt;Targeted therapy is a type of systemic therapy considered as an option, particularly when immunotherapy or clinical trials are not viable.&lt;SEP&gt;Targeted therapy is a form of systemic therapy that focuses on specific features of cancer cells to stop their growth and survival.&lt;SEP&gt;Targeted therapy is a type of systemic therapy that works throughout the body to treat cancer.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249801</data>
  <data key="d6"></data>
</node>
<node id="Metastatic Squamous Cell Skin Cancer">
  <data key="d0">Metastatic Squamous Cell Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell carcinoma that has spread.&lt;SEP&gt;Metastatic squamous cell skin cancer is cancer that has spread to form tumors in other areas of the body, requiring systemic therapy.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249806</data>
  <data key="d6"></data>
</node>
<node id="Stereotactic Body Radiotherapy">
  <data key="d0">Stereotactic Body Radiotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Stereotactic body radiotherapy is a special radiation technique that sends high doses of radiation to small areas to kill cancer cells.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249806</data>
  <data key="d6"></data>
</node>
<node id="Regional Squamous Cell Skin Cancer">
  <data key="d0">Regional Squamous Cell Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell skin cancer that has spread to the lymph nodes.&lt;SEP&gt;Regional squamous cell skin cancer refers to cancer that has spread to nearby lymph nodes, with surgery as the primary treatment.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249807</data>
  <data key="d6"></data>
</node>
<node id="Skin Exams">
  <data key="d0">Skin Exams</data>
  <data key="d1">method</data>
  <data key="d2">Skin exams are follow-up procedures conducted by a doctor to monitor for the return of squamous cell skin cancer after treatment.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249807</data>
  <data key="d6"></data>
</node>
<node id="NCCN Experts">
  <data key="d0">NCCN Experts</data>
  <data key="d1">organization</data>
  <data key="d2">NCCN experts are a group that recommends annual skin exams for life after a specific post-treatment monitoring period.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249808</data>
  <data key="d6"></data>
</node>
<node id="Immune Checkpoint Inhibitor">
  <data key="d0">Immune Checkpoint Inhibitor</data>
  <data key="d1">method</data>
  <data key="d2">A specific type of immunotherapy recommended as a treatment option for CSCC.&lt;SEP&gt;An immune checkpoint inhibitor is a type of immunotherapy drug that is the preferred option for systemic therapy in CSCC treatment.&lt;SEP&gt;An immune checkpoint inhibitor is a type of immunotherapy preferred for eligible patients with metastatic or inoperable cancer.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249808</data>
  <data key="d6"></data>
</node>
<node id="Part 6: When Treatment Is Over">
  <data key="d0">Part 6: When Treatment Is Over</data>
  <data key="d1">content</data>
  <data key="d2">Part 6: When Treatment Is Over is a referenced section providing information on monitoring and follow-up care after cancer treatment.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249808</data>
  <data key="d6"></data>
</node>
<node id="Metastasis">
  <data key="d0">Metastasis</data>
  <data key="d1">concept</data>
  <data key="d2">Metastasis is the spread of cancer from its original site to another part of the body.&lt;SEP&gt;Metastasis is the process where cancer cells spread through blood and lymph to form tumors in other areas of the body.&lt;SEP&gt;Metastasis is the spread of cancer to an area of the body such as lymph nodes or lung.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249808</data>
  <data key="d6"></data>
</node>
<node id="Distant Tumors">
  <data key="d0">Distant Tumors</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Distant tumors are metastatic tumors causing pain or side effects, which may be treated with radiation or surgery for symptom relief.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249810</data>
  <data key="d6"></data>
</node>
<node id="Scans">
  <data key="d0">Scans</data>
  <data key="d1">method</data>
  <data key="d2">Scans are diagnostic tests of the upper body, stomach, and pelvis used to check for metastatic disease spread.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249810</data>
  <data key="d6"></data>
</node>
<node id="High-Risk Patients">
  <data key="d0">High-Risk Patients</data>
  <data key="d1">concept</data>
  <data key="d2">High-risk patients are individuals who require more frequent skin exams after treatment due to a greater likelihood of cancer recurrence.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249811</data>
  <data key="d6"></data>
</node>
<node id="Paper Gown">
  <data key="d0">Paper Gown</data>
  <data key="d1">artifact</data>
  <data key="d2">A paper gown is a garment worn by a patient during a skin exam to allow the doctor to inspect different areas of the body.</data>
  <data key="d3">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249811</data>
  <data key="d6"></data>
</node>
<node id="High-Risk CSCC">
  <data key="d0">High-Risk CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">A category of cutaneous squamous cell carcinoma based on risk assessment, often involving features like nerve invasion or deep skin invasion.&lt;SEP&gt;High-risk CSCC is a category of squamous cell skin cancer with an increased risk of local recurrence.&lt;SEP&gt;High-risk CSCC is a classification of cutaneous squamous cell carcinoma that requires specific surgical treatments like Mohs surgery or standard excision with wider margins.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249812</data>
  <data key="d6"></data>
</node>
<node id="Very High-Risk CSCC">
  <data key="d0">Very High-Risk CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">A category of cutaneous squamous cell carcinoma based on risk assessment, often involving features like nerve invasion or deep skin invasion.&lt;SEP&gt;Very high-risk CSCC is a category of squamous cell skin cancer with an increased risk of both local recurrence and metastasis.&lt;SEP&gt;Very high-risk CSCC is a classification of cutaneous squamous cell carcinoma for which Mohs surgery or PDEMA is the preferred surgical treatment.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249813</data>
  <data key="d6"></data>
</node>
<node id="Low-Risk CSCC">
  <data key="d0">Low-Risk CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">A category of cutaneous squamous cell carcinoma based on risk assessment, treated with less aggressive surgical options.&lt;SEP&gt;Low-risk CSCC is a category of squamous cell skin cancer with a lower likelihood of recurrence, treated differently than higher-risk categories.&lt;SEP&gt;Low-risk CSCC is a classification of cutaneous squamous cell carcinoma for which surgery is the preferred treatment when it has not spread to lymph nodes.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249813</data>
  <data key="d6"></data>
</node>
<node id="Regional CSCC">
  <data key="d0">Regional CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell carcinoma that has spread to nearby lymph nodes.&lt;SEP&gt;Regional CSCC is a form of cutaneous squamous cell carcinoma that has spread to nearby lymph nodes, requiring more frequent follow-up exams and imaging.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249813</data>
  <data key="d6"></data>
</node>
<node id="Computed Tomography Scan">
  <data key="d0">Computed Tomography Scan</data>
  <data key="d1">method</data>
  <data key="d2">An imaging test recommended to assess the number, location, and size of cancerous lymph nodes in regional CSCC.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249816</data>
  <data key="d6"></data>
</node>
<node id="PET/CT">
  <data key="d0">PET/CT</data>
  <data key="d1">method</data>
  <data key="d2">An advanced imaging test that may be needed to see if cancer has spread beyond lymph nodes or to help plan treatment.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249816</data>
  <data key="d6"></data>
</node>
<node id="Fine-Needle Aspiration">
  <data key="d0">Fine-Needle Aspiration</data>
  <data key="d1">method</data>
  <data key="d2">A type of biopsy, also known as needle biopsy, used for squamous cell skin cancer in lymph nodes.&lt;SEP&gt;Fine-needle aspiration (FNA) is a type of biopsy that uses a needle to remove a sample of tumor or lymph node.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249817</data>
  <data key="d6"></data>
</node>
<node id="Core Needle Biopsy">
  <data key="d0">Core Needle Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A type of biopsy used for squamous cell skin cancer in lymph nodes.&lt;SEP&gt;A Core Needle Biopsy is an alternative diagnostic method where a doctor uses a wide needle to remove a tissue sample from a lymph node without removing the entire node.&lt;SEP&gt;Core needle biopsy (CNB) is a type of biopsy that uses a needle to remove a sample of tumor or lymph node.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249817</data>
  <data key="d6"></data>
</node>
<node id="Cemiplimab-Rwlc">
  <data key="d0">Cemiplimab-Rwlc</data>
  <data key="d1">artifact</data>
  <data key="d2">An immunotherapy drug (Libtayo) that may be used to shrink tumors before surgery for regional CSCC.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249818</data>
  <data key="d6"></data>
</node>
<node id="Local CSCC">
  <data key="d0">Local CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell skin cancer that has not spread to nearby lymph nodes.&lt;SEP&gt;Local CSCC is a form of cutaneous squamous cell carcinoma that has not spread to lymph nodes, requiring specific follow-up exam schedules.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249819</data>
  <data key="d6"></data>
</node>
<node id="Risk Assessment">
  <data key="d0">Risk Assessment</data>
  <data key="d1">concept</data>
  <data key="d2">The process of considering key features of the cancer to determine if it is low-, high-, or very high-risk CSCC.&lt;SEP&gt;Risk assessment is the process a doctor uses to determine if a squamous cell skin cancer is low-, high-, or very high-risk based on several features.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249819</data>
  <data key="d6"></data>
</node>
<node id="Tumor Grade">
  <data key="d0">Tumor Grade</data>
  <data key="d1">concept</data>
  <data key="d2">A rating of how fast doctors expect the cancer to grow and spread.&lt;SEP&gt;Tumor grade is a rating based on how different tumor cells look from normal cells under a microscope, indicating the expected speed of cancer growth and spread.&lt;SEP&gt;Tumor grade is a rating of how fast cancer is expected to grow and spread, based on how different tumor cells look from normal cells.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249819</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Tumors">
  <data key="d0">Head And Neck Tumors</data>
  <data key="d1">concept</data>
  <data key="d2">Tumors located in the head and neck region, for which lymph node removal surgery may be more extensive.</data>
  <data key="d3">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249820</data>
  <data key="d6"></data>
</node>
<node id="Lungs">
  <data key="d0">Lungs</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A pair of organs in the chest that move oxygen into the blood and carbon dioxide out, consisting of lobes and surrounded by the pleural membrane.&lt;SEP&gt;The lungs are a pair of organs responsible for gas exchange, moving oxygen into the blood and carbon dioxide out.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249820</data>
  <data key="d6"></data>
</node>
<node id="Small Cell Lung Cancer">
  <data key="d0">Small Cell Lung Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Small cell lung cancer is another type of lung cancer, distinct from NSCLC and covered in a different resource.&lt;SEP&gt;A fast-dividing cancer of neuroendocrine cells in the lungs, which is the second most common type.&lt;SEP&gt;Small cell lung cancer is a fast-dividing cancer of neuroendocrine cells, appearing small and oval-shaped under a microscope, and is the second most common type of lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249821</data>
  <data key="d6"></data>
</node>
<node id="Lung Cancer Screening">
  <data key="d0">Lung Cancer Screening</data>
  <data key="d1">method</data>
  <data key="d2">A process for people at high risk for lung cancer to help find it at its earliest, most treatable stages.&lt;SEP&gt;Lung cancer screening aims to detect lung cancer at an early, asymptomatic stage to increase the success of treatment and prevent death.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249821</data>
  <data key="d6"></data>
</node>
<node id="Health Care Provider">
  <data key="d0">Health Care Provider</data>
  <data key="d1">person</data>
  <data key="d2">A health care provider is a professional or entity that discusses screening eligibility, provides checkups, and manages cancer screenings with patients.&lt;SEP&gt;A health care provider is a medical professional who receives imaging reports from radiologists and discusses results with patients.&lt;SEP&gt;A health care provider is a professional with whom patients should discuss their test results.&lt;SEP&gt;A health care provider is a medical professional with whom a patient should discuss their test results.&lt;SEP&gt;A professional who conducts a physical exam, checking vital signs and examining the patient's body.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249823</data>
  <data key="d6"></data>
</node>
<node id="Risk Factors">
  <data key="d0">Risk Factors</data>
  <data key="d1">concept</data>
  <data key="d2">Risk factors are activities, environmental elements, or inherited traits that increase a person's chance of developing lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249824</data>
  <data key="d6"></data>
</node>
<node id="Genes">
  <data key="d0">Genes</data>
  <data key="d1">concept</data>
  <data key="d2">Genes are sets of instructions that determine cell function and type, and can be passed from biological parents, influencing cancer risk.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249824</data>
  <data key="d6"></data>
</node>
<node id="Adenosquamous Carcinoma">
  <data key="d0">Adenosquamous Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Adenosquamous carcinoma is a subtype of non-small cell lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249824</data>
  <data key="d6"></data>
</node>
<node id="Sarcomatoid Carcinoma">
  <data key="d0">Sarcomatoid Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Sarcomatoid carcinoma is a subtype of non-small cell lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249825</data>
  <data key="d6"></data>
</node>
<node id="Combined Cell Lung Carcinoma">
  <data key="d0">Combined Cell Lung Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Combined cell lung carcinoma contains both small cell and non-small cell cancer cells and is usually treated like small cell lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249825</data>
  <data key="d6"></data>
</node>
<node id="Smoking Cigarettes">
  <data key="d0">Smoking Cigarettes</data>
  <data key="d1">concept</data>
  <data key="d2">Smoking cigarettes is the main cause of small cell lung cancer, with most affected individuals having a history of heavy smoking.&lt;SEP&gt;The act of smoking tobacco, identified as the main cause of Small Cell Lung Cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249826</data>
  <data key="d6"></data>
</node>
<node id="Second-Hand Smoke">
  <data key="d0">Second-Hand Smoke</data>
  <data key="d1">concept</data>
  <data key="d2">Smoke exhaled by another person and smoke from the burning end of tobacco products, which increases lung cancer risk.&lt;SEP&gt;Exposure to second-hand smoke, exhaled by others or from tobacco products, increases the risk of developing lung cancer.&lt;SEP&gt;Smoke exhaled by a smoker or from combustible tobacco products, which increases the risk of lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249827</data>
  <data key="d6"></data>
</node>
<node id="Bronchus">
  <data key="d0">Bronchus</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The bronchus is part of the airways of the lungs where lung cancer can start.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249828</data>
  <data key="d6"></data>
</node>
<node id="Bronchioles">
  <data key="d0">Bronchioles</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Small tubes inside the lungs that branch off from the bronchi.&lt;SEP&gt;Bronchioles are part of the airways of the lungs where lung cancer can start.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249828</data>
  <data key="d6"></data>
</node>
<node id="Neuroendocrine Cells">
  <data key="d0">Neuroendocrine Cells</data>
  <data key="d1">concept</data>
  <data key="d2">The cells from which small cell lung cancer, a fast-dividing cancer, originates.&lt;SEP&gt;Neuroendocrine cells are the cell type from which small cell lung cancer originates.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249828</data>
  <data key="d6"></data>
</node>
<node id="Respiration">
  <data key="d0">Respiration</data>
  <data key="d1">concept</data>
  <data key="d2">Respiration is the process of transferring gases in and out of the body, performed by the lungs.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249830</data>
  <data key="d6"></data>
</node>
<node id="Lymph">
  <data key="d0">Lymph</data>
  <data key="d1">concept</data>
  <data key="d2">Lymph is a body fluid through which cancer cells can spread to other parts of the body.&lt;SEP&gt;Lymph is a clear fluid, also called lymphatic fluid, that carries infection-fighting white blood cells (lymphocytes) throughout the body via lymphatic vessels.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249830</data>
  <data key="d6"></data>
</node>
<node id="Small Cell Carcinoma">
  <data key="d0">Small Cell Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Small cell carcinoma is a subtype of small cell lung cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249831</data>
  <data key="d6"></data>
</node>
<node id="Skin Exam">
  <data key="d0">Skin Exam</data>
  <data key="d1">method</data>
  <data key="d2">A skin exam is a component of the diagnostic process for basal cell skin cancer.&lt;SEP&gt;A skin exam is a medical examination performed by a doctor to check for skin cancer, with frequency based on patient risk and cancer type.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249831</data>
  <data key="d6"></data>
</node>
<node id="Imaging Test">
  <data key="d0">Imaging Test</data>
  <data key="d1">method</data>
  <data key="d2">Imaging tests, such as CT scans, are used to monitor for cancer spread in patients with local or regional CSCC.&lt;SEP&gt;An imaging test is a diagnostic tool, such as an ultrasound, used to examine the GI tract or other areas of the body.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249832</data>
  <data key="d6"></data>
</node>
<node id="Chronic Myeloid Leukemia (CML)">
  <data key="d0">Chronic Myeloid Leukemia (CML)</data>
  <data key="d1">concept</data>
  <data key="d2">Chronic Myeloid Leukemia is a type of blood cancer characterized by a slow progression and an overproduction of white blood cells.&lt;SEP&gt;CML is a type of cancer thought to arise from blood stem cells that produce an increased amount of myeloid progenitor cells, characterized by the Philadelphia chromosome.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249832</data>
  <data key="d6"></data>
</node>
<node id="BCR::ABL1 Gene">
  <data key="d0">BCR::ABL1 Gene</data>
  <data key="d1">concept</data>
  <data key="d2">The BCR::ABL1 gene is a fused, abnormal gene created by a genetic translocation, which is the cause of Chronic Myeloid Leukemia.&lt;SEP&gt;The BCR::ABL1 gene is a specific abnormal fused gene created by a translocation between chromosomes 9 and 22, which produces a protein leading to uncontrolled blood cell growth in CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249832</data>
  <data key="d6"></data>
</node>
<node id="Philadelphia (Ph) Chromosome">
  <data key="d0">Philadelphia (Ph) Chromosome</data>
  <data key="d1">concept</data>
  <data key="d2">The Philadelphia Chromosome is a shortened chromosome 22 resulting from a genetic translocation and is associated with the BCR::ABL1 gene in CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249834</data>
  <data key="d6"></data>
</node>
<node id="Blood">
  <data key="d0">Blood</data>
  <data key="d1">concept</data>
  <data key="d2">Blood is a bodily tissue composed of plasma, red blood cells, white blood cells, and platelets, responsible for transporting substances and immune function.&lt;SEP&gt;Blood is a tissue composed of plasma, red blood cells, white blood cells, and platelets, functioning to transport oxygen, nutrients, and waste, and support the immune system.&lt;SEP&gt;Blood is a bodily fluid that transports oxygen, fights infections, prevents bleeding, and consists of plasma, red blood cells, white blood cells, and platelets.&lt;SEP&gt;Blood is a bodily fluid that can be used as a sample in tumor mutation testing to detect cancer DNA mutations.&lt;SEP&gt;Blood is a sample source required for a karyotype test.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249834</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow">
  <data key="d0">Bone Marrow</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Bone marrow is the spongy tissue inside bones where blood stem cells produce all types of blood cells through a process of differentiation.&lt;SEP&gt;Bone Marrow is the soft, spongy tissue inside most bones where new blood cells, including lymphocytes, are produced.&lt;SEP&gt;Bone marrow is the sponge-like tissue in the center of most bones and is the organ that creates blood cells in the body.&lt;SEP&gt;Bone marrow is a sample source required for a karyotype test.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249834</data>
  <data key="d6"></data>
</node>
<node id="Blood Stem Cell">
  <data key="d0">Blood Stem Cell</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Blood stem cells are early cells in the bone marrow that give rise to progenitor cells, which become red blood cells, white blood cells, and platelets.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249837</data>
  <data key="d6"></data>
</node>
<node id="Myeloid Progenitor Cell">
  <data key="d0">Myeloid Progenitor Cell</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Myeloid progenitor cells are intermediary cells that form myeloblasts and other non-lymphoid blood cells, and are overproduced in CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249838</data>
  <data key="d6"></data>
</node>
<node id="Blast Phase CML (BP-CML)">
  <data key="d0">Blast Phase CML (BP-CML)</data>
  <data key="d1">concept</data>
  <data key="d2">Blast Phase CML is an advanced form of Chronic Myeloid Leukemia characterized by an increased number of immature blast cells.&lt;SEP&gt;Blast Phase CML is an advanced form of CML that can cause an increased amount of lymphoid or myeloid progenitor cells, affecting treatment.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249838</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines for Patients">
  <data key="d0">NCCN Guidelines for Patients</data>
  <data key="d1">content</data>
  <data key="d2">The NCCN Guidelines for Patients provide information on squamous cell skin cancer and melanoma and are available at NCCN.org/patientguidelines and on the NCCN Patient Guides for Cancer app.&lt;SEP&gt;The NCCN Guidelines for Patients are resources that explain expert cancer care recommendations to help patients make informed decisions.&lt;SEP&gt;The NCCN Guidelines for Patients are resources designed to help patients understand cancer care and prepare for discussions with their care team.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249838</data>
  <data key="d6"></data>
</node>
<node id="Low-Risk Patient">
  <data key="d0">Low-Risk Patient</data>
  <data key="d1">concept</data>
  <data key="d2">A low-risk patient is a category of skin cancer patient for whom follow-up skin exams are recommended every 3 to 12 months initially.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249839</data>
  <data key="d6"></data>
</node>
<node id="High-Risk Patient">
  <data key="d0">High-Risk Patient</data>
  <data key="d1">concept</data>
  <data key="d2">A high-risk patient is a category of skin cancer patient for whom follow-up skin exams are recommended every 3 to 6 months initially.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249841</data>
  <data key="d6"></data>
</node>
<node id="Very High-Risk Local CSCC">
  <data key="d0">Very High-Risk Local CSCC</data>
  <data key="d1">concept</data>
  <data key="d2">Very high-risk local CSCC is a subcategory of local cutaneous squamous cell carcinoma requiring exams every 3 to 6 months for the first 2 years.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249841</data>
  <data key="d6"></data>
</node>
<node id="NCCN">
  <data key="d0">NCCN</data>
  <data key="d1">organization</data>
  <data key="d2">The National Comprehensive Cancer Network (NCCN) is an organization comprised of experts that develops and publishes comprehensive guidelines for cancer care. These guidelines serve both healthcare professionals and patients. For patients, NCCN provides a wide array of accessible resources, including detailed patient guideline bookssuch as those for non-small cell lung cancer (NSCLC)a dedicated website, and a mobile application.

The content of NCCN's patient-focused materials covers the full spectrum of cancer care. This includes prevention and screening, such as referring high-risk individuals to specialized centers for cutaneous squamous cell carcinoma (CSCC) management. It also encompasses treatment guidelines for specific cancers like head and neck cancers, and post-treatment follow-up protocols for conditions like skin cancer. Furthermore, the resources provide extensive support for managing treatment side effects, including immunotherapy-related issues, nausea, and vomiting. NCCN also addresses specialized supportive care needs, such as fertility preservation for adolescents and young adults with cancer.</data>
  <data key="d3">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249841</data>
  <data key="d6"></data>
</node>
<node id="Red Blood Cell (RBC)">
  <data key="d0">Red Blood Cell (RBC)</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Red blood cells are blood cells that carry oxygen throughout the body, formed from blood stem cells in the bone marrow.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249842</data>
  <data key="d6"></data>
</node>
<node id="White Blood Cell (WBC)">
  <data key="d0">White Blood Cell (WBC)</data>
  <data key="d1">naturalobject</data>
  <data key="d2">White blood cells are blood cells that fight infections, including granulocytes, monocytes, and lymphocytes, and are often overproduced in CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249844</data>
  <data key="d6"></data>
</node>
<node id="Platelet (PLT)">
  <data key="d0">Platelet (PLT)</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Platelets are blood cells that help control bleeding, and their counts can be abnormal in patients with Chronic Myeloid Leukemia.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249845</data>
  <data key="d6"></data>
</node>
<node id="Granulocyte">
  <data key="d0">Granulocyte</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Granulocytes are a type of white blood cell that includes neutrophils, eosinophils, and basophils, and are typically overproduced in CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249845</data>
  <data key="d6"></data>
</node>
<node id="Lymphoid Progenitor Cell">
  <data key="d0">Lymphoid Progenitor Cell</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Lymphoid progenitor cells are intermediary cells that form lymphoblasts, which mature into lymphocytes.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249845</data>
  <data key="d6"></data>
</node>
<node id="Blast">
  <data key="d0">Blast</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Blasts are very immature blood cells, such as myeloblasts or lymphoblasts, whose increased number characterizes blast phase CML.</data>
  <data key="d3">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249846</data>
  <data key="d6"></data>
</node>
<node id="Physical Exam">
  <data key="d0">Physical Exam</data>
  <data key="d1">method</data>
  <data key="d2">A health assessment where a provider checks vital signs, examines the body, and feels for abnormalities like enlarged lymph nodes or lumps.&lt;SEP&gt;A physical exam is a component of the diagnostic process for basal cell skin cancer.&lt;SEP&gt;A physical exam involves checking vital signs, examining the body, and feeling for enlarged lymph nodes to assess a patient's health.&lt;SEP&gt;A physical exam involves checking height and weight, listening to lungs and heart, examining eyes, ears, nose, and throat, and palpating the body to assess organ size, texture, and tenderness.&lt;SEP&gt;A physical exam is an assessment that informs a care team about a patient's overall health.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249846</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Exam">
  <data key="d0">Head And Neck Exam</data>
  <data key="d1">method</data>
  <data key="d2">A head and neck exam is part of a physical exam and may include palpation of the oral cavity and the use of a mirror or fiberoptic scope to view hard-to-see areas.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249847</data>
  <data key="d6"></data>
</node>
<node id="Dental Exam">
  <data key="d0">Dental Exam</data>
  <data key="d1">method</data>
  <data key="d2">A dental exam involves regular cleanings and checkups, and is important for patients with head and neck cancer as the disease and its treatment can affect jaw, teeth, and gum health.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249848</data>
  <data key="d6"></data>
</node>
<node id="Distress Screening">
  <data key="d0">Distress Screening</data>
  <data key="d1">method</data>
  <data key="d2">Distress screening is a process where a treatment team assesses a patient's level of mental, physical, social, or spiritual distress as part of cancer care.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249848</data>
  <data key="d6"></data>
</node>
<node id="Endocrine Tests">
  <data key="d0">Endocrine Tests</data>
  <data key="d1">method</data>
  <data key="d2">Endocrine tests, such as blood tests for thyroid hormone levels, are performed before and/or after radiation therapy to the head and neck to assess the function of endocrine glands.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249850</data>
  <data key="d6"></data>
</node>
<node id="Hearing Test">
  <data key="d0">Hearing Test</data>
  <data key="d1">method</data>
  <data key="d2">A hearing test, which may produce an audiogram, assesses hearing loss, its type, severity, and cause, as head and neck tumors and their treatment can affect hearing.&lt;SEP&gt;A hearing test (audiogram) is mentioned as part of the testing for treatment planning.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249851</data>
  <data key="d6"></data>
</node>
<node id="Nutrition Assessment">
  <data key="d0">Nutrition Assessment</data>
  <data key="d1">method</data>
  <data key="d2">A nutrition assessment involves meeting with a nutrition expert before treatment to receive dietary recommendations for adequate and sustained nutrition.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249851</data>
  <data key="d6"></data>
</node>
<node id="Speech And Swallowing Assessment">
  <data key="d0">Speech And Swallowing Assessment</data>
  <data key="d1">method</data>
  <data key="d2">A speech and swallowing assessment involves a therapist testing a patient's ability to swallow and speak before and after treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249852</data>
  <data key="d6"></data>
</node>
<node id="Fertility Preservation">
  <data key="d0">Fertility Preservation</data>
  <data key="d1">concept</data>
  <data key="d2">Fertility preservation involves actions taken before cancer treatment to maintain the option of having children in the future, often requiring consultation with a fertility specialist.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249852</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Cancer">
  <data key="d0">Head And Neck Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Head and neck cancer is a group of cancers that arise in the head or neck area, including the mouth, throat, nasal cavity, and larynx, and are often treated similarly.&lt;SEP&gt;Head and neck cancers are a group of cancers that arise in the head or neck area of the body.&lt;SEP&gt;Head and neck cancer is a disease that can affect the health of the jaw, teeth, and gums, and its treatment can impact hearing, fertility, and endocrine function.&lt;SEP&gt;Head and neck cancer is a disease that can affect the health of the jaw, teeth, and gums, and its treatment requires stopping smoking.&lt;SEP&gt;Head and neck cancer is a type of cancer that can affect the health of the jaw, teeth, and gums.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0&lt;SEP&gt;chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249852</data>
  <data key="d6"></data>
</node>
<node id="Fertility Specialist">
  <data key="d0">Fertility Specialist</data>
  <data key="d1">person</data>
  <data key="d2">A fertility specialist is a doctor who discusses fertility preservation options with patients before they start cancer treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249853</data>
  <data key="d6"></data>
</node>
<node id="Nutritionist">
  <data key="d0">Nutritionist</data>
  <data key="d1">person</data>
  <data key="d2">A nutritionist or dietitian is an expert who suggests the best foods and fluids for a patient before starting cancer treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249854</data>
  <data key="d6"></data>
</node>
<node id="Speech Or Swallowing Therapist">
  <data key="d0">Speech Or Swallowing Therapist</data>
  <data key="d1">person</data>
  <data key="d2">A speech or swallowing therapist tests a patient's ability to swallow and speak before and after cancer treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249855</data>
  <data key="d6"></data>
</node>
<node id="Eastern Cooperative Oncology Group">
  <data key="d0">Eastern Cooperative Oncology Group</data>
  <data key="d1">organization</data>
  <data key="d2">The Eastern Cooperative Oncology Group (ECOG) provides a scale used to rate a patient's performance status, which is a factor in treatment planning.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249855</data>
  <data key="d6"></data>
</node>
<node id="Distress">
  <data key="d0">Distress</data>
  <data key="d1">concept</data>
  <data key="d2">Distress is an unpleasant mental, physical, social, or spiritual experience that can affect feelings, thoughts, and actions, and includes emotions like sadness, fear, and anxiety.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249855</data>
  <data key="d6"></data>
</node>
<node id="Audiogram">
  <data key="d0">Audiogram</data>
  <data key="d1">artifact</data>
  <data key="d2">An audiogram is a graph showing the results of a pure-tone hearing test.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249856</data>
  <data key="d6"></data>
</node>
<node id="Barrier Methods">
  <data key="d0">Barrier Methods</data>
  <data key="d1">artifact</data>
  <data key="d2">Barrier methods of birth control include condoms, diaphragms, cervical caps, and the contraceptive sponge, used to prevent pregnancy during cancer treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249856</data>
  <data key="d6"></data>
</node>
<node id="Intrauterine Devices">
  <data key="d0">Intrauterine Devices</data>
  <data key="d1">artifact</data>
  <data key="d2">Intrauterine devices (IUDs) are a form of birth control that may be recommended to prevent pregnancy during cancer treatment.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249857</data>
  <data key="d6"></data>
</node>
<node id="Pregnancy Test">
  <data key="d0">Pregnancy Test</data>
  <data key="d1">method</data>
  <data key="d2">A pregnancy test is conducted before starting cancer treatment for those who can become pregnant, as treatment can harm a developing baby.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249857</data>
  <data key="d6"></data>
</node>
<node id="Social Worker">
  <data key="d0">Social Worker</data>
  <data key="d1">person</data>
  <data key="d2">A social worker is a professional whom a patient's family or loved ones can talk to for help with anxiety or depression related to a cancer diagnosis.</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249858</data>
  <data key="d6"></data>
</node>
<node id="Skin Cancer">
  <data key="d0">Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Skin cancer is a condition where abnormal cells grow in the skin, with increased risk from factors like UV exposure and environmental toxins.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249858</data>
  <data key="d6"></data>
</node>
<node id="Marjolins Ulcer">
  <data key="d0">Marjolins Ulcer</data>
  <data key="d1">concept</data>
  <data key="d2">Marjolins ulcer is a term for Squamous Cell Carcinoma that forms in scars or chronic, nonhealing wounds like ulcers and burns.&lt;SEP&gt;Squamous cell skin cancer that forms in old wounds, burns, or scars, which can be harder to treat.&lt;SEP&gt;Marjolin's ulcer is a specific, harder-to-treat form of squamous cell skin cancer that develops in old wounds, burns, or scars.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249859</data>
  <data key="d6"></data>
</node>
<node id="Genetic Syndromes">
  <data key="d0">Genetic Syndromes</data>
  <data key="d1">concept</data>
  <data key="d2">Genetic syndromes are inherited conditions, such as Xeroderma Pigmentosum and Recessive Dystrophic Epidermolysis Bullosa, that increase the risk of Squamous Cell Carcinoma.&lt;SEP&gt;Certain inherited conditions that may increase a person's likelihood of developing squamous cell skin cancer.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249860</data>
  <data key="d6"></data>
</node>
<node id="Recessive Dystrophic Epidermolysis Bullosa">
  <data key="d0">Recessive Dystrophic Epidermolysis Bullosa</data>
  <data key="d1">concept</data>
  <data key="d2">Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare, inherited skin disorder causing fragile skin and painful blisters, increasing skin cancer risk.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249861</data>
  <data key="d6"></data>
</node>
<node id="Weakened Immune System">
  <data key="d0">Weakened Immune System</data>
  <data key="d1">concept</data>
  <data key="d2">A weakened immune system, due to conditions like organ transplantation, lymphoma, or HIV, reduces the body's ability to fight disease and increases skin cancer risk.&lt;SEP&gt;A weakened immune system increases the risk of developing and having a recurrence of cutaneous squamous cell carcinoma (CSCC).</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249861</data>
  <data key="d6"></data>
</node>
<node id="Immunosuppressants">
  <data key="d0">Immunosuppressants</data>
  <data key="d1">concept</data>
  <data key="d2">Immunosuppressants are drugs taken after organ transplantation to prevent organ rejection, which also weaken the immune system and increase infection and cancer risk.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249862</data>
  <data key="d6"></data>
</node>
<node id="Skin Biopsy">
  <data key="d0">Skin Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A skin biopsy is a procedure to remove a sample of a skin lesion for laboratory analysis, which is the definitive method to diagnose Squamous Cell Carcinoma.&lt;SEP&gt;A skin biopsy is a diagnostic procedure to remove a sample of skin for testing to determine if cancer is present.&lt;SEP&gt;A skin biopsy is a procedure where a small tissue sample is removed for testing to diagnose squamous cell skin cancer.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249862</data>
  <data key="d6"></data>
</node>
<node id="Skin Shave Biopsy">
  <data key="d0">Skin Shave Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A skin shave biopsy removes the top layers of skin using a razor-like tool and is used for superficial or flat lesions.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249863</data>
  <data key="d6"></data>
</node>
<node id="Skin Punch Biopsy">
  <data key="d0">Skin Punch Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A skin punch biopsy uses a hand-held tool to remove a small core of skin and connective tissue, often requiring stitches to close the wound.&lt;SEP&gt;A method where a small piece of skin and connective tissue are removed using a hand-held tool, often requiring stitches to close the opening.&lt;SEP&gt;A skin punch biopsy removes a small piece of skin and connective tissue to obtain DNA unaltered by AML, used to test for inherited leukemia predisposition syndromes.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249864</data>
  <data key="d6"></data>
</node>
<node id="Excision Biopsy">
  <data key="d0">Excision Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">An excision biopsy involves removing all or part of a skin lesion for diagnostic purposes.&lt;SEP&gt;A method where all or part of a lesion is removed, which can be performed in a doctor's office or hospital.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249864</data>
  <data key="d6"></data>
</node>
<node id="Doctor">
  <data key="d0">Doctor</data>
  <data key="d1">person</data>
  <data key="d2">A doctor is a healthcare professional who examines skin, takes health histories, and performs procedures like biopsies.&lt;SEP&gt;A medical professional who performs biopsies, orders imaging tests, and conducts skin exams for CSCC diagnosis and follow-up.&lt;SEP&gt;The doctor is the medical professional who confirms squamous cell skin cancer and performs risk assessment.&lt;SEP&gt;A doctor is a healthcare provider who considers treatment options, recommends quitting smoking, and may perform procedures like SLNB for CSCC patients.&lt;SEP&gt;A medical professional with whom a patient discusses test results.&lt;SEP&gt;The doctor monitors how well chemotherapy is working and assesses for side effects through physical exams, imaging, and blood tests.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249866</data>
  <data key="d6"></data>
</node>
<node id="Dermatologist">
  <data key="d0">Dermatologist</data>
  <data key="d1">person</data>
  <data key="d2">A dermatologist is a skin specialist who examines skin for conditions like actinic keratosis and skin cancer.&lt;SEP&gt;A dermatologist is a doctor who diagnoses and treats skin conditions, including skin cancer, performs skin exams, and educates patients on self-examination.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249868</data>
  <data key="d6"></data>
</node>
<node id="Genetic Counselor">
  <data key="d0">Genetic Counselor</data>
  <data key="d1">person</data>
  <data key="d2">A genetic counselor is a professional who provides counseling on genetic risks, such as for those with a hereditary predisposition to skin cancer.&lt;SEP&gt;A genetic counselor is a health expert with special training to help patients understand gene changes related to disease, particularly after positive genetic test results.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249868</data>
  <data key="d6"></data>
</node>
<node id="Tanning Beds">
  <data key="d0">Tanning Beds</data>
  <data key="d1">artifact</data>
  <data key="d2">Tanning beds are a source of ultraviolet (UV) radiation that increases the risk of developing basal cell skin cancer.&lt;SEP&gt;Tanning beds are devices that emit ultraviolet (UV) radiation, and their use increases the risk of developing skin cancer.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249869</data>
  <data key="d6"></data>
</node>
<node id="Arsenic">
  <data key="d0">Arsenic</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Arsenic is an environmental toxin found in soil, water, and air; exposure to it can cause skin damage leading to Squamous Cell Carcinoma.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249869</data>
  <data key="d6"></data>
</node>
<node id="Scars">
  <data key="d0">Scars</data>
  <data key="d1">concept</data>
  <data key="d2">Scars are areas of fibrous tissue that replace normal skin after an injury, and Squamous Cell Carcinoma can form within them.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249870</data>
  <data key="d6"></data>
</node>
<node id="Chronic Wounds">
  <data key="d0">Chronic Wounds</data>
  <data key="d1">concept</data>
  <data key="d2">Chronic wounds are nonhealing injuries, such as ulcers and burns, which can be sites for the development of Squamous Cell Carcinoma.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249870</data>
  <data key="d6"></data>
</node>
<node id="Local Anesthetic">
  <data key="d0">Local Anesthetic</data>
  <data key="d1">concept</data>
  <data key="d2">A local anesthetic is a numbing medicine injected into the skin to prevent pain during procedures like a skin biopsy.</data>
  <data key="d3">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249871</data>
  <data key="d6"></data>
</node>
<node id="Lung Nodule">
  <data key="d0">Lung Nodule</data>
  <data key="d1">concept</data>
  <data key="d2">A small mass of tissue in the lung, often found by imaging; most are not cancer.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249871</data>
  <data key="d6"></data>
</node>
<node id="Tobacco Smoke">
  <data key="d0">Tobacco Smoke</data>
  <data key="d1">concept</data>
  <data key="d2">The biggest risk factor for lung cancer, containing more than 50 compounds known to cause cancer.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249872</data>
  <data key="d6"></data>
</node>
<node id="Chemopreventive Agents">
  <data key="d0">Chemopreventive Agents</data>
  <data key="d1">concept</data>
  <data key="d2">Treatments designed to prevent cancer, studied in the context of lung cancer caused by smoking.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249872</data>
  <data key="d6"></data>
</node>
<node id="Radon">
  <data key="d0">Radon</data>
  <data key="d1">concept</data>
  <data key="d2">A cancer-causing agent that increases lung cancer risk, especially for smokers.&lt;SEP&gt;A carcinogenic chemical that increases the risk of lung cancer when a person is exposed to it.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249872</data>
  <data key="d6"></data>
</node>
<node id="Asbestos">
  <data key="d0">Asbestos</data>
  <data key="d1">concept</data>
  <data key="d2">A cancer-causing agent that increases lung cancer risk, especially for smokers.&lt;SEP&gt;A carcinogenic chemical that increases the risk of lung cancer when a person is exposed to it.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249873</data>
  <data key="d6"></data>
</node>
<node id="Pleural Membrane">
  <data key="d0">Pleural Membrane</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A thin layer of tissue that surrounds and protects the lungs.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249874</data>
  <data key="d6"></data>
</node>
<node id="Lung Cancer">
  <data key="d0">Lung Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A disease that starts in the cells of the lungs, with the main types being non-small cell lung cancer and small cell lung cancer.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249874</data>
  <data key="d6"></data>
</node>
<node id="Histology">
  <data key="d0">Histology</data>
  <data key="d1">method</data>
  <data key="d2">A method of breaking down non-small cell lung cancer into subtypes by looking at cancer cells under a microscope.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249874</data>
  <data key="d6"></data>
</node>
<node id="Risk Factor">
  <data key="d0">Risk Factor</data>
  <data key="d1">concept</data>
  <data key="d2">Anything that increases a person's chance of getting lung cancer, such as smoking tobacco.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249874</data>
  <data key="d6"></data>
</node>
<node id="Respiratory System">
  <data key="d0">Respiratory System</data>
  <data key="d1">concept</data>
  <data key="d2">The series of airways through which air moves, including the throat, trachea, bronchi, bronchioles, and alveoli.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249875</data>
  <data key="d6"></data>
</node>
<node id="Carcinomas">
  <data key="d0">Carcinomas</data>
  <data key="d1">concept</data>
  <data key="d2">The subtype of cancer that almost all lung cancers are, which start in the cells lining the airways of the lungs.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249875</data>
  <data key="d6"></data>
</node>
<node id="Breast Cancer">
  <data key="d0">Breast Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A type of cancer that can spread to the lungs but is still called breast cancer when it does.</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249876</data>
  <data key="d6"></data>
</node>
<node id="Mouth Cancer">
  <data key="d0">Mouth Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Mouth cancer, also known as oral cancer or oral cavity cancer, is a type of head and neck cancer that develops in the squamous cells lining parts of the mouth such as the lips, tongue, gums, and cheeks.&lt;SEP&gt;Mouth cancer is a type of head and neck cancer that develops in the oral cavity, including the lips, cheeks, tongue, gums, floor of the mouth, hard palate, and retromolar trigone.&lt;SEP&gt;Mouth cancer refers to squamous cell carcinoma (SCC) of the mouth, including the mucosa of the lip, which starts in the epithelial layer lining the inside of the mouth.&lt;SEP&gt;Mouth cancer is a specific type of cancer for which staging is explained, involving the tumor, lymph nodes, and potential metastasis.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249876</data>
  <data key="d6"></data>
</node>
<node id="Oral Cavity">
  <data key="d0">Oral Cavity</data>
  <data key="d1">concept</data>
  <data key="d2">The oral cavity, also known as the mouth or buccal cavity, is the first part of the digestive and respiratory systems, composed of structures like the lips, cheeks, palate, teeth, and tongue, and is involved in eating and speaking.&lt;SEP&gt;The oral cavity is the area of the mouth where mouth cancer can develop, comprising parts such as the lips, cheeks, tongue, gums, floor of the mouth, hard palate, and retromolar trigone.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249878</data>
  <data key="d6"></data>
</node>
<node id="Oral Mucosa">
  <data key="d0">Oral Mucosa</data>
  <data key="d1">concept</data>
  <data key="d2">The oral mucosa is the mucous membrane lining the inside of the mouth and lips, composed of an epithelium layer and a lamina propria layer, and can be nonkeratinized or keratinized.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249878</data>
  <data key="d6"></data>
</node>
<node id="Depth Of Invasion">
  <data key="d0">Depth Of Invasion</data>
  <data key="d1">concept</data>
  <data key="d2">Depth of Invasion (DOI) is a measure of how deep a tumor has grown through the layers of the oral mucosa.&lt;SEP&gt;Depth of invasion (DOI) is a measure of how deep a tumor has grown into tissue layers, not its thickness, and is associated with an increased risk of regional lymph node metastases.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249880</data>
  <data key="d6"></data>
</node>
<node id="Medical History">
  <data key="d0">Medical History</data>
  <data key="d1">method</data>
  <data key="d2">A record of all past health issues, injuries, treatments, and medications a person has had, used to inform current medical care.&lt;SEP&gt;A medical history, or health history, is information about a patient's past illnesses, injuries, and symptoms used to determine the best treatment.&lt;SEP&gt;A medical history is a record of health issues and treatments used to determine the best treatment for a patient.&lt;SEP&gt;A medical history is a record of all health issues and treatments a person has had, used to determine the best cancer treatment.&lt;SEP&gt;A medical history is an assessment that informs a care team about a patient's overall health.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249880</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines For Patients">
  <data key="d0">NCCN Guidelines For Patients</data>
  <data key="d1">content</data>
  <data key="d2">The NCCN Guidelines for Patients are a trusted resource that explains current cancer care recommendations based on expert consensus and latest research to help patients understand their care.&lt;SEP&gt;The NCCN Guidelines for Patients are educational resources that explain expert cancer care recommendations in plain language.&lt;SEP&gt;The NCCN Guidelines for Patients are trusted resources that explain current cancer care recommendations to help patients make informed decisions and advocate for their care.&lt;SEP&gt;The NCCN Guidelines for Patients are resources, such as those for Squamous Cell Skin Cancer, found at NCCN.org/patientguidelines and on the NCCN Patient Guides for Cancer app.&lt;SEP&gt;The NCCN Guidelines for Patients are trusted resources that clearly explain current cancer care recommendations based on the latest research and practices from leading cancer centers.&lt;SEP&gt;The NCCN Guidelines for Patients is a book that helps patients understand cancer care, specifically for AML, and includes chapters on testing, treatment, and resources.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249882</data>
  <data key="d6"></data>
</node>
<node id="High-Volume Center">
  <data key="d0">High-Volume Center</data>
  <data key="d1">organization</data>
  <data key="d2">A high-volume center is a hospital or medical center with significant experience in treating specific types of cancer, such as head and neck cancers.&lt;SEP&gt;A high-volume center is a hospital or medical facility with significant experience in treating specific types of cancer, such as head and neck cancer, and is recommended for patient care.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249882</data>
  <data key="d6"></data>
</node>
<node id="Tongue">
  <data key="d0">Tongue</data>
  <data key="d1">concept</data>
  <data key="d2">The tongue is a muscular organ in the mouth that aids in chewing, speaking, and breathing, and its front two-thirds are a site where mouth cancer can develop.&lt;SEP&gt;The tongue is an organ in the mouth area where one might feel something different.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249885</data>
  <data key="d6"></data>
</node>
<node id="Lips">
  <data key="d0">Lips</data>
  <data key="d1">concept</data>
  <data key="d2">Lips surround the opening of the mouth, help form words and hold food, and the mucosal lip is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249885</data>
  <data key="d6"></data>
</node>
<node id="Gums">
  <data key="d0">Gums</data>
  <data key="d1">concept</data>
  <data key="d2">Gums, or gingiva, surround the base of the teeth to keep them in place and are a site where mouth cancer can develop.&lt;SEP&gt;Gums are tissues whose health can be affected by head and neck cancer and its treatment.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249886</data>
  <data key="d6"></data>
</node>
<node id="Hard Palate">
  <data key="d0">Hard Palate</data>
  <data key="d1">concept</data>
  <data key="d2">The hard palate is the hard, bony part of the roof of the mouth and is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249886</data>
  <data key="d6"></data>
</node>
<node id="Buccal Mucosa">
  <data key="d0">Buccal Mucosa</data>
  <data key="d1">concept</data>
  <data key="d2">Buccal mucosa is the lining inside the cheeks and inside where the lips touch the teeth, and it is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249887</data>
  <data key="d6"></data>
</node>
<node id="Alveolar Ridge">
  <data key="d0">Alveolar Ridge</data>
  <data key="d1">concept</data>
  <data key="d2">The alveolar ridge is the bony, raised area of the upper and lower jaw that holds the sockets of the teeth and is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249887</data>
  <data key="d6"></data>
</node>
<node id="Floor Of The Mouth">
  <data key="d0">Floor Of The Mouth</data>
  <data key="d1">concept</data>
  <data key="d2">The floor of the mouth is the area under the tongue and is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249888</data>
  <data key="d6"></data>
</node>
<node id="Retromolar Trigone">
  <data key="d0">Retromolar Trigone</data>
  <data key="d1">concept</data>
  <data key="d2">The retromolar trigone is the small area of gum behind the wisdom teeth and is a site where mouth cancer can develop.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249888</data>
  <data key="d6"></data>
</node>
<node id="Lamina Propria">
  <data key="d0">Lamina Propria</data>
  <data key="d1">concept</data>
  <data key="d2">A thin layer of connective tissue under the epithelium in the mucosa.&lt;SEP&gt;The lamina propria is the bottom layer of connective tissue in the oral mucosa.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249889</data>
  <data key="d6"></data>
</node>
<node id="Nonkeratinized Squamous Epithelium">
  <data key="d0">Nonkeratinized Squamous Epithelium</data>
  <data key="d1">concept</data>
  <data key="d2">Nonkeratinized squamous epithelium covers soft surfaces in the mouth like the soft palate, inner lips, inner cheeks, and the floor of the mouth.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249889</data>
  <data key="d6"></data>
</node>
<node id="Keratinized Squamous Epithelium">
  <data key="d0">Keratinized Squamous Epithelium</data>
  <data key="d1">concept</data>
  <data key="d2">Keratinized squamous epithelium is present on rough surfaces in the mouth caused by chewing, such as the gums, hard palate, and top of the tongue.</data>
  <data key="d3">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249891</data>
  <data key="d6"></data>
</node>
<node id="AML">
  <data key="d0">AML</data>
  <data key="d1">concept</data>
  <data key="d2">Acute Myeloid Leukemia (AML) is a cancer that starts in blood stem cells, producing abnormal myeloblasts that crowd out normal blood cells.&lt;SEP&gt;Acute Myeloid Leukemia, a type of cancer affecting blood and bone marrow, for which various tests and procedures are described.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249891</data>
  <data key="d6"></data>
</node>
<node id="Medical History And Physical Exam">
  <data key="d0">Medical History And Physical Exam</data>
  <data key="d1">method</data>
  <data key="d2">Medical history and physical exam is a foundational diagnostic procedure for AML.&lt;SEP&gt;A diagnostic procedure involving a record of a patient's health issues and a physical examination by a healthcare provider.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249892</data>
  <data key="d6"></data>
</node>
<node id="Complete Blood Count And Differential">
  <data key="d0">Complete Blood Count And Differential</data>
  <data key="d1">method</data>
  <data key="d2">A blood test that measures levels of red blood cells, white blood cells, and platelets, and counts different types of white blood cells.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249892</data>
  <data key="d6"></data>
</node>
<node id="Comprehensive Metabolic Panel">
  <data key="d0">Comprehensive Metabolic Panel</data>
  <data key="d1">method</data>
  <data key="d2">Comprehensive Metabolic Panel (CMP) is a blood test mentioned as part of the possible tests for AML.&lt;SEP&gt;A blood test measuring substances to assess kidney and liver function, electrolytes, and other metabolic factors.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249893</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow Aspirate And Biopsy">
  <data key="d0">Bone Marrow Aspirate And Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">Bone marrow aspirate and biopsy is a diagnostic procedure to obtain samples from the bone marrow for testing, including for AML biomarkers.&lt;SEP&gt;A procedure to extract bone marrow samples for AML biomarker and genetic testing.&lt;SEP&gt;Bone marrow aspirate and biopsy involve removing samples of bone and liquid bone marrow for testing, used to detect AML biomarkers and genetic changes.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249893</data>
  <data key="d6"></data>
</node>
<node id="Human Leukocyte Antigen Typing">
  <data key="d0">Human Leukocyte Antigen Typing</data>
  <data key="d1">method</data>
  <data key="d2">A test to identify HLA markers, often used in preparation for treatments like stem cell transplants.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249894</data>
  <data key="d6"></data>
</node>
<node id="Brain CT Without Contrast">
  <data key="d0">Brain CT Without Contrast</data>
  <data key="d1">method</data>
  <data key="d2">An imaging test used if a central nervous system bleed is suspected in an AML patient.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249894</data>
  <data key="d6"></data>
</node>
<node id="Brain MRI With Contrast">
  <data key="d0">Brain MRI With Contrast</data>
  <data key="d1">method</data>
  <data key="d2">An imaging test used if leukemic meningitis is suspected in an AML patient.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249895</data>
  <data key="d6"></data>
</node>
<node id="FDG-PET/CT">
  <data key="d0">FDG-PET/CT</data>
  <data key="d1">method</data>
  <data key="d2">FDG-PET/CT is a specific imaging test mentioned as potentially needed for treatment planning.&lt;SEP&gt;An imaging test used if extramedullary leukemia (outside blood and bone marrow) is suspected.&lt;SEP&gt;A combined PET/CT scan that uses a radiotracer called fluorodeoxyglucose.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249895</data>
  <data key="d6"></data>
</node>
<node id="Lumbar Puncture">
  <data key="d0">Lumbar Puncture</data>
  <data key="d1">method</data>
  <data key="d2">Lumbar puncture is a possible diagnostic procedure mentioned in the overview of testing for AML.&lt;SEP&gt;A procedure to collect cerebrospinal fluid for testing.&lt;SEP&gt;A lumbar puncture is a procedure to remove spinal fluid via a needle in the lower back to check for leukemia cells.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249896</data>
  <data key="d6"></data>
</node>
<node id="Heart Tests">
  <data key="d0">Heart Tests</data>
  <data key="d1">method</data>
  <data key="d2">Heart tests are a category of possible diagnostic procedures mentioned in the overview of testing for AML.&lt;SEP&gt;Tests to assess cardiac health, mentioned as part of general health evaluations for AML.&lt;SEP&gt;Heart or cardiac tests are used to see how well the heart works and to monitor treatment side effects.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249896</data>
  <data key="d6"></data>
</node>
<node id="Family History">
  <data key="d0">Family History</data>
  <data key="d1">method</data>
  <data key="d2">Information about the health issues, such as cancer or heart disease, diagnosed in blood relatives, used to assess genetic risk factors.&lt;SEP&gt;Family history is information about the health history of blood relatives, used to assess inherited risks for cancer and other diseases.&lt;SEP&gt;An assessment of health issues among blood relatives to inform treatment decisions and genetic risk.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249898</data>
  <data key="d6"></data>
</node>
<node id="Blood Clotting Tests">
  <data key="d0">Blood Clotting Tests</data>
  <data key="d1">method</data>
  <data key="d2">Blood clotting tests are a category of diagnostic tests mentioned for AML.&lt;SEP&gt;Tests to evaluate the blood's ability to clot, mentioned as part of AML diagnostic workup.&lt;SEP&gt;Tests known as a coagulation panel or DIC panel that screen for clotting problems by assessing proteins called coagulation factors made by the liver.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249898</data>
  <data key="d6"></data>
</node>
<node id="Uric Acid Test">
  <data key="d0">Uric Acid Test</data>
  <data key="d1">method</data>
  <data key="d2">A blood test measuring uric acid levels, part of the initial AML diagnostic panel.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249899</data>
  <data key="d6"></data>
</node>
<node id="Lactate Dehydrogenase Test">
  <data key="d0">Lactate Dehydrogenase Test</data>
  <data key="d1">method</data>
  <data key="d2">A blood test measuring LDH, an enzyme released by dying or fast-growing cells like tumors.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249899</data>
  <data key="d6"></data>
</node>
<node id="B12 And Folic Acid Test">
  <data key="d0">B12 And Folic Acid Test</data>
  <data key="d1">method</data>
  <data key="d2">Blood tests monitoring levels of Vitamin B12 and folic acid, needed for normal blood cell formation.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249900</data>
  <data key="d6"></data>
</node>
<node id="Red Blood Cells">
  <data key="d0">Red Blood Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Red blood cells (RBCs or erythrocytes) are blood cells that carry oxygen throughout the body.&lt;SEP&gt;Red Blood Cells, also known as erythrocytes or RBCs, are blood cells that carry oxygen throughout the body.&lt;SEP&gt;Cells in the blood that carry oxygen; their levels are measured by a Complete Blood Count.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249900</data>
  <data key="d6"></data>
</node>
<node id="White Blood Cells">
  <data key="d0">White Blood Cells</data>
  <data key="d1">concept</data>
  <data key="d2">White blood cells are cells of the immune system, including lymphocytes, which help fight infection.&lt;SEP&gt;White blood cells are blood cells that are part of the immune system.&lt;SEP&gt;White Blood Cells, also known as leukocytes or WBCs, are blood cells that fight infections and include granulocytes, monocytes, and lymphocytes.&lt;SEP&gt;Cells in the blood that fight infection; their levels and types are analyzed in a CBC differential.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249901</data>
  <data key="d6"></data>
</node>
<node id="Platelets">
  <data key="d0">Platelets</data>
  <data key="d1">concept</data>
  <data key="d2">Platelets are blood cells involved in preventing bleeding.&lt;SEP&gt;Platelets, also known as thrombocytes or PLTs, are blood cells that help control bleeding.&lt;SEP&gt;Blood cells that help with clotting to prevent or stop bleeding; their count is part of a CBC.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249901</data>
  <data key="d6"></data>
</node>
<node id="Blasts">
  <data key="d0">Blasts</data>
  <data key="d1">concept</data>
  <data key="d2">Blasts is a term used in CML to refer to the very immature cells, either myeloblasts or lymphoblasts.&lt;SEP&gt;Blasts, or myeloblasts, are immature white blood cells; in AML, abnormal blasts are found in the bone marrow or blood.&lt;SEP&gt;Abnormal, immature white blood cells (leukemia cells) that can be detected in the blood.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249903</data>
  <data key="d6"></data>
</node>
<node id="Hemoglobin">
  <data key="d0">Hemoglobin</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A protein in red blood cells that carries oxygen; its level is a key CBC measurement.&lt;SEP&gt;A molecule in blood that carries oxygen; its production requires iron.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249903</data>
  <data key="d6"></data>
</node>
<node id="Absolute Neutrophil Count">
  <data key="d0">Absolute Neutrophil Count</data>
  <data key="d1">data</data>
  <data key="d2">A measurement of neutrophils, cells that fight bacteria and protect from infections.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249905</data>
  <data key="d6"></data>
</node>
<node id="Creatinine">
  <data key="d0">Creatinine</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A waste product filtered by the kidneys; its blood level indicates kidney function.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249905</data>
  <data key="d6"></data>
</node>
<node id="Blood Urea Nitrogen">
  <data key="d0">Blood Urea Nitrogen</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A waste product filtered by the kidneys; high levels can signal poor kidney function.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249906</data>
  <data key="d6"></data>
</node>
<node id="Electrolytes">
  <data key="d0">Electrolytes</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Ions that help nerves, muscles, heart, and brain function; their levels are part of a CMP.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249906</data>
  <data key="d6"></data>
</node>
<node id="Liver Function Tests">
  <data key="d0">Liver Function Tests</data>
  <data key="d1">method</data>
  <data key="d2">Tests measuring chemicals made or processed by the liver to assess its health.&lt;SEP&gt;Liver function tests measure chemicals processed by the liver to check for liver damage or cancer spread.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249906</data>
  <data key="d6"></data>
</node>
<node id="Guide 1">
  <data key="d0">Guide 1</data>
  <data key="d1">content</data>
  <data key="d2">Guide 1 is a reference within the text that lists possible tests and procedures for AML, including medical history, CBC, CMP, and bone marrow tests.&lt;SEP&gt;A guide listing possible tests and procedures for AML, referenced at the beginning of the input text.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249906</data>
  <data key="d6"></data>
</node>
<node id="Uric Acid">
  <data key="d0">Uric Acid</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A substance measured in a blood test, part of the initial diagnostic panel for AML.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249908</data>
  <data key="d6"></data>
</node>
<node id="Lactate Dehydrogenase">
  <data key="d0">Lactate Dehydrogenase</data>
  <data key="d1">naturalobject</data>
  <data key="d2">An enzyme found in most cells, released by dying or fast-growing cells like tumors; its level is measured in a blood test.&lt;SEP&gt;Lactate dehydrogenase (LDH) is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249908</data>
  <data key="d6"></data>
</node>
<node id="B12">
  <data key="d0">B12</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Vitamin B12, a nutrient monitored for its role in normal red and white blood cell formation.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249909</data>
  <data key="d6"></data>
</node>
<node id="Folic Acid">
  <data key="d0">Folic Acid</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A vitamin (folate) that helps the body make new proteins and is needed for the normal formation of red and white blood cells; its levels are monitored.&lt;SEP&gt;Folate, a nutrient monitored for its role in normal red and white blood cell formation.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249909</data>
  <data key="d6"></data>
</node>
<node id="Red Blood Cell Transfusion">
  <data key="d0">Red Blood Cell Transfusion</data>
  <data key="d1">method</data>
  <data key="d2">A potential treatment indicated by hemoglobin levels, which may be needed during AML care.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249910</data>
  <data key="d6"></data>
</node>
<node id="Supplements">
  <data key="d0">Supplements</data>
  <data key="d1">artifact</data>
  <data key="d2">Over-the-counter products, herbals, or supplements that a patient takes, which can interact with prescribed medicines.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249910</data>
  <data key="d6"></data>
</node>
<node id="Medicines">
  <data key="d0">Medicines</data>
  <data key="d1">artifact</data>
  <data key="d2">Old, new, and prescribed drugs taken by a patient, relevant to their medical history and treatment.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249911</data>
  <data key="d6"></data>
</node>
<node id="Bile Ducts">
  <data key="d0">Bile Ducts</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Tubes that carry bile; they can become blocked, which is signaled by abnormal levels of liver-made chemicals.&lt;SEP&gt;Ducts that carry bile; blockage can be signaled by abnormal liver function test results.</data>
  <data key="d3">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249911</data>
  <data key="d6"></data>
</node>
<node id="Stage 4 Cancer">
  <data key="d0">Stage 4 Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 4 cancer is the most advanced numbered stage of cancer, though not all stage 4 cancers are metastatic.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249911</data>
  <data key="d6"></data>
</node>
<node id="TNM Staging">
  <data key="d0">TNM Staging</data>
  <data key="d1">method</data>
  <data key="d2">TNM staging is a system used to classify the extent of cancer, with numbered stages from 0 to 4 based on TNM scores.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249911</data>
  <data key="d6"></data>
</node>
<node id="Resectable Tumor">
  <data key="d0">Resectable Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A resectable tumor is a tumor that can be completely removed with surgery.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249912</data>
  <data key="d6"></data>
</node>
<node id="Unresectable Tumor">
  <data key="d0">Unresectable Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">An unresectable tumor is a tumor that cannot be completely removed with surgery, often because it involves major vessels or other critical structures.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249912</data>
  <data key="d6"></data>
</node>
<node id="Regional Lymph Node">
  <data key="d0">Regional Lymph Node</data>
  <data key="d1">concept</data>
  <data key="d2">Regional lymph nodes are lymph nodes found near a tumor; cancer found in these nodes is a lymph node metastasis, distinct from a distant metastasis.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249913</data>
  <data key="d6"></data>
</node>
<node id="Extranodal Extension">
  <data key="d0">Extranodal Extension</data>
  <data key="d1">concept</data>
  <data key="d2">Extranodal extension refers to cancer that has grown through and spread outside of a lymph node.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249913</data>
  <data key="d6"></data>
</node>
<node id="Acute Myeloid Leukemia">
  <data key="d0">Acute Myeloid Leukemia</data>
  <data key="d1">concept</data>
  <data key="d2">Acute myeloid leukemia (AML) is a type of blood cancer that starts in the stem cells of bone marrow, leading to a buildup of immature white blood cells called blasts.&lt;SEP&gt;A type of leukemia that starts in the bone marrow, diagnosed through bone marrow tests.&lt;SEP&gt;Acute Myeloid Leukemia (AML) is a cancer where immature white blood cells (myeloblasts) build up, preventing normal blood function.&lt;SEP&gt;Acute myeloid leukemia is a rare but serious side effect, a fast-growing cancer with too many immature white blood cells in the bone marrow and blood.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249913</data>
  <data key="d6"></data>
</node>
<node id="Myeloid Blasts">
  <data key="d0">Myeloid Blasts</data>
  <data key="d1">concept</data>
  <data key="d2">Myeloid blasts, or myeloblasts, are very immature white blood cells that, in AML, fail to mature, causing a buildup in bone marrow and blood.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249913</data>
  <data key="d6"></data>
</node>
<node id="Plasma">
  <data key="d0">Plasma</data>
  <data key="d1">concept</data>
  <data key="d2">Plasma is the clear, yellowish fluid component of blood, made mostly of water, in which blood cells float.&lt;SEP&gt;Plasma is a clear, yellowish fluid component of blood, made mostly of water, in which blood cells are suspended.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249915</data>
  <data key="d6"></data>
</node>
<node id="Carcinoma In Situ">
  <data key="d0">Carcinoma In Situ</data>
  <data key="d1">concept</data>
  <data key="d2">Carcinoma in situ (Tis) is an early stage of cancer where abnormal cells are present but have not invaded nearby tissues.&lt;SEP&gt;Carcinoma in situ (Tis) is a stage where cancerous cells are found only in the squamous cell layer and have not invaded deeper tissues.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249915</data>
  <data key="d6"></data>
</node>
<node id="T1 Tumor">
  <data key="d0">T1 Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A T1 tumor is 2 cm or less in size with a depth of invasion (DOI) of 5 mm or less.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249916</data>
  <data key="d6"></data>
</node>
<node id="T2 Tumor">
  <data key="d0">T2 Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A T2 tumor is either 2 cm or less with a DOI of more than 5 mm, or between 2 cm and 4 cm with a DOI of 10 mm or less.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249916</data>
  <data key="d6"></data>
</node>
<node id="T3 Tumor">
  <data key="d0">T3 Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A T3 tumor is either between 2 cm and 4 cm with a DOI of more than 10 mm, or larger than 4 cm with a DOI of 10 mm or less.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249917</data>
  <data key="d6"></data>
</node>
<node id="T4a Tumor">
  <data key="d0">T4a Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A T4a tumor indicates moderately advanced local disease, being more than 4 cm with a DOI of more than 10 mm, or invading nearby structures like bone or the maxillary sinus.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249917</data>
  <data key="d6"></data>
</node>
<node id="T4b Tumor">
  <data key="d0">T4b Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A T4b tumor indicates very advanced local disease, having invaded the masticator space, pterygoid plates, or skull base, or encasing the internal carotid artery.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249918</data>
  <data key="d6"></data>
</node>
<node id="Lymph Node Metastasis">
  <data key="d0">Lymph Node Metastasis</data>
  <data key="d1">concept</data>
  <data key="d2">Lymph node metastasis is cancer that has spread to a regional lymph node near the primary tumor.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249918</data>
  <data key="d6"></data>
</node>
<node id="Distant Metastasis">
  <data key="d0">Distant Metastasis</data>
  <data key="d1">concept</data>
  <data key="d2">Distant metastasis (M) is a factor in staging that describes if cancer has spread to distant organs like the lungs or liver.&lt;SEP&gt;Distant metastasis is cancer that has spread to parts of the body outside the neck region, distinct from regional lymph node metastasis.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249919</data>
  <data key="d6"></data>
</node>
<node id="Acute Promyelocytic Leukemia">
  <data key="d0">Acute Promyelocytic Leukemia</data>
  <data key="d1">concept</data>
  <data key="d2">Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) mentioned as being included in the informational book.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249919</data>
  <data key="d6"></data>
</node>
<node id="Blastic Plasmacytoid Dendritic Cell Neoplasm">
  <data key="d0">Blastic Plasmacytoid Dendritic Cell Neoplasm</data>
  <data key="d1">concept</data>
  <data key="d2">Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a condition mentioned as being included in the informational book alongside AML.&lt;SEP&gt;A suspected subtype of AML for which a lymph node or skin lesion biopsy might also be performed.</data>
  <data key="d3">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249920</data>
  <data key="d6"></data>
</node>
<node id="NCCN Patient Guides for Cancer App">
  <data key="d0">NCCN Patient Guides for Cancer App</data>
  <data key="d1">artifact</data>
  <data key="d2">The NCCN Patient Guides for Cancer app is a resource for information on managing cancer treatment side effects.&lt;SEP&gt;The NCCN Patient Guides for Cancer app is a digital tool that provides patient guidelines for cancer, including information on head and neck cancers.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249920</data>
  <data key="d6"></data>
</node>
<node id="Throat">
  <data key="d0">Throat</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The throat is located in the back of the mouth and neck, and cancer can form in a part of it called the oropharynx.&lt;SEP&gt;The throat is a hollow, muscular tube in the neck that serves as a passageway for air to the lungs and food to the esophagus, containing structures like the tonsils, pharynx, and larynx.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249921</data>
  <data key="d6"></data>
</node>
<node id="Oropharynx">
  <data key="d0">Oropharynx</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The oropharynx is part of the throat that includes the back of the roof of the mouth (soft palate) and is a site where cancer can form.&lt;SEP&gt;The oropharynx is a part of the throat that includes the soft palate, tonsils, side and back walls of the throat, and the base of the tongue; it is the primary site for throat cancer discussed in the text.&lt;SEP&gt;The oropharynx is the part of the throat that includes the soft palate, tonsils, side and back walls of the throat, and the base of the tongue.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249921</data>
  <data key="d6"></data>
</node>
<node id="Pharynx">
  <data key="d0">Pharynx</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The pharynx is a hollow, muscular tube in the neck with three parts: nasopharynx, oropharynx, and hypopharynx; it is part of the throat where cancer can occur.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249923</data>
  <data key="d6"></data>
</node>
<node id="Head and Neck Cancers">
  <data key="d0">Head and Neck Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Head and neck cancers are a group of cancers that arise in the head or neck area, including the mouth, oropharynx, nasal cavity, nasopharynx, larynx, and hypopharynx.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249923</data>
  <data key="d6"></data>
</node>
<node id="Squamous Cell Carcinoma of the Head and Neck">
  <data key="d0">Squamous Cell Carcinoma of the Head and Neck</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell carcinoma of the head and neck is the most common type of head and neck cancer, forming in the thin, flat cells of the mucus membranes of the mouth, nose, and throat.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249924</data>
  <data key="d6"></data>
</node>
<node id="Throat Cancer">
  <data key="d0">Throat Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Throat cancer starts in the oropharynx, with squamous cell carcinoma being the most common type, forming tumors that can grow into nearby tissues and spread to lymph nodes or other organs.&lt;SEP&gt;Throat cancer is a disease for which testing and treatment planning are discussed.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249924</data>
  <data key="d6"></data>
</node>
<node id="Primary Tumor">
  <data key="d0">Primary Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A primary tumor is a mass of cancer cells that forms within the oropharynx in cases of throat cancer.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249925</data>
  <data key="d6"></data>
</node>
<node id="Testing for Throat Cancer">
  <data key="d0">Testing for Throat Cancer</data>
  <data key="d1">method</data>
  <data key="d2">Testing for throat cancer involves various procedures including general health tests, fertility assessment, p16 (HPV) testing, imaging, scoping, biopsy, and biomarker testing to plan treatment.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249925</data>
  <data key="d6"></data>
</node>
<node id="Immune Checkpoint Inhibitors">
  <data key="d0">Immune Checkpoint Inhibitors</data>
  <data key="d1">method</data>
  <data key="d2">Immune Checkpoint Inhibitors are a type of immunotherapy treatment for cancer, with side effects guidelines provided by NCCN.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249926</data>
  <data key="d6"></data>
</node>
<node id="Soft Palate">
  <data key="d0">Soft Palate</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The soft palate is the soft, back part of the roof of the mouth and is included in the oropharynx.&lt;SEP&gt;The soft palate is the back of the roof of the mouth and is part of the oropharynx.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249926</data>
  <data key="d6"></data>
</node>
<node id="Tonsils">
  <data key="d0">Tonsils</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The Tonsils are small masses of lymph tissue at the back of the throat that help trap disease-causing germs.&lt;SEP&gt;The tonsils are structures located in the throat and are part of the oropharynx.&lt;SEP&gt;The tonsils are part of the oropharynx.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249927</data>
  <data key="d6"></data>
</node>
<node id="Base of the Tongue">
  <data key="d0">Base of the Tongue</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The base of the tongue is the back portion of the tongue found in the throat and is part of the oropharynx.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249927</data>
  <data key="d6"></data>
</node>
<node id="Larynx">
  <data key="d0">Larynx</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The larynx, also known as the voice box, is a specific part of the throat that can be affected by tumor growth from throat cancer.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249928</data>
  <data key="d6"></data>
</node>
<node id="p16 (HPV) Testing">
  <data key="d0">p16 (HPV) Testing</data>
  <data key="d1">method</data>
  <data key="d2">p16 (HPV) testing is a specific diagnostic test mentioned as part of the testing process for throat cancer.</data>
  <data key="d3">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249928</data>
  <data key="d6"></data>
</node>
<node id="Dentists">
  <data key="d0">Dentists</data>
  <data key="d1">person</data>
  <data key="d2">Dentists are professionals who commonly perform dental procedures such as extractions and implants.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249929</data>
  <data key="d6"></data>
</node>
<node id="Oral Surgeons">
  <data key="d0">Oral Surgeons</data>
  <data key="d1">person</data>
  <data key="d2">Oral surgeons are professionals who commonly perform dental procedures such as extractions and implants.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249929</data>
  <data key="d6"></data>
</node>
<node id="Ear Nose And Throat Doctor">
  <data key="d0">Ear Nose And Throat Doctor</data>
  <data key="d1">person</data>
  <data key="d2">An ear, nose, and throat (ENT) doctor is a specialist to consult if one feels something different around the neck, glands, tongue, or mouth area.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249930</data>
  <data key="d6"></data>
</node>
<node id="Dentist">
  <data key="d0">Dentist</data>
  <data key="d1">person</data>
  <data key="d2">A dentist is a professional who should be informed about a patient's head and neck cancer and who performs regular dental cleanings and checkups.&lt;SEP&gt;A dentist is a healthcare professional whom a patient should inform about their head and neck cancer diagnosis and with whom they should maintain regular checkups.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249930</data>
  <data key="d6"></data>
</node>
<node id="SmokeFree.gov">
  <data key="d0">SmokeFree.gov</data>
  <data key="d1">content</data>
  <data key="d2">SmokeFree.gov is a website offering online support for quitting smoking.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249931</data>
  <data key="d6"></data>
</node>
<node id="BeTobaccoFree.gov">
  <data key="d0">BeTobaccoFree.gov</data>
  <data key="d1">content</data>
  <data key="d2">BeTobaccoFree.gov is a website offering online support for quitting tobacco use.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249931</data>
  <data key="d6"></data>
</node>
<node id="CDC.gov/tobacco">
  <data key="d0">CDC.gov/tobacco</data>
  <data key="d1">content</data>
  <data key="d2">CDC.gov/tobacco is a website offering online support and information about tobacco.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249932</data>
  <data key="d6"></data>
</node>
<node id="Fine Needle Biopsy">
  <data key="d0">Fine Needle Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">Fine needle biopsy (FNB) is a type of biopsy that uses a needle to remove a sample of tumor or lymph node.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249932</data>
  <data key="d6"></data>
</node>
<node id="Deoxyribonucleic Acid">
  <data key="d0">Deoxyribonucleic Acid</data>
  <data key="d1">concept</data>
  <data key="d2">Deoxyribonucleic acid (DNA) molecules are tightly packaged into chromosomes and contain genetic information in a cell.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249932</data>
  <data key="d6"></data>
</node>
<node id="Chromosome">
  <data key="d0">Chromosome</data>
  <data key="d1">concept</data>
  <data key="d2">A chromosome is a structure that contains most of the genetic information in a cell, with normal human cells containing 23 pairs.&lt;SEP&gt;Chromosomes contain most of the genetic information in a cell, with normal human cells having 23 pairs (46 total); AML cells can have changes in chromosomes visible under a microscope.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249932</data>
  <data key="d6"></data>
</node>
<node id="Gene">
  <data key="d0">Gene</data>
  <data key="d1">concept</data>
  <data key="d2">Genes are coded instructions for the proteins cells make, with each chromosome containing thousands of genes.&lt;SEP&gt;Genes are coded instructions for proteins, located on chromosomes; AML cells can have changes in genes, such as mutations, which are identified in testing.&lt;SEP&gt;A gene can have mutations that affect how it works, which can be detected by methods like Next-Generation Sequencing.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249933</data>
  <data key="d6"></data>
</node>
<node id="Mutation">
  <data key="d0">Mutation</data>
  <data key="d1">concept</data>
  <data key="d2">A mutation is when something goes wrong in the genetic code.&lt;SEP&gt;A mutation is a change in the genetic code; in AML, mutation testing looks for unique changes like deletions, insertions, inversions, amplifications, translocations, and point mutations.&lt;SEP&gt;A mutation is a change in a gene that might affect how the gene works, detectable by NGS.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249933</data>
  <data key="d6"></data>
</node>
<node id="Molecular Testing">
  <data key="d0">Molecular Testing</data>
  <data key="d1">method</data>
  <data key="d2">Molecular testing, also called tumor profiling, is a type of biomarker test used in advanced or metastatic cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249935</data>
  <data key="d6"></data>
</node>
<node id="Tumor Profiling">
  <data key="d0">Tumor Profiling</data>
  <data key="d1">method</data>
  <data key="d2">Tumor profiling, also called molecular testing, is a type of biomarker test used in advanced or metastatic cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249935</data>
  <data key="d6"></data>
</node>
<node id="Tumor Sequencing">
  <data key="d0">Tumor Sequencing</data>
  <data key="d1">method</data>
  <data key="d2">Tumor sequencing is a type of biomarker test used in advanced or metastatic cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249936</data>
  <data key="d6"></data>
</node>
<node id="Gene Expression Profiling">
  <data key="d0">Gene Expression Profiling</data>
  <data key="d1">method</data>
  <data key="d2">Gene expression profiling is a type of biomarker test used in advanced or metastatic cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249936</data>
  <data key="d6"></data>
</node>
<node id="Genomic Testing">
  <data key="d0">Genomic Testing</data>
  <data key="d1">method</data>
  <data key="d2">Genomic testing is a type of biomarker test used in advanced or metastatic cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249937</data>
  <data key="d6"></data>
</node>
<node id="Mouth Cancers">
  <data key="d0">Mouth Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Mouth cancers are a type of cancer for which molecular testing has limited value due to few targeted drugs.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249937</data>
  <data key="d6"></data>
</node>
<node id="MSI-H/dMMR Mutation">
  <data key="d0">MSI-H/dMMR Mutation</data>
  <data key="d1">concept</data>
  <data key="d2">MSI-H/dMMR mutation refers to microsatellite instability-high or deficient mismatch repair, which occurs when errors in DNA are not fixed.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249937</data>
  <data key="d6"></data>
</node>
<node id="Microsatellite">
  <data key="d0">Microsatellite</data>
  <data key="d1">concept</data>
  <data key="d2">Microsatellites are short, repeated strings of DNA.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249937</data>
  <data key="d6"></data>
</node>
<node id="Mismatch Repair Proteins">
  <data key="d0">Mismatch Repair Proteins</data>
  <data key="d1">concept</data>
  <data key="d2">Mismatch repair (MMR) proteins fix errors or defects in DNA.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249938</data>
  <data key="d6"></data>
</node>
<node id="PD-L1 Testing">
  <data key="d0">PD-L1 Testing</data>
  <data key="d1">method</data>
  <data key="d2">PD-L1 testing measures the expression of the PD-L1 protein on cancer cells to guide treatment with immune checkpoint inhibitors.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249938</data>
  <data key="d6"></data>
</node>
<node id="Programmed Death Ligand 1">
  <data key="d0">Programmed Death Ligand 1</data>
  <data key="d1">concept</data>
  <data key="d2">Programmed death ligand 1 (PD-L1) is an immune protein that can cause immune cells to ignore cancer cells.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249939</data>
  <data key="d6"></data>
</node>
<node id="Combined Positive Score">
  <data key="d0">Combined Positive Score</data>
  <data key="d1">concept</data>
  <data key="d2">The combined positive score (CPS) measures immune proteins in a tumor and the immune system to assess PD-L1 expression.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249939</data>
  <data key="d6"></data>
</node>
<node id="Tumor Mutational Burden">
  <data key="d0">Tumor Mutational Burden</data>
  <data key="d1">concept</data>
  <data key="d2">Tumor mutational burden-high (TMB-H) is defined as 10 or more mutations per million base pairs of tumor DNA.&lt;SEP&gt;Tumor mutational burden (TMB) is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249940</data>
  <data key="d6"></data>
</node>
<node id="Tumor Mutation Testing">
  <data key="d0">Tumor Mutation Testing</data>
  <data key="d1">method</data>
  <data key="d2">Tumor mutation testing uses a sample of tumor or blood to see if cancer cells have specific DNA mutations for targeted therapy.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249940</data>
  <data key="d6"></data>
</node>
<node id="Tumor Genomic Aberration Testing">
  <data key="d0">Tumor Genomic Aberration Testing</data>
  <data key="d1">method</data>
  <data key="d2">Tumor genomic aberration testing uses a sample of tumor or blood to see if cancer cells have specific DNA mutations for targeted therapy.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249941</data>
  <data key="d6"></data>
</node>
<node id="Imaging Studies">
  <data key="d0">Imaging Studies</data>
  <data key="d1">method</data>
  <data key="d2">Imaging studies are diagnostic techniques that create visual representations of the body's internal structures.&lt;SEP&gt;Imaging studies, such as CT scans and MRI, are used in testing to help determine the cancer stage and treatment plan.&lt;SEP&gt;Imaging studies are diagnostic procedures whose results may help determine a cancer treatment plan.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249941</data>
  <data key="d6"></data>
</node>
<node id="Online Portals">
  <data key="d0">Online Portals</data>
  <data key="d1">method</data>
  <data key="d2">Online portals are digital platforms that provide a way to access medical test results.&lt;SEP&gt;Online portals are digital platforms used by patients to access their medical test results.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249943</data>
  <data key="d6"></data>
</node>
<node id="Nicotine">
  <data key="d0">Nicotine</data>
  <data key="d1">concept</data>
  <data key="d2">Nicotine is the chemical in tobacco that causes addiction and makes quitting smoking challenging.&lt;SEP&gt;Nicotine is the chemical in tobacco that causes addiction and makes quitting smoking or vaping challenging.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249943</data>
  <data key="d6"></data>
</node>
<node id="Smoking">
  <data key="d0">Smoking</data>
  <data key="d1">concept</data>
  <data key="d2">Smoking tobacco or using e-cigarettes can limit cancer treatment effectiveness, increase surgical side effects, and raise the risk of other cancers.&lt;SEP&gt;Smoking increases the risk of cancers, limits treatment effectiveness, prevents wound healing, and increases surgical side effects.&lt;SEP&gt;Smoking is a behavior that negatively affects cancer treatment outcomes and increases treatment toxicity.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249944</data>
  <data key="d6"></data>
</node>
<node id="Vaping">
  <data key="d0">Vaping</data>
  <data key="d1">concept</data>
  <data key="d2">Vaping increases the risk of cancers, limits treatment effectiveness, prevents wound healing, and increases surgical side effects.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249944</data>
  <data key="d6"></data>
</node>
<node id="Cannabis Use">
  <data key="d0">Cannabis Use</data>
  <data key="d1">concept</data>
  <data key="d2">Cannabis use might affect the amount of anesthesia used during surgery.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249945</data>
  <data key="d6"></data>
</node>
<node id="Nicotine Withdrawal">
  <data key="d0">Nicotine Withdrawal</data>
  <data key="d1">concept</data>
  <data key="d2">Nicotine withdrawal is a challenging process for people who smoke or vape, exacerbated by the stress of having cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249945</data>
  <data key="d6"></data>
</node>
<node id="Dentures">
  <data key="d0">Dentures</data>
  <data key="d1">artifact</data>
  <data key="d2">Dentures are a type of dental prosthesis for which treatment planning may involve dental procedures.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249946</data>
  <data key="d6"></data>
</node>
<node id="Braces">
  <data key="d0">Braces</data>
  <data key="d1">artifact</data>
  <data key="d2">Braces are orthodontic devices for which treatment planning may involve dental procedures.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249946</data>
  <data key="d6"></data>
</node>
<node id="Implants">
  <data key="d0">Implants</data>
  <data key="d1">artifact</data>
  <data key="d2">Implants are dental prostheses for which treatment planning may involve dental procedures.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249947</data>
  <data key="d6"></data>
</node>
<node id="Anesthesia">
  <data key="d0">Anesthesia</data>
  <data key="d1">concept</data>
  <data key="d2">Anesthesia is used during surgery, and its required amount might be affected by cannabis use.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249947</data>
  <data key="d6"></data>
</node>
<node id="Immune Checkpoint Inhibitor Therapy">
  <data key="d0">Immune Checkpoint Inhibitor Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Immune checkpoint inhibitor therapy is a cancer treatment that targets proteins like PD-1 and PD-L1, used alone or with chemotherapy.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249947</data>
  <data key="d6"></data>
</node>
<node id="Programmed Death Protein 1">
  <data key="d0">Programmed Death Protein 1</data>
  <data key="d1">concept</data>
  <data key="d2">Programmed death protein 1 (PD-1) is a protein targeted by immune checkpoint inhibitors for treating certain cancers.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249947</data>
  <data key="d6"></data>
</node>
<node id="Fertility">
  <data key="d0">Fertility</data>
  <data key="d1">concept</data>
  <data key="d2">Fertility can be affected by cancer treatment, and patients should discuss concerns with their care team.&lt;SEP&gt;Fertility is the ability to conceive children, which can be affected by cancer treatment.&lt;SEP&gt;The ability to have children, which can be affected by targeted therapy and other systemic cancer treatments.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249948</data>
  <data key="d6"></data>
</node>
<node id="Dental Procedures">
  <data key="d0">Dental Procedures</data>
  <data key="d1">method</data>
  <data key="d2">Dental procedures are performed on teeth, jaws, and surrounding structures and are used to plan treatment for dentures, braces, extractions, and implants.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249948</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Cancers">
  <data key="d0">Head And Neck Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Head and neck cancers are a type of cancer for which stopping smoking or vaping is essential to maximize cure chances and minimize side effects.&lt;SEP&gt;Head and neck cancers is a category of cancers that includes throat cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249949</data>
  <data key="d6"></data>
</node>
<node id="Lung Cancers">
  <data key="d0">Lung Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Lung cancers are a type of cancer whose risk is increased by a history of smoking or vaping nicotine.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249949</data>
  <data key="d6"></data>
</node>
<node id="Other Cancers">
  <data key="d0">Other Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Other cancers are types of cancer whose risk is increased by a history of smoking or vaping nicotine.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249951</data>
  <data key="d6"></data>
</node>
<node id="Cancer Treatment">
  <data key="d0">Cancer Treatment</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer treatment is based on the tumor location and cancer stage, and planning starts with testing.&lt;SEP&gt;Cancer treatment involves medical procedures to manage or eliminate cancer, which can damage sperm and affect fertility.&lt;SEP&gt;Cancer treatment effectiveness can be limited by smoking and vaping, which also increase surgical side effects.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249951</data>
  <data key="d6"></data>
</node>
<node id="Wound Healing">
  <data key="d0">Wound Healing</data>
  <data key="d1">concept</data>
  <data key="d2">Wound healing is a biological process that can be prevented by smoking and vaping.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249952</data>
  <data key="d6"></data>
</node>
<node id="Cytology">
  <data key="d0">Cytology</data>
  <data key="d1">method</data>
  <data key="d2">Cytology is the examination of cells using a microscope, performed by a pathologist to confirm cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249952</data>
  <data key="d6"></data>
</node>
<node id="Tumor Histology">
  <data key="d0">Tumor Histology</data>
  <data key="d1">concept</data>
  <data key="d2">Tumor histology is the cancer subtype determined by a pathologist after examining biopsy samples.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249953</data>
  <data key="d6"></data>
</node>
<node id="Lymph Node">
  <data key="d0">Lymph Node</data>
  <data key="d1">concept</data>
  <data key="d2">A lymph node is a structure that can be biopsied using a needle, potentially guided by ultrasound or CT scan, and is a site of cancer metastasis.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249953</data>
  <data key="d6"></data>
</node>
<node id="Cell">
  <data key="d0">Cell</data>
  <data key="d1">concept</data>
  <data key="d2">A cell is the basic unit of life containing DNA packaged into chromosomes and genes.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249954</data>
  <data key="d6"></data>
</node>
<node id="Protein">
  <data key="d0">Protein</data>
  <data key="d1">concept</data>
  <data key="d2">Proteins are molecules made by cells based on instructions from genes, and their presence can be tested in biomarker analysis.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249954</data>
  <data key="d6"></data>
</node>
<node id="Advanced Cancers">
  <data key="d0">Advanced Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Advanced cancers are a stage of disease for which biomarker tests like molecular testing are generally used.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249954</data>
  <data key="d6"></data>
</node>
<node id="Metastatic Cancers">
  <data key="d0">Metastatic Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Metastatic cancers are a stage of disease for which TMB-H cancers are often treated with immune checkpoint inhibitors.&lt;SEP&gt;Metastatic cancers are widely spread cancers for which biomarker tests like molecular testing are generally used.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249954</data>
  <data key="d6"></data>
</node>
<node id="Drugs">
  <data key="d0">Drugs</data>
  <data key="d1">artifact</data>
  <data key="d2">Drugs are therapeutic substances, with few specifically targeting the genetic mutations causing mouth cancers to grow and spread.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249955</data>
  <data key="d6"></data>
</node>
<node id="Microsatellite Instability-High">
  <data key="d0">Microsatellite Instability-High</data>
  <data key="d1">concept</data>
  <data key="d2">Microsatellite instability-high (MSI-H) is a condition where cancer cells have more than a normal number of microsatellites, often due to dMMR genes.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249955</data>
  <data key="d6"></data>
</node>
<node id="Deficient Mismatch Repair">
  <data key="d0">Deficient Mismatch Repair</data>
  <data key="d1">concept</data>
  <data key="d2">Deficient mismatch repair (dMMR) refers to genes that prevent errors in DNA microsatellites from being fixed.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249957</data>
  <data key="d6"></data>
</node>
<node id="Immune Protein">
  <data key="d0">Immune Protein</data>
  <data key="d1">concept</data>
  <data key="d2">An immune protein, such as PD-L1, can be expressed on cancer cells to suppress the anti-tumor immune response.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249957</data>
  <data key="d6"></data>
</node>
<node id="Immune Cells">
  <data key="d0">Immune Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Immune cells are body cells that can be caused to ignore cancer cells by the PD-L1 protein.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249957</data>
  <data key="d6"></data>
</node>
<node id="Anti-Tumor Immune Response">
  <data key="d0">Anti-Tumor Immune Response</data>
  <data key="d1">concept</data>
  <data key="d2">The anti-tumor immune response is the body's immune defense against cancer, which can be suppressed by PD-L1 protein.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249957</data>
  <data key="d6"></data>
</node>
<node id="Immune System">
  <data key="d0">Immune System</data>
  <data key="d1">concept</data>
  <data key="d2">A body system that fights infection and disease; a weakened immune system increases the risk of getting squamous cell skin cancer.&lt;SEP&gt;The immune system is the body's defense network against infection and disease, which includes the lymphatic system.&lt;SEP&gt;The immune system is the body's defense network, and its proteins are measured by the combined positive score (CPS) in PD-L1 testing.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249958</data>
  <data key="d6"></data>
</node>
<node id="Unresectable Cancers">
  <data key="d0">Unresectable Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Unresectable cancers are tumors that cannot be surgically removed and for which TMB-H cancers are often treated with immune checkpoint inhibitors.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249958</data>
  <data key="d6"></data>
</node>
<node id="Genetic Testing">
  <data key="d0">Genetic Testing</data>
  <data key="d1">method</data>
  <data key="d2">Genetic testing is for inherited mutations from biological parents and is different from tumor mutation testing.&lt;SEP&gt;Genetic testing identifies mutations in genes like BRCA1 and BRCA2 to assess hereditary cancer risk and guide treatment decisions like maintenance therapy.&lt;SEP&gt;Genetic testing of the blood is recommended for everyone diagnosed with ovarian cancer to check for inherited BRCA mutations.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249960</data>
  <data key="d6"></data>
</node>
<node id="Specific Therapies">
  <data key="d0">Specific Therapies</data>
  <data key="d1">method</data>
  <data key="d2">Specific therapies are targeted treatments that may be used against certain mutations or proteins found in a tumor.&lt;SEP&gt;Specific therapies are treatments that can target mutations identified through tumor mutation testing.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249960</data>
  <data key="d6"></data>
</node>
<node id="Neck">
  <data key="d0">Neck</data>
  <data key="d1">location</data>
  <data key="d2">The neck is one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.&lt;SEP&gt;The neck is an area of the body where one might feel something different, prompting a visit to an ENT doctor.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249961</data>
  <data key="d6"></data>
</node>
<node id="Glands">
  <data key="d0">Glands</data>
  <data key="d1">location</data>
  <data key="d2">Glands are structures in the body, around the neck or mouth area, where one might feel something different.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249961</data>
  <data key="d6"></data>
</node>
<node id="Mouth Area">
  <data key="d0">Mouth Area</data>
  <data key="d1">location</data>
  <data key="d2">The mouth area is a region of the body where one might feel something different, prompting a visit to an ENT doctor.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249962</data>
  <data key="d6"></data>
</node>
<node id="Jaw">
  <data key="d0">Jaw</data>
  <data key="d1">location</data>
  <data key="d2">The jaw is a part of the body whose health can be affected by head and neck cancer and its treatment.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249962</data>
  <data key="d6"></data>
</node>
<node id="Teeth">
  <data key="d0">Teeth</data>
  <data key="d1">location</data>
  <data key="d2">Teeth are structures whose health can be affected by head and neck cancer and its treatment.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249963</data>
  <data key="d6"></data>
</node>
<node id="Regular Dental Cleanings">
  <data key="d0">Regular Dental Cleanings</data>
  <data key="d1">method</data>
  <data key="d2">Regular dental cleanings are maintenance procedures that patients should keep up with, informing their dentist about their cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249963</data>
  <data key="d6"></data>
</node>
<node id="Regular Dental Checkups">
  <data key="d0">Regular Dental Checkups</data>
  <data key="d1">method</data>
  <data key="d2">Regular dental checkups are maintenance procedures that patients should keep up with, informing their dentist about their cancer.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249964</data>
  <data key="d6"></data>
</node>
<node id="Pregnancy">
  <data key="d0">Pregnancy</data>
  <data key="d1">concept</data>
  <data key="d2">Pregnancy is a state that patients planning for should discuss with their care team, as cancer treatment can affect fertility.</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249964</data>
  <data key="d6"></data>
</node>
<node id="Basal Cell Skin Cancer">
  <data key="d0">Basal Cell Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Basal cell skin cancer, also known as basal cell carcinoma (BCC), is the most common type of skin cancer, originating from abnormal basal cells in the epidermis and often developing in sun-exposed areas.&lt;SEP&gt;Basal cell skin cancer is a type of skin cancer that can recur in its original location or metastasize to lymph nodes or distant body parts.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249965</data>
  <data key="d6"></data>
</node>
<node id="Treatment By Risk And Recurrence">
  <data key="d0">Treatment By Risk And Recurrence</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 4: Treatment by risk and recurrence provides information on how to treat basal cell skin cancer based on its risk of returning or spreading.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249965</data>
  <data key="d6"></data>
</node>
<node id="Types Of Treatment">
  <data key="d0">Types Of Treatment</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 3: Types of treatment provides information on the various methods available for treating cancer.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249966</data>
  <data key="d6"></data>
</node>
<node id="Questions To Ask">
  <data key="d0">Questions To Ask</data>
  <data key="d1">content</data>
  <data key="d2">Questions to ask is a section at the end of each chapter in the NCCN Guidelines for Patients, providing suggested questions for patients to discuss with their care team.&lt;SEP&gt;Questions to Ask is a section at the end of each chapter in the NCCN Guidelines for Patients book, providing suggested questions for patients to discuss with their care team.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249966</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Tumors">
  <data key="d0">Adrenal Tumors</data>
  <data key="d1">concept</data>
  <data key="d2">A specific type of cancer mentioned in the context of patient guidelines and for which certain PET scans can be helpful.&lt;SEP&gt;Adrenal tumors are growths that form in one or both adrenal glands; they can be benign or malignant and are often found incidentally during imaging tests.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249967</data>
  <data key="d6"></data>
</node>
<node id="Cushing Syndrome">
  <data key="d0">Cushing Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">Cushing syndrome is a condition caused by an adrenal adenoma producing too much of the hormone cortisol.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249967</data>
  <data key="d6"></data>
</node>
<node id="Patient">
  <data key="d0">Patient</data>
  <data key="d1">person</data>
  <data key="d2">The patient is the individual diagnosed with cancer who is encouraged to advocate for themselves, ask questions, and make shared decisions with their care team.&lt;SEP&gt;The patient is the individual with cancer who is considering treatment options, including clinical trials and standard care.&lt;SEP&gt;The patient is the individual undergoing testing, treatment planning, and care for mouth cancer, who is advised to manage appointments, ask questions, and seek support.&lt;SEP&gt;The patient is the individual undergoing cancer diagnosis, treatment, and care management as described in the text.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249969</data>
  <data key="d6"></data>
</node>
<node id="Adrenal Adenoma">
  <data key="d0">Adrenal Adenoma</data>
  <data key="d1">concept</data>
  <data key="d2">An adrenal adenoma is a benign tumor of the adrenal gland; a subtype called an aldosteronoma produces too much aldosterone, and another subtype can cause Cushing syndrome by producing excess cortisol.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249969</data>
  <data key="d6"></data>
</node>
<node id="Aldosteronoma">
  <data key="d0">Aldosteronoma</data>
  <data key="d1">concept</data>
  <data key="d2">An aldosteronoma is an adrenal adenoma that produces an excessive amount of the hormone aldosterone.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249971</data>
  <data key="d6"></data>
</node>
<node id="Medical And Family History">
  <data key="d0">Medical And Family History</data>
  <data key="d1">data</data>
  <data key="d2">Medical and family history is part of the diagnostic process for basal cell skin cancer, used alongside physical exams and biopsies.</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249971</data>
  <data key="d6"></data>
</node>
<node id="Health Organization Classification">
  <data key="d0">Health Organization Classification</data>
  <data key="d1">organization</data>
  <data key="d2">The Health Organization Classification, referred to as WHO5, is a system for classifying follicular lymphoma grades.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249971</data>
  <data key="d6"></data>
</node>
<node id="International Consensus Classification">
  <data key="d0">International Consensus Classification</data>
  <data key="d1">organization</data>
  <data key="d2">The International Consensus Classification (ICC) is a system that groups follicular lymphoma grades for treatment purposes.&lt;SEP&gt;The International Consensus Classification (ICC) is a system that groups follicular lymphoma grades 1 and 2 as classic FL.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249971</data>
  <data key="d6"></data>
</node>
<node id="Classic Follicular Lymphoma">
  <data key="d0">Classic Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Classic follicular lymphoma (cFL) is a treatment category for FL grades 1, 2, and sometimes 3A, as defined by classification systems.&lt;SEP&gt;Classic Follicular Lymphoma (cFL) is a type of slow-growing lymphoma, defined as grades 1 and 2 by ICC and grades 1, 2, and 3A by WHO5.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249973</data>
  <data key="d6"></data>
</node>
<node id="Follicular Lymphoma Grade 1">
  <data key="d0">Follicular Lymphoma Grade 1</data>
  <data key="d1">concept</data>
  <data key="d2">Follicular Lymphoma Grade 1 is a classification of lymphoma treated as classic FL according to the ICC.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249973</data>
  <data key="d6"></data>
</node>
<node id="Follicular Lymphoma Grade 2">
  <data key="d0">Follicular Lymphoma Grade 2</data>
  <data key="d1">concept</data>
  <data key="d2">Follicular Lymphoma Grade 2 is a classification of lymphoma treated as classic FL according to the ICC.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249974</data>
  <data key="d6"></data>
</node>
<node id="Follicular Lymphoma Grade 3A">
  <data key="d0">Follicular Lymphoma Grade 3A</data>
  <data key="d1">concept</data>
  <data key="d2">Follicular Lymphoma Grade 3A is a classification that may be treated as classic FL or DLBCL depending on the cancer center and cell testing.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249974</data>
  <data key="d6"></data>
</node>
<node id="Follicular Lymphoma Grade 3B">
  <data key="d0">Follicular Lymphoma Grade 3B</data>
  <data key="d1">concept</data>
  <data key="d2">Follicular Lymphoma Grade 3B (FL3B), called follicular large B cell lymphoma in WHO5, is rare and treated as DLBCL.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249975</data>
  <data key="d6"></data>
</node>
<node id="Diffuse Large B-Cell Lymphoma">
  <data key="d0">Diffuse Large B-Cell Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Diffuse Large B-Cell Lymphoma is a type of fast-growing cancer that Nodular Lymphocyte-Predominant Hodgkin Lymphoma can transform into over time.&lt;SEP&gt;Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma with germinal centers distinct from those in follicular lymphoma.&lt;SEP&gt;Diffuse Large B-Cell Lymphoma (DLBCL) is a fast-growing, aggressive lymphoma into which FL can transform.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249975</data>
  <data key="d6"></data>
</node>
<node id="Uncommon Follicular Lymphoma">
  <data key="d0">Uncommon Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Uncommon Follicular Lymphoma (uFL) has uncommon pathologic features or is t(14;18)-negative and is treated as classic FL in the book.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249977</data>
  <data key="d6"></data>
</node>
<node id="Pediatric-Type Follicular Lymphoma">
  <data key="d0">Pediatric-Type Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Pediatric-Type Follicular Lymphoma (PTFL) usually occurs in children, can occur in adults, and typically involves one enlarged lymph node in the head/neck.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249977</data>
  <data key="d6"></data>
</node>
<node id="Transformed Follicular Lymphoma">
  <data key="d0">Transformed Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Transformed follicular lymphoma is a potential progression of FL that may require different treatment strategies.&lt;SEP&gt;Transformed Follicular Lymphoma occurs when FL transforms into the more aggressive DLBCL, which can happen before, during, or after treatment.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249978</data>
  <data key="d6"></data>
</node>
<node id="Non-Hodgkin Lymphoma">
  <data key="d0">Non-Hodgkin Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Non-Hodgkin lymphoma (NHL) is a cancer of lymphocytes that begins in the lymphatic system.&lt;SEP&gt;Non-Hodgkin Lymphoma (NHL) is a cancer that develops from lymphocytes, a type of white blood cell.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249978</data>
  <data key="d6"></data>
</node>
<node id="Lymphatic System">
  <data key="d0">Lymphatic System</data>
  <data key="d1">concept</data>
  <data key="d2">The lymphatic system is part of the immune system, made of tissues and organs that help fight infection and disease.&lt;SEP&gt;The Lymphatic System is part of the immune system, made of tissues and organs that help fight infection and disease, including lymph nodes, spleen, bone marrow, thymus, and tonsils.&lt;SEP&gt;The lymphatic system is a major part of the body's immune system, including lymph nodes, vessels, and organs that fight germs and cancer.&lt;SEP&gt;The lymphatic or lymph system is a network of tissues and organs that helps fight infections and disease as part of the immune system.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249980</data>
  <data key="d6"></data>
</node>
<node id="BCL2 Protein">
  <data key="d0">BCL2 Protein</data>
  <data key="d1">concept</data>
  <data key="d2">Excess levels of the BCL2 protein are found in the tumors of almost everyone with Follicular Lymphoma.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249980</data>
  <data key="d6"></data>
</node>
<node id="Chromosome Translocation">
  <data key="d0">Chromosome Translocation</data>
  <data key="d1">concept</data>
  <data key="d2">A chromosome translocation is the switching of part of one chromosome with another within lymphoma cells, commonly associated with FL.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249982</data>
  <data key="d6"></data>
</node>
<node id="Immunophenotyping">
  <data key="d0">Immunophenotyping</data>
  <data key="d1">method</data>
  <data key="d2">Immunophenotyping is a test used in the diagnosis and treatment planning for Follicular Lymphoma.&lt;SEP&gt;A process, commonly performed via flow cytometry, for identifying markers on cells, particularly in the immune system.&lt;SEP&gt;Immunophenotyping is a process that uses antibodies to detect the presence or absence of white blood cell antigens (biomarkers) on the surface or inside cells, commonly used in AML diagnosis.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249982</data>
  <data key="d6"></data>
</node>
<node id="This Book">
  <data key="d0">This Book</data>
  <data key="d1">content</data>
  <data key="d2">This book follows the ICC classification system for follicular lymphoma and describes various types of FL.&lt;SEP&gt;This book focuses on the oropharynx and throat cancer.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249983</data>
  <data key="d6"></data>
</node>
<node id="WHO5">
  <data key="d0">WHO5</data>
  <data key="d1">organization</data>
  <data key="d2">WHO5 is a classification system for follicular lymphoma, grouping grades 1, 2, and 3A as classic FL.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249983</data>
  <data key="d6"></data>
</node>
<node id="ICC">
  <data key="d0">ICC</data>
  <data key="d1">organization</data>
  <data key="d2">ICC is a classification system for follicular lymphoma, grouping grades 1 and 2 as classic FL.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249984</data>
  <data key="d6"></data>
</node>
<node id="Follicular Lymphoma">
  <data key="d0">Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Follicular lymphoma (FL) is a slow-growing (indolent) non-Hodgkin lymphoma (NHL) that develops from B lymphocytes and forms clusters in lymph nodes.&lt;SEP&gt;Follicular Lymphoma (FL) is a slow-growing Non-Hodgkin Lymphoma that typically forms tumors in lymph nodes.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249984</data>
  <data key="d6"></data>
</node>
<node id="B Symptoms">
  <data key="d0">B Symptoms</data>
  <data key="d1">concept</data>
  <data key="d2">B symptoms refer to fever, night sweats, fatigue, and weight loss that can occur with Follicular Lymphoma.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249985</data>
  <data key="d6"></data>
</node>
<node id="Germinal Centers">
  <data key="d0">Germinal Centers</data>
  <data key="d1">concept</data>
  <data key="d2">Germinal centers are areas in lymph nodes where abnormal B lymphocytes form clusters (follicles) in Follicular Lymphoma.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249985</data>
  <data key="d6"></data>
</node>
<node id="Lymphocytes">
  <data key="d0">Lymphocytes</data>
  <data key="d1">concept</data>
  <data key="d2">White blood cells contained within lymph nodes that help the body fight infection and disease.&lt;SEP&gt;Lymphocytes are a type of white blood cell, the most important for understanding Hodgkin Lymphoma, which are carried in lymph fluid and made in organs like the spleen and bone marrow.&lt;SEP&gt;Lymphocytes are a type of white blood cell that can grow out of control to cause lymphoma.&lt;SEP&gt;Lymphocytes are a type of white blood cell from which Non-Hodgkin Lymphoma, including Follicular Lymphoma, develops.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249986</data>
  <data key="d6"></data>
</node>
<node id="B Lymphocytes">
  <data key="d0">B Lymphocytes</data>
  <data key="d1">concept</data>
  <data key="d2">B lymphocytes are the specific type of white blood cell that form abnormal clusters in Follicular Lymphoma.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249986</data>
  <data key="d6"></data>
</node>
<node id="t(14;18)-Negative">
  <data key="d0">t(14;18)-Negative</data>
  <data key="d1">concept</data>
  <data key="d2">t(14;18)-negative is a genetic feature that can characterize Uncommon Follicular Lymphoma.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249988</data>
  <data key="d6"></data>
</node>
<node id="MyChart">
  <data key="d0">MyChart</data>
  <data key="d1">artifact</data>
  <data key="d2">MyChart is a specific type of online patient portal used to track appointments and communicate with healthcare providers.&lt;SEP&gt;MyChart is a type of health record account that helps patients track appointments and communicate with their care team.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249988</data>
  <data key="d6"></data>
</node>
<node id="Patient Portal">
  <data key="d0">Patient Portal</data>
  <data key="d1">artifact</data>
  <data key="d2">Online patient portals are a way for patients to access test results and communications from their healthcare team.&lt;SEP&gt;A patient portal is an online system that allows patients to view their test results and other medical records.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249989</data>
  <data key="d6"></data>
</node>
<node id="Primary Care Physician">
  <data key="d0">Primary Care Physician</data>
  <data key="d1">person</data>
  <data key="d2">A doctor who provides general medical care and should be kept informed of changes to a patient's contact list and medical information.&lt;SEP&gt;A primary care physician is a doctor who provides general medical care and coordinates with specialists.&lt;SEP&gt;The primary care physician is a partner in a patient's care who should be kept informed of medical changes and contact information.&lt;SEP&gt;A Primary Care Physician (PCP) is a doctor who should be updated regarding any changes in a patient's cancer treatment.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249989</data>
  <data key="d6"></data>
</node>
<node id="Caregiver">
  <data key="d0">Caregiver</data>
  <data key="d1">person</data>
  <data key="d2">A caregiver is a person, such as a friend or family member, who provides support and may ask questions during a patient's medical care.</data>
  <data key="d3">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249990</data>
  <data key="d6"></data>
</node>
<node id="Connective Tissue">
  <data key="d0">Connective Tissue</data>
  <data key="d1">concept</data>
  <data key="d2">The presence of fibrous or connective tissue within a tumor is a sign of a high-risk or very high-risk cancer.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249990</data>
  <data key="d6"></data>
</node>
<node id="Tumor Depth">
  <data key="d0">Tumor Depth</data>
  <data key="d1">concept</data>
  <data key="d2">The depth a tumor has invaded into the skin is a factor; deeper invasion indicates a higher risk of cancer returning or spreading.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249991</data>
  <data key="d6"></data>
</node>
<node id="Lymphovascular Invasion">
  <data key="d0">Lymphovascular Invasion</data>
  <data key="d1">concept</data>
  <data key="d2">Lymphovascular invasion occurs when cancer cells are found in blood or lymph vessels outside the main tumor, increasing the likelihood of spread.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249991</data>
  <data key="d6"></data>
</node>
<node id="Shave Excision">
  <data key="d0">Shave Excision</data>
  <data key="d1">method</data>
  <data key="d2">Shave excision is a surgical treatment option recommended for low-risk, local CSCC, often considered for early, small tumors on the skin's surface.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249992</data>
  <data key="d6"></data>
</node>
<node id="Corticosteroid Use">
  <data key="d0">Corticosteroid Use</data>
  <data key="d1">concept</data>
  <data key="d2">Long-term corticosteroid use is an example of a condition that can weaken the immune system, increasing the risk of CSCC.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249992</data>
  <data key="d6"></data>
</node>
<node id="HIV">
  <data key="d0">HIV</data>
  <data key="d1">concept</data>
  <data key="d2">Human Immunodeficiency Virus (HIV) is an example of a condition that weakens the immune system, increasing the risk of CSCC.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249992</data>
  <data key="d6"></data>
</node>
<node id="AIDS">
  <data key="d0">AIDS</data>
  <data key="d1">concept</data>
  <data key="d2">Acquired Immunodeficiency Syndrome (AIDS) is an example of a condition that weakens the immune system, increasing the risk of CSCC.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249992</data>
  <data key="d6"></data>
</node>
<node id="Organ Transplant">
  <data key="d0">Organ Transplant</data>
  <data key="d1">event</data>
  <data key="d2">Having received an organ transplant is an example of a condition that weakens the immune system, increasing the risk of CSCC.</data>
  <data key="d3">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249993</data>
  <data key="d6"></data>
</node>
<node id="Systemic Therapies">
  <data key="d0">Systemic Therapies</data>
  <data key="d1">concept</data>
  <data key="d2">Systemic therapies are treatments that affect both cancer cells and normal cells, administered intravenously or orally, and can have side effects.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249993</data>
  <data key="d6"></data>
</node>
<node id="Epidermal Growth Factor Receptor">
  <data key="d0">Epidermal Growth Factor Receptor</data>
  <data key="d1">concept</data>
  <data key="d2">EGFR is a protein on cell surfaces that causes cell division; inhibiting it can prevent cancer cell growth.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249994</data>
  <data key="d6"></data>
</node>
<node id="Cetuximab">
  <data key="d0">Cetuximab</data>
  <data key="d1">artifact</data>
  <data key="d2">Cetuximab is an EGFR inhibitor used to treat CSCC and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249994</data>
  <data key="d6"></data>
</node>
<node id="Programmed Death Ligand 1 Inhibitors">
  <data key="d0">Programmed Death Ligand 1 Inhibitors</data>
  <data key="d1">concept</data>
  <data key="d2">PD-1 inhibitors are a type of immune checkpoint inhibitor used in immunotherapy for cancers like CSCC.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249994</data>
  <data key="d6"></data>
</node>
<node id="Cemiplimab">
  <data key="d0">Cemiplimab</data>
  <data key="d1">artifact</data>
  <data key="d2">Cemiplimab is a PD-1 inhibitor used to treat squamous cell skin cancer and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249994</data>
  <data key="d6"></data>
</node>
<node id="Pembrolizumab">
  <data key="d0">Pembrolizumab</data>
  <data key="d1">artifact</data>
  <data key="d2">Pembrolizumab is a PD-1 inhibitor used to treat squamous cell skin cancer and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249995</data>
  <data key="d6"></data>
</node>
<node id="Side Effects">
  <data key="d0">Side Effects</data>
  <data key="d1">concept</data>
  <data key="d2">Side effects are adverse reactions to systemic therapy, varying by medicine and including fatigue, nausea, and organ damage.&lt;SEP&gt;Side effects of chemotherapy include loss of appetite, nausea, vomiting, mouth sores, hair loss, fatigue, increased infection risk, bleeding, bruising, and nerve damage.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249995</data>
  <data key="d6"></data>
</node>
<node id="Immune-Related Adverse Events">
  <data key="d0">Immune-Related Adverse Events</data>
  <data key="d1">concept</data>
  <data key="d2">irAEs are side effects specifically associated with immunotherapy treatments.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249996</data>
  <data key="d6"></data>
</node>
<node id="U.S. Food and Drug Administration">
  <data key="d0">U.S. Food and Drug Administration</data>
  <data key="d1">organization</data>
  <data key="d2">The FDA is the regulatory body that approves drugs, devices, or treatments based on clinical trial results.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249996</data>
  <data key="d6"></data>
</node>
<node id="Phase 1 Trial">
  <data key="d0">Phase 1 Trial</data>
  <data key="d1">event</data>
  <data key="d2">Phase 1 trials study the dose, safety, and side effects of an investigational drug or treatment approach.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249997</data>
  <data key="d6"></data>
</node>
<node id="Phase 2 Trial">
  <data key="d0">Phase 2 Trial</data>
  <data key="d1">event</data>
  <data key="d2">Phase 2 trials study how well a drug or approach works against a specific type of cancer.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249997</data>
  <data key="d6"></data>
</node>
<node id="Phase 3 Trial">
  <data key="d0">Phase 3 Trial</data>
  <data key="d1">event</data>
  <data key="d2">Phase 3 trials test a drug or approach against a standard treatment for potential FDA approval.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249997</data>
  <data key="d6"></data>
</node>
<node id="Phase 4 Trial">
  <data key="d0">Phase 4 Trial</data>
  <data key="d1">event</data>
  <data key="d2">Phase 4 trials study the long-term safety and benefit of an FDA-approved treatment.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249997</data>
  <data key="d6"></data>
</node>
<node id="Eligibility Criteria">
  <data key="d0">Eligibility Criteria</data>
  <data key="d1">concept</data>
  <data key="d2">Eligibility criteria are rules for joining a clinical trial, based on factors like age, cancer type, and health.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249998</data>
  <data key="d6"></data>
</node>
<node id="Informed Consent">
  <data key="d0">Informed Consent</data>
  <data key="d1">concept</data>
  <data key="d2">Informed consent is the process where the research team explains a clinical trial's purpose, risks, and benefits to a participant.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249998</data>
  <data key="d6"></data>
</node>
<node id="Placebo">
  <data key="d0">Placebo</data>
  <data key="d1">concept</data>
  <data key="d2">A placebo is an inactive version of a medicine, rarely used alone in cancer clinical trials.&lt;SEP&gt;A placebo is an inactive version of a real medicine, rarely used alone in cancer clinical trials but sometimes combined with standard treatment.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249998</data>
  <data key="d6"></data>
</node>
<node id="Erbitux">
  <data key="d0">Erbitux</data>
  <data key="d1">artifact</data>
  <data key="d2">Erbitux is the brand name for the EGFR inhibitor cetuximab, used to treat CSCC and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249998</data>
  <data key="d6"></data>
</node>
<node id="Libtayo">
  <data key="d0">Libtayo</data>
  <data key="d1">artifact</data>
  <data key="d2">Libtayo is the brand name for the PD-1 inhibitor cemiplimab, used to treat squamous cell skin cancer and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249999</data>
  <data key="d6"></data>
</node>
<node id="Keytruda">
  <data key="d0">Keytruda</data>
  <data key="d1">artifact</data>
  <data key="d2">Keytruda is the brand name for the PD-1 inhibitor pembrolizumab, used to treat squamous cell skin cancer and other cancers.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767249999</data>
  <data key="d6"></data>
</node>
<node id="Research Team">
  <data key="d0">Research Team</data>
  <data key="d1">organization</data>
  <data key="d2">A research team is a group of experts that manages a clinical trial and explains the study to participants.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250000</data>
  <data key="d6"></data>
</node>
<node id="Standard Treatment">
  <data key="d0">Standard Treatment</data>
  <data key="d1">concept</data>
  <data key="d2">Standard treatment refers to established cancer therapies that are compared against new approaches in clinical trials.</data>
  <data key="d3">chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250000</data>
  <data key="d6"></data>
</node>
<node id="Fertility Tests">
  <data key="d0">Fertility Tests</data>
  <data key="d1">method</data>
  <data key="d2">Fertility tests for all genders are part of the testing process for throat cancer.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250001</data>
  <data key="d6"></data>
</node>
<node id="Pregnancy Prevention During Treatment">
  <data key="d0">Pregnancy Prevention During Treatment</data>
  <data key="d1">concept</data>
  <data key="d2">Preventing pregnancy during treatment is a consideration discussed in the context of throat cancer.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250001</data>
  <data key="d6"></data>
</node>
<node id="P16 (HPV) Testing">
  <data key="d0">P16 (HPV) Testing</data>
  <data key="d1">method</data>
  <data key="d2">P16 (HPV) testing is a specific biomarker test used in the diagnosis of throat cancer.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250001</data>
  <data key="d6"></data>
</node>
<node id="Scoping Procedures">
  <data key="d0">Scoping Procedures</data>
  <data key="d1">method</data>
  <data key="d2">Scoping procedures are diagnostic methods used to examine the throat.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250001</data>
  <data key="d6"></data>
</node>
<node id="Treatment Planning">
  <data key="d0">Treatment Planning</data>
  <data key="d1">concept</data>
  <data key="d2">Treatment planning for throat cancer begins with the results of diagnostic tests.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250002</data>
  <data key="d6"></data>
</node>
<node id="Test Results">
  <data key="d0">Test Results</data>
  <data key="d1">data</data>
  <data key="d2">Test results refer to the outcomes of diagnostic procedures like blood tests, imaging studies, and biopsies.&lt;SEP&gt;Test results from imaging studies and biopsies are used to determine a treatment plan for throat cancer.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250002</data>
  <data key="d6"></data>
</node>
<node id="Online Patient Portal">
  <data key="d0">Online Patient Portal</data>
  <data key="d1">artifact</data>
  <data key="d2">An online patient portal is a tool mentioned for managing health information.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250003</data>
  <data key="d6"></data>
</node>
<node id="Base Of The Tongue">
  <data key="d0">Base Of The Tongue</data>
  <data key="d1">location</data>
  <data key="d2">The base of the tongue is found in the throat and is part of the oropharynx.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250003</data>
  <data key="d6"></data>
</node>
<node id="This Chapter">
  <data key="d0">This Chapter</data>
  <data key="d1">content</data>
  <data key="d2">This chapter presents an overview of tests for throat cancer and what to expect.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250003</data>
  <data key="d6"></data>
</node>
<node id="Key Points">
  <data key="d0">Key Points</data>
  <data key="d1">content</data>
  <data key="d2">Key points are summarized information, such as treatment planning starting with testing.</data>
  <data key="d3">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250003</data>
  <data key="d6"></data>
</node>
<node id="Treatment Team">
  <data key="d0">Treatment Team</data>
  <data key="d1">organization</data>
  <data key="d2">The treatment team is the medical group a patient consults to determine eligibility for clinical trials and standard care.&lt;SEP&gt;The treatment team reviews prior surgery and testing results to plan the course of treatment for a patient diagnosed with ovarian cancer.&lt;SEP&gt;The treatment team gives patients instructions on how to prepare for ovarian cancer surgery.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250004</data>
  <data key="d6"></data>
</node>
<node id="National Cancer Institute (NCI)">
  <data key="d0">National Cancer Institute (NCI)</data>
  <data key="d1">organization</data>
  <data key="d2">The NCI provides resources for finding clinical trials, including a search tool and a Cancer Information Service.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250004</data>
  <data key="d6"></data>
</node>
<node id="U.S. National Library of Medicine (NLM)">
  <data key="d0">U.S. National Library of Medicine (NLM)</data>
  <data key="d1">organization</data>
  <data key="d2">The NLM maintains ClinicalTrials.gov, a worldwide database for finding clinical trials.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250005</data>
  <data key="d6"></data>
</node>
<node id="NCIs Cancer Information Service (CIS)">
  <data key="d0">NCIs Cancer Information Service (CIS)</data>
  <data key="d1">organization</data>
  <data key="d2">The CIS is a service that provides help finding a clinical trial, accessible via phone.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250005</data>
  <data key="d6"></data>
</node>
<node id="Study Sponsor">
  <data key="d0">Study Sponsor</data>
  <data key="d1">organization</data>
  <data key="d2">The study sponsor is the entity that pays for research-related costs in a clinical trial, including the study drug.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250005</data>
  <data key="d6"></data>
</node>
<node id="Insurance">
  <data key="d0">Insurance</data>
  <data key="d1">organization</data>
  <data key="d2">Insurance is billed for standard cancer care received during a clinical trial, with the patient responsible for uncovered costs and copays.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250005</data>
  <data key="d6"></data>
</node>
<node id="Photodynamic Therapy">
  <data key="d0">Photodynamic Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Photodynamic therapy is a treatment where a light-sensitive drug is applied to the skin and activated by light to kill cancer cells, with side effects like itching, burning, and pain.&lt;SEP&gt;Photodynamic therapy is a treatment option for actinic keratoses, which are pre-cancerous lesions.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250006</data>
  <data key="d6"></data>
</node>
<node id="Topical Therapy">
  <data key="d0">Topical Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Topical therapy is a treatment option for actinic keratoses, which are pre-cancerous lesions.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250006</data>
  <data key="d6"></data>
</node>
<node id="PDEMA/Mohs Surgery">
  <data key="d0">PDEMA/Mohs Surgery</data>
  <data key="d1">method</data>
  <data key="d2">PDEMA/Mohs surgery is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250007</data>
  <data key="d6"></data>
</node>
<node id="Local Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d0">Local Cutaneous Squamous Cell Carcinoma (CSCC)</data>
  <data key="d1">concept</data>
  <data key="d2">Local CSCC is squamous cell skin cancer that has not spread to nearby lymph nodes and is usually treated with surgery.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250007</data>
  <data key="d6"></data>
</node>
<node id="Recurrent Tumor">
  <data key="d0">Recurrent Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">A recurrent tumor is cancer that has returned after a period of undetectability following treatment, and is considered high-risk.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250008</data>
  <data key="d6"></data>
</node>
<node id="Perineural Invasion">
  <data key="d0">Perineural Invasion</data>
  <data key="d1">concept</data>
  <data key="d2">Perineural invasion is when a tumor has grown into a nerve or group of nerves, indicating a high- or very high-risk cancer.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250008</data>
  <data key="d6"></data>
</node>
<node id="Actinic Keratoses">
  <data key="d0">Actinic Keratoses</data>
  <data key="d1">concept</data>
  <data key="d2">Actinic keratoses are pre-cancerous skin lesions that can be treated with superficial treatments, often found in the same area as Bowen's disease lesions.&lt;SEP&gt;Actinic keratoses are pre-cancerous lesions for which photodynamic therapy, cryotherapy, and topical therapy are treatment options.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250009</data>
  <data key="d6"></data>
</node>
<node id="Local Recurrence">
  <data key="d0">Local Recurrence</data>
  <data key="d1">concept</data>
  <data key="d2">Local recurrence is when cancer returns to the same place as the original tumor after treatment.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250009</data>
  <data key="d6"></data>
</node>
<node id="Location And Size">
  <data key="d0">Location And Size</data>
  <data key="d1">concept</data>
  <data key="d2">Location and size are specific factors used in risk assessment to classify a tumor as high-risk or very high-risk.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250010</data>
  <data key="d6"></data>
</node>
<node id="Tumor Shape">
  <data key="d0">Tumor Shape</data>
  <data key="d1">concept</data>
  <data key="d2">Tumor shape, specifically the definition of its border, is a factor used in risk assessment to classify cancer risk.</data>
  <data key="d3">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250010</data>
  <data key="d6"></data>
</node>
<node id="Karyotype">
  <data key="d0">Karyotype</data>
  <data key="d1">method</data>
  <data key="d2">A karyotype is a picture of chromosomes showing extra, missing, rearranged, or abnormal pieces; it requires growing cells from bone marrow or blood samples.&lt;SEP&gt;A method that creates a picture of chromosomes to detect extra, missing, rearranged, or abnormal pieces of chromosomes, requiring a sample of bone marrow or blood.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250011</data>
  <data key="d6"></data>
</node>
<node id="Next-Generation Sequencing">
  <data key="d0">Next-Generation Sequencing</data>
  <data key="d1">method</data>
  <data key="d2">Next-generation sequencing (NGS) determines a portion of a person's DNA sequence to identify gene mutations affecting AML, part of mutation testing.&lt;SEP&gt;A method used to determine a portion of a person's DNA sequence to find mutations in a gene with high detail.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250011</data>
  <data key="d6"></data>
</node>
<node id="Polymerase Chain Reaction">
  <data key="d0">Polymerase Chain Reaction</data>
  <data key="d1">method</data>
  <data key="d2">Polymerase chain reaction (PCR) is a method used in AML mutation testing to detect genetic changes in leukemia cells.&lt;SEP&gt;A technique that makes millions or billions of copies of DNA or RNA, used for sensitive detection of abnormal cells and can produce PCR products for NGS.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250013</data>
  <data key="d6"></data>
</node>
<node id="Real-Time Or Reverse Transcriptase PCR">
  <data key="d0">Real-Time Or Reverse Transcriptase PCR</data>
  <data key="d1">method</data>
  <data key="d2">A type of PCR used to look for gene rearrangements such as PML::RARA, aiding in diagnosis and monitoring response to targeted therapies.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250013</data>
  <data key="d6"></data>
</node>
<node id="Contrast Material">
  <data key="d0">Contrast Material</data>
  <data key="d1">artifact</data>
  <data key="d2">Contrast material is a substance used in imaging tests to enhance the clarity of pictures of internal organs and structures.&lt;SEP&gt;A substance used to improve the quality of pictures from imaging tests, which can be taken orally or given intravenously and is excreted from the body.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250014</data>
  <data key="d6"></data>
</node>
<node id="Brain CT Scan">
  <data key="d0">Brain CT Scan</data>
  <data key="d1">method</data>
  <data key="d2">A computed tomography scan that uses x-rays and computer technology to take detailed pictures of the brain to look for bleeding.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250014</data>
  <data key="d6"></data>
</node>
<node id="Brain MRI Scan">
  <data key="d0">Brain MRI Scan</data>
  <data key="d1">method</data>
  <data key="d2">A magnetic resonance imaging scan that uses radio waves and magnets to take pictures of the brain to check for leukemic meningitis, without using x-rays.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250015</data>
  <data key="d6"></data>
</node>
<node id="Electrocardiogram">
  <data key="d0">Electrocardiogram</data>
  <data key="d1">method</data>
  <data key="d2">A test that shows electrical changes in the heart, revealing heart rate and rhythm, and can detect a prolonged corrected QT interval.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250015</data>
  <data key="d6"></data>
</node>
<node id="Echocardiogram">
  <data key="d0">Echocardiogram</data>
  <data key="d1">method</data>
  <data key="d2">A test that uses sound waves to make pictures of the heart, a type of ultrasound performed with a wand on the chest.&lt;SEP&gt;An echocardiogram is a test that uses sound waves to create pictures of the heart's structure and function, including ejection fraction.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250017</data>
  <data key="d6"></data>
</node>
<node id="Radiologist">
  <data key="d0">Radiologist</data>
  <data key="d1">person</data>
  <data key="d2">A medical expert who interprets imaging test results and writes reports for the patient's doctor.&lt;SEP&gt;A medical specialist who interprets imaging scans such as CT, MRI, and PET scans.&lt;SEP&gt;A radiologist is a medical expert who interprets imaging test results and writes reports for healthcare providers.&lt;SEP&gt;A medical expert who interprets imaging tests and sends reports to doctors.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250017</data>
  <data key="d6"></data>
</node>
<node id="Cardiologist">
  <data key="d0">Cardiologist</data>
  <data key="d1">person</data>
  <data key="d2">A heart specialist to whom a patient might be referred for heart tests.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250018</data>
  <data key="d6"></data>
</node>
<node id="Leukemia">
  <data key="d0">Leukemia</data>
  <data key="d1">concept</data>
  <data key="d2">A condition that can spread outside the bloodstream to lymph nodes, liver, spleen, skin, and rarely to the lining of the brain and spinal cord.&lt;SEP&gt;Leukemia is a type of cancer that can travel to the fluid surrounding the spine or brain.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250018</data>
  <data key="d6"></data>
</node>
<node id="PCR Products">
  <data key="d0">PCR Products</data>
  <data key="d1">artifact</data>
  <data key="d2">Copies of DNA or RNA made by PCR that might be used for Next-Generation Sequencing.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250019</data>
  <data key="d6"></data>
</node>
<node id="PML::RARA">
  <data key="d0">PML::RARA</data>
  <data key="d1">concept</data>
  <data key="d2">A gene rearrangement that can be detected by Real-Time or Reverse Transcriptase PCR.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250019</data>
  <data key="d6"></data>
</node>
<node id="Chromosomes">
  <data key="d0">Chromosomes</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Normal human cells contain 23 pairs of chromosomes for a total of 46 chromosomes.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250020</data>
  <data key="d6"></data>
</node>
<node id="DNA">
  <data key="d0">DNA</data>
  <data key="d1">naturalobject</data>
  <data key="d2">DNA controls how cells grow and function; damage to DNA inside basal skin cells from UV radiation can lead to abnormal cell growth and basal cell skin cancer.&lt;SEP&gt;DNA (deoxyribonucleic acid) molecules are tightly packaged into chromosomes, containing genetic information and genes that code for proteins; mutations can occur in this genetic code.&lt;SEP&gt;DNA is genetic information that can be copied by PCR and sequenced by NGS.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250020</data>
  <data key="d6"></data>
</node>
<node id="RNA">
  <data key="d0">RNA</data>
  <data key="d1">naturalobject</data>
  <data key="d2">RNA is genetic information that can be copied by PCR.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250022</data>
  <data key="d6"></data>
</node>
<node id="Treatment Response">
  <data key="d0">Treatment Response</data>
  <data key="d1">concept</data>
  <data key="d2">Treatment response is a condition that PCR and NGS testing can be important for monitoring.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250022</data>
  <data key="d6"></data>
</node>
<node id="Remission">
  <data key="d0">Remission</data>
  <data key="d1">concept</data>
  <data key="d2">Remission is a condition that PCR and NGS testing can be important for monitoring.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250022</data>
  <data key="d6"></data>
</node>
<node id="Targeted Therapies">
  <data key="d0">Targeted Therapies</data>
  <data key="d1">concept</data>
  <data key="d2">Targeted therapies are treatments whose response can be monitored using tests like Real-Time or Reverse Transcriptase PCR.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250022</data>
  <data key="d6"></data>
</node>
<node id="Skin">
  <data key="d0">Skin</data>
  <data key="d1">location</data>
  <data key="d2">Skin is the body's largest organ, acting as a barrier against bacteria and chemicals, helping control body temperature, and consisting of three layers: epidermis, dermis, and hypodermis.&lt;SEP&gt;The skin is a site where leukemia can spread outside the bloodstream.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250023</data>
  <data key="d6"></data>
</node>
<node id="Spinal Cord">
  <data key="d0">Spinal Cord</data>
  <data key="d1">location</data>
  <data key="d2">The spinal cord is rarely a site where leukemia spreads.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250023</data>
  <data key="d6"></data>
</node>
<node id="Infection">
  <data key="d0">Infection</data>
  <data key="d1">concept</data>
  <data key="d2">Infection is a condition that imaging tests can show and that may impact patient care.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250024</data>
  <data key="d6"></data>
</node>
<node id="Bleeding">
  <data key="d0">Bleeding</data>
  <data key="d1">concept</data>
  <data key="d2">Bleeding is a condition that imaging tests like a Brain CT scan can look for.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250024</data>
  <data key="d6"></data>
</node>
<node id="Allergic Reaction">
  <data key="d0">Allergic Reaction</data>
  <data key="d1">concept</data>
  <data key="d2">An allergic reaction to contrast material is important to report to the care team.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250025</data>
  <data key="d6"></data>
</node>
<node id="Kidneys">
  <data key="d0">Kidneys</data>
  <data key="d1">location</data>
  <data key="d2">Kidney function can affect whether contrast material is used in imaging tests.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250025</data>
  <data key="d6"></data>
</node>
<node id="Leukemic Meningitis">
  <data key="d0">Leukemic Meningitis</data>
  <data key="d1">concept</data>
  <data key="d2">Leukemic meningitis is a condition where the outer layer of the brain is swollen from leukemia, detectable by an MRI.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250026</data>
  <data key="d6"></data>
</node>
<node id="Claustrophobia">
  <data key="d0">Claustrophobia</data>
  <data key="d1">concept</data>
  <data key="d2">Claustrophobia is a fear of enclosed spaces, which patients should discuss with their care team before an MRI scan.&lt;SEP&gt;Claustrophobia is a dread or fear of enclosed spaces that should be discussed with the care team before an MRI.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250026</data>
  <data key="d6"></data>
</node>
<node id="Tracer">
  <data key="d0">Tracer</data>
  <data key="d1">artifact</data>
  <data key="d2">A radioactive drug used in PET scans, injected into a vein, which collects in organs and tissues to highlight areas of abnormal cellular activity.&lt;SEP&gt;A tracer is a radioactive drug injected into a vein for PET scans to detect cancer cells by their sugar consumption.&lt;SEP&gt;A tracer is a radioactive drug injected for a PET scan to see where cancer cells are in the body.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250027</data>
  <data key="d6"></data>
</node>
<node id="Cancer Cells">
  <data key="d0">Cancer Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer cells show up as bright spots on PET scans and take up sugar, indicating their growth rate.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250027</data>
  <data key="d6"></data>
</node>
<node id="Inflammation">
  <data key="d0">Inflammation</data>
  <data key="d1">concept</data>
  <data key="d2">Inflammation can show up as a bright spot on a PET scan.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250028</data>
  <data key="d6"></data>
</node>
<node id="PET/CT Scan">
  <data key="d0">PET/CT Scan</data>
  <data key="d1">method</data>
  <data key="d2">A combined imaging scan that integrates PET and CT scans to provide detailed anatomical and metabolic information.&lt;SEP&gt;A PET/CT scan is a combination of a PET scan and a CT scan.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250028</data>
  <data key="d6"></data>
</node>
<node id="Fluorodeoxyglucose">
  <data key="d0">Fluorodeoxyglucose</data>
  <data key="d1">artifact</data>
  <data key="d2">Fluorodeoxyglucose (FDG) is a radiotracer used in an FDG-PET/CT scan.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250029</data>
  <data key="d6"></data>
</node>
<node id="Prolonged Corrected QT Interval">
  <data key="d0">Prolonged Corrected QT Interval</data>
  <data key="d1">concept</data>
  <data key="d2">A prolonged corrected QT interval (QTc) occurs when the heart muscle takes longer than normal to recharge between beats, which can be caused by certain treatments.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250029</data>
  <data key="d6"></data>
</node>
<node id="Dangerous Heart Rhythms">
  <data key="d0">Dangerous Heart Rhythms</data>
  <data key="d1">concept</data>
  <data key="d2">Dangerous heart rhythms are a potential medical risk caused by a prolonged QTc interval.&lt;SEP&gt;Dangerous heart rhythms can be caused if the QTc becomes too prolonged.</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250031</data>
  <data key="d6"></data>
</node>
<node id="Tobacco And Alcohol Use History">
  <data key="d0">Tobacco And Alcohol Use History</data>
  <data key="d1">data</data>
  <data key="d2">Tobacco and alcohol use history is a known risk factor for head and neck cancer and can affect treatment efficacy and survival.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250031</data>
  <data key="d6"></data>
</node>
<node id="Complete Head And Neck Exam">
  <data key="d0">Complete Head And Neck Exam</data>
  <data key="d1">method</data>
  <data key="d2">A complete head and neck exam is part of a physical exam, specifically focusing on areas that are not easily visible.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250032</data>
  <data key="d6"></data>
</node>
<node id="Patient Portals">
  <data key="d0">Patient Portals</data>
  <data key="d1">artifact</data>
  <data key="d2">Online patient portals are tools that allow patients to access their test results and communicate with their care team.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250032</data>
  <data key="d6"></data>
</node>
<node id="Support Groups">
  <data key="d0">Support Groups</data>
  <data key="d1">organization</data>
  <data key="d2">Support groups are resources available at hospitals, through social media, or listed in guides, offering emotional support during cancer treatment.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250032</data>
  <data key="d6"></data>
</node>
<node id="Mirror And Fiberoptic Exam">
  <data key="d0">Mirror And Fiberoptic Exam</data>
  <data key="d1">method</data>
  <data key="d2">A mirror and fiberoptic exam is a diagnostic procedure mentioned as potentially needed during the testing and planning phase.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250032</data>
  <data key="d6"></data>
</node>
<node id="Chest CT">
  <data key="d0">Chest CT</data>
  <data key="d1">method</data>
  <data key="d2">Chest CT, with or without contrast, is listed as a potential imaging test needed for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250033</data>
  <data key="d6"></data>
</node>
<node id="CT With Contrast">
  <data key="d0">CT With Contrast</data>
  <data key="d1">method</data>
  <data key="d2">CT with contrast of the primary tumor and neck is a specific imaging test mentioned for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250033</data>
  <data key="d6"></data>
</node>
<node id="MRI With And Without Contrast">
  <data key="d0">MRI With And Without Contrast</data>
  <data key="d1">method</data>
  <data key="d2">MRI with and without contrast of the primary tumor and neck is a specific imaging test mentioned for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250034</data>
  <data key="d6"></data>
</node>
<node id="Endoscopy With Examination Under Anesthesia">
  <data key="d0">Endoscopy With Examination Under Anesthesia</data>
  <data key="d1">method</data>
  <data key="d2">Endoscopy with examination under anesthesia is a diagnostic procedure mentioned as potentially needed for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250034</data>
  <data key="d6"></data>
</node>
<node id="Dental Exam With X-Ray">
  <data key="d0">Dental Exam With X-Ray</data>
  <data key="d1">method</data>
  <data key="d2">A dental exam with x-ray (Panorex) or CT without contrast is mentioned as part of the testing for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250035</data>
  <data key="d6"></data>
</node>
<node id="Nutrition, Speech, And Swallowing Evaluation">
  <data key="d0">Nutrition, Speech, And Swallowing Evaluation</data>
  <data key="d1">method</data>
  <data key="d2">Nutrition, speech, and swallowing evaluation is mentioned as part of the testing for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250035</data>
  <data key="d6"></data>
</node>
<node id="Help To Quit Smoking">
  <data key="d0">Help To Quit Smoking</data>
  <data key="d1">method</data>
  <data key="d2">Help to quit smoking is mentioned as a supportive measure during the testing and treatment planning phase.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250036</data>
  <data key="d6"></data>
</node>
<node id="Fertility Counseling">
  <data key="d0">Fertility Counseling</data>
  <data key="d1">method</data>
  <data key="d2">Fertility counseling is mentioned as a supportive measure during the testing and treatment planning phase.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250036</data>
  <data key="d6"></data>
</node>
<node id="Screening For Hepatitis B">
  <data key="d0">Screening For Hepatitis B</data>
  <data key="d1">method</data>
  <data key="d2">Screening for hepatitis B is mentioned as part of the testing for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250037</data>
  <data key="d6"></data>
</node>
<node id="Screen For Depression">
  <data key="d0">Screen For Depression</data>
  <data key="d1">method</data>
  <data key="d2">Screening for depression is mentioned as part of the testing for treatment planning.</data>
  <data key="d3">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250037</data>
  <data key="d6"></data>
</node>
<node id="Flow Cytometry">
  <data key="d0">Flow Cytometry</data>
  <data key="d1">method</data>
  <data key="d2">A laboratory method that uses light-sensitive dyes and a light beam to detect, identify, and count specific cells, often for immunophenotyping.&lt;SEP&gt;Flow cytometry is a method used to analyze cells from peripheral blood or bone marrow aspirate, detecting subtle differences between cell types and identifying cell markers, particularly in immunophenotyping.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250037</data>
  <data key="d6"></data>
</node>
<node id="Immunohistochemistry">
  <data key="d0">Immunohistochemistry</data>
  <data key="d1">method</data>
  <data key="d2">Immunohistochemistry (IHC) is a staining process that adds a chemical marker to cells from a biopsy or tissue sample, which are then studied under a microscope to determine immunophenotype.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250037</data>
  <data key="d6"></data>
</node>
<node id="AML Biomarker And Genetic Tests">
  <data key="d0">AML Biomarker And Genetic Tests</data>
  <data key="d1">method</data>
  <data key="d2">AML biomarker and genetic tests analyze leukemia cells to identify subtype, target treatment, and determine prognosis, focusing on changes specific to AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250039</data>
  <data key="d6"></data>
</node>
<node id="Amplification">
  <data key="d0">Amplification</data>
  <data key="d1">concept</data>
  <data key="d2">Amplification is a genetic change where a part or whole chromosome or gene is increased, such as through duplication, observed in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250039</data>
  <data key="d6"></data>
</node>
<node id="Deletion">
  <data key="d0">Deletion</data>
  <data key="d1">concept</data>
  <data key="d2">Deletion is a genetic change where part of a chromosome or gene is missing, such as del(5q), found in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250040</data>
  <data key="d6"></data>
</node>
<node id="Insertion">
  <data key="d0">Insertion</data>
  <data key="d1">concept</data>
  <data key="d2">Insertion is a genetic change where a new part of a chromosome or gene is included, identified in AML mutation testing.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250040</data>
  <data key="d6"></data>
</node>
<node id="Inversion">
  <data key="d0">Inversion</data>
  <data key="d1">concept</data>
  <data key="d2">Inversion is a genetic change involving the switching of parts within one chromosome, such as inv(16) and inv(3), detected in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250041</data>
  <data key="d6"></data>
</node>
<node id="Point Mutation">
  <data key="d0">Point Mutation</data>
  <data key="d1">concept</data>
  <data key="d2">Point mutation is a genetic change where part of a gene is altered, examined in AML mutation testing.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250041</data>
  <data key="d6"></data>
</node>
<node id="Chromosome Translocation And Gene Rearrangement">
  <data key="d0">Chromosome Translocation And Gene Rearrangement</data>
  <data key="d1">concept</data>
  <data key="d2">Chromosome translocation and gene rearrangement involve switching parts between two chromosomes; at the chromosome level it's called translocation (e.g., t(8;21)), and at the gene level it's called rearrangement (e.g., RUNX1::RUNX1T1).</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250041</data>
  <data key="d6"></data>
</node>
<node id="Leukemia Predisposition Syndromes">
  <data key="d0">Leukemia Predisposition Syndromes</data>
  <data key="d1">concept</data>
  <data key="d2">Leukemia predisposition syndromes are hereditary conditions passed from parent to child, affecting treatment and risk; testing via skin punch biopsy can identify inherited genetic risks.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250041</data>
  <data key="d6"></data>
</node>
<node id="AML Mutation Testing">
  <data key="d0">AML Mutation Testing</data>
  <data key="d1">method</data>
  <data key="d2">AML mutation testing uses methods like karyotype, FISH, NGS, and PCR to look for unique changes in genes and chromosomes within AML cells, guiding treatment decisions.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250042</data>
  <data key="d6"></data>
</node>
<node id="FISH">
  <data key="d0">FISH</data>
  <data key="d1">method</data>
  <data key="d2">Fluorescence in situ hybridization (FISH) is a method using dye probes that attach to DNA to detect genetic abnormalities too small for other methods, applicable to bone marrow or blood samples.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250042</data>
  <data key="d6"></data>
</node>
<node id="White Blood Cell Antigens">
  <data key="d0">White Blood Cell Antigens</data>
  <data key="d1">concept</data>
  <data key="d2">White blood cell antigens, also called biomarkers, are proteins on the surface or inside white blood cells detected via immunophenotyping for AML diagnosis.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250043</data>
  <data key="d6"></data>
</node>
<node id="Prognosis">
  <data key="d0">Prognosis</data>
  <data key="d1">concept</data>
  <data key="d2">A prognosis is the predicted course that a patient's cancer will likely take, which staging helps to determine.&lt;SEP&gt;Prognosis refers to the likely path cancer will take, determined through biomarker and genetic testing in AML to guide treatment and outcomes.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250043</data>
  <data key="d6"></data>
</node>
<node id="Blood Test">
  <data key="d0">Blood Test</data>
  <data key="d1">method</data>
  <data key="d2">A blood test can count the number of white blood cells but cannot detect subtle differences between different types of blood cancers.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250045</data>
  <data key="d6"></data>
</node>
<node id="Biomarker">
  <data key="d0">Biomarker</data>
  <data key="d1">concept</data>
  <data key="d2">Biomarkers are white blood cell antigens (proteins) detected via immunophenotyping; certain biomarkers are targeted in AML treatment.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250045</data>
  <data key="d6"></data>
</node>
<node id="Proteins">
  <data key="d0">Proteins</data>
  <data key="d1">concept</data>
  <data key="d2">Proteins are molecules for which genes provide coded instructions; they are given names such as FLT3 and are involved in cellular functions.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250045</data>
  <data key="d6"></data>
</node>
<node id="FLT3">
  <data key="d0">FLT3</data>
  <data key="d1">concept</data>
  <data key="d2">FLT3 is a gene where mutations (such as FLT3-ITD and FLT3-TKD) occur in AML, and targeted therapies like Gilteritinib, Quizartinib, Midostaurin, or Sorafenib are used to treat it.&lt;SEP&gt;FLT3 is an example of a gene identified in italics in the text, associated with proteins and potential changes in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250045</data>
  <data key="d6"></data>
</node>
<node id="Del(5q)">
  <data key="d0">Del(5q)</data>
  <data key="d1">concept</data>
  <data key="d2">Del(5q) is a specific example of a deletion, where part of chromosome 5 is missing, as mentioned in the context of AML genetic changes.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250047</data>
  <data key="d6"></data>
</node>
<node id="Inv(16)">
  <data key="d0">Inv(16)</data>
  <data key="d1">concept</data>
  <data key="d2">Inv(16) is a specific example of a chromosome inversion, a genetic change found in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250047</data>
  <data key="d6"></data>
</node>
<node id="Inv(3)">
  <data key="d0">Inv(3)</data>
  <data key="d1">concept</data>
  <data key="d2">Inv(3) is a specific example of a chromosome inversion, a genetic change found in AML cells.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250048</data>
  <data key="d6"></data>
</node>
<node id="T(8;21)(q22;q1)">
  <data key="d0">T(8;21)(q22;q1)</data>
  <data key="d1">concept</data>
  <data key="d2">T(8;21)(q22;q1) is a specific example of a chromosome translocation written at the chromosome level, found in AML.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250048</data>
  <data key="d6"></data>
</node>
<node id="RUNX1::RUNX1T1">
  <data key="d0">RUNX1::RUNX1T1</data>
  <data key="d1">concept</data>
  <data key="d2">RUNX1::RUNX1T1 is a specific example of a gene rearrangement written at the gene level, corresponding to the t(8;21) translocation in AML.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250048</data>
  <data key="d6"></data>
</node>
<node id="Hematopoietic Cell Donors">
  <data key="d0">Hematopoietic Cell Donors</data>
  <data key="d1">concept</data>
  <data key="d2">Hematopoietic cell donors are biological family members who might be tested for leukemia predisposition syndrome when AML is in remission.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250048</data>
  <data key="d6"></data>
</node>
<node id="Cytogenetics">
  <data key="d0">Cytogenetics</data>
  <data key="d1">method</data>
  <data key="d2">Cytogenetics, also referred to as karyotype, is a method used in AML mutation testing to analyze chromosomes.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250049</data>
  <data key="d6"></data>
</node>
<node id="Probes">
  <data key="d0">Probes</data>
  <data key="d1">artifact</data>
  <data key="d2">Probes are special dyes used in the FISH method that attach to pieces of DNA to detect genetic abnormalities.</data>
  <data key="d3">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250049</data>
  <data key="d6"></data>
</node>
<node id="Surveillance">
  <data key="d0">Surveillance</data>
  <data key="d1">method</data>
  <data key="d2">Surveillance involves monitoring after treatment for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250050</data>
  <data key="d6"></data>
</node>
<node id="Hysterectomy">
  <data key="d0">Hysterectomy</data>
  <data key="d1">method</data>
  <data key="d2">Hysterectomy is surgery to remove the uterus, often part of treatment for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250050</data>
  <data key="d6"></data>
</node>
<node id="Bilateral Salpingooophorectomy (BSO)">
  <data key="d0">Bilateral Salpingooophorectomy (BSO)</data>
  <data key="d1">method</data>
  <data key="d2">BSO is surgery to remove both ovaries and both fallopian tubes, commonly performed for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250051</data>
  <data key="d6"></data>
</node>
<node id="Debulking Surgery">
  <data key="d0">Debulking Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Debulking or cytoreductive surgery aims to remove as much cancer as possible when it has spread outside the ovaries.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250051</data>
  <data key="d6"></data>
</node>
<node id="Fertility-Sparing Surgery">
  <data key="d0">Fertility-Sparing Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Fertility-sparing surgery removes one or both ovaries and fallopian tubes but leaves the uterus to preserve fertility.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250052</data>
  <data key="d6"></data>
</node>
<node id="Unilateral Salpingooophorectomy (USO)">
  <data key="d0">Unilateral Salpingooophorectomy (USO)</data>
  <data key="d1">method</data>
  <data key="d2">USO is surgery to remove one ovary and its fallopian tube, an option for cancer confined to one ovary.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250052</data>
  <data key="d6"></data>
</node>
<node id="In Vitro Fertilization (IVF)">
  <data key="d0">In Vitro Fertilization (IVF)</data>
  <data key="d1">method</data>
  <data key="d2">IVF is an assisted reproductive approach where eggs are fertilized in a lab to create embryos, used after fertility-sparing surgery.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250053</data>
  <data key="d6"></data>
</node>
<node id="Laparotomy">
  <data key="d0">Laparotomy</data>
  <data key="d1">method</data>
  <data key="d2">Laparotomy is a common surgical method for ovarian cancer involving a long abdominal cut for tumor visibility.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250053</data>
  <data key="d6"></data>
</node>
<node id="Laparoscopy">
  <data key="d0">Laparoscopy</data>
  <data key="d1">method</data>
  <data key="d2">Laparoscopy is a minimally invasive surgery performed through small abdominal cuts, used in select ovarian cancer cases.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250054</data>
  <data key="d6"></data>
</node>
<node id="Surgical Staging">
  <data key="d0">Surgical Staging</data>
  <data key="d1">method</data>
  <data key="d2">Surgical staging involves taking tissue samples during surgery to accurately determine the stage of ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250054</data>
  <data key="d6"></data>
</node>
<node id="Omentum">
  <data key="d0">Omentum</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The omentum is the fatty layer of tissue that covers organs in the abdomen and is removed during ovarian cancer surgery to check for cancer spread.&lt;SEP&gt;The omentum is a fatty tissue layer covering abdominal organs, often removed during surgical staging for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250055</data>
  <data key="d6"></data>
</node>
<node id="BRCA Genes">
  <data key="d0">BRCA Genes</data>
  <data key="d1">concept</data>
  <data key="d2">BRCA genes are associated with hereditary ovarian cancer; mutations in these genes increase cancer risk.&lt;SEP&gt;BRCA genes are genes that can have mutations, which are important biomarkers for planning ovarian cancer treatment and indicate hereditary cancer risk.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250055</data>
  <data key="d6"></data>
</node>
<node id="Microsatellite Instability (MSI)">
  <data key="d0">Microsatellite Instability (MSI)</data>
  <data key="d1">concept</data>
  <data key="d2">MSI is a biomarker tested on tumor tissue for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250056</data>
  <data key="d6"></data>
</node>
<node id="Mismatch Repair (MMR)">
  <data key="d0">Mismatch Repair (MMR)</data>
  <data key="d1">concept</data>
  <data key="d2">MMR is a biomarker tested on tumor tissue for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250056</data>
  <data key="d6"></data>
</node>
<node id="HER2 Expression">
  <data key="d0">HER2 Expression</data>
  <data key="d1">concept</data>
  <data key="d2">HER2 expression is a biomarker tested on tumor tissue for ovarian cancer.&lt;SEP&gt;HER2 expression is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250056</data>
  <data key="d6"></data>
</node>
<node id="Tumor Mutational Burden (TMB)">
  <data key="d0">Tumor Mutational Burden (TMB)</data>
  <data key="d1">concept</data>
  <data key="d2">TMB is a biomarker tested on tumor tissue for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250056</data>
  <data key="d6"></data>
</node>
<node id="BRAF V600E Mutation">
  <data key="d0">BRAF V600E Mutation</data>
  <data key="d1">concept</data>
  <data key="d2">The BRAF V600E mutation is a biomarker tested on tumor tissue for ovarian cancer.&lt;SEP&gt;The BRAF V600E mutation is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250057</data>
  <data key="d6"></data>
</node>
<node id="Folate Receptor Alpha (FR) Expression">
  <data key="d0">Folate Receptor Alpha (FR) Expression</data>
  <data key="d1">concept</data>
  <data key="d2">FR expression is a biomarker tested on tumor tissue for ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250057</data>
  <data key="d6"></data>
</node>
<node id="RET Mutations">
  <data key="d0">RET Mutations</data>
  <data key="d1">concept</data>
  <data key="d2">RET mutations are biomarkers tested on tumor tissue for ovarian cancer.&lt;SEP&gt;RET mutations are biomarkers tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250058</data>
  <data key="d6"></data>
</node>
<node id="NTRK Gene Fusion">
  <data key="d0">NTRK Gene Fusion</data>
  <data key="d1">concept</data>
  <data key="d2">NTRK gene fusion is a biomarker tested on tumor tissue for ovarian cancer.&lt;SEP&gt;NTRK gene fusion is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250058</data>
  <data key="d6"></data>
</node>
<node id="High-Grade Serous Carcinoma">
  <data key="d0">High-Grade Serous Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">High-grade serous carcinoma is one of the most common types of ovarian cancer.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250059</data>
  <data key="d6"></data>
</node>
<node id="Microscopic Metastases">
  <data key="d0">Microscopic Metastases</data>
  <data key="d1">concept</data>
  <data key="d2">Microscopic metastases are cancer cells that have spread outside the ovaries or pelvis and can only be seen with a microscope.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250059</data>
  <data key="d6"></data>
</node>
<node id="Donor Eggs">
  <data key="d0">Donor Eggs</data>
  <data key="d1">artifact</data>
  <data key="d2">Donor eggs are eggs removed from women who have volunteered to undergo hormone treatment to stimulate egg production for use in IVF.</data>
  <data key="d3">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250060</data>
  <data key="d6"></data>
</node>
<node id="Chest X-Ray">
  <data key="d0">Chest X-Ray</data>
  <data key="d1">method</data>
  <data key="d2">A chest X-ray is a fast, painless test using small radiation amounts to check if ovarian cancer has spread to the lungs or to monitor treatment.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250060</data>
  <data key="d6"></data>
</node>
<node id="Diagnostic Laparoscopy">
  <data key="d0">Diagnostic Laparoscopy</data>
  <data key="d1">method</data>
  <data key="d2">A minimally invasive procedure using a laparoscope to view the abdomen and take tissue samples to determine the extent of cancer and plan treatment.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250060</data>
  <data key="d6"></data>
</node>
<node id="Fine-Needle Aspiration Biopsy">
  <data key="d0">Fine-Needle Aspiration Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">FNA biopsy uses a very thin needle to remove a small tissue sample from a tumor for testing.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250060</data>
  <data key="d6"></data>
</node>
<node id="Core Biopsy">
  <data key="d0">Core Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A core biopsy uses a hollow needle to remove tissue samples for pathological examination.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250061</data>
  <data key="d6"></data>
</node>
<node id="Paracentesis">
  <data key="d0">Paracentesis</data>
  <data key="d1">method</data>
  <data key="d2">Paracentesis involves inserting a long, thin needle through the belly skin to remove a fluid sample for testing.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250061</data>
  <data key="d6"></data>
</node>
<node id="Hereditary Ovarian Cancer">
  <data key="d0">Hereditary Ovarian Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Hereditary ovarian cancer is caused by inherited gene mutations, such as in BRCA1, BRCA2, or Lynch syndrome, and often starts at a younger age.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250062</data>
  <data key="d6"></data>
</node>
<node id="BRCA1 Gene">
  <data key="d0">BRCA1 Gene</data>
  <data key="d1">concept</data>
  <data key="d2">BRCA1 is a gene that, when functioning properly, helps repair cells; mutations in this gene increase the risk of ovarian, breast, and other cancers.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250062</data>
  <data key="d6"></data>
</node>
<node id="BRCA2 Gene">
  <data key="d0">BRCA2 Gene</data>
  <data key="d1">concept</data>
  <data key="d2">BRCA2 is a gene that, when functioning properly, helps repair cells; mutations in this gene increase the risk of ovarian, breast, and other cancers.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250062</data>
  <data key="d6"></data>
</node>
<node id="Somatic Tumor Mutations">
  <data key="d0">Somatic Tumor Mutations</data>
  <data key="d1">concept</data>
  <data key="d2">Somatic or tumor mutations are genetic changes found in the tumor itself, distinct from inherited germline mutations, and should be tested for in ovarian cancer.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250062</data>
  <data key="d6"></data>
</node>
<node id="Nutritional And Digestive Tract Health">
  <data key="d0">Nutritional And Digestive Tract Health</data>
  <data key="d1">concept</data>
  <data key="d2">Nutritional and digestive health is assessed by providers, as ovarian cancer symptoms like bloating and difficulty eating can impact diet and nutrient intake.&lt;SEP&gt;Nutritional and digestive tract health involves diet, eating habits, and overall nutrition, which can impact surgery and treatment success for ovarian cancer patients.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250063</data>
  <data key="d6"></data>
</node>
<node id="Sugar Radiotracer">
  <data key="d0">Sugar Radiotracer</data>
  <data key="d1">concept</data>
  <data key="d2">A sugar radiotracer is a substance put into the body through a vein for a PET scan; it emits energy detected by the machine, and cancer cells use it faster, appearing brighter.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250063</data>
  <data key="d6"></data>
</node>
<node id="Gynecology Care Team">
  <data key="d0">Gynecology Care Team</data>
  <data key="d1">organization</data>
  <data key="d2">The gynecology care team is one of the teams through which genetic testing for ovarian cancer may be arranged.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250065</data>
  <data key="d6"></data>
</node>
<node id="Oncology Care Team">
  <data key="d0">Oncology Care Team</data>
  <data key="d1">organization</data>
  <data key="d2">The oncology care team is one of the teams through which genetic testing for ovarian cancer may be arranged.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250065</data>
  <data key="d6"></data>
</node>
<node id="Commercial Genetic Tests">
  <data key="d0">Commercial Genetic Tests</data>
  <data key="d1">artifact</data>
  <data key="d2">Commercial genetic tests are available over the counter and look for common gene mutations, but they are not comprehensive for all hereditary syndromes.</data>
  <data key="d3">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250065</data>
  <data key="d6"></data>
</node>
<node id="Vitamin B12">
  <data key="d0">Vitamin B12</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A vitamin that helps the body make new proteins and is needed for the normal formation of red and white blood cells; its levels are monitored.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250065</data>
  <data key="d6"></data>
</node>
<node id="Red Blood Cell">
  <data key="d0">Red Blood Cell</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A type of blood cell whose normal formation requires Vitamin B12 and folic acid.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250066</data>
  <data key="d6"></data>
</node>
<node id="White Blood Cell">
  <data key="d0">White Blood Cell</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A type of blood cell whose normal formation requires Vitamin B12 and folic acid.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250066</data>
  <data key="d6"></data>
</node>
<node id="Iron">
  <data key="d0">Iron</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A mineral important for producing hemoglobin; levels are monitored for deficiency or overload, and supplements may be given.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250067</data>
  <data key="d6"></data>
</node>
<node id="Coagulation Factors">
  <data key="d0">Coagulation Factors</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Proteins made by the liver that are needed for the blood clotting process.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250067</data>
  <data key="d6"></data>
</node>
<node id="Coagulopathy">
  <data key="d0">Coagulopathy</data>
  <data key="d1">concept</data>
  <data key="d2">An impaired clotting process that is common in leukemia, potentially leading to bleeding, bruises, or blood clots.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250068</data>
  <data key="d6"></data>
</node>
<node id="Human Leukocyte Antigen">
  <data key="d0">Human Leukocyte Antigen</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A protein found on the surface of most cells that plays an important role in the body's immune response and is unique to each person.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250068</data>
  <data key="d6"></data>
</node>
<node id="HLA Typing">
  <data key="d0">HLA Typing</data>
  <data key="d1">method</data>
  <data key="d2">A blood test that detects a person's HLA type, performed before an allogeneic hematopoietic cell transplant to find a donor match.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250069</data>
  <data key="d6"></data>
</node>
<node id="Allogeneic Hematopoietic Cell Transplant">
  <data key="d0">Allogeneic Hematopoietic Cell Transplant</data>
  <data key="d1">method</data>
  <data key="d2">A donor transplant procedure for which HLA typing is done to find a very good match to prevent rejection or adverse reactions.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250069</data>
  <data key="d6"></data>
</node>
<node id="Eastern Cooperative Oncology Group Score">
  <data key="d0">Eastern Cooperative Oncology Group Score</data>
  <data key="d1">method</data>
  <data key="d2">A scale used to rate a person's performance status and general health.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250070</data>
  <data key="d6"></data>
</node>
<node id="Karnofsky Performance Status">
  <data key="d0">Karnofsky Performance Status</data>
  <data key="d1">method</data>
  <data key="d2">A scale used to rate a person's performance status and general health.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250070</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow Tests">
  <data key="d0">Bone Marrow Tests</data>
  <data key="d1">method</data>
  <data key="d2">Procedures to remove and test bone marrow samples to diagnose AML, including aspirate and biopsy, reviewed by an expert pathologist.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250071</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow Aspirate">
  <data key="d0">Bone Marrow Aspirate</data>
  <data key="d1">method</data>
  <data key="d2">A bedside procedure using a hollow needle to draw liquid bone marrow from the hip bone for testing.&lt;SEP&gt;A bone marrow aspirate is a procedure to remove a sample of bone marrow tissue for testing to confirm an AML diagnosis.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250071</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow Biopsy">
  <data key="d0">Bone Marrow Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A bedside procedure using a wider needle to remove a small piece of bone from the hip for testing.&lt;SEP&gt;A bone marrow biopsy is a procedure to remove a sample of bone marrow cells for testing to confirm an AML diagnosis.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250072</data>
  <data key="d6"></data>
</node>
<node id="Disseminated Intravascular Coagulation Panel">
  <data key="d0">Disseminated Intravascular Coagulation Panel</data>
  <data key="d1">method</data>
  <data key="d2">A set of tests, also known as a coagulation panel, used to screen for clotting problems.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250072</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines For Patients: Adolescent And Young Adult Cancer">
  <data key="d0">NCCN Guidelines For Patients: Adolescent And Young Adult Cancer</data>
  <data key="d1">content</data>
  <data key="d2">A resource providing information on fertility preservation, accessible at NCCN.org/patientguidelines and on the NCCN Patient Guides for Cancer app.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250073</data>
  <data key="d6"></data>
</node>
<node id="Histology Review">
  <data key="d0">Histology Review</data>
  <data key="d1">method</data>
  <data key="d2">The review of bone marrow samples by a pathologist, often referred to as histology, histopathology, or hematopathology review.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250073</data>
  <data key="d6"></data>
</node>
<node id="Pelvis">
  <data key="d0">Pelvis</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The hip bone from which bone marrow samples are usually taken during aspirate and biopsy procedures.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250074</data>
  <data key="d6"></data>
</node>
<node id="Lymph Node Biopsy">
  <data key="d0">Lymph Node Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A lymph node biopsy is a diagnostic procedure performed by a doctor when the spread of squamous cell skin cancer to lymph nodes is suspected.&lt;SEP&gt;A diagnostic procedure that might be performed if the BPDCN subtype of AML is suspected.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250074</data>
  <data key="d6"></data>
</node>
<node id="Skin Lesion Biopsy">
  <data key="d0">Skin Lesion Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A diagnostic procedure that might be performed if the BPDCN subtype of AML is suspected.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250075</data>
  <data key="d6"></data>
</node>
<node id="Peripheral Blood">
  <data key="d0">Peripheral Blood</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Circulating blood from which cells can be taken for analysis using flow cytometry.</data>
  <data key="d3">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250075</data>
  <data key="d6"></data>
</node>
<node id="Bevacizumab">
  <data key="d0">Bevacizumab</data>
  <data key="d1">artifact</data>
  <data key="d2">Bevacizumab is a drug used in chemotherapy regimens and as maintenance therapy for ovarian cancer.&lt;SEP&gt;Bevacizumab, also known as Avastin, is a medication that may be added to chemotherapy to stop the growth of new blood vessels that feed a tumor.&lt;SEP&gt;Bevacizumab is a targeted therapy, also known as Avastin, used as a preferred option for treating platinum-resistant recurrent ovarian cancer.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250076</data>
  <data key="d6"></data>
</node>
<node id="Intravenous Administration">
  <data key="d0">Intravenous Administration</data>
  <data key="d1">method</data>
  <data key="d2">Intravenous administration is a method of delivering chemotherapy medicine directly into the bloodstream through a vein, often using a port.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250076</data>
  <data key="d6"></data>
</node>
<node id="Intraperitoneal Chemotherapy">
  <data key="d0">Intraperitoneal Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Intraperitoneal chemotherapy involves injecting chemotherapy medicine directly into the abdomen, delivering higher doses to cancer cells in that area.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250078</data>
  <data key="d6"></data>
</node>
<node id="Catheter">
  <data key="d0">Catheter</data>
  <data key="d1">artifact</data>
  <data key="d2">A catheter is a thin tube placed in a vein to deliver systemic therapy, fluids, and blood products during AML treatment.&lt;SEP&gt;A catheter is a thin tube used to deliver intraperitoneal chemotherapy, usually connected to a port placed inside the abdomen.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250078</data>
  <data key="d6"></data>
</node>
<node id="CA-125">
  <data key="d0">CA-125</data>
  <data key="d1">data</data>
  <data key="d2">CA-125 is a tumor marker that may be tested before each cycle of chemotherapy to monitor the disease.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250079</data>
  <data key="d6"></data>
</node>
<node id="Myelodysplastic Syndrome">
  <data key="d0">Myelodysplastic Syndrome</data>
  <data key="d1">concept</data>
  <data key="d2">Myelodysplastic syndrome is a rare but serious side effect of some treatments, a cancer where the bone marrow does not make enough healthy blood cells.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250079</data>
  <data key="d6"></data>
</node>
<node id="PARP Inhibitors">
  <data key="d0">PARP Inhibitors</data>
  <data key="d1">artifact</data>
  <data key="d2">PARP inhibitors are oral targeted therapies used for maintenance therapy after initial treatment, especially effective in HRD-positive cancers.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250080</data>
  <data key="d6"></data>
</node>
<node id="Olaparib">
  <data key="d0">Olaparib</data>
  <data key="d1">artifact</data>
  <data key="d2">Olaparib, also known as Lynparza, is a PARP inhibitor used for maintenance therapy, given alone or with bevacizumab.&lt;SEP&gt;Olaparib is a PARP inhibitor used as maintenance therapy for ovarian cancer, recommended to be continued for up to 2 years total.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250080</data>
  <data key="d6"></data>
</node>
<node id="Niraparib">
  <data key="d0">Niraparib</data>
  <data key="d1">artifact</data>
  <data key="d2">Niraparib, also known as Zejula, is a PARP inhibitor used for maintenance therapy, especially if olaparib cannot be used.&lt;SEP&gt;Niraparib is a PARP inhibitor used as maintenance therapy for ovarian cancer, recommended to be given alone for up to 3 years.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250082</data>
  <data key="d6"></data>
</node>
<node id="Rucaparib">
  <data key="d0">Rucaparib</data>
  <data key="d1">artifact</data>
  <data key="d2">Rucaparib, also known as Rubraca, is a PARP inhibitor used for maintenance therapy, particularly for HRD-positive cancers.&lt;SEP&gt;Rucaparib is a PARP inhibitor used as maintenance therapy for ovarian cancer, recommended to be given alone for up to 2 years.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250082</data>
  <data key="d6"></data>
</node>
<node id="Homologous Recombination Deficiency">
  <data key="d0">Homologous Recombination Deficiency</data>
  <data key="d1">concept</data>
  <data key="d2">Homologous recombination deficiency (HRD) is a condition where a tumor, often due to a BRCA mutation or other DNA changes, is deficient in DNA repair, making it HRD positive.&lt;SEP&gt;Homologous recombination deficiency is a genetic condition in cancers, including those with BRCA mutations, that makes them responsive to PARP inhibitors.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250083</data>
  <data key="d6"></data>
</node>
<node id="BRCA Mutation">
  <data key="d0">BRCA Mutation</data>
  <data key="d1">concept</data>
  <data key="d2">A BRCA mutation is a genetic alteration that can cause HRD-positive ovarian cancer and influences the choice of maintenance therapy.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250083</data>
  <data key="d6"></data>
</node>
<node id="Observation">
  <data key="d0">Observation</data>
  <data key="d1">method</data>
  <data key="d2">Observation is a management option after chemotherapy, involving monitoring without active drug treatment, typically after a complete response.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250085</data>
  <data key="d6"></data>
</node>
<node id="Avastin">
  <data key="d0">Avastin</data>
  <data key="d1">artifact</data>
  <data key="d2">Avastin is the brand name for the medication bevacizumab, which may be added to chemotherapy to stop tumor blood vessel growth.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250085</data>
  <data key="d6"></data>
</node>
<node id="Lynparza">
  <data key="d0">Lynparza</data>
  <data key="d1">artifact</data>
  <data key="d2">Lynparza is the brand name for the PARP inhibitor olaparib, used in maintenance therapy for ovarian cancer.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250086</data>
  <data key="d6"></data>
</node>
<node id="Zejula">
  <data key="d0">Zejula</data>
  <data key="d1">artifact</data>
  <data key="d2">Zejula is the brand name for the PARP inhibitor niraparib, used in maintenance therapy for ovarian cancer.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250086</data>
  <data key="d6"></data>
</node>
<node id="Rubraca">
  <data key="d0">Rubraca</data>
  <data key="d1">artifact</data>
  <data key="d2">Rubraca is the brand name for the PARP inhibitor rucaparib, used in maintenance therapy for ovarian cancer.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250087</data>
  <data key="d6"></data>
</node>
<node id="Pelvic And Rectovaginal Exam">
  <data key="d0">Pelvic And Rectovaginal Exam</data>
  <data key="d1">method</data>
  <data key="d2">A pelvic and rectovaginal exam may be performed every 1 to 3 cycles during chemotherapy to monitor the patient.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250087</data>
  <data key="d6"></data>
</node>
<node id="Neuropathy">
  <data key="d0">Neuropathy</data>
  <data key="d1">concept</data>
  <data key="d2">Neuropathy, or nerve damage, is a potential side effect of chemotherapy.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250088</data>
  <data key="d6"></data>
</node>
<node id="Complete Response">
  <data key="d0">Complete Response</data>
  <data key="d1">concept</data>
  <data key="d2">A complete response to chemotherapy means there are no signs of cancer in the body, making observation a possible maintenance option.</data>
  <data key="d3">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250088</data>
  <data key="d6"></data>
</node>
<node id="Serosa">
  <data key="d0">Serosa</data>
  <data key="d1">concept</data>
  <data key="d2">The serosa is also called the serous membrane or visceral peritoneum, which is a thin layer covering a surface.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250088</data>
  <data key="d6"></data>
</node>
<node id="Bile Duct">
  <data key="d0">Bile Duct</data>
  <data key="d1">concept</data>
  <data key="d2">A bile duct is made up of several layers, including inner and outer membranes, with muscle and connective tissue in between.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250088</data>
  <data key="d6"></data>
</node>
<node id="Intrahepatic Bile Duct Cancer">
  <data key="d0">Intrahepatic Bile Duct Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer that originates within the bile ducts of the liver, with stages defined by tumor size and spread.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250089</data>
  <data key="d6"></data>
</node>
<node id="Lymphocyte">
  <data key="d0">Lymphocyte</data>
  <data key="d1">concept</data>
  <data key="d2">A lymphocyte is a type of white blood cell that helps fight infection and is found in blood and lymph tissue.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250089</data>
  <data key="d6"></data>
</node>
<node id="B Lymphocyte">
  <data key="d0">B Lymphocyte</data>
  <data key="d1">concept</data>
  <data key="d2">B lymphocytes or B cells are a type of lymphocyte that make antibodies to target infections or cancer cells.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250090</data>
  <data key="d6"></data>
</node>
<node id="Germinal Center">
  <data key="d0">Germinal Center</data>
  <data key="d1">concept</data>
  <data key="d2">Germinal centers are short-lived structures in lymph nodes that form in response to infection; abnormal B cell growth here can lead to follicular lymphoma.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250090</data>
  <data key="d6"></data>
</node>
<node id="Centrocyte">
  <data key="d0">Centrocyte</data>
  <data key="d1">concept</data>
  <data key="d2">Centrocytes are smaller B cells found in the light zone of a germinal center, which divide less frequently.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250091</data>
  <data key="d6"></data>
</node>
<node id="Centroblast">
  <data key="d0">Centroblast</data>
  <data key="d1">concept</data>
  <data key="d2">Centroblasts are larger B cells found in the dark zone of a germinal center, which reproduce more frequently.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250091</data>
  <data key="d6"></data>
</node>
<node id="World Health Organization Classification">
  <data key="d0">World Health Organization Classification</data>
  <data key="d1">organization</data>
  <data key="d2">The World Health Organization provides a classification system (WHO5) that categorizes follicular lymphoma grades.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250092</data>
  <data key="d6"></data>
</node>
<node id="Burkitt Lymphoma">
  <data key="d0">Burkitt Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Burkitt lymphoma (BL) is a type of non-Hodgkin lymphoma with germinal centers distinct from those in follicular lymphoma.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250092</data>
  <data key="d6"></data>
</node>
<node id="Grade 3B Follicular Lymphoma">
  <data key="d0">Grade 3B Follicular Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Grade 3B follicular lymphoma is a high-grade FL containing only centroblasts, as opposed to other grades which contain a mixture of cell types.</data>
  <data key="d3">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250093</data>
  <data key="d6"></data>
</node>
<node id="Myeloid Progenitor Cells">
  <data key="d0">Myeloid Progenitor Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Myeloid progenitor cells are blood cells that form into myeloblasts and other non-lymphoid blood cells, and their increased production is associated with CML.&lt;SEP&gt;Myeloid progenitor cells are cells that develop from blood stem cells and mature into red blood cells, granulocytes, and platelets.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250093</data>
  <data key="d6"></data>
</node>
<node id="Myeloblasts">
  <data key="d0">Myeloblasts</data>
  <data key="d1">concept</data>
  <data key="d2">Myeloblasts are very immature non-lymphoid blood cells formed from myeloid progenitor cells, often referred to as blasts in CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250094</data>
  <data key="d6"></data>
</node>
<node id="Lymphoblasts">
  <data key="d0">Lymphoblasts</data>
  <data key="d1">concept</data>
  <data key="d2">Lymphoblasts are very immature lymphoid blood cells that, along with myeloblasts, are referred to as blasts in the context of CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250094</data>
  <data key="d6"></data>
</node>
<node id="Blood Stem Cells">
  <data key="d0">Blood Stem Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Blood stem cells are the origin cells from which CML is thought to arise, leading to increased production of myeloid progenitor cells.&lt;SEP&gt;Blood stem cells, or hematopoietic stem cells, are early blood-forming cells in the bone marrow that multiply and differentiate into various blood cells.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250095</data>
  <data key="d6"></data>
</node>
<node id="Chromosome 9">
  <data key="d0">Chromosome 9</data>
  <data key="d1">concept</data>
  <data key="d2">Chromosome 9 is involved in the genetic translocation with chromosome 22 that creates the BCR::ABL1 gene in CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250095</data>
  <data key="d6"></data>
</node>
<node id="Chromosome 22">
  <data key="d0">Chromosome 22</data>
  <data key="d1">concept</data>
  <data key="d2">Chromosome 22 is involved in the genetic translocation with chromosome 9, resulting in the abnormal Philadelphia chromosome in CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250096</data>
  <data key="d6"></data>
</node>
<node id="Philadelphia Chromosome (Ph)">
  <data key="d0">Philadelphia Chromosome (Ph)</data>
  <data key="d1">concept</data>
  <data key="d2">The Philadelphia chromosome is an abnormal chromosome 22 containing a part of chromosome 9, which carries the BCR::ABL1 gene and is the hallmark of CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250096</data>
  <data key="d6"></data>
</node>
<node id="BCR::ABL1 Protein">
  <data key="d0">BCR::ABL1 Protein</data>
  <data key="d1">concept</data>
  <data key="d2">The BCR::ABL1 protein is produced by the BCR::ABL1 gene and leads to uncontrolled blood cell growth, which is the target of CML treatment.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250097</data>
  <data key="d6"></data>
</node>
<node id="CML Treatment">
  <data key="d0">CML Treatment</data>
  <data key="d1">concept</data>
  <data key="d2">Treatment for CML aims to stop the activity of the BCR::ABL1 protein and should be administered at experienced cancer centers.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250097</data>
  <data key="d6"></data>
</node>
<node id="Patient Advocacy">
  <data key="d0">Patient Advocacy</data>
  <data key="d1">concept</data>
  <data key="d2">Patient advocacy involves asking questions, making shared decisions with the care team, and playing an active role in one's own care to achieve better outcomes.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250098</data>
  <data key="d6"></data>
</node>
<node id="CML Specialist">
  <data key="d0">CML Specialist</data>
  <data key="d1">concept</data>
  <data key="d2">A CML specialist is a medical professional whose opinion should be considered for optimal care management of CML.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250098</data>
  <data key="d6"></data>
</node>
<node id="Primary Care Physician (PCP)">
  <data key="d0">Primary Care Physician (PCP)</data>
  <data key="d1">person</data>
  <data key="d2">The primary care physician is a healthcare provider who should be updated regarding any changes in a patient's cancer treatment and status.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250099</data>
  <data key="d6"></data>
</node>
<node id="Support System">
  <data key="d0">Support System</data>
  <data key="d1">concept</data>
  <data key="d2">A support system consists of friends, family, or peers who provide transportation, meals, and emotional support during diagnosis and treatment.&lt;SEP&gt;A support system consists of friends, family, or peers who provide practical and emotional assistance during diagnosis and treatment.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250099</data>
  <data key="d6"></data>
</node>
<node id="Non-Small Cell Lung Cancer (NSCLC)">
  <data key="d0">Non-Small Cell Lung Cancer (NSCLC)</data>
  <data key="d1">concept</data>
  <data key="d2">NSCLC is the most common type of lung cancer, where cells grow out of control, form tumors, and can spread outside the lung.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250101</data>
  <data key="d6"></data>
</node>
<node id="Lung Carcinoma">
  <data key="d0">Lung Carcinoma</data>
  <data key="d1">concept</data>
  <data key="d2">Lung carcinoma is a type of cancer that forms from cells lining the airways of the lungs, with NSCLC being the most common form.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250101</data>
  <data key="d6"></data>
</node>
<node id="Lung Neuroendocrine Tumors">
  <data key="d0">Lung Neuroendocrine Tumors</data>
  <data key="d1">concept</data>
  <data key="d2">Lung neuroendocrine tumors are other types of lung carcinomas, with information available at a specific resource.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250102</data>
  <data key="d6"></data>
</node>
<node id="Questions to Ask">
  <data key="d0">Questions to Ask</data>
  <data key="d1">content</data>
  <data key="d2">Questions to Ask is a section at the end of each chapter in the book that provides suggested questions to help patients get more information on all aspects of their care.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250102</data>
  <data key="d6"></data>
</node>
<node id="Guide">
  <data key="d0">Guide</data>
  <data key="d1">content</data>
  <data key="d2">Guide is a resource where tests used to diagnose CML can be found.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250103</data>
  <data key="d6"></data>
</node>
<node id="Early and Locally Advanced NSCLC">
  <data key="d0">Early and Locally Advanced NSCLC</data>
  <data key="d1">concept</data>
  <data key="d2">Early and locally advanced NSCLC refers to stages of non-small cell lung cancer that are discussed in the chapter for understanding the disease.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250103</data>
  <data key="d6"></data>
</node>
<node id="Windpipe">
  <data key="d0">Windpipe</data>
  <data key="d1">concept</data>
  <data key="d2">The windpipe, or trachea, is the airway that carries air from the throat into the lungs.</data>
  <data key="d3">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250104</data>
  <data key="d6"></data>
</node>
<node id="QTc">
  <data key="d0">QTc</data>
  <data key="d1">concept</data>
  <data key="d2">QTc is a measurement of the heart's electrical cycle; if prolonged, it can cause dangerous heart rhythms.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250104</data>
  <data key="d6"></data>
</node>
<node id="Ejection Fraction">
  <data key="d0">Ejection Fraction</data>
  <data key="d1">concept</data>
  <data key="d2">Ejection fraction is the amount of blood pumped from the left side of the heart per beat; a lower amount indicates decreased heart function.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250105</data>
  <data key="d6"></data>
</node>
<node id="Myeloblast">
  <data key="d0">Myeloblast</data>
  <data key="d1">concept</data>
  <data key="d2">Myeloblasts are very immature white blood cells that accumulate in AML, with diagnosis typically requiring 20% or more in bone marrow or blood.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250105</data>
  <data key="d6"></data>
</node>
<node id="Genetic And Biomarker Tests">
  <data key="d0">Genetic And Biomarker Tests</data>
  <data key="d1">method</data>
  <data key="d2">Genetic and biomarker tests are used to determine AML subtype, target treatment, and establish a prognosis.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250106</data>
  <data key="d6"></data>
</node>
<node id="Hematologist">
  <data key="d0">Hematologist</data>
  <data key="d1">person</data>
  <data key="d2">A hematologist is a medical expert in blood diseases and blood cancers who treats conditions like AML.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250106</data>
  <data key="d6"></data>
</node>
<node id="Multidisciplinary Team">
  <data key="d0">Multidisciplinary Team</data>
  <data key="d1">organization</data>
  <data key="d2">A Multidisciplinary Team (MDT) is a group of healthcare professionals from different backgrounds who plan and implement cancer treatment.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250107</data>
  <data key="d6"></data>
</node>
<node id="Hematologic Oncologist">
  <data key="d0">Hematologic Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">A hematologic oncologist is a medical expert in blood diseases and blood cancers who treats these conditions.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250107</data>
  <data key="d6"></data>
</node>
<node id="Hematopathologist">
  <data key="d0">Hematopathologist</data>
  <data key="d1">person</data>
  <data key="d2">A hematopathologist analyzes cells and tissues to provide cancer diagnosis, staging, and biomarker information.</data>
  <data key="d3">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250108</data>
  <data key="d6"></data>
</node>
<node id="Imaging Scans">
  <data key="d0">Imaging Scans</data>
  <data key="d1">method</data>
  <data key="d2">Imaging scans are diagnostic tools used to determine if squamous cell skin cancer has penetrated deeper into the skin or spread to other parts of the body.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250108</data>
  <data key="d6"></data>
</node>
<node id="Oncologist">
  <data key="d0">Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">An oncologist is a cancer doctor who is part of the care team for a patient diagnosed with squamous cell skin cancer.&lt;SEP&gt;An oncologist is a doctor who provides regular surveillance exams and care for cancer survivors after treatment.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250109</data>
  <data key="d6"></data>
</node>
<node id="Mohs Surgeon">
  <data key="d0">Mohs Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A Mohs surgeon is a doctor, often a dermatologist, with advanced training in Mohs surgery and reconstruction, who removes tumors and restores the affected area's appearance.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250109</data>
  <data key="d6"></data>
</node>
<node id="Surgical Oncologist">
  <data key="d0">Surgical Oncologist</data>
  <data key="d1">person</data>
  <data key="d2">A surgical oncologist is a doctor trained to diagnose and surgically remove cancerous tumors, including those that have spread beyond the skin.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250110</data>
  <data key="d6"></data>
</node>
<node id="Plastic Surgeon">
  <data key="d0">Plastic Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A plastic surgeon is a doctor who can remove cancer and reconstruct body parts, often working with a pathologist during surgery and skilled in closing complex wounds.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250110</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Surgeon">
  <data key="d0">Head And Neck Surgeon</data>
  <data key="d1">person</data>
  <data key="d2">A head and neck surgeon is a doctor trained to treat conditions, both cancerous and noncancerous, of the deeper parts of the head and neck.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250111</data>
  <data key="d6"></data>
</node>
<node id="Pharmacist">
  <data key="d0">Pharmacist</data>
  <data key="d1">person</data>
  <data key="d2">A pharmacist is a medical professional trained to prepare and dispense medicine, explain its use and side effects, with some specializing in cancer care.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250111</data>
  <data key="d6"></data>
</node>
<node id="Geneticist">
  <data key="d0">Geneticist</data>
  <data key="d1">person</data>
  <data key="d2">A geneticist is a doctor who studies genetic inheritance, diagnoses and treats genetic disorders, and counsels individuals and families at risk.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250112</data>
  <data key="d6"></data>
</node>
<node id="Oncology Nurse">
  <data key="d0">Oncology Nurse</data>
  <data key="d1">person</data>
  <data key="d2">An oncology nurse provides hands-on care, administers systemic therapy, manages patient care, answers questions, and helps cope with side effects; sometimes called a nurse navigator.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250112</data>
  <data key="d6"></data>
</node>
<node id="Superficial Treatments">
  <data key="d0">Superficial Treatments</data>
  <data key="d1">concept</data>
  <data key="d2">Superficial treatments are therapies that affect only the top layer of the skin, used for early squamous cell skin cancer (Bowen's disease) and actinic keratoses.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250113</data>
  <data key="d6"></data>
</node>
<node id="Bowens Disease">
  <data key="d0">Bowens Disease</data>
  <data key="d1">concept</data>
  <data key="d2">Bowen's disease is the earliest form of squamous cell skin cancer, which can be treated with superficial treatments.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250113</data>
  <data key="d6"></data>
</node>
<node id="Topical Therapies">
  <data key="d0">Topical Therapies</data>
  <data key="d1">method</data>
  <data key="d2">Topical therapies are treatments applied directly to the skin, such as prescription creams, to treat early squamous cell skin cancer and actinic keratoses.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250114</data>
  <data key="d6"></data>
</node>
<node id="Bowens Lesion">
  <data key="d0">Bowens Lesion</data>
  <data key="d1">concept</data>
  <data key="d2">A Bowen's lesion is an area of skin affected by Bowen's disease, the earliest form of squamous cell skin cancer, which can be treated with superficial treatments.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250114</data>
  <data key="d6"></data>
</node>
<node id="Nurse Navigator">
  <data key="d0">Nurse Navigator</data>
  <data key="d1">person</data>
  <data key="d2">A nurse navigator is another term for an oncology nurse, a professional who provides hands-on care and guidance throughout cancer treatment.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250115</data>
  <data key="d6"></data>
</node>
<node id="Liquid Nitrogen">
  <data key="d0">Liquid Nitrogen</data>
  <data key="d1">artifact</data>
  <data key="d2">Liquid nitrogen is a very cold substance often used in cryotherapy to freeze and destroy precancerous and cancerous skin cells.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250115</data>
  <data key="d6"></data>
</node>
<node id="5-FU">
  <data key="d0">5-FU</data>
  <data key="d1">artifact</data>
  <data key="d2">5-FU is an abbreviation for 5-fluorouracil, a chemotherapy cream applied topically to treat early squamous cell skin cancer and actinic keratoses.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250116</data>
  <data key="d6"></data>
</node>
<node id="Vitamin D">
  <data key="d0">Vitamin D</data>
  <data key="d1">concept</data>
  <data key="d2">Vitamin D is a nutrient; calcipotriene is a synthetic form of vitamin D used in a cream to activate the skin's immune system against actinic keratosis.</data>
  <data key="d3">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250116</data>
  <data key="d6"></data>
</node>
<node id="Computed Tomography (CT) Scan">
  <data key="d0">Computed Tomography (CT) Scan</data>
  <data key="d1">method</data>
  <data key="d2">An imaging procedure using a computer linked to an x-ray machine to create detailed 3D pictures of areas inside the body, often with contrast dye.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250117</data>
  <data key="d6"></data>
</node>
<node id="Magnetic Resonance Imaging (MRI)">
  <data key="d0">Magnetic Resonance Imaging (MRI)</data>
  <data key="d1">method</data>
  <data key="d2">An imaging procedure using radio waves, a magnet, and a computer to make detailed pictures of areas inside the body, often with contrast dye.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250117</data>
  <data key="d6"></data>
</node>
<node id="Positron Emission Tomography (PET) Scan">
  <data key="d0">Positron Emission Tomography (PET) Scan</data>
  <data key="d1">method</data>
  <data key="d2">An imaging scan using a radioactive tracer injected into a vein to show how cells and tissues use substances, highlighting abnormal activity like cancer.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250118</data>
  <data key="d6"></data>
</node>
<node id="Contrast Dye">
  <data key="d0">Contrast Dye</data>
  <data key="d1">artifact</data>
  <data key="d2">A liquid injected into a vein during CT scans and MRIs to help tissues and organs show up more clearly, unless contraindicated.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250118</data>
  <data key="d6"></data>
</node>
<node id="Needle Biopsy">
  <data key="d0">Needle Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A procedure to take a sample from a lymph node using a needle to test for the spread of cancer.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250119</data>
  <data key="d6"></data>
</node>
<node id="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d0">Cutaneous Squamous Cell Carcinoma (CSCC)</data>
  <data key="d1">concept</data>
  <data key="d2">A very common type of skin cancer, often found in sun-exposed areas, which can be cured by complete removal but may cause severe damage or spread if untreated.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250119</data>
  <data key="d6"></data>
</node>
<node id="Local Squamous Cell Skin Cancer">
  <data key="d0">Local Squamous Cell Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Squamous cell skin cancer that has not spread to nearby lymph nodes.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250120</data>
  <data key="d6"></data>
</node>
<node id="Shave Biopsy">
  <data key="d0">Shave Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">A biopsy method that removes the epidermis and part of the dermis using a tool similar to a razor.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250120</data>
  <data key="d6"></data>
</node>
<node id="Sun">
  <data key="d0">Sun</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A primary environmental factor; excessive exposure over many years is a common cause of squamous cell skin cancer.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250120</data>
  <data key="d6"></data>
</node>
<node id="Lymphatic Fluid">
  <data key="d0">Lymphatic Fluid</data>
  <data key="d1">naturalobject</data>
  <data key="d2">A fluid in which cancer cells can travel to form tumors in other parts of the body; it is filtered by lymph nodes.</data>
  <data key="d3">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250120</data>
  <data key="d6"></data>
</node>
<node id="National Comprehensive Cancer Network">
  <data key="d0">National Comprehensive Cancer Network</data>
  <data key="d1">organization</data>
  <data key="d2">The National Comprehensive Cancer Network is an alliance of leading cancer centers that develops evidence-based cancer care guidelines.&lt;SEP&gt;National Comprehensive Cancer Network (NCCN) is an organization that holds the copyright for the patient guidelines and develops cancer care standards.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250121</data>
  <data key="d6"></data>
</node>
<node id="NCCN Clinical Practice Guidelines In Oncology">
  <data key="d0">NCCN Clinical Practice Guidelines In Oncology</data>
  <data key="d1">content</data>
  <data key="d2">The NCCN Clinical Practice Guidelines in Oncology are evidence-based recommendations used by healthcare providers worldwide for cancer care.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250121</data>
  <data key="d6"></data>
</node>
<node id="NCCN Foundation">
  <data key="d0">NCCN Foundation</data>
  <data key="d1">organization</data>
  <data key="d2">The NCCN Foundation is an organization that funds and distributes patient guidelines and supports cancer research.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250122</data>
  <data key="d6"></data>
</node>
<node id="Pfizer Inc.">
  <data key="d0">Pfizer Inc.</data>
  <data key="d1">organization</data>
  <data key="d2">Pfizer Inc. is a corporate supporter that provides funding for the NCCN Guidelines for Patients.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250122</data>
  <data key="d6"></data>
</node>
<node id="Hodgkin Lymphoma">
  <data key="d0">Hodgkin Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Hodgkin Lymphoma is a highly curable type of cancer that usually starts in lymph nodes and involves abnormal lymphocytes called Reed-Sternberg cells.&lt;SEP&gt;Hodgkin Lymphoma is a type of cancer affecting the lymphatic system, with two main types: Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250123</data>
  <data key="d6"></data>
</node>
<node id="Reed-Sternberg Cells">
  <data key="d0">Reed-Sternberg Cells</data>
  <data key="d1">concept</data>
  <data key="d2">Reed-Sternberg cells are abnormally large lymphocytes with multiple nuclei, characteristic of Hodgkin Lymphoma.&lt;SEP&gt;Reed-Sternberg Cells are large lymphocytes characteristic of Classic Hodgkin Lymphoma.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250123</data>
  <data key="d6"></data>
</node>
<node id="Insurance Forms">
  <data key="d0">Insurance Forms</data>
  <data key="d1">content</data>
  <data key="d2">Insurance forms are documents related to healthcare coverage and billing that patients are advised to organize.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250125</data>
  <data key="d6"></data>
</node>
<node id="Medical Records">
  <data key="d0">Medical Records</data>
  <data key="d1">data</data>
  <data key="d2">Medical records are comprehensive files containing a patient's health history, test results, and treatment details.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250125</data>
  <data key="d6"></data>
</node>
<node id="Contact List">
  <data key="d0">Contact List</data>
  <data key="d1">data</data>
  <data key="d2">A contact list is a compiled record of information for a patient's care team, including treatment details and emergency access.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250125</data>
  <data key="d6"></data>
</node>
<node id="Non-Hodgkin Lymphomas">
  <data key="d0">Non-Hodgkin Lymphomas</data>
  <data key="d1">concept</data>
  <data key="d2">Non-Hodgkin lymphomas are a large and varied group of cancers distinct from Hodgkin lymphoma.</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250125</data>
  <data key="d6"></data>
</node>
<node id="Thymus">
  <data key="d0">Thymus</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The Thymus is a small organ in the upper chest where lymphocytes develop into T lymphocytes (T cells).</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250126</data>
  <data key="d6"></data>
</node>
<node id="Classic Hodgkin Lymphoma">
  <data key="d0">Classic Hodgkin Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Classic Hodgkin Lymphoma is the most common type of Hodgkin Lymphoma, characterized by large lymphocytes called Reed-Sternberg cells.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250126</data>
  <data key="d6"></data>
</node>
<node id="Nodular Lymphocyte-Predominant Hodgkin Lymphoma">
  <data key="d0">Nodular Lymphocyte-Predominant Hodgkin Lymphoma</data>
  <data key="d1">concept</data>
  <data key="d2">Nodular Lymphocyte-Predominant Hodgkin Lymphoma is a rare form of Hodgkin Lymphoma known for popcorn-shaped cells, which usually grows slowly but can transform into aggressive cancers.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250127</data>
  <data key="d6"></data>
</node>
<node id="Excisional Lymph Node Biopsy">
  <data key="d0">Excisional Lymph Node Biopsy</data>
  <data key="d1">method</data>
  <data key="d2">An Excisional Lymph Node Biopsy is the preferred diagnostic method for Hodgkin Lymphoma, involving the removal of one or more whole lymph nodes for testing.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250127</data>
  <data key="d6"></data>
</node>
<node id="Lymphatic Vessels">
  <data key="d0">Lymphatic Vessels</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Lymphatic Vessels are a network of ducts that transport lymph throughout the body, analogous to how blood vessels transport blood.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250128</data>
  <data key="d6"></data>
</node>
<node id="T Lymphocytes">
  <data key="d0">T Lymphocytes</data>
  <data key="d1">naturalobject</data>
  <data key="d2">T Lymphocytes, or T cells, are one of the two main types of lymphocytes that develop in the thymus.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250128</data>
  <data key="d6"></data>
</node>
<node id="Popcorn-Shaped Cells">
  <data key="d0">Popcorn-Shaped Cells</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Popcorn-Shaped Cells are the characteristic cells found in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250129</data>
  <data key="d6"></data>
</node>
<node id="Guide 1 Testing For Hodgkin Lymphoma">
  <data key="d0">Guide 1 Testing For Hodgkin Lymphoma</data>
  <data key="d1">content</data>
  <data key="d2">Guide 1 Testing for Hodgkin Lymphoma is a chapter or section explaining the diagnostic process for Hodgkin lymphoma, including biopsy and lab testing.</data>
  <data key="d3">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250129</data>
  <data key="d6"></data>
</node>
<node id="Differentiation">
  <data key="d0">Differentiation</data>
  <data key="d1">concept</data>
  <data key="d2">Differentiation is the process by which blood stem cells gradually develop into mature blood cells.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250130</data>
  <data key="d6"></data>
</node>
<node id="Granulocytes">
  <data key="d0">Granulocytes</data>
  <data key="d1">concept</data>
  <data key="d2">Granulocytes, also known as neutrophils, are a type of white blood cell that mature from myeloblasts and help prevent and control infection.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250130</data>
  <data key="d6"></data>
</node>
<node id="Complete Blood Count">
  <data key="d0">Complete Blood Count</data>
  <data key="d1">method</data>
  <data key="d2">Complete Blood Count (CBC) is a blood test used in the diagnosis and monitoring of AML.&lt;SEP&gt;A complete blood count (CBC) measures red blood cells, white blood cells, and platelets in a blood sample to assess general health.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250131</data>
  <data key="d6"></data>
</node>
<node id="PML::RARA Fusion Gene">
  <data key="d0">PML::RARA Fusion Gene</data>
  <data key="d1">concept</data>
  <data key="d2">The PML::RARA fusion gene is an abnormal genetic finding associated with a rare subtype of AML called APL.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250131</data>
  <data key="d6"></data>
</node>
<node id="APL">
  <data key="d0">APL</data>
  <data key="d1">concept</data>
  <data key="d2">Acute Promyelocytic Leukemia (APL) is a rare subtype of AML characterized by the presence of the PML::RARA fusion gene.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250133</data>
  <data key="d6"></data>
</node>
<node id="BPDCN">
  <data key="d0">BPDCN</data>
  <data key="d1">concept</data>
  <data key="d2">Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive subtype of AML that can be found in blood, bone marrow, lymph nodes, and/or skin.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250133</data>
  <data key="d6"></data>
</node>
<node id="Chapter 2: Testing For AML">
  <data key="d0">Chapter 2: Testing For AML</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 2: Testing for AML is a section in the NCCN Guidelines for Patients that provides an overview of diagnostic tests for AML.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250134</data>
  <data key="d6"></data>
</node>
<node id="Chapter 3: Types Of Treatment">
  <data key="d0">Chapter 3: Types Of Treatment</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 3: Types of Treatment is a resource that provides information on the various treatment methods for basal cell skin cancer.&lt;SEP&gt;Chapter 3: Types of treatment is a section in the NCCN Guidelines for Patients that gives a general overview of AML treatment.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250134</data>
  <data key="d6"></data>
</node>
<node id="Chapter 4: AML">
  <data key="d0">Chapter 4: AML</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 4: AML is a section in the NCCN Guidelines for Patients that discusses treatment for AML.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250135</data>
  <data key="d6"></data>
</node>
<node id="Chapter 5: APL">
  <data key="d0">Chapter 5: APL</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 5: APL is a section in the NCCN Guidelines for Patients that discusses treatment for the rare AML subtype APL.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250135</data>
  <data key="d6"></data>
</node>
<node id="Chapter 6: BPDCN">
  <data key="d0">Chapter 6: BPDCN</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 6: BPDCN is a section in the NCCN Guidelines for Patients that discusses treatment for the aggressive AML subtype BPDCN.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250136</data>
  <data key="d6"></data>
</node>
<node id="Chapter 7: Other Resources">
  <data key="d0">Chapter 7: Other Resources</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 7: Other resources is a section in the NCCN Guidelines for Patients that provides information on patient advocacy groups and support.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250136</data>
  <data key="d6"></data>
</node>
<node id="AML Specialist">
  <data key="d0">AML Specialist</data>
  <data key="d1">concept</data>
  <data key="d2">An AML specialist is a type of medical professional whose opinion a patient is advised to consider seeking for optimal care.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250137</data>
  <data key="d6"></data>
</node>
<node id="Genetic And Biomarker Mutation Testing">
  <data key="d0">Genetic And Biomarker Mutation Testing</data>
  <data key="d1">method</data>
  <data key="d2">Genetic and biomarker mutation testing is a type of diagnostic test discussed in Chapter 2 for assessing AML.</data>
  <data key="d3">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250137</data>
  <data key="d6"></data>
</node>
<node id="Hereditary Cancer">
  <data key="d0">Hereditary Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Hereditary cancer refers to cancers caused by inherited genetic mutations, such as those in the BRCA genes or other genes.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250138</data>
  <data key="d6"></data>
</node>
<node id="Registered Dietitian Or Nutritionist">
  <data key="d0">Registered Dietitian Or Nutritionist</data>
  <data key="d1">person</data>
  <data key="d2">A registered dietitian or nutritionist is a healthcare professional who can provide help with meal planning and dietary questions.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250138</data>
  <data key="d6"></data>
</node>
<node id="Gastrointestinal Tract">
  <data key="d0">Gastrointestinal Tract</data>
  <data key="d1">concept</data>
  <data key="d2">Part of the digestive system through which food passes, including the esophagus, stomach, and intestines.&lt;SEP&gt;The gastrointestinal (GI) tract is the system of organs, including the stomach, small bowel, and large bowel, through which food passes.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250139</data>
  <data key="d6"></data>
</node>
<node id="Scope">
  <data key="d0">Scope</data>
  <data key="d1">artifact</data>
  <data key="d2">A scope is a long, thin tube with a light and camera used in procedures like colonoscopy and upper endoscopy to examine internal organs.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250139</data>
  <data key="d6"></data>
</node>
<node id="Colonoscopy">
  <data key="d0">Colonoscopy</data>
  <data key="d1">method</data>
  <data key="d2">Colonoscopy is a procedure that uses a scope inserted into the anus to examine the rectum and colon (large bowel).</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250140</data>
  <data key="d6"></data>
</node>
<node id="Upper Endoscopy">
  <data key="d0">Upper Endoscopy</data>
  <data key="d1">method</data>
  <data key="d2">Upper endoscopy is a procedure that uses a scope guided down the throat to examine the esophagus, stomach, and small bowel (upper GI tract).</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250140</data>
  <data key="d6"></data>
</node>
<node id="Blood Chemistry Profile">
  <data key="d0">Blood Chemistry Profile</data>
  <data key="d1">method</data>
  <data key="d2">A blood chemistry profile measures chemical levels affected by organs like the kidneys and bones, providing information on organ function and nutrient intake.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250141</data>
  <data key="d6"></data>
</node>
<node id="Tumor Markers">
  <data key="d0">Tumor Markers</data>
  <data key="d1">concept</data>
  <data key="d2">Tumor markers are substances in body tissue or fluid that may indicate cancer and help diagnose ovarian cancer and monitor treatment response.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250141</data>
  <data key="d6"></data>
</node>
<node id="Cancer Antigen-125">
  <data key="d0">Cancer Antigen-125</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer antigen-125 (CA-125) is a protein; high levels in blood may signal ovarian or other cancers, but the test alone cannot diagnose ovarian cancer.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250142</data>
  <data key="d6"></data>
</node>
<node id="Inhibin">
  <data key="d0">Inhibin</data>
  <data key="d1">concept</data>
  <data key="d2">Inhibin (typically inhibin A and inhibin B) is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250142</data>
  <data key="d6"></data>
</node>
<node id="Beta-Human Chorionic Gonadotropin">
  <data key="d0">Beta-Human Chorionic Gonadotropin</data>
  <data key="d1">concept</data>
  <data key="d2">Beta-human chorionic gonadotropin (-hCG) is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250143</data>
  <data key="d6"></data>
</node>
<node id="Alpha-Fetoprotein">
  <data key="d0">Alpha-Fetoprotein</data>
  <data key="d1">concept</data>
  <data key="d2">Alpha-fetoprotein (AFP) is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250143</data>
  <data key="d6"></data>
</node>
<node id="Carcinoembryonic Antigen">
  <data key="d0">Carcinoembryonic Antigen</data>
  <data key="d1">concept</data>
  <data key="d2">Carcinoembryonic antigen (CEA) is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250144</data>
  <data key="d6"></data>
</node>
<node id="CA 19-9">
  <data key="d0">CA 19-9</data>
  <data key="d1">concept</data>
  <data key="d2">CA 19-9 is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250144</data>
  <data key="d6"></data>
</node>
<node id="HE4">
  <data key="d0">HE4</data>
  <data key="d1">concept</data>
  <data key="d2">HE4 is a tumor marker that may be elevated in people with less common ovarian cancers.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250145</data>
  <data key="d6"></data>
</node>
<node id="Microsatellite Instability">
  <data key="d0">Microsatellite Instability</data>
  <data key="d1">concept</data>
  <data key="d2">Microsatellite instability (MSI) is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250145</data>
  <data key="d6"></data>
</node>
<node id="Mismatch Repair">
  <data key="d0">Mismatch Repair</data>
  <data key="d1">concept</data>
  <data key="d2">Mismatch repair (MMR) is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250146</data>
  <data key="d6"></data>
</node>
<node id="Folate Receptor Alpha Expression">
  <data key="d0">Folate Receptor Alpha Expression</data>
  <data key="d1">concept</data>
  <data key="d2">Folate receptor alpha (FR) expression is a biomarker tested on tumor tissue, often for recurrent ovarian cancer.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250146</data>
  <data key="d6"></data>
</node>
<node id="Provider">
  <data key="d0">Provider</data>
  <data key="d1">person</data>
  <data key="d2">A provider is a healthcare professional who may ask about diet, eating habits, and can refer patients to a dietitian or nutritionist.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250147</data>
  <data key="d6"></data>
</node>
<node id="Endometriosis">
  <data key="d0">Endometriosis</data>
  <data key="d1">concept</data>
  <data key="d2">Endometriosis is a non-cancerous health problem that can raise CA-125 levels.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250147</data>
  <data key="d6"></data>
</node>
<node id="Diverticulitis">
  <data key="d0">Diverticulitis</data>
  <data key="d1">concept</data>
  <data key="d2">Diverticulitis is a non-cancerous health problem that can raise CA-125 levels.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250148</data>
  <data key="d6"></data>
</node>
<node id="Less Common Ovarian Cancers">
  <data key="d0">Less Common Ovarian Cancers</data>
  <data key="d1">concept</data>
  <data key="d2">Less common ovarian cancers (LCOCs) are types of ovarian cancer where tumor markers like inhibin, -hCG, AFP, LDH, CEA, CA 19-9, and HE4 may be elevated.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250148</data>
  <data key="d6"></data>
</node>
<node id="Somatic Mutations">
  <data key="d0">Somatic Mutations</data>
  <data key="d1">concept</data>
  <data key="d2">Somatic mutations, also known as tumor mutations, are genetic changes found in the tumor itself, as opposed to inherited germline mutations.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250149</data>
  <data key="d6"></data>
</node>
<node id="Germline Mutations">
  <data key="d0">Germline Mutations</data>
  <data key="d1">concept</data>
  <data key="d2">Germline mutations are inherited genetic changes, such as those in the BRCA genes, tested for in the blood.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250149</data>
  <data key="d6"></data>
</node>
<node id="Precision Oncology">
  <data key="d0">Precision Oncology</data>
  <data key="d1">concept</data>
  <data key="d2">Precision oncology is an approach to cancer treatment that uses biomarker testing to tailor therapy, also known as molecular testing or tumor profiling.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250150</data>
  <data key="d6"></data>
</node>
<node id="Recurrent Ovarian Cancer">
  <data key="d0">Recurrent Ovarian Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Recurrent ovarian cancer is cancer that returns after treatment, for which testing for additional biomarkers like MSI, MMR, HER2, TMB, BRAF V600E, FR, RET, and NTRK is generally recommended.</data>
  <data key="d3">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250150</data>
  <data key="d6"></data>
</node>
<node id="Treatment">
  <data key="d0">Treatment</data>
  <data key="d1">concept</data>
  <data key="d2">Treatment refers to medical interventions for cancer that can affect fertility and patient outcomes.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250151</data>
  <data key="d6"></data>
</node>
<node id="DNA Mutations">
  <data key="d0">DNA Mutations</data>
  <data key="d1">concept</data>
  <data key="d2">DNA mutations are specific genetic changes that may be found in a tumor sample and could be targeted with specific therapies.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250151</data>
  <data key="d6"></data>
</node>
<node id="Heavy Alcohol Use">
  <data key="d0">Heavy Alcohol Use</data>
  <data key="d1">concept</data>
  <data key="d2">Heavy alcohol use is a behavior that negatively affects cancer treatment outcomes and increases treatment toxicity.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250152</data>
  <data key="d6"></data>
</node>
<node id="Cancer Staging">
  <data key="d0">Cancer Staging</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer staging is a process used to reflect prognosis and guide treatment decisions by describing the size, location, and spread of a tumor.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250152</data>
  <data key="d6"></data>
</node>
<node id="American Joint Committee On Cancer">
  <data key="d0">American Joint Committee On Cancer</data>
  <data key="d1">organization</data>
  <data key="d2">The American Joint Committee on Cancer (AJCC) is the organization that created a system for staging cancer.&lt;SEP&gt;The American Joint Committee on Cancer (AJCC) developed one of the staging systems for ovarian cancer.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250153</data>
  <data key="d6"></data>
</node>
<node id="TNM System">
  <data key="d0">TNM System</data>
  <data key="d1">method</data>
  <data key="d2">The TNM system is a staging method that uses the letters T, N, and M to describe the size of the tumor, spread to lymph nodes, and metastasis.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250153</data>
  <data key="d6"></data>
</node>
<node id="Tumor Size">
  <data key="d0">Tumor Size</data>
  <data key="d1">concept</data>
  <data key="d2">Tumor size (T) is a factor in staging that describes how large the cancer is and if it has grown into nearby areas.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250154</data>
  <data key="d6"></data>
</node>
<node id="Lymph Node Status">
  <data key="d0">Lymph Node Status</data>
  <data key="d1">concept</data>
  <data key="d2">Lymph node status (N) is a factor in staging that describes if and how cancer has spread to nearby lymph nodes.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250154</data>
  <data key="d6"></data>
</node>
<node id="Anatomic Stage">
  <data key="d0">Anatomic Stage</data>
  <data key="d1">concept</data>
  <data key="d2">Anatomic stage is a type of staging based on the extent of cancer as defined by tumor size (T), lymph node status (N), and distant metastasis (M).</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250155</data>
  <data key="d6"></data>
</node>
<node id="Prognostic Stage">
  <data key="d0">Prognostic Stage</data>
  <data key="d1">concept</data>
  <data key="d2">Prognostic stage includes anatomic TNM information and assumes the patient is treated with standard-of-care approaches, divided into clinical and pathologic stages.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250155</data>
  <data key="d6"></data>
</node>
<node id="Pathologic Stage">
  <data key="d0">Pathologic Stage</data>
  <data key="d1">concept</data>
  <data key="d2">Pathologic stage (p) or surgical stage is determined by examining tissue removed during surgery, providing more specific details.&lt;SEP&gt;The pathologic stage is determined after surgery and provides the most accurate picture of how far ovarian cancer has spread to guide treatment.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250156</data>
  <data key="d6"></data>
</node>
<node id="Locoregional Disease">
  <data key="d0">Locoregional Disease</data>
  <data key="d1">concept</data>
  <data key="d2">Locoregional or locally advanced disease refers to a tumor that has spread to tissue, organs, or lymph nodes near the mouth.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250156</data>
  <data key="d6"></data>
</node>
<node id="Moderately Advanced Disease">
  <data key="d0">Moderately Advanced Disease</data>
  <data key="d1">concept</data>
  <data key="d2">Moderately or very advanced disease includes cancer that has spread to parts of the neck such as bones, muscles, sinuses, or skin.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250157</data>
  <data key="d6"></data>
</node>
<node id="Metastatic Disease">
  <data key="d0">Metastatic Disease</data>
  <data key="d1">concept</data>
  <data key="d2">Metastatic disease is cancer that has spread to other parts of the body, such as the lungs or distant lymph nodes, and may be called very advanced disease.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250157</data>
  <data key="d6"></data>
</node>
<node id="Numbered Stages">
  <data key="d0">Numbered Stages</data>
  <data key="d1">concept</data>
  <data key="d2">Numbered stages, ranging from stage 0 to stage 4, are the final cancer classification based on combined TNM scores.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250158</data>
  <data key="d6"></data>
</node>
<node id="Jaw Teeth Gums">
  <data key="d0">Jaw Teeth Gums</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The jaw, teeth, and gums are parts of the body whose health can be affected by head and neck cancer and its treatment.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250158</data>
  <data key="d6"></data>
</node>
<node id="Tissue Fluid">
  <data key="d0">Tissue Fluid</data>
  <data key="d1">naturalobject</data>
  <data key="d2">Tissue or fluid is a biological sample removed from the body during a biopsy for testing.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250159</data>
  <data key="d6"></data>
</node>
<node id="Standard-Of-Care Approaches">
  <data key="d0">Standard-Of-Care Approaches</data>
  <data key="d1">concept</data>
  <data key="d2">Standard-of-care approaches are the established, recommended treatment methods assumed in the prognostic stage of cancer.</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250159</data>
  <data key="d6"></data>
</node>
<node id="Contrast">
  <data key="d0">Contrast</data>
  <data key="d1">artifact</data>
  <data key="d2">A substance used in imaging tests to enhance picture clarity, administered orally or intravenously, and excreted in urine.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250160</data>
  <data key="d6"></data>
</node>
<node id="MRI Scan">
  <data key="d0">MRI Scan</data>
  <data key="d1">method</data>
  <data key="d2">Magnetic resonance imaging that uses radio waves and magnets (not x-rays) to take pictures inside the body, sometimes using contrast.&lt;SEP&gt;An MRI scan uses radio waves and strong magnets to produce images of the body's interior, without using X-rays, and often uses contrast.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250160</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines for Patients Adrenal Tumors, 2022">
  <data key="d0">NCCN Guidelines for Patients Adrenal Tumors, 2022</data>
  <data key="d1">content</data>
  <data key="d2">A specific set of patient guidelines for adrenal tumors published in 2022, referenced in the text.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250161</data>
  <data key="d6"></data>
</node>
<node id="Diphenhydramine (Benadryl)">
  <data key="d0">Diphenhydramine (Benadryl)</data>
  <data key="d1">artifact</data>
  <data key="d2">A medicine that may be given to patients to avoid allergic reactions to contrast material used in imaging tests.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250161</data>
  <data key="d6"></data>
</node>
<node id="Prednisone (Steroids)">
  <data key="d0">Prednisone (Steroids)</data>
  <data key="d1">artifact</data>
  <data key="d2">A steroid medicine that may be given to patients to avoid allergic reactions to contrast material used in imaging tests.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250162</data>
  <data key="d6"></data>
</node>
<node id="SSTRPET">
  <data key="d0">SSTRPET</data>
  <data key="d1">method</data>
  <data key="d2">A type of PET scan mentioned as being helpful for those with adrenal tumors.</data>
  <data key="d3">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250162</data>
  <data key="d6"></data>
</node>
<node id="Standard Of Care">
  <data key="d0">Standard Of Care</data>
  <data key="d1">concept</data>
  <data key="d2">Standard of care is the best-known way to treat a particular disease based on past clinical trials, and there may be more than one treatment regimen considered standard.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250163</data>
  <data key="d6"></data>
</node>
<node id="Multi-Agent Chemotherapy">
  <data key="d0">Multi-Agent Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Multi-agent chemotherapy involves combining different chemotherapies to treat AML, with each drug working in a different way and causing different side effects.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250163</data>
  <data key="d6"></data>
</node>
<node id="Antimetabolites">
  <data key="d0">Antimetabolites</data>
  <data key="d1">method</data>
  <data key="d2">Antimetabolites are a type of chemotherapy that prevent the building blocks of DNA from being used; examples include Cladribine, Clofarabine, Cytarabine, Fludarabine, and Methotrexate.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250164</data>
  <data key="d6"></data>
</node>
<node id="Anthracyclines">
  <data key="d0">Anthracyclines</data>
  <data key="d1">method</data>
  <data key="d2">Anthracyclines are a type of chemotherapy that damage and disrupt the making of DNA, causing cell death; examples include daunorubicin, idarubicin, and mitoxantrone, and they may cause heart issues.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250164</data>
  <data key="d6"></data>
</node>
<node id="Cytarabine">
  <data key="d0">Cytarabine</data>
  <data key="d1">method</data>
  <data key="d2">Cytarabine, also called Ara-C, is an antimetabolite used in many AML treatment regimens, available in different doses (Standard, High, Intermediate, Low) and can be administered intrathecally.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250165</data>
  <data key="d6"></data>
</node>
<node id="Intrathecal Chemotherapy">
  <data key="d0">Intrathecal Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Intrathecal chemotherapy involves injecting drugs like Cytarabine or Methotrexate into the spinal fluid to treat AML in the fluid surrounding the spine or brain.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250165</data>
  <data key="d6"></data>
</node>
<node id="Hypomethylating Agents">
  <data key="d0">Hypomethylating Agents</data>
  <data key="d1">method</data>
  <data key="d2">Hypomethylating agents block methyl groups from binding to DNA, turning silenced genes back on to allow leukemic blasts to mature; examples include Azacitidine and Decitabine.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250167</data>
  <data key="d6"></data>
</node>
<node id="Gemtuzumab Ozogamicin">
  <data key="d0">Gemtuzumab Ozogamicin</data>
  <data key="d1">method</data>
  <data key="d2">Gemtuzumab ozogamicin is a targeted therapy linked to a chemotherapy drug that attaches to the CD33 protein on leukemic blasts and may delay blood count recovery and cause liver issues.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250167</data>
  <data key="d6"></data>
</node>
<node id="Core Binding Factor">
  <data key="d0">Core Binding Factor</data>
  <data key="d1">concept</data>
  <data key="d2">Core binding factor creates a shortage of all types of mature blood cells and is associated with certain genetic abnormalities in AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250168</data>
  <data key="d6"></data>
</node>
<node id="Cladribine">
  <data key="d0">Cladribine</data>
  <data key="d1">method</data>
  <data key="d2">Cladribine, also known as Mavenclad, is an antimetabolite chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250168</data>
  <data key="d6"></data>
</node>
<node id="Clofarabine">
  <data key="d0">Clofarabine</data>
  <data key="d1">method</data>
  <data key="d2">Clofarabine, also known as Clolar, is an antimetabolite chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250169</data>
  <data key="d6"></data>
</node>
<node id="Fludarabine">
  <data key="d0">Fludarabine</data>
  <data key="d1">method</data>
  <data key="d2">Fludarabine is an antimetabolite chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250169</data>
  <data key="d6"></data>
</node>
<node id="Methotrexate">
  <data key="d0">Methotrexate</data>
  <data key="d1">method</data>
  <data key="d2">Methotrexate is an antimetabolite chemotherapy drug used to treat AML and can be administered intrathecally.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250170</data>
  <data key="d6"></data>
</node>
<node id="Daunorubicin">
  <data key="d0">Daunorubicin</data>
  <data key="d1">method</data>
  <data key="d2">Daunorubicin is an anthracycline chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250170</data>
  <data key="d6"></data>
</node>
<node id="Idarubicin">
  <data key="d0">Idarubicin</data>
  <data key="d1">method</data>
  <data key="d2">Idarubicin, also known as Idamycin PFS, is an anthracycline chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250171</data>
  <data key="d6"></data>
</node>
<node id="Mitoxantrone">
  <data key="d0">Mitoxantrone</data>
  <data key="d1">method</data>
  <data key="d2">Mitoxantrone, also known as Novantrone, is an anthracycline chemotherapy drug used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250171</data>
  <data key="d6"></data>
</node>
<node id="CPX-351">
  <data key="d0">CPX-351</data>
  <data key="d1">method</data>
  <data key="d2">CPX-351, also known as Vyxeos, is a dual-drug liposome containing cytarabine and daunorubicin, combining an antimetabolite and an anthracycline.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250172</data>
  <data key="d6"></data>
</node>
<node id="Azacitidine">
  <data key="d0">Azacitidine</data>
  <data key="d1">method</data>
  <data key="d2">Azacitidine, also known as Vidaza, is a hypomethylating agent used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250172</data>
  <data key="d6"></data>
</node>
<node id="Decitabine">
  <data key="d0">Decitabine</data>
  <data key="d1">method</data>
  <data key="d2">Decitabine, also known as Dacogen, is a hypomethylating agent used to treat AML.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250173</data>
  <data key="d6"></data>
</node>
<node id="CD33">
  <data key="d0">CD33</data>
  <data key="d1">concept</data>
  <data key="d2">CD33 is a cell surface protein found on many leukemic blasts and is the target for the drug Gemtuzumab ozogamicin.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250173</data>
  <data key="d6"></data>
</node>
<node id="Gilteritinib">
  <data key="d0">Gilteritinib</data>
  <data key="d1">method</data>
  <data key="d2">Gilteritinib is a targeted therapy used to treat AML with certain FLT3 mutations.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250173</data>
  <data key="d6"></data>
</node>
<node id="Quizartinib">
  <data key="d0">Quizartinib</data>
  <data key="d1">method</data>
  <data key="d2">Quizartinib is a targeted therapy used to treat AML with certain FLT3 mutations, specifically FLT3-ITD.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250173</data>
  <data key="d6"></data>
</node>
<node id="Midostaurin">
  <data key="d0">Midostaurin</data>
  <data key="d1">method</data>
  <data key="d2">Midostaurin is a targeted therapy used to treat AML with certain FLT3 mutations.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250174</data>
  <data key="d6"></data>
</node>
<node id="Sorafenib">
  <data key="d0">Sorafenib</data>
  <data key="d1">method</data>
  <data key="d2">Sorafenib is a targeted therapy used to treat AML with certain FLT3 mutations, specifically FLT3-ITD.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250174</data>
  <data key="d6"></data>
</node>
<node id="Fallopian Tubes">
  <data key="d0">Fallopian Tubes</data>
  <data key="d1">naturalobject</data>
  <data key="d2">The fallopian tubes are part of the female reproductive system and are a site where ovarian cancer can start.&lt;SEP&gt;The fallopian tubes are structures that, along with the ovaries and uterus, are removed during ovarian cancer surgery.</data>
  <data key="d3">chunk-53afdc6713818c4177b64a712ecce11b&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250175</data>
  <data key="d6"></data>
</node>
<node id="CA-125 Level">
  <data key="d0">CA-125 Level</data>
  <data key="d1">data</data>
  <data key="d2">CA-125 is a tumor marker that may be checked regularly after ovarian cancer treatment if it was originally high.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250175</data>
  <data key="d6"></data>
</node>
<node id="Biomarkers">
  <data key="d0">Biomarkers</data>
  <data key="d1">concept</data>
  <data key="d2">Biomarkers are biological markers that help guide treatment for recurrent ovarian cancer, including BRCA mutations and HRD status.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250176</data>
  <data key="d6"></data>
</node>
<node id="Platinum-Resistant Cancer">
  <data key="d0">Platinum-Resistant Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Platinum-resistant ovarian cancer does not improve or worsens during platinum-based chemotherapy or returns within 6 months of such treatment.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250176</data>
  <data key="d6"></data>
</node>
<node id="Mirvetuximab Soravtansine-Gynx">
  <data key="d0">Mirvetuximab Soravtansine-Gynx</data>
  <data key="d1">artifact</data>
  <data key="d2">Mirvetuximab soravtansine-gynx is a targeted therapy, also known as Elahere, preferred for recurrent ovarian cancer with the FR biomarker.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250177</data>
  <data key="d6"></data>
</node>
<node id="Platinum-Sensitive Cancer">
  <data key="d0">Platinum-Sensitive Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Platinum-sensitive ovarian cancer returns more than 6 months after successful platinum-based chemotherapy, indicating the drugs remain effective.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250177</data>
  <data key="d6"></data>
</node>
<node id="Secondary Cytoreductive Surgery">
  <data key="d0">Secondary Cytoreductive Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Secondary cytoreductive surgery is a procedure to remove all visible cancer before starting recurrence treatment for platinum-sensitive disease.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250178</data>
  <data key="d6"></data>
</node>
<node id="Hypersensitivity Reactions">
  <data key="d0">Hypersensitivity Reactions</data>
  <data key="d1">concept</data>
  <data key="d2">Hypersensitivity reactions are allergic, potentially life-threatening reactions that can occur with repeat use of carboplatin or cisplatin chemotherapy.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250178</data>
  <data key="d6"></data>
</node>
<node id="PARP Inhibitor">
  <data key="d0">PARP Inhibitor</data>
  <data key="d1">artifact</data>
  <data key="d2">A PARP inhibitor is a type of drug used in maintenance therapy for ovarian cancer, with examples including olaparib, niraparib, and rucaparib.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250178</data>
  <data key="d6"></data>
</node>
<node id="Stage 2 Ovarian Cancer">
  <data key="d0">Stage 2 Ovarian Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">Stage 2 ovarian cancer is a specific stage of the disease where there is limited research on maintenance therapy with PARP inhibitors after initial treatment.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250178</data>
  <data key="d6"></data>
</node>
<node id="Survivorship">
  <data key="d0">Survivorship</data>
  <data key="d1">concept</data>
  <data key="d2">Survivorship refers to the phase of care after cancer treatment, encompassing surveillance and other important care for cancer survivors.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250179</data>
  <data key="d6"></data>
</node>
<node id="NCCN Guidelines">
  <data key="d0">NCCN Guidelines</data>
  <data key="d1">content</data>
  <data key="d2">The NCCN Guidelines for Patients provide information on managing side effects of treatments like immunotherapy for cancer.</data>
  <data key="d3">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250179</data>
  <data key="d6"></data>
</node>
<node id="Ultraviolet (UV) Radiation">
  <data key="d0">Ultraviolet (UV) Radiation</data>
  <data key="d1">concept</data>
  <data key="d2">Ultraviolet (UV) radiation from the sun or tanning beds is the primary cause of basal cell skin cancer, as it can damage the DNA inside basal skin cells.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250180</data>
  <data key="d6"></data>
</node>
<node id="Basal Cell Carcinoma (BCC)">
  <data key="d0">Basal Cell Carcinoma (BCC)</data>
  <data key="d1">concept</data>
  <data key="d2">Basal cell carcinoma (BCC) is an alternative name for basal cell skin cancer, the most common type of skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250180</data>
  <data key="d6"></data>
</node>
<node id="United States">
  <data key="d0">United States</data>
  <data key="d1">location</data>
  <data key="d2">The United States is the country where about 3 million cases of basal cell skin cancer are diagnosed every year.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250181</data>
  <data key="d6"></data>
</node>
<node id="Face">
  <data key="d0">Face</data>
  <data key="d1">location</data>
  <data key="d2">The face is one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250181</data>
  <data key="d6"></data>
</node>
<node id="Head">
  <data key="d0">Head</data>
  <data key="d1">location</data>
  <data key="d2">The head is one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250181</data>
  <data key="d6"></data>
</node>
<node id="Arms">
  <data key="d0">Arms</data>
  <data key="d1">location</data>
  <data key="d2">The arms are one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250181</data>
  <data key="d6"></data>
</node>
<node id="Legs">
  <data key="d0">Legs</data>
  <data key="d1">location</data>
  <data key="d2">The legs are one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250182</data>
  <data key="d6"></data>
</node>
<node id="Trunk">
  <data key="d0">Trunk</data>
  <data key="d1">location</data>
  <data key="d2">The trunk is one of the common areas of the body where basal cell skin cancer usually develops due to sun exposure.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250182</data>
  <data key="d6"></data>
</node>
<node id="Fair Skin">
  <data key="d0">Fair Skin</data>
  <data key="d1">concept</data>
  <data key="d2">Fair skin is a risk factor for basal cell skin cancer, as lighter-colored skin has less melanin to filter harmful UV rays.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250183</data>
  <data key="d6"></data>
</node>
<node id="Red Or Blond Hair">
  <data key="d0">Red Or Blond Hair</data>
  <data key="d1">concept</data>
  <data key="d2">Having red or blond hair is a risk factor associated with an increased likelihood of developing basal cell skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250183</data>
  <data key="d6"></data>
</node>
<node id="Light Eye Color">
  <data key="d0">Light Eye Color</data>
  <data key="d1">concept</data>
  <data key="d2">Having a light eye color is a risk factor associated with an increased likelihood of developing basal cell skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250184</data>
  <data key="d6"></data>
</node>
<node id="Age">
  <data key="d0">Age</data>
  <data key="d1">concept</data>
  <data key="d2">Age is a risk factor for basal cell skin cancer, with risk increasing as sun exposure accumulates over time.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250184</data>
  <data key="d6"></data>
</node>
<node id="History Of Skin Cancer">
  <data key="d0">History Of Skin Cancer</data>
  <data key="d1">concept</data>
  <data key="d2">A personal or family history of skin cancer is a risk factor that increases the chance of developing basal cell skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250184</data>
  <data key="d6"></data>
</node>
<node id="Immune Suppression">
  <data key="d0">Immune Suppression</data>
  <data key="d1">concept</data>
  <data key="d2">Immune suppression, resulting from conditions like organ transplants or autoimmune diseases, weakens the immune system and increases the risk for basal cell skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250184</data>
  <data key="d6"></data>
</node>
<node id="Full Skin Exams">
  <data key="d0">Full Skin Exams</data>
  <data key="d1">method</data>
  <data key="d2">Full skin exams are medical check-ups performed by a doctor at least once a year following treatment for basal cell skin cancer.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250185</data>
  <data key="d6"></data>
</node>
<node id="Chapter 2: Testing For Basal Cell Skin Cancer">
  <data key="d0">Chapter 2: Testing For Basal Cell Skin Cancer</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 2: Testing for Basal Cell Skin Cancer is a resource that provides information on how basal cell skin cancer is diagnosed.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250185</data>
  <data key="d6"></data>
</node>
<node id="Chapter 4: Treatment By Risk And Recurrence">
  <data key="d0">Chapter 4: Treatment By Risk And Recurrence</data>
  <data key="d1">content</data>
  <data key="d2">Chapter 4: Treatment by Risk and Recurrence is a resource that provides detailed information on treatment options for basal cell skin cancer based on risk and recurrence.</data>
  <data key="d3">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250186</data>
  <data key="d6"></data>
</node>
<node id="NSCLC">
  <data key="d0">NSCLC</data>
  <data key="d1">concept</data>
  <data key="d2">Non-Small Cell Lung Cancer, a type of lung cancer for which patient guidelines are available from NCCN.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250186</data>
  <data key="d6"></data>
</node>
<node id="SCLC">
  <data key="d0">SCLC</data>
  <data key="d1">concept</data>
  <data key="d2">Small Cell Lung Cancer, a type of lung cancer primarily caused by smoking.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250187</data>
  <data key="d6"></data>
</node>
<node id="Radiation Therapy To The Chest">
  <data key="d0">Radiation Therapy To The Chest</data>
  <data key="d1">method</data>
  <data key="d2">A prior medical treatment that increases a person's chances of developing SCLC.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250187</data>
  <data key="d6"></data>
</node>
<node id="Carcinogens">
  <data key="d0">Carcinogens</data>
  <data key="d1">concept</data>
  <data key="d2">Cancer-causing chemicals, such as radon and asbestos, exposure to which increases the risk of SCLC.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250187</data>
  <data key="d6"></data>
</node>
<node id="Nicotine Addiction">
  <data key="d0">Nicotine Addiction</data>
  <data key="d1">concept</data>
  <data key="d2">An addiction to nicotine, described as one of the hardest addictions to stop, complicating smoking cessation.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250187</data>
  <data key="d6"></data>
</node>
<node id="Lung Tumor">
  <data key="d0">Lung Tumor</data>
  <data key="d1">concept</data>
  <data key="d2">An abnormal growth in the lung, the development of which is less likely after quitting smoking.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250188</data>
  <data key="d6"></data>
</node>
<node id="Paraneoplastic Syndromes">
  <data key="d0">Paraneoplastic Syndromes</data>
  <data key="d1">concept</data>
  <data key="d2">Symptoms caused by an abnormal body response to lung cancer, distinct from direct tumor effects.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250188</data>
  <data key="d6"></data>
</node>
<node id="X-Rays">
  <data key="d0">X-Rays</data>
  <data key="d1">method</data>
  <data key="d2">An imaging technique that can sometimes detect SCLC before symptoms start.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250188</data>
  <data key="d6"></data>
</node>
<node id="CT Scans">
  <data key="d0">CT Scans</data>
  <data key="d1">method</data>
  <data key="d2">An imaging technique that can sometimes detect SCLC before symptoms start.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250188</data>
  <data key="d6"></data>
</node>
<node id="Airways">
  <data key="d0">Airways</data>
  <data key="d1">concept</data>
  <data key="d2">The series of passages through which air moves in the body, including the trachea and bronchi.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250189</data>
  <data key="d6"></data>
</node>
<node id="Lobes">
  <data key="d0">Lobes</data>
  <data key="d1">concept</data>
  <data key="d2">The parts of the lung; the right lung has three and the left lung has two.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250189</data>
  <data key="d6"></data>
</node>
<node id="Assessment Team">
  <data key="d0">Assessment Team</data>
  <data key="d1">organization</data>
  <data key="d2">A group of board-certified medical specialists assembled to determine if a patient has cancer.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250190</data>
  <data key="d6"></data>
</node>
<node id="Interventional Radiologist">
  <data key="d0">Interventional Radiologist</data>
  <data key="d1">person</data>
  <data key="d2">A board-certified expert who performs image-guided procedures, part of a cancer assessment team.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250190</data>
  <data key="d6"></data>
</node>
<node id="Digestive System">
  <data key="d0">Digestive System</data>
  <data key="d1">concept</data>
  <data key="d2">The bodily system that transports and breaks down food, absorbs nutrients, and removes waste.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250191</data>
  <data key="d6"></data>
</node>
<node id="Peristalsis">
  <data key="d0">Peristalsis</data>
  <data key="d1">concept</data>
  <data key="d2">Small contractions, along with gravity and pressure, that move food down the esophagus during swallowing.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250191</data>
  <data key="d6"></data>
</node>
<node id="Sphincters">
  <data key="d0">Sphincters</data>
  <data key="d1">concept</data>
  <data key="d2">Circular muscles in the esophagus that remain closed except during swallowing.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250191</data>
  <data key="d6"></data>
</node>
<node id="Muscularis Mucosa">
  <data key="d0">Muscularis Mucosa</data>
  <data key="d1">concept</data>
  <data key="d2">A very thin layer of muscle under the lamina propria in the mucosa.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250191</data>
  <data key="d6"></data>
</node>
<node id="Guide SCLC">
  <data key="d0">Guide SCLC</data>
  <data key="d1">content</data>
  <data key="d2">A guide that lists symptoms caused by Small Cell Lung Cancer.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250192</data>
  <data key="d6"></data>
</node>
<node id="Spine">
  <data key="d0">Spine</data>
  <data key="d1">concept</data>
  <data key="d2">The spinal column, located in front of which the esophagus is positioned.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250192</data>
  <data key="d6"></data>
</node>
<node id="Stomach">
  <data key="d0">Stomach</data>
  <data key="d1">concept</data>
  <data key="d2">The organ into which the esophagus delivers food and drink.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250193</data>
  <data key="d6"></data>
</node>
<node id="Small Intestine">
  <data key="d0">Small Intestine</data>
  <data key="d1">concept</data>
  <data key="d2">The part of the digestive tract where liquefied food enters after the stomach.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250193</data>
  <data key="d6"></data>
</node>
<node id="Colon">
  <data key="d0">Colon</data>
  <data key="d1">concept</data>
  <data key="d2">Part of the large intestine in the digestive tract.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250194</data>
  <data key="d6"></data>
</node>
<node id="Rectum">
  <data key="d0">Rectum</data>
  <data key="d1">concept</data>
  <data key="d2">Part of the large intestine in the digestive tract.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250194</data>
  <data key="d6"></data>
</node>
<node id="Anus">
  <data key="d0">Anus</data>
  <data key="d1">concept</data>
  <data key="d2">The final part of the digestive tract through which waste is removed.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250195</data>
  <data key="d6"></data>
</node>
<node id="Large Intestine">
  <data key="d0">Large Intestine</data>
  <data key="d1">concept</data>
  <data key="d2">The part of the digestive tract that prepares unused food to be expelled from the body.</data>
  <data key="d3">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250195</data>
  <data key="d6"></data>
</node>
<node id="Contraception">
  <data key="d0">Contraception</data>
  <data key="d1">concept</data>
  <data key="d2">Contraception, such as condoms, is used to prevent pregnancy during and after cancer treatment.</data>
  <data key="d3">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250195</data>
  <data key="d6"></data>
</node>
<node id="FDG-PET/CT Scan">
  <data key="d0">FDG-PET/CT Scan</data>
  <data key="d1">method</data>
  <data key="d2">An FDG-PET/CT scan combines PET and CT technologies using a fluorodeoxyglucose tracer to find cancer in lymph nodes and distant sites.</data>
  <data key="d3">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250195</data>
  <data key="d6"></data>
</node>
<node id="Panoramic Dental X-Ray">
  <data key="d0">Panoramic Dental X-Ray</data>
  <data key="d1">method</data>
  <data key="d2">A panoramic dental X-ray uses a low dose of radiation to capture an image of the entire mouth and jaw for dental treatment planning.</data>
  <data key="d3">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250196</data>
  <data key="d6"></data>
</node>
<node id="Smoking And Vaping">
  <data key="d0">Smoking And Vaping</data>
  <data key="d1">concept</data>
  <data key="d2">Smoking or vaping nicotine increases cancer risk, reduces treatment effectiveness, impairs healing, and raises side effect chances.</data>
  <data key="d3">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250196</data>
  <data key="d6"></data>
</node>
<node id="Peritoneal Washing">
  <data key="d0">Peritoneal Washing</data>
  <data key="d1">method</data>
  <data key="d2">Peritoneal washing is a procedure where the abdominal space is rinsed with a special liquid to sample for cancer cells, used when there is no fluid buildup.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250197</data>
  <data key="d6"></data>
</node>
<node id="Surgical Menopause">
  <data key="d0">Surgical Menopause</data>
  <data key="d1">concept</data>
  <data key="d2">Surgical menopause is caused by the removal of both ovaries, leading to a sudden drop in estrogen and symptoms like hot flashes, night sweats, and vaginal atrophy.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250197</data>
  <data key="d6"></data>
</node>
<node id="Hormone Replacement Therapy">
  <data key="d0">Hormone Replacement Therapy</data>
  <data key="d1">method</data>
  <data key="d2">Hormone Replacement Therapy (HRT) is a potential treatment suggested by doctors for symptoms of surgical menopause.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250199</data>
  <data key="d6"></data>
</node>
<node id="Deep Vein Thrombosis">
  <data key="d0">Deep Vein Thrombosis</data>
  <data key="d1">concept</data>
  <data key="d2">Deep Vein Thrombosis (DVT) is a risk factor for blood clots that can occur after ovarian cancer surgery, with patients often placed on blood thinners to prevent it.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250199</data>
  <data key="d6"></data>
</node>
<node id="Interval Cytoreductive Surgery">
  <data key="d0">Interval Cytoreductive Surgery</data>
  <data key="d1">method</data>
  <data key="d2">Interval Cytoreductive Surgery (ICS) is surgery performed after several cycles of chemotherapy to remove as much cancer as possible.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250200</data>
  <data key="d6"></data>
</node>
<node id="Hyperthermic Intraperitoneal Chemotherapy">
  <data key="d0">Hyperthermic Intraperitoneal Chemotherapy</data>
  <data key="d1">method</data>
  <data key="d2">Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a technique where warmed chemotherapy is circulated in the abdominal cavity during surgery for stage 3 disease.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250200</data>
  <data key="d6"></data>
</node>
<node id="FIGO Staging System">
  <data key="d0">FIGO Staging System</data>
  <data key="d1">concept</data>
  <data key="d2">The FIGO staging system, developed by the International Federation of Gynecology and Obstetrics, is a standard way to describe the extent of ovarian cancer based on tumor extent, lymph node involvement, and distant spread.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250201</data>
  <data key="d6"></data>
</node>
<node id="International Federation Of Gynecology And Obstetrics">
  <data key="d0">International Federation Of Gynecology And Obstetrics</data>
  <data key="d1">organization</data>
  <data key="d2">The International Federation of Gynecology and Obstetrics (FIGO) developed the staging system most often used for ovarian cancer.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250201</data>
  <data key="d6"></data>
</node>
<node id="Blood Thinners">
  <data key="d0">Blood Thinners</data>
  <data key="d1">artifact</data>
  <data key="d2">Blood thinners are oral medications or injections given to patients after ovarian cancer surgery to help prevent blood clots like Deep Vein Thrombosis.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250202</data>
  <data key="d6"></data>
</node>
<node id="Estrogen">
  <data key="d0">Estrogen</data>
  <data key="d1">concept</data>
  <data key="d2">Estrogen is a hormone whose sudden drop due to ovary removal causes surgical menopause and its associated symptoms and long-term risks.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250202</data>
  <data key="d6"></data>
</node>
<node id="Cardiovascular Disease">
  <data key="d0">Cardiovascular Disease</data>
  <data key="d1">concept</data>
  <data key="d2">Cardiovascular disease is a long-term risk of not having enough estrogen following surgical menopause for ovarian cancer.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250203</data>
  <data key="d6"></data>
</node>
<node id="Osteoporosis">
  <data key="d0">Osteoporosis</data>
  <data key="d1">concept</data>
  <data key="d2">Osteoporosis, or bone loss, is a long-term risk of not having enough estrogen following surgical menopause for ovarian cancer.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250203</data>
  <data key="d6"></data>
</node>
<node id="Menopausal Symptom Team">
  <data key="d0">Menopausal Symptom Team</data>
  <data key="d1">organization</data>
  <data key="d2">A menopausal symptom team is recommended for discussion to determine if Hormone Replacement Therapy is right for a patient with surgical menopause.</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250204</data>
  <data key="d6"></data>
</node>
<node id="Stage 2, 3, and 4">
  <data key="d0">Stage 2, 3, and 4</data>
  <data key="d3">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d2">Chemotherapy is recommended after surgery for all newly diagnosed stage 2, 3, and 4 ovarian cancers.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250219</data>
  <data key="d6"></data>
</node>
<node id="Cancer Care Team">
  <data key="d0">Cancer Care Team</data>
  <data key="d3">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d2">Healthcare teams use the metric system to measure treatment aspects in cancer care.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250331</data>
  <data key="d6"></data>
</node>
<node id="Preventing Pregnancy">
  <data key="d0">Preventing Pregnancy</data>
  <data key="d3">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d2">Barrier methods are recommended as a form of contraception to prevent pregnancy during cancer treatment.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250395</data>
  <data key="d6"></data>
</node>
<node id="Lung Diseases">
  <data key="d0">Lung Diseases</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d2">A pulmonologist is a doctor who specializes in and is an expert in lung diseases.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250405</data>
  <data key="d6"></data>
</node>
<node id="Operations">
  <data key="d0">Operations</data>
  <data key="d3">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d2">A thoracic surgeon is a doctor who specializes in performing operations within the chest.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250406</data>
  <data key="d6"></data>
</node>
<node id="Head And Neck Cancer Treatment">
  <data key="d0">Head And Neck Cancer Treatment</data>
  <data key="d3">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d2">Treatment for head and neck cancer can affect fertility, and patients should discuss this with their care team.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250490</data>
  <data key="d6"></data>
</node>
<node id="Diagnosis">
  <data key="d0">Diagnosis</data>
  <data key="d3">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d2">The diagnosis of basal cell skin cancer determines the subsequent treatment plan for the patient.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250524</data>
  <data key="d6"></data>
</node>
<node id="Bone Marrow Or Blood Sample">
  <data key="d0">Bone Marrow Or Blood Sample</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d2">A karyotype requires a sample of bone marrow or blood to grow cells for analysis.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250602</data>
  <data key="d6"></data>
</node>
<node id="DNA Sequence">
  <data key="d0">DNA Sequence</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d2">Next-Generation Sequencing is used to determine a portion of a person's DNA sequence to find mutations.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250603</data>
  <data key="d6"></data>
</node>
<node id="Heart">
  <data key="d0">Heart</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d2">An electrocardiogram shows electrical changes in the heart to reveal information about heart rate and rhythm.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250610</data>
  <data key="d6"></data>
</node>
<node id="Treatment Side Effects">
  <data key="d0">Treatment Side Effects</data>
  <data key="d3">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d2">Heart tests might be used to monitor treatment side effects.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250621</data>
  <data key="d6"></data>
</node>
<node id="Lymphoma">
  <data key="d0">Lymphoma</data>
  <data key="d3">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d2">Lymphoma is a cancer that begins when white blood cells called lymphocytes grow out of control.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250779</data>
  <data key="d6"></data>
</node>
<node id="Body">
  <data key="d0">Body</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d2">Imaging tests are used to take pictures of the inside of the body for diagnostic purposes.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250824</data>
  <data key="d6"></data>
</node>
<node id="Treatment Outcomes">
  <data key="d0">Treatment Outcomes</data>
  <data key="d3">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d2">Smoking or heavy alcohol use negatively affects cancer treatment outcomes and increases treatment toxicity.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250826</data>
  <data key="d6"></data>
</node>
<node id="Ovarian Cancer Surgery">
  <data key="d0">Ovarian Cancer Surgery</data>
  <data key="d3">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d2">Ovarian cancer surgery is a risk factor for developing Deep Vein Thrombosis, leading to preventive use of blood thinners.</data>
  <data key="d1">UNKNOWN</data>
  <data key="d4">unknown_source</data>
  <data key="d5">1767250894</data>
  <data key="d6"></data>
</node>
<edge source="Ovarian Cancer" target="FIGO Stages">
  <data key="d7">1.0</data>
  <data key="d8">The FIGO stages provide a detailed system for classifying the extent and progression of ovarian cancer.</data>
  <data key="d9">disease classification,staging system</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250204</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Abdominal Exam">
  <data key="d7">1.0</data>
  <data key="d8">An abdominal exam is performed to check for signs and symptoms that may indicate the presence of ovarian cancer.</data>
  <data key="d9">diagnostic evaluation,symptom assessment</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250253</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Pelvic Exam">
  <data key="d7">1.0</data>
  <data key="d8">A pelvic exam is conducted to detect abnormal changes in reproductive organs that may be caused by ovarian cancer.</data>
  <data key="d9">diagnostic evaluation,physical examination</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250256</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Ultrasound">
  <data key="d7">3.0</data>
  <data key="d8">Ultrasound is the first imaging test used to look for ovarian cancer by visualizing the ovaries and detecting masses.&lt;SEP&gt;Ultrasound is often the first imaging test performed for suspected ovarian cancer.&lt;SEP&gt;Ultrasound is often the first imaging test used in the diagnostic process for ovarian cancer.</data>
  <data key="d9">diagnostic tool,imaging,imaging diagnosis,initial assessment,initial imaging,tumor detection</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250258</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="CT Scan">
  <data key="d7">1.0</data>
  <data key="d8">CT scans are used to determine if ovarian cancer has spread beyond the ovaries to other areas like the abdomen, pelvis, or chest.</data>
  <data key="d9">imaging diagnosis,metastasis detection</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250259</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="MRI">
  <data key="d7">1.0</data>
  <data key="d8">MRI is used to look for ovarian cancer, especially when ultrasound images are unclear, and to check for signs of cancer spread.</data>
  <data key="d9">clarification,imaging diagnosis</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250260</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Clinical Stage">
  <data key="d7">1.0</data>
  <data key="d8">Testing for ovarian cancer helps determine its clinical stage, which estimates how far the cancer has spread and guides treatment decisions.</data>
  <data key="d9">disease assessment,treatment planning</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250261</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Symptoms Of Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer causes specific symptoms such as bloating and pelvic pain, which are used to suspect its presence.</data>
  <data key="d9">disease manifestation,symptom correlation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250261</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Surgery">
  <data key="d7">2.0</data>
  <data key="d8">Surgery is considered as a first treatment for ovarian cancer, but its possibility is evaluated based on the tumor and patient health.&lt;SEP&gt;Surgery is a primary treatment for ovarian cancer to remove the cancer and determine its spread.</data>
  <data key="d9">feasibility assessment,primary treatment,treatment option,tumor removal</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250263</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Testing">
  <data key="d7">1.0</data>
  <data key="d8">Testing is initiated when ovarian cancer is suspected to establish its clinical stage and to plan the appropriate treatment.</data>
  <data key="d9">diagnostic process,staging determination</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250265</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">A biopsy is performed on tumor tissue to diagnose ovarian cancer.&lt;SEP&gt;A biopsy is the procedure usually performed during initial surgery to diagnose ovarian cancer.</data>
  <data key="d9">diagnosis,diagnostic procedure,surgical step,tissue analysis</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250657</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Blood Tests">
  <data key="d7">1.0</data>
  <data key="d8">Blood tests, including tumor markers, are used in the diagnostic process for suspected ovarian cancer.</data>
  <data key="d9">diagnostic testing,health assessment</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250660</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Genetic Testing">
  <data key="d7">1.0</data>
  <data key="d8">Everyone diagnosed with ovarian cancer should have genetic testing for inherited BRCA mutations.</data>
  <data key="d9">hereditary risk,mutation screening</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250661</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Biomarker Testing">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing looks for cancer features to help guide treatment for ovarian cancer.</data>
  <data key="d9">mutation analysis,treatment guidance</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250662</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Chemotherapy">
  <data key="d7">2.0</data>
  <data key="d8">Chemotherapy is used to treat ovarian cancer, especially to shrink the tumor when surgery first is not an option.&lt;SEP&gt;Chemotherapy is used to treat ovarian cancer, sometimes before surgery.</data>
  <data key="d9">cancer management,primary treatment,systemic treatment,tumor reduction</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250663</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Maintenance Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Maintenance therapy may be an option for advanced ovarian cancers after successful initial treatment.</data>
  <data key="d9">disease control,ongoing treatment</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250665</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="BRCA Genes">
  <data key="d7">2.0</data>
  <data key="d8">Hereditary ovarian cancer is most often caused by mutations in the BRCA genes.&lt;SEP&gt;Testing for mutations in the BRCA genes is used to plan treatment for ovarian cancer and assess hereditary risk.</data>
  <data key="d9">biomarker,genetic mutation,genetic testing,hereditary cause</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250667</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Lynch Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Families with a history of Lynch syndrome are at increased risk for ovarian cancer.</data>
  <data key="d9">family history,hereditary risk</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250669</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="High-Grade Serous Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">High-grade serous carcinoma is one of the most common types of ovarian cancer.</data>
  <data key="d9">cancer type,classification</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250672</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="High-Grade Endometrioid Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">High-grade endometrioid carcinoma is one of the most common types of ovarian cancer.</data>
  <data key="d9">cancer type,classification</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250674</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Hereditary Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer can be linked to hereditary cancer through mutations in genes like BRCA.</data>
  <data key="d9">causation,genetic risk</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250811</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Nutritional And Digestive Tract Health">
  <data key="d7">1.0</data>
  <data key="d8">Symptoms of ovarian cancer can affect eating habits and nutrition, which in turn impacts the success of surgery and treatment.</data>
  <data key="d9">symptom impact,treatment outcome</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250813</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer can return after treatment, which is then classified as recurrent ovarian cancer.</data>
  <data key="d9">disease progression,post-treatment</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Fallopian Tubes">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer can also start in the fallopian tubes, near where they meet the ovary.</data>
  <data key="d9">anatomical site,disease origin</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250844</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Microscopic Metastases">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer can spread as microscopic metastases, which are cells only visible under a microscope outside the primary site.</data>
  <data key="d9">cancer spread,detection</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250892</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Omentum">
  <data key="d7">1.0</data>
  <data key="d8">During ovarian cancer surgery, the omentum is removed to check for the spread of cancer cells.</data>
  <data key="d9">cancer spread,surgical removal</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250894</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer can spread to nearby lymph nodes, which may be removed during surgical staging.</data>
  <data key="d9">cancer spread,surgical removal</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250897</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Peritoneal Washing">
  <data key="d7">1.0</data>
  <data key="d8">Peritoneal washing is performed to test for ovarian cancer cells in the abdominal cavity.</data>
  <data key="d9">cell detection,diagnostic procedure</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250899</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Surgical Menopause">
  <data key="d7">1.0</data>
  <data key="d8">Surgery for ovarian cancer that removes both ovaries causes surgical menopause due to a sudden drop in estrogen.</data>
  <data key="d9">hormone change,treatment side effect</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250900</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Pathologic Stage">
  <data key="d7">1.0</data>
  <data key="d8">The pathologic stage of ovarian cancer is determined after surgery to guide further treatment.</data>
  <data key="d9">disease classification,treatment guidance</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250903</data>
  <data key="d13"></data>
</edge>
<edge source="Ovarian Cancer" target="Ovaries">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer originates in the ovaries, which are a primary target for surgical removal.</data>
  <data key="d9">disease origin,surgical target</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250905</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 1A">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1A is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250205</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 1B">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1B is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250205</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 1C">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1C is a specific substage within the FIGO staging system for ovarian cancer, with further subdivisions.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250206</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 2A">
  <data key="d7">1.0</data>
  <data key="d8">Stage 2A is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250206</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 2B">
  <data key="d7">1.0</data>
  <data key="d8">Stage 2B is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250207</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 3A1">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3A1 is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250208</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 3A2">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3A2 is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250209</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 3B">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3B is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250211</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 3C">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3C is a specific substage within the FIGO staging system for ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250212</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Stages" target="Stage 4">
  <data key="d7">1.0</data>
  <data key="d8">Stage 4 is a specific substage within the FIGO staging system for ovarian cancer, indicating distant spread.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250214</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 1A" target="Stage 1">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1A is a specific substage within the broader Stage 1 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250212</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 1B" target="Stage 1">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1B is a specific substage within the broader Stage 1 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250214</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 1C" target="Stage 1">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1C is a specific substage within the broader Stage 1 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250216</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 2A" target="Stage 2">
  <data key="d7">1.0</data>
  <data key="d8">Stage 2A is a specific substage within the broader Stage 2 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250214</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 2B" target="Stage 2">
  <data key="d7">1.0</data>
  <data key="d8">Stage 2B is a specific substage within the broader Stage 2 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250216</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 3A1" target="Stage 3">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3A1 is a specific substage within the broader Stage 3 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250214</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 3A2" target="Stage 3">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3A2 is a specific substage within the broader Stage 3 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250216</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 3B" target="Stage 3">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3B is a specific substage within the broader Stage 3 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250217</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 3C" target="Stage 3">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3C is a specific substage within the broader Stage 3 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250219</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 4" target="Stage 4A">
  <data key="d7">1.0</data>
  <data key="d8">Stage 4A is a specific substage within the broader Stage 4 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250216</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 4" target="Stage 4B">
  <data key="d7">1.0</data>
  <data key="d8">Stage 4B is a specific substage within the broader Stage 4 category of ovarian cancer.</data>
  <data key="d9">classification,substage</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250218</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Platinum-based chemotherapy is a recommended type of chemotherapy for treating ovarian cancer.</data>
  <data key="d9">drug class,treatment type</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250206</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Carboplatin">
  <data key="d7">1.0</data>
  <data key="d8">Carboplatin is an example of a platinum-based chemotherapy drug used in ovarian cancer treatment.</data>
  <data key="d9">drug example,treatment component</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250207</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Taxane">
  <data key="d7">1.0</data>
  <data key="d8">Platinum-based chemotherapy is often given in combination with a taxane drug for ovarian cancer treatment.</data>
  <data key="d9">drug combination,treatment regimen</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250208</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Cisplatin">
  <data key="d7">1.0</data>
  <data key="d8">Cisplatin is an example of a platinum-based chemotherapy drug.</data>
  <data key="d9">drug example,treatment component</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250218</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Oxaliplatin">
  <data key="d7">1.0</data>
  <data key="d8">Oxaliplatin is an example of a platinum-based chemotherapy drug.</data>
  <data key="d9">drug example,treatment component</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250219</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Systemic Therapy">
  <data key="d7">2.0</data>
  <data key="d8">Platinum-based chemotherapy is a specific type of systemic therapy recommended for use with radiation.&lt;SEP&gt;Platinum-based chemotherapy is a preferred option for systemic therapy when used with radiation.</data>
  <data key="d9">drug class,preferred regimen,treatment option,treatment type</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250346</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Radiation Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Platinum-based chemotherapy is a recommended systemic therapy option for use with radiation therapy.</data>
  <data key="d9">combination treatment,recommended option</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250364</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Maintenance Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Maintenance therapy is an option for cancers that respond well to initial surgery and platinum-based chemotherapy.</data>
  <data key="d9">eligibility,treatment prerequisite</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250701</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Platinum-Resistant Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Platinum-resistant cancer is defined by a lack of improvement or worsening during platinum-based chemotherapy.</data>
  <data key="d9">definition,treatment response</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250854</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Based Chemotherapy" target="Platinum-Sensitive Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Platinum-sensitive cancer is defined by a return more than 6 months after successful platinum-based chemotherapy.</data>
  <data key="d9">definition,treatment response</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250857</data>
  <data key="d13"></data>
</edge>
<edge source="Taxane" target="Paclitaxel">
  <data key="d7">1.0</data>
  <data key="d8">Paclitaxel is an example of a taxane chemotherapy drug used in ovarian cancer treatment.</data>
  <data key="d9">drug example,treatment component</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250209</data>
  <data key="d13"></data>
</edge>
<edge source="Taxane" target="Docetaxel">
  <data key="d7">1.0</data>
  <data key="d8">Docetaxel is an example of a taxane chemotherapy drug.</data>
  <data key="d9">drug example,treatment component</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250219</data>
  <data key="d13"></data>
</edge>
<edge source="Paclitaxel" target="Carboplatin">
  <data key="d7">1.0</data>
  <data key="d8">Paclitaxel combined with carboplatin is the preferred chemotherapy regimen for ovarian cancer.</data>
  <data key="d9">drug combination,preferred regimen</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250211</data>
  <data key="d13"></data>
</edge>
<edge source="Paclitaxel" target="Peripheral Neuropathy">
  <data key="d7">1.0</data>
  <data key="d8">Paclitaxel can cause peripheral neuropathy, a common side effect considered during treatment planning.</data>
  <data key="d9">risk factor,side effect</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250212</data>
  <data key="d13"></data>
</edge>
<edge source="Paclitaxel" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Paclitaxel is a key component of preferred chemotherapy regimens for ovarian cancer.</data>
  <data key="d9">drug regimen,treatment component</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250901</data>
  <data key="d13"></data>
</edge>
<edge source="Carboplatin" target="Chemotherapy">
  <data key="d7">3.0</data>
  <data key="d8">Carboplatin is a platinum-based Chemotherapy drug used to treat squamous cell skin cancer.&lt;SEP&gt;Carboplatin is a platinum chemotherapy drug used within chemotherapy treatments.&lt;SEP&gt;Carboplatin is a key component of preferred chemotherapy regimens for ovarian cancer.</data>
  <data key="d9">cancer treatment,drug regimen,drug type,pharmaceutical agent,platinum-based treatment,treatment component</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250292</data>
  <data key="d13"></data>
</edge>
<edge source="Carboplatin" target="Hypersensitivity Reactions">
  <data key="d7">2.0</data>
  <data key="d8">Hypersensitivity reactions are an increased risk with the repeat use of chemotherapy drugs like carboplatin.&lt;SEP&gt;Repeat use of carboplatin increases the risk of a potentially life-threatening hypersensitivity reaction.</data>
  <data key="d9">allergic reaction,drug risk</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250851</data>
  <data key="d13"></data>
</edge>
<edge source="Bevacizumab (Avastin)" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">The drug bevacizumab may be added to chemotherapy to inhibit blood vessel growth in tumors.</data>
  <data key="d9">adjunct therapy,angiogenesis inhibition</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250210</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Chemotherapy">
  <data key="d7">2.0</data>
  <data key="d8">Maintenance therapy is a potential follow-up treatment after successful chemotherapy for ovarian cancer.&lt;SEP&gt;If chemotherapy works well, the next step may include maintenance therapy to reduce the risk of cancer returning.</data>
  <data key="d9">follow-up care,risk reduction,treatment sequence</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250211</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Genetic Testing">
  <data key="d7">1.0</data>
  <data key="d8">BRCA status determined by genetic testing plays an important role in guiding decisions about maintenance therapy.</data>
  <data key="d9">decision support,treatment guidance</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250677</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="PARP Inhibitors">
  <data key="d7">1.0</data>
  <data key="d8">PARP inhibitors are a newer option for maintenance therapy after initial treatment for ovarian cancer.</data>
  <data key="d9">targeted therapy,treatment option</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250696</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Observation">
  <data key="d7">1.0</data>
  <data key="d8">Observation is an option for maintenance therapy, especially after a complete response to chemotherapy.</data>
  <data key="d9">management strategy,post-treatment option</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250698</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Homologous Recombination Deficiency">
  <data key="d7">1.0</data>
  <data key="d8">The tumor's HRD status, along with BRCA status, is used to guide decisions about maintenance therapy after initial treatment.</data>
  <data key="d9">biomarker status,treatment guidance</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Olaparib">
  <data key="d7">1.0</data>
  <data key="d8">Olaparib is a PARP inhibitor used in maintenance therapy for ovarian cancer, with a recommended duration of up to 2 years.</data>
  <data key="d9">PARP inhibitor,treatment duration</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250846</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Niraparib">
  <data key="d7">1.0</data>
  <data key="d8">Niraparib is a PARP inhibitor used as maintenance therapy for ovarian cancer, with a recommended duration of up to 3 years.</data>
  <data key="d9">PARP inhibitor,treatment duration</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250847</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Rucaparib">
  <data key="d7">1.0</data>
  <data key="d8">Rucaparib is a PARP inhibitor used as maintenance therapy for ovarian cancer, with a recommended duration of up to 2 years.</data>
  <data key="d9">PARP inhibitor,treatment duration</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250850</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Recurrence">
  <data key="d7">1.0</data>
  <data key="d8">Maintenance therapy is administered to prevent cancer recurrence and is stopped if the cancer grows or spreads.</data>
  <data key="d9">prevention,treatment cessation</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250853</data>
  <data key="d13"></data>
</edge>
<edge source="Maintenance Therapy" target="Platinum-Sensitive Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Maintenance therapy is an option after successful chemotherapy for recurrent platinum-sensitive ovarian cancer.</data>
  <data key="d9">post-chemotherapy,prevention</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250855</data>
  <data key="d13"></data>
</edge>
<edge source="Intravenous Chemotherapy" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy for ovarian cancer is most commonly administered intravenously.</data>
  <data key="d9">administration method,treatment delivery</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250213</data>
  <data key="d13"></data>
</edge>
<edge source="Intravenous Chemotherapy" target="Port">
  <data key="d7">1.0</data>
  <data key="d8">A port is a device used to facilitate the intravenous administration of chemotherapy.</data>
  <data key="d9">administration device,treatment delivery</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250219</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 1" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy is recommended after surgery for most newly diagnosed stage 1 ovarian cancers.</data>
  <data key="d9">post-surgery care,treatment recommendation</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250217</data>
  <data key="d13"></data>
</edge>
<edge source="Neoadjuvant Therapy" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Neoadjuvant therapy is a form of chemotherapy administered before surgery.</data>
  <data key="d9">pre-surgical care,treatment timing</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250221</data>
  <data key="d13"></data>
</edge>
<edge source="Adjuvant Chemotherapy" target="Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Adjuvant chemotherapy is a form of chemotherapy administered after surgery.</data>
  <data key="d9">post-surgical care,treatment timing</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250223</data>
  <data key="d13"></data>
</edge>
<edge source="Cisplatin" target="Chemotherapy">
  <data key="d7">2.0</data>
  <data key="d8">Cisplatin is a platinum-based Chemotherapy drug used to treat squamous cell skin cancer.&lt;SEP&gt;Cisplatin is a platinum chemotherapy drug used within chemotherapy treatments.</data>
  <data key="d9">cancer treatment,drug type,pharmaceutical agent,platinum-based treatment</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250290</data>
  <data key="d13"></data>
</edge>
<edge source="Cisplatin" target="Hypersensitivity Reactions">
  <data key="d7">1.0</data>
  <data key="d8">Repeat use of cisplatin increases the risk of a potentially life-threatening hypersensitivity reaction.</data>
  <data key="d9">allergic reaction,drug risk</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250854</data>
  <data key="d13"></data>
</edge>
<edge source="Port" target="Intravenous Administration">
  <data key="d7">1.0</data>
  <data key="d8">A port may be placed under the skin to receive intravenous chemotherapy.</data>
  <data key="d9">drug delivery,medical device</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250692</data>
  <data key="d13"></data>
</edge>
<edge source="Port" target="Systemic Therapy">
  <data key="d7">1.0</data>
  <data key="d8">A port is used to deliver systemic therapy into the body during AML treatment.</data>
  <data key="d9">medical device,treatment delivery</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250739</data>
  <data key="d13"></data>
</edge>
<edge source="5-Fluorouracil" target="Actinic Keratosis">
  <data key="d7">1.0</data>
  <data key="d8">5-Fluorouracil is a topical chemotherapy cream used specifically to treat actinic keratosis.</data>
  <data key="d9">chemotherapy,topical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250220</data>
  <data key="d13"></data>
</edge>
<edge source="5-Fluorouracil" target="Calcipotriene">
  <data key="d7">2.0</data>
  <data key="d8">Calcipotriene is often used in combination with 5-fluorouracil to enhance the treatment of actinic keratosis.&lt;SEP&gt;Calcipotriene is often used in combination with 5-fluorouracil to treat actinic keratosis.</data>
  <data key="d9">combination therapy,immune activation,treatment enhancement</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250221</data>
  <data key="d13"></data>
</edge>
<edge source="5-Fluorouracil" target="Topical Therapies">
  <data key="d7">1.0</data>
  <data key="d8">5-Fluorouracil is a specific topical therapy, a chemotherapy cream, used to treat early squamous cell skin cancer and actinic keratoses.</data>
  <data key="d9">medication,treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250751</data>
  <data key="d13"></data>
</edge>
<edge source="5-Fluorouracil" target="5-FU">
  <data key="d7">1.0</data>
  <data key="d8">5-FU is the common abbreviation for the chemotherapy drug 5-fluorouracil.</data>
  <data key="d9">abbreviation,same substance</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250756</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Stage 2, 3, and 4">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy is recommended after surgery for all newly diagnosed stage 2, 3, and 4 ovarian cancers.</data>
  <data key="d9">standard care,treatment recommendation</data>
  <data key="d10">chunk-b69d38fafe014cece3427bd0459ae42b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250219</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Systemic Therapy">
  <data key="d7">3.0</data>
  <data key="d8">Chemotherapy is a category of Systemic Therapy that uses drugs to kill fast-growing cancer cells.&lt;SEP&gt;Chemotherapy is a type of systemic therapy used for CSCC.&lt;SEP&gt;Chemotherapy is a type of systemic therapy used as the standard of care for treating AML.</data>
  <data key="d9">drug therapy,inclusion,standard care,treatment category,treatment type</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250288</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Medical Oncologist">
  <data key="d7">2.0</data>
  <data key="d8">A medical oncologist specializes in prescribing chemotherapy and other cancer-treatment drugs.&lt;SEP&gt;A medical oncologist is an expert in treating cancer with chemotherapy and other medicines.</data>
  <data key="d9">medical specialty,prescription,specialization,treatment method</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250340</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Biopsy">
  <data key="d7">3.0</data>
  <data key="d8">If chemotherapy is planned as the first treatment for ovarian cancer, a biopsy is performed to obtain a tumor sample for diagnosis.&lt;SEP&gt;A biopsy is required to confirm an ovarian cancer diagnosis before starting chemotherapy.&lt;SEP&gt;If chemotherapy is recommended before surgery for ovarian cancer, a biopsy must be done before starting the chemotherapy.</data>
  <data key="d9">diagnosis confirmation,diagnostic requirement,prerequisite,treatment prerequisite,treatment sequence</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-96238b4b361e393ff452a09d1ce26154&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250345</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Fertility Preservation">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy can affect fertility, making fertility preservation an important consideration before starting treatment.</data>
  <data key="d9">reproductive health,treatment side effect</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250397</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Systemic Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy is a category of systemic therapy used to treat cancer.</data>
  <data key="d9">drug administration,treatment category</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250564</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy is used to treat squamous cell skin cancer.</data>
  <data key="d9">cancer treatment,drug application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250566</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Diagnostic Laparoscopy">
  <data key="d7">1.0</data>
  <data key="d8">The results of a diagnostic laparoscopy help doctors decide if chemotherapy is needed before surgery as the first treatment.</data>
  <data key="d9">decision support,treatment planning</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250676</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Bevacizumab">
  <data key="d7">2.0</data>
  <data key="d8">Bevacizumab is used in chemotherapy regimens and as maintenance therapy for ovarian cancer.&lt;SEP&gt;Bevacizumab may be added to chemotherapy to stop the growth of blood vessels feeding the tumor.</data>
  <data key="d9">adjunct therapy,anti-angiogenesis,maintenance therapy,treatment component</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250691</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Intravenous Administration">
  <data key="d7">1.0</data>
  <data key="d8">Most chemotherapy for ovarian cancer is given intravenously, directly into the bloodstream.</data>
  <data key="d9">delivery method,systemic treatment</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250695</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Intraperitoneal Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy can also be given intraperitoneally, injecting medicine directly into the abdomen.</data>
  <data key="d9">delivery method,localized treatment</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250696</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">The doctor monitors how well the chemotherapy is working and assesses for side effects.</data>
  <data key="d9">assessment,monitoring</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250697</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Side Effects">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy causes side effects such as nausea, fatigue, and hair loss due to the death of fast-growing cells.</data>
  <data key="d9">adverse reactions,toxicity</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250698</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Myelodysplastic Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy can have rare but serious side effects, including myelodysplastic syndrome.</data>
  <data key="d9">cancer risk,serious side effect</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250701</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Acute Myeloid Leukemia">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy can have rare but serious side effects, including acute myeloid leukemia.</data>
  <data key="d9">cancer risk,serious side effect</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250703</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Standard Of Care">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy is described as the standard of care for treating AML, based on the best-known methods from past clinical trials.</data>
  <data key="d9">clinical evidence,treatment protocol</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Multi-Agent Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Chemotherapy for AML often involves multi-agent regimens, which combine different chemotherapies to treat the disease.</data>
  <data key="d9">drug combination,treatment regimen</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250839</data>
  <data key="d13"></data>
</edge>
<edge source="Chemotherapy" target="Interval Cytoreductive Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Interval Cytoreductive Surgery is performed after several cycles of chemotherapy to remove residual cancer.</data>
  <data key="d9">surgical timing,treatment sequence</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250895</data>
  <data key="d13"></data>
</edge>
<edge source="Calcipotriene" target="Sorilux">
  <data key="d7">1.0</data>
  <data key="d8">Sorilux is a brand name for the medication calcipotriene.</data>
  <data key="d9">brand name,medication form</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250227</data>
  <data key="d13"></data>
</edge>
<edge source="Calcipotriene" target="Dovonex">
  <data key="d7">1.0</data>
  <data key="d8">Dovonex is a brand name for the medication calcipotriene.</data>
  <data key="d9">brand name,medication form</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250229</data>
  <data key="d13"></data>
</edge>
<edge source="Calcipotriene" target="Vitamin D">
  <data key="d7">1.0</data>
  <data key="d8">Calcipotriene is a synthetic form of vitamin D used in a cream to activate the skin's immune response.</data>
  <data key="d9">activation,derivative</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250756</data>
  <data key="d13"></data>
</edge>
<edge source="Imiquimod" target="Actinic Keratosis">
  <data key="d7">1.0</data>
  <data key="d8">Imiquimod is a topical cream used to treat actinic keratosis by activating the immune system against abnormal cells.</data>
  <data key="d9">immune modulation,topical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250221</data>
  <data key="d13"></data>
</edge>
<edge source="Imiquimod" target="Topical Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Imiquimod is a prescription cream classified as a topical therapy for treating early squamous cell skin cancer and actinic keratoses.</data>
  <data key="d9">medication,treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250753</data>
  <data key="d13"></data>
</edge>
<edge source="Tirbanibulin" target="Actinic Keratosis">
  <data key="d7">1.0</data>
  <data key="d8">Tirbanibulin is a topical microtubule inhibitor used to treat actinic keratosis by killing fast-growing abnormal cells.</data>
  <data key="d9">microtubule inhibition,topical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250223</data>
  <data key="d13"></data>
</edge>
<edge source="Tirbanibulin" target="Klisyri">
  <data key="d7">1.0</data>
  <data key="d8">Klisyri is a brand name for the medication tirbanibulin.</data>
  <data key="d9">brand name,medication form</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250227</data>
  <data key="d13"></data>
</edge>
<edge source="Hyperkeratosis" target="Cryotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Cryotherapy is one of the methods used to treat hyperkeratotic actinic keratoses before other therapies.</data>
  <data key="d9">destruction,pretreatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250221</data>
  <data key="d13"></data>
</edge>
<edge source="Hyperkeratosis" target="Topical Tazarotene">
  <data key="d7">1.0</data>
  <data key="d8">Topical tazarotene is used to treat hyperkeratotic actinic keratoses.</data>
  <data key="d9">pretreatment,retinoid treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250223</data>
  <data key="d13"></data>
</edge>
<edge source="Hyperkeratosis" target="Curettage">
  <data key="d7">1.0</data>
  <data key="d8">Curettage is used to treat hyperkeratotic actinic keratoses.</data>
  <data key="d9">pretreatment,surgical scraping</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250225</data>
  <data key="d13"></data>
</edge>
<edge source="Hyperkeratosis" target="Topical Keratolytics">
  <data key="d7">1.0</data>
  <data key="d8">Topical keratolytics are used to treat hyperkeratotic actinic keratoses.</data>
  <data key="d9">chemical treatment,pretreatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250227</data>
  <data key="d13"></data>
</edge>
<edge source="Hyperkeratosis" target="Actinic Keratosis">
  <data key="d7">1.0</data>
  <data key="d8">Hyperkeratosis, a thickening of the skin, is a condition that may be present in actinic keratoses and requires pretreatment.</data>
  <data key="d9">pretreatment,skin condition</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250229</data>
  <data key="d13"></data>
</edge>
<edge source="Cryotherapy" target="Actinic Keratoses">
  <data key="d7">1.0</data>
  <data key="d8">Cryotherapy is a treatment option for actinic keratoses.</data>
  <data key="d9">management,treatment</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250591</data>
  <data key="d13"></data>
</edge>
<edge source="Cryotherapy" target="Superficial Treatments">
  <data key="d7">1.0</data>
  <data key="d8">Cryotherapy is a superficial treatment method that freezes and destroys precancerous and cancerous skin cells.</data>
  <data key="d9">method,treatment type</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250751</data>
  <data key="d13"></data>
</edge>
<edge source="Cryotherapy" target="Liquid Nitrogen">
  <data key="d7">1.0</data>
  <data key="d8">Cryotherapy often uses liquid nitrogen as the very cold substance to freeze and destroy abnormal skin cells.</data>
  <data key="d9">substance,tool</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250756</data>
  <data key="d13"></data>
</edge>
<edge source="Chemical Peels" target="Trichloroacetic Acid">
  <data key="d7">1.0</data>
  <data key="d8">Trichloroacetic acid is the chemical agent used in chemical peels for actinic keratosis.</data>
  <data key="d9">chemical agent,treatment component</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250228</data>
  <data key="d13"></data>
</edge>
<edge source="Resurfacing Techniques" target="Laser">
  <data key="d7">1.0</data>
  <data key="d8">Laser is a specific type of resurfacing technique used for actinic keratoses.</data>
  <data key="d9">technology,treatment method</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250229</data>
  <data key="d13"></data>
</edge>
<edge source="Resurfacing Techniques" target="Dermabrasion">
  <data key="d7">1.0</data>
  <data key="d8">Dermabrasion is a specific type of resurfacing technique used for actinic keratoses.</data>
  <data key="d9">procedure,treatment method</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250231</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="PDEMA">
  <data key="d7">2.0</data>
  <data key="d8">Mohs surgery is the most common form of PDEMA, a surgical method for margin assessment.&lt;SEP&gt;Mohs surgery is a form of PDEMA.</data>
  <data key="d9">categorization,margin assessment,surgical method,surgical technique</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250224</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Mohs surgery is a recommended surgical option for treating CSCC that has not spread to lymph nodes.</data>
  <data key="d9">cancer removal,surgical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250225</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Scalpel">
  <data key="d7">1.0</data>
  <data key="d8">A scalpel is used in Mohs surgery to remove the visible tumor.</data>
  <data key="d9">surgical tool,tumor removal</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250229</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Microscope">
  <data key="d7">1.0</data>
  <data key="d8">A microscope is used by the Mohs surgeon to evaluate tissue margins during the procedure.</data>
  <data key="d9">diagnostic tool,margin assessment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250231</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Dermatologic Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">Mohs surgery should be performed by a dermatologic surgeon with special training and experience.</data>
  <data key="d9">professional execution,specialized procedure</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250232</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Very High-Risk CSCC">
  <data key="d7">2.0</data>
  <data key="d8">Mohs surgery is a recommended surgical option for very high-risk CSCC.&lt;SEP&gt;Mohs surgery is the preferred treatment option for very high-risk CSCC that has not spread to lymph nodes.</data>
  <data key="d9">preferred treatment,surgical management,surgical option,treatment recommendation</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250361</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Mohs surgery is a recommended surgical option for high-risk CSCC.</data>
  <data key="d9">surgical option,treatment recommendation</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250363</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Mohs surgery is a recommended surgical treatment for low-risk squamous cell skin cancer and is preferred for very high-risk cases.</data>
  <data key="d9">surgery,treatment</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250557</data>
  <data key="d13"></data>
</edge>
<edge source="Mohs Surgery" target="Cancer Doctors">
  <data key="d7">1.0</data>
  <data key="d8">A discussion with different cancer doctors is recommended if concerning features are noted during Mohs surgery for CSCC.</data>
  <data key="d9">consultation,decision-making</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250563</data>
  <data key="d13"></data>
</edge>
<edge source="Curettage And Electrodesiccation" target="CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Curettage and electrodesiccation is a recommended surgical option for treating early CSCC on the skin surface.</data>
  <data key="d9">early cancer,surgical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250227</data>
  <data key="d13"></data>
</edge>
<edge source="Curettage And Electrodesiccation" target="Low-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Curettage and electrodesiccation is a recommended surgical option for low-risk CSCC.</data>
  <data key="d9">surgical option,treatment recommendation</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250363</data>
  <data key="d13"></data>
</edge>
<edge source="Curettage And Electrodesiccation" target="Squamous Cell Skin Cancer">
  <data key="d7">2.0</data>
  <data key="d8">Curettage and electrodesiccation is a recommended surgical treatment option for low-risk, local squamous cell skin cancer.&lt;SEP&gt;Curettage and electrodesiccation is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d9">removal,surgery,surgical treatment,treatment</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250554</data>
  <data key="d13"></data>
</edge>
<edge source="Curettage And Electrodesiccation" target="Shave Excision">
  <data key="d7">1.0</data>
  <data key="d8">Curettage and electrodesiccation or shave excision are grouped as recommended treatment options for low-risk, local CSCC.</data>
  <data key="d9">alternative procedures,surgical technique</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250560</data>
  <data key="d13"></data>
</edge>
<edge source="PDEMA" target="Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">PDEMA is a form of surgery recommended as a treatment option for low-risk and very high-risk squamous cell skin cancer.</data>
  <data key="d9">surgery,treatment</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250559</data>
  <data key="d13"></data>
</edge>
<edge source="PDEMA" target="Sentinel Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A sentinel lymph node biopsy may be considered before or during PDEMA surgery to check for cancer spread to lymph nodes.</data>
  <data key="d9">diagnostic procedure,surgical planning</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250561</data>
  <data key="d13"></data>
</edge>
<edge source="PDEMA" target="Very High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">PDEMA is the preferred treatment option for very high-risk CSCC that has not spread to lymph nodes.</data>
  <data key="d9">preferred treatment,surgical management</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250564</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="Squamous Cell Skin Cancer">
  <data key="d7">3.0</data>
  <data key="d8">Standard surgical excision is a surgical option used to treat squamous cell skin cancer.&lt;SEP&gt;Standard surgical excision is a recommended surgical treatment for both low-risk and high-risk/very high-risk local squamous cell skin cancer.&lt;SEP&gt;Standard surgical excision is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d9">removal,surgery,surgical treatment,treatment,tumor removal</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250225</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="Pathologist">
  <data key="d7">1.0</data>
  <data key="d8">A pathologist examines the tissue removed during standard surgical excision under a microscope.</data>
  <data key="d9">professional analysis,tissue examination</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250231</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="Scalpel">
  <data key="d7">1.0</data>
  <data key="d8">A scalpel is used in standard surgical excision to remove the tumor and surrounding tissue.</data>
  <data key="d9">surgical tool,tumor removal</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250232</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Standard surgical excision is a recommended treatment option for high-risk CSCC.</data>
  <data key="d9">surgical option,treatment recommendation</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250360</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="Very High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Standard surgical excision is a recommended treatment option for very high-risk CSCC.</data>
  <data key="d9">surgical option,treatment recommendation</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250363</data>
  <data key="d13"></data>
</edge>
<edge source="Standard Surgical Excision" target="Cancer Doctors">
  <data key="d7">2.0</data>
  <data key="d8">If concerning features are noted during standard surgical excision, a discussion with cancer doctors is recommended to determine next steps.&lt;SEP&gt;A discussion with different cancer doctors is recommended if concerning features are noted during standard surgical excision for CSCC.</data>
  <data key="d9">consultation,decision-making,post-operative consultation,treatment planning</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250365</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Node Dissection" target="Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Lymph node dissection is a surgical procedure used when squamous cell skin cancer has spread to lymph nodes.</data>
  <data key="d9">metastasis management,surgical treatment</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250226</data>
  <data key="d13"></data>
</edge>
<edge source="Sentinel Lymph Node Biopsy" target="Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Sentinel lymph node biopsy is a surgical procedure used to check for the spread of squamous cell skin cancer to lymph nodes.</data>
  <data key="d9">diagnostic surgery,metastasis detection</data>
  <data key="d10">chunk-7d994e430bb9890c905d7914fad9c118</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250228</data>
  <data key="d13"></data>
</edge>
<edge source="Sentinel Lymph Node Biopsy" target="General Anesthesia">
  <data key="d7">1.0</data>
  <data key="d8">A Sentinel Lymph Node Biopsy is generally performed while the patient is under General Anesthesia.</data>
  <data key="d9">patient care,surgical procedure</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250280</data>
  <data key="d13"></data>
</edge>
<edge source="Sentinel Lymph Node Biopsy" target="Pathologist">
  <data key="d7">1.0</data>
  <data key="d8">Tissue samples removed during a Sentinel Lymph Node Biopsy are sent to a Pathologist to be checked for cancer cells.</data>
  <data key="d9">diagnostic analysis,medical examination</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250283</data>
  <data key="d13"></data>
</edge>
<edge source="Sentinel Lymph Node Biopsy" target="Surgeon">
  <data key="d7">2.0</data>
  <data key="d8">A Surgeon performs a Sentinel Lymph Node Biopsy by injecting a substance to locate nodes and removing them.&lt;SEP&gt;A surgeon performs a sentinel lymph node biopsy by using dye and radioactive solution to find and remove sentinel nodes.</data>
  <data key="d9">medical procedure,procedure performance,surgical execution,surgical role</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250284</data>
  <data key="d13"></data>
</edge>
<edge source="Sentinel Lymph Node Biopsy" target="Sentinel Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">A Sentinel Lymph Node Biopsy is a surgery that removes tissue samples from the Sentinel Lymph Node(s) to examine them for cancer.</data>
  <data key="d9">diagnostic target,surgical removal</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250290</data>
  <data key="d13"></data>
</edge>
<edge source="Actinic Keratosis" target="Squamous Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Actinic keratosis, caused by sun exposure, is a precancerous lesion that may develop into Squamous Cell Carcinoma.</data>
  <data key="d9">progression,risk factor</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250398</data>
  <data key="d13"></data>
</edge>
<edge source="Actinic Keratosis" target="Dermatologist">
  <data key="d7">1.0</data>
  <data key="d8">A dermatologist examines the skin to identify and assess actinic keratoses, which indicate an increased risk for skin cancer.</data>
  <data key="d9">medical examination,screening</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250401</data>
  <data key="d13"></data>
</edge>
<edge source="Actinic Keratosis" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Having actinic keratosis increases the likelihood of developing Cutaneous Squamous Cell Carcinoma.</data>
  <data key="d9">disease progression,risk factor</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250761</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Basal Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell skin cancer and basal cell carcinoma are the two most common types, often grouped together as nonmelanoma skin cancers.</data>
  <data key="d9">nonmelanoma classification,skin cancer types</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250301</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Melanoma">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell skin cancer is more common but less aggressive than melanoma, the third main type of skin cancer.</data>
  <data key="d9">aggressiveness,skin cancer comparison</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250303</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Keratinocyte Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell skin cancer is also referred to as a keratinocyte carcinoma, a term for nonmelanoma skin cancers.</data>
  <data key="d9">disease classification,terminology</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250306</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Ultraviolet Rays">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to ultraviolet rays from the sun is a major risk factor for developing squamous cell skin cancer.</data>
  <data key="d9">risk factor,sun exposure</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250307</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Indoor Tanning">
  <data key="d7">1.0</data>
  <data key="d8">Indoor tanning using machines is a major risk factor that increases the chance of getting squamous cell skin cancer.</data>
  <data key="d9">artificial UV exposure,cancer risk</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250309</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Environmental Toxins">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to environmental toxins like tobacco smoke and arsenic can cause skin damage leading to squamous cell carcinoma.</data>
  <data key="d9">carcinogenic exposure,skin damage</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250312</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Marjolin Ulcer">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma, known as a Marjolin ulcer, can form in scars or chronic wounds such as ulcers and burns.</data>
  <data key="d9">cancer development,chronic wound complication</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250313</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Cutaneous Squamous Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell skin cancer is also called cutaneous squamous cell carcinoma (CSCC), and the terms are used interchangeably.</data>
  <data key="d9">disease synonym,terminology</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250315</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Skin Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">A skin biopsy is a key diagnostic test used to confirm the presence of squamous cell skin cancer by examining a tissue sample.&lt;SEP&gt;Squamous cell skin cancer is diagnosed through a procedure called a skin biopsy.</data>
  <data key="d9">diagnosis,testing</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250544</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Tumor Grade">
  <data key="d7">1.0</data>
  <data key="d8">The tumor grade is a factor used to assess the risk and expected behavior of squamous cell skin cancer.</data>
  <data key="d9">prognosis,risk assessment</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250546</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Connective Tissue">
  <data key="d7">1.0</data>
  <data key="d8">The presence of connective tissue in a tumor is an indicator of high-risk or very high-risk squamous cell skin cancer.</data>
  <data key="d9">pathology,risk indicator</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250547</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Tumor Depth">
  <data key="d7">1.0</data>
  <data key="d8">The depth of tumor invasion into the skin is a prognostic factor for the risk of squamous cell skin cancer returning or spreading.</data>
  <data key="d9">invasion,prognostic factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250549</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Lymphovascular Invasion">
  <data key="d7">1.0</data>
  <data key="d8">Lymphovascular invasion indicates that squamous cell skin cancer is more likely to spread to lymph nodes and other body parts.</data>
  <data key="d9">metastasis,spread</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250550</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Weakened Immune System">
  <data key="d7">1.0</data>
  <data key="d8">Having a weakened immune system is a risk factor for developing squamous cell skin cancer and for its recurrence after treatment.</data>
  <data key="d9">recurrence,risk factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250552</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Radiation Therapy">
  <data key="d7">2.0</data>
  <data key="d8">Radiation therapy is a recommended treatment for squamous cell skin cancer when surgery is not an option or as adjuvant therapy.&lt;SEP&gt;Radiation therapy is a treatment option for squamous cell skin cancer, especially when surgery is not possible or as a follow-up to surgery.</data>
  <data key="d9">adjuvant therapy,therapy,treatment,treatment option</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250561</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Smoking">
  <data key="d7">1.0</data>
  <data key="d8">Smoking can limit the effectiveness of cancer treatment and increase side effects and risks for patients with squamous cell skin cancer.</data>
  <data key="d9">risk factor,treatment complication</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250564</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="CSCC">
  <data key="d7">1.0</data>
  <data key="d8">CSCC is the abbreviation for cutaneous squamous cell carcinoma, a type of squamous cell skin cancer.</data>
  <data key="d9">abbreviation,medical terminology</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250577</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="PDEMA/Mohs Surgery">
  <data key="d7">1.0</data>
  <data key="d8">PDEMA/Mohs surgery is a type of surgery used to treat squamous cell skin cancer.</data>
  <data key="d9">removal,surgical treatment</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250591</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Marjolins Ulcer">
  <data key="d7">1.0</data>
  <data key="d8">Marjolin's ulcer is a specific, harder-to-treat form of squamous cell skin cancer that develops in old wounds, burns, or scars.</data>
  <data key="d9">complication,subtype</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250739</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Imaging Scans">
  <data key="d7">1.0</data>
  <data key="d8">Imaging scans are used to assess the extent of squamous cell skin cancer, checking for deeper invasion or spread to other body parts.</data>
  <data key="d9">diagnosis,staging</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250741</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A lymph node biopsy is performed when squamous cell skin cancer is suspected to have spread to the lymph nodes.</data>
  <data key="d9">diagnosis,metastasis detection</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250743</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">An oncologist is a primary doctor involved in the treatment and management of a patient diagnosed with squamous cell skin cancer.</data>
  <data key="d9">care team,treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250743</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Dermatologist">
  <data key="d7">1.0</data>
  <data key="d8">A dermatologist diagnoses and treats skin conditions, including squamous cell skin cancer, and performs related skin exams.</data>
  <data key="d9">diagnosis,treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250744</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Mohs Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">A Mohs surgeon performs specialized surgery to remove squamous cell skin cancer tumors and reconstruct the affected area.</data>
  <data key="d9">surgical treatment,tumor removal</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250745</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Surgical Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">A surgical oncologist is trained to surgically remove cancerous tumors, including advanced cases of squamous cell skin cancer.</data>
  <data key="d9">surgical treatment,tumor removal</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250745</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Medical Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">A medical oncologist prescribes and manages systemic drug therapies, such as chemotherapy, for treating squamous cell skin cancer.</data>
  <data key="d9">drug therapy,systemic treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250746</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Pathologist">
  <data key="d7">1.0</data>
  <data key="d8">A pathologist examines biopsy samples under a microscope to diagnose and determine the stage of squamous cell skin cancer.</data>
  <data key="d9">diagnosis,staging</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250747</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Plastic Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">A plastic surgeon can remove squamous cell skin cancer and perform reconstructive surgery to repair the affected area.</data>
  <data key="d9">reconstruction,surgical treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250748</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Head And Neck Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">A head and neck surgeon treats squamous cell skin cancer when it involves the deeper structures of the head and neck region.</data>
  <data key="d9">specialized treatment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250749</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Radiation Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">A radiation oncologist uses radiation therapy as a treatment modality for squamous cell skin cancer.</data>
  <data key="d9">radiation therapy</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250751</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Pharmacist">
  <data key="d7">1.0</data>
  <data key="d8">A pharmacist prepares and dispenses medications used in the treatment of squamous cell skin cancer and explains their use and side effects.</data>
  <data key="d9">medication management</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250753</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Geneticist">
  <data key="d7">1.0</data>
  <data key="d8">A geneticist may be involved in assessing genetic risk factors and providing counseling related to squamous cell skin cancer.</data>
  <data key="d9">counseling,risk assessment</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250755</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Skin Cancer" target="Oncology Nurse">
  <data key="d7">1.0</data>
  <data key="d8">An oncology nurse provides direct care, administers treatments, and supports patients undergoing therapy for squamous cell skin cancer.</data>
  <data key="d9">patient care,therapy administration</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250758</data>
  <data key="d13"></data>
</edge>
<edge source="CSCC" target="Cetuximab">
  <data key="d7">1.0</data>
  <data key="d8">Cetuximab is used to treat CSCC.</data>
  <data key="d9">cancer treatment,drug application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250579</data>
  <data key="d13"></data>
</edge>
<edge source="CSCC" target="Cemiplimab">
  <data key="d7">1.0</data>
  <data key="d8">Cemiplimab is used to treat CSCC.</data>
  <data key="d9">cancer treatment,drug application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250580</data>
  <data key="d13"></data>
</edge>
<edge source="CSCC" target="Pembrolizumab">
  <data key="d7">1.0</data>
  <data key="d8">Pembrolizumab is used to treat CSCC.</data>
  <data key="d9">cancer treatment,drug application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250582</data>
  <data key="d13"></data>
</edge>
<edge source="Microscope" target="Immunohistochemistry">
  <data key="d7">1.0</data>
  <data key="d8">Immunohistochemistry involves adding a chemical marker to cells, which are then studied using a microscope.</data>
  <data key="d9">staining analysis,visualization tool</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250647</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Adrenocortical Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Adrenocortical carcinoma is a specific type of adrenal gland cancer that begins in the adrenal cortex.</data>
  <data key="d9">classification,type</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250231</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Neuroblastoma">
  <data key="d7">1.0</data>
  <data key="d8">Neuroblastoma is a rare, cancerous type of adrenal tumor categorized under adrenal gland cancer.</data>
  <data key="d9">classification,type</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250233</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Pheochromocytoma">
  <data key="d7">1.0</data>
  <data key="d8">Pheochromocytoma is a type of adrenal tumor that can be cancerous and is a category of adrenal gland cancer.</data>
  <data key="d9">classification,type</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250234</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Adenoma">
  <data key="d7">1.0</data>
  <data key="d8">Adenoma is the most common type of adrenal gland tumor, though it is noncancerous, and is a category within adrenal tumors.</data>
  <data key="d9">classification,type</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250236</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Beckwith-Wiedemann Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Beckwith-Wiedemann syndrome is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250238</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Carney Complex">
  <data key="d7">1.0</data>
  <data key="d8">Carney complex is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250239</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Familial Adenomatous Polyposis">
  <data key="d7">1.0</data>
  <data key="d8">Familial adenomatous polyposis (FAP) is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250240</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Hereditary Paraganglioma-Pheochromocytoma Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250241</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Li-Fraumeni Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Li-Fraumeni syndrome is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250242</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Lynch Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Lynch syndrome is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250243</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Multiple Endocrine Neoplasia Type 1">
  <data key="d7">1.0</data>
  <data key="d8">Multiple endocrine neoplasia type 1 (MEN 1) is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250245</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Multiple Endocrine Neoplasia Type 2">
  <data key="d7">1.0</data>
  <data key="d8">Multiple endocrine neoplasia type 2 (MEN 2) is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250246</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Neurofibromatosis Type 1">
  <data key="d7">1.0</data>
  <data key="d8">Neurofibromatosis type 1 (NF1) is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250248</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Von Hippel-Lindau Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Von Hippel-Lindau syndrome (VHL) is a hereditary condition that can put an individual at a higher risk for developing an adrenal tumor.</data>
  <data key="d9">genetic link,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250249</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Gland Cancer" target="Testing">
  <data key="d7">1.0</data>
  <data key="d8">Testing is used to diagnose adrenal tumors and plan their treatment.</data>
  <data key="d9">diagnosis,treatment planning</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250253</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Adrenal Glands">
  <data key="d7">1.0</data>
  <data key="d8">Adrenocortical carcinoma starts in one or both of the adrenal glands.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250232</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Hormones">
  <data key="d7">1.0</data>
  <data key="d8">If functioning, an adrenocortical carcinoma tumor can produce more than one hormone, leading to symptoms.</data>
  <data key="d9">production,symptom cause</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250236</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Adrenal Cortex">
  <data key="d7">2.0</data>
  <data key="d8">Adrenocortical carcinoma is a cancer that begins in the adrenal cortex, the outer layer of the adrenal gland.&lt;SEP&gt;Adrenocortical carcinoma begins in the adrenal cortex.</data>
  <data key="d9">cancer type,disease origin,location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250243</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Functioning Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Adrenocortical carcinoma can be a functioning tumor, meaning it may produce hormones.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250245</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Nonfunctioning Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Adrenocortical carcinoma can be a nonfunctioning tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250246</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenocortical Carcinoma" target="Cancerous Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Adrenocortical carcinoma is a cancerous (malignant) tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250249</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Treatment For NSCLC">
  <data key="d7">1.0</data>
  <data key="d8">Surgery is used as a primary treatment for early or locally advanced NSCLC when possible.</data>
  <data key="d9">primary treatment,therapeutic option</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250271</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Gynecologic Oncologist">
  <data key="d7">2.0</data>
  <data key="d8">A gynecologic oncologist is an expert in surgery for gynecologic cancers and should perform the initial surgery for ovarian cancer.&lt;SEP&gt;Ovarian cancer surgery should be performed by a gynecologic oncologist.</data>
  <data key="d9">medical specialty,procedure performance,surgical expertise,treatment procedure</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250338</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">If surgery is planned first, tumor tissue is removed and tested; if chemotherapy is first, a biopsy is performed to sample the tumor.&lt;SEP&gt;A biopsy to diagnose ovarian cancer is usually done during the initial surgery to remove the cancer.</data>
  <data key="d9">diagnostic procedure,diagnostic procedures,tissue sampling,treatment integration</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250342</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">The extent of surgery depends on the number, location, and size of the lymph nodes with cancer.</data>
  <data key="d9">anatomical target,treatment decision</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250345</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Radiation Therapy">
  <data key="d7">2.0</data>
  <data key="d8">After surgery for regional CSCC, radiation therapy is often given to decrease the chance of the tumor returning.&lt;SEP&gt;Radiation therapy is often given after surgery to decrease the chance of the tumor returning.</data>
  <data key="d9">adjuvant treatment,recurrence prevention</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250353</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Regional Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">The best way to treat regional squamous cell skin cancer is with surgery to remove the tumor and nearby lymph nodes.</data>
  <data key="d9">primary intervention,standard care</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250355</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Head And Neck Tumors">
  <data key="d7">1.0</data>
  <data key="d8">For head and neck tumors, lymph nodes may be removed from one or both sides of the neck during surgery.</data>
  <data key="d9">lymph node removal,surgical procedure</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250366</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Regional CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Surgery is recommended to treat squamous cell skin cancer that has spread to nearby lymph nodes (regional CSCC).</data>
  <data key="d9">primary treatment,tumor removal</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250373</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Vaping">
  <data key="d7">1.0</data>
  <data key="d8">Vaping greatly increases the chances of having side effects during and after surgery.</data>
  <data key="d9">negative effect,side effect increase</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250498</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Smoking">
  <data key="d7">1.0</data>
  <data key="d8">Smoking greatly increases the chances of having side effects during and after surgery.</data>
  <data key="d9">negative effect,side effect increase</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250500</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Low-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Surgery is the preferred treatment for low-risk CSCC that has not spread to lymph nodes.</data>
  <data key="d9">management,treatment protocol</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250557</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Surgery is the preferred treatment for high-risk CSCC that has not spread to lymph nodes.</data>
  <data key="d9">management,treatment protocol</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250558</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Systemic Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Systemic therapy may be used as an option if surgery is not possible or successful for CSCC.</data>
  <data key="d9">therapeutic option,treatment alternative</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250572</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Local Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Local CSCC is usually treated with surgery to remove the cancer.</data>
  <data key="d9">management,primary treatment</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250593</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Hysterectomy">
  <data key="d7">1.0</data>
  <data key="d8">Hysterectomy is a common component of surgery for ovarian cancer.</data>
  <data key="d9">cancer treatment,organ removal</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250660</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Bilateral Salpingooophorectomy (BSO)">
  <data key="d7">1.0</data>
  <data key="d8">BSO is the most common surgery performed for ovarian cancer.</data>
  <data key="d9">organ removal,standard procedure</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250661</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Debulking Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Debulking surgery is performed when ovarian cancer has spread outside the ovaries.</data>
  <data key="d9">advanced cancer,tumor reduction</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250662</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Fertility-Sparing Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Fertility-sparing surgery is an option for some early ovarian cancers to preserve the ability to become pregnant.</data>
  <data key="d9">fertility preservation,surgical option</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250663</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Laparotomy">
  <data key="d7">1.0</data>
  <data key="d8">Laparotomy is the most common surgical method for ovarian cancer surgery.</data>
  <data key="d9">abdominal access,surgical method</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250665</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Laparoscopy">
  <data key="d7">1.0</data>
  <data key="d8">Laparoscopy is a minimally invasive surgical method used in select ovarian cancer cases.</data>
  <data key="d9">minimally invasive surgery,select cases</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250667</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Surgical Staging">
  <data key="d7">1.0</data>
  <data key="d8">Surgical staging is performed during surgery to accurately determine the stage of ovarian cancer.</data>
  <data key="d9">cancer staging,tissue sampling</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250669</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Treatment Team">
  <data key="d7">1.0</data>
  <data key="d8">The treatment team reviews prior surgery results to plan further treatment for ovarian cancer.</data>
  <data key="d9">planning,treatment review</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250677</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Pathologic Stage">
  <data key="d7">1.0</data>
  <data key="d8">Pathologic stage is determined by examining tissue removed from the patient during surgery.</data>
  <data key="d9">analysis,determination</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250830</data>
  <data key="d13"></data>
</edge>
<edge source="Surgery" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Surgery is the most common and effective treatment for removing and curing basal cell skin cancer.</data>
  <data key="d9">cure,primary treatment</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250858</data>
  <data key="d13"></data>
</edge>
<edge source="Neuroblastoma" target="Adrenal Glands">
  <data key="d7">1.0</data>
  <data key="d8">Neuroblastoma is a type of adrenal tumor, meaning it originates in the adrenal glands.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250234</data>
  <data key="d13"></data>
</edge>
<edge source="Neuroblastoma" target="Cancerous Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Neuroblastoma is a cancerous (malignant) tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250252</data>
  <data key="d13"></data>
</edge>
<edge source="Pheochromocytoma" target="Adrenal Glands">
  <data key="d7">1.0</data>
  <data key="d8">Pheochromocytoma begins in the adrenal medulla, which is part of the adrenal glands.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250236</data>
  <data key="d13"></data>
</edge>
<edge source="Pheochromocytoma" target="Adrenal Medulla">
  <data key="d7">1.0</data>
  <data key="d8">Pheochromocytoma begins in the adrenal medulla.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250243</data>
  <data key="d13"></data>
</edge>
<edge source="Pheochromocytoma" target="Benign Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Most pheochromocytomas are benign tumors.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250247</data>
  <data key="d13"></data>
</edge>
<edge source="Pheochromocytoma" target="Cancerous Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Some pheochromocytomas can be cancerous tumors.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250249</data>
  <data key="d13"></data>
</edge>
<edge source="Adenoma" target="Adrenal Glands">
  <data key="d7">1.0</data>
  <data key="d8">Adenoma is a tumor found on the adrenal glands.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250239</data>
  <data key="d13"></data>
</edge>
<edge source="Adenoma" target="Functioning Tumor">
  <data key="d7">1.0</data>
  <data key="d8">An adenoma can be a functioning tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250246</data>
  <data key="d13"></data>
</edge>
<edge source="Adenoma" target="Nonfunctioning Tumor">
  <data key="d7">1.0</data>
  <data key="d8">An adenoma can be a nonfunctioning tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250248</data>
  <data key="d13"></data>
</edge>
<edge source="Adenoma" target="Benign Tumor">
  <data key="d7">1.0</data>
  <data key="d8">An adenoma is a benign (noncancerous) tumor.</data>
  <data key="d9">characteristic,classification</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250249</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Glands" target="Endocrine System">
  <data key="d7">2.0</data>
  <data key="d8">Adrenal glands are part of the endocrine system, which is made up of tissues and organs that produce hormones.&lt;SEP&gt;The adrenal glands are small, yellow glands that are important components of the body's endocrine system.</data>
  <data key="d9">component,function,hormone production</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250238</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Glands" target="Adrenal Tumors">
  <data key="d7">1.0</data>
  <data key="d8">Adrenal tumors form in one or both of the adrenal glands, which are small glands located on top of the kidneys.</data>
  <data key="d9">anatomical location,disease origin</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250519</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Glands" target="Adrenal Cortex">
  <data key="d7">1.0</data>
  <data key="d8">The adrenal cortex is the outer part of the adrenal gland responsible for producing hormones like cortisol and aldosterone.</data>
  <data key="d9">anatomical part,hormone production</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250521</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Glands" target="Adrenal Medulla">
  <data key="d7">1.0</data>
  <data key="d8">The adrenal medulla is the inner part of the adrenal gland responsible for producing stress-response hormones like epinephrine.</data>
  <data key="d9">anatomical part,hormone production</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250524</data>
  <data key="d13"></data>
</edge>
<edge source="Endocrine System" target="Hormones">
  <data key="d7">1.0</data>
  <data key="d8">The endocrine system is made up of tissues and organs that produce hormones.</data>
  <data key="d9">production,regulation</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250234</data>
  <data key="d13"></data>
</edge>
<edge source="Hereditary Paraganglioma-Pheochromocytoma Syndrome" target="NCCN Guidelines For Patients: Kidney Cancer">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients: Kidney Cancer provide information on hereditary conditions like PGL/PCC syndrome that can also increase kidney tumor risk.</data>
  <data key="d9">condition reference,information resource</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250242</data>
  <data key="d13"></data>
</edge>
<edge source="Lynch Syndrome" target="Hereditary Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Lynch syndrome is another cause of hereditary ovarian cancer.</data>
  <data key="d9">genetic cause,risk factor</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250675</data>
  <data key="d13"></data>
</edge>
<edge source="Von Hippel-Lindau Syndrome" target="Kidney Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Von Hippel-Lindau syndrome (VHL) is a condition that can put one at risk for developing a kidney tumor.</data>
  <data key="d9">association,risk factor</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250252</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="General Health Tests">
  <data key="d7">2.0</data>
  <data key="d8">General health tests are part of the testing process for adrenal tumors.&lt;SEP&gt;General health tests, such as medical history and physical exams, are part of the testing process for treatment planning.</data>
  <data key="d9">diagnostic component,diagnostic process,health assessment,includes</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250250</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Imaging Tests">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests are part of the testing process for adrenal tumors.</data>
  <data key="d9">diagnostic process,includes</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250252</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Blood Tests">
  <data key="d7">2.0</data>
  <data key="d8">Blood tests are part of the testing process for adrenal tumors.&lt;SEP&gt;Testing for CML includes blood tests, which are used to determine the treatment plan.</data>
  <data key="d9">diagnostic procedure,diagnostic process,includes,treatment planning</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250255</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Genetic Tests">
  <data key="d7">1.0</data>
  <data key="d8">Genetic tests are part of the testing process for adrenal tumors.</data>
  <data key="d9">diagnostic process,includes</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250256</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Biopsy">
  <data key="d7">3.0</data>
  <data key="d8">A biopsy is part of the testing process for adrenal tumors.&lt;SEP&gt;Testing for CML may include a biopsy, which is used alongside blood tests to determine the treatment plan.&lt;SEP&gt;A biopsy is a key test used in the diagnostic process to determine cancer stage and treatment plan.</data>
  <data key="d9">diagnostic component,diagnostic procedure,diagnostic process,includes,tissue analysis,treatment planning</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250257</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Cancer Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Treatment planning for cancer starts with testing, which includes various diagnostic methods.</data>
  <data key="d9">diagnostic phase,planning dependency</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250625</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Imaging Studies">
  <data key="d7">1.0</data>
  <data key="d8">Imaging studies are a component of the testing process used to determine cancer stage and treatment.</data>
  <data key="d9">diagnostic component,staging tool</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250627</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Biomarker Testing">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing is listed as a type of test used in treatment planning.</data>
  <data key="d9">diagnostic component,molecular analysis</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250629</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Cancer Stage">
  <data key="d7">1.0</data>
  <data key="d8">Testing, including imaging and biopsy, is used to determine the cancer stage.</data>
  <data key="d9">determination,diagnostic outcome</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250631</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Treatment Plan">
  <data key="d7">1.0</data>
  <data key="d8">Results from testing are used to formulate the treatment plan.</data>
  <data key="d9">informational basis,planning dependency</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250631</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Mirror And Fiberoptic Exam">
  <data key="d7">1.0</data>
  <data key="d8">A mirror and fiberoptic exam is listed as a potential test needed for treatment planning.</data>
  <data key="d9">diagnostic component,procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250632</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Chest CT">
  <data key="d7">1.0</data>
  <data key="d8">Chest CT is listed as a potential imaging test needed for treatment planning.</data>
  <data key="d9">diagnostic component,imaging procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250633</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="CT With Contrast">
  <data key="d7">1.0</data>
  <data key="d8">CT with contrast is listed as a potential imaging test needed for treatment planning.</data>
  <data key="d9">diagnostic component,imaging procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250633</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="MRI With And Without Contrast">
  <data key="d7">1.0</data>
  <data key="d8">MRI with and without contrast is listed as a potential imaging test needed for treatment planning.</data>
  <data key="d9">diagnostic component,imaging procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250634</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="FDG-PET/CT">
  <data key="d7">1.0</data>
  <data key="d8">FDG-PET/CT is listed as a potential imaging test needed for treatment planning.</data>
  <data key="d9">diagnostic component,imaging procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250634</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Endoscopy With Examination Under Anesthesia">
  <data key="d7">1.0</data>
  <data key="d8">Endoscopy with examination under anesthesia is listed as a potential test needed for treatment planning.</data>
  <data key="d9">diagnostic component,surgical procedure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250635</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Dental Exam With X-Ray">
  <data key="d7">1.0</data>
  <data key="d8">A dental exam with x-ray is listed as part of the testing for treatment planning.</data>
  <data key="d9">dental procedure,diagnostic component</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250635</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Nutrition, Speech, And Swallowing Evaluation">
  <data key="d7">1.0</data>
  <data key="d8">Nutrition, speech, and swallowing evaluation is listed as part of the testing for treatment planning.</data>
  <data key="d9">diagnostic component,functional assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250637</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Hearing Test">
  <data key="d7">1.0</data>
  <data key="d8">A hearing test is listed as part of the testing for treatment planning.</data>
  <data key="d9">diagnostic component,sensory assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250638</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Help To Quit Smoking">
  <data key="d7">1.0</data>
  <data key="d8">Help to quit smoking is mentioned as a supportive measure during the testing and planning phase.</data>
  <data key="d9">behavioral intervention,supportive measure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250640</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Fertility Counseling">
  <data key="d7">1.0</data>
  <data key="d8">Fertility counseling is mentioned as a supportive measure during the testing and planning phase.</data>
  <data key="d9">reproductive planning,supportive measure</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250642</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Screening For Hepatitis B">
  <data key="d7">1.0</data>
  <data key="d8">Screening for hepatitis B is mentioned as part of the testing for treatment planning.</data>
  <data key="d9">diagnostic component,infection screening</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250643</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Screen For Depression">
  <data key="d7">1.0</data>
  <data key="d8">Screening for depression is mentioned as part of the testing for treatment planning.</data>
  <data key="d9">diagnostic component,mental health assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250645</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Online Patient Portals">
  <data key="d7">1.0</data>
  <data key="d8">Online patient portals are one way for patients to access their test results from CML testing.</data>
  <data key="d9">patient resources,result access</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250726</data>
  <data key="d13"></data>
</edge>
<edge source="Testing" target="Support System">
  <data key="d7">1.0</data>
  <data key="d8">Having a support system in place is beneficial during the diagnosis and treatment process, which begins with testing.</data>
  <data key="d9">emotional support,practical assistance</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250729</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Cancer Grade">
  <data key="d7">1.0</data>
  <data key="d8">The pathologist determines the cancer grade by examining how abnormal the cancer cells look under a microscope.</data>
  <data key="d9">evaluation,medical diagnosis</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250336</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Cancer Type">
  <data key="d7">1.0</data>
  <data key="d8">The pathologist determines the type of ovarian cancer by examining cancerous tissue removed during surgery or biopsy.</data>
  <data key="d9">identification,medical diagnosis</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250339</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Skin Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">A pathologist examines the tissue sample from a skin biopsy under a microscope to provide a diagnosis.&lt;SEP&gt;The tissue sample from a skin biopsy is analyzed by a pathologist to determine the cancer type and subtype.</data>
  <data key="d9">analysis,evaluation,examination</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250409</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">A pathologist examines tissue or fluid samples removed during a biopsy to confirm the presence of cancer.&lt;SEP&gt;Biopsy samples are sent to a pathologist, who examines them under a microscope to diagnose cancer.</data>
  <data key="d9">cancer diagnosis,diagnosis,sample analysis</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250478</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Cytology">
  <data key="d7">1.0</data>
  <data key="d8">A pathologist is an expert in examining cells using a microscope, a method called cytology.</data>
  <data key="d9">diagnostic method,expertise</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250495</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Tumor Histology">
  <data key="d7">1.0</data>
  <data key="d8">The pathologist determines the cancer subtype called tumor histology.</data>
  <data key="d9">cancer classification,determination</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250496</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Bone Marrow Tests">
  <data key="d7">1.0</data>
  <data key="d8">A pathologist reviews the bone marrow samples obtained from tests for diagnosis.</data>
  <data key="d9">expert review,sample analysis</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250687</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologist" target="Care Team">
  <data key="d7">1.0</data>
  <data key="d8">A pathologist is a member of the multidisciplinary care team, providing diagnosis and biomarker analysis for AML.</data>
  <data key="d9">diagnostic support,team composition</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250739</data>
  <data key="d13"></data>
</edge>
<edge source="General Health Tests" target="Medical History">
  <data key="d7">1.0</data>
  <data key="d8">A medical history is a specific type of general health test used to inform treatment decisions.</data>
  <data key="d9">assessment tool,data collection</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250626</data>
  <data key="d13"></data>
</edge>
<edge source="General Health Tests" target="Family History">
  <data key="d7">1.0</data>
  <data key="d8">Family history is collected as part of general health tests to assess inherited health risks.</data>
  <data key="d9">data collection,risk assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250628</data>
  <data key="d13"></data>
</edge>
<edge source="General Health Tests" target="Tobacco And Alcohol Use History">
  <data key="d7">1.0</data>
  <data key="d8">Tobacco and alcohol use history is gathered during general health tests as it is a known risk factor for cancer.</data>
  <data key="d9">data collection,risk factor assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250629</data>
  <data key="d13"></data>
</edge>
<edge source="General Health Tests" target="Physical Exam">
  <data key="d7">1.0</data>
  <data key="d8">A physical exam is a component of general health tests conducted by a health care provider.</data>
  <data key="d9">clinical assessment,health evaluation</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250631</data>
  <data key="d13"></data>
</edge>
<edge source="Medical Binder" target="Care Team">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to keep a list of their care team's contact information in a medical binder.</data>
  <data key="d9">contact management,organization tool</data>
  <data key="d10">chunk-7102a43dfb62e649d725bc95ba292688</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250253</data>
  <data key="d13"></data>
</edge>
<edge source="Medical Binder" target="Online Patient Portals">
  <data key="d7">2.0</data>
  <data key="d8">Records from online patient portals can be downloaded or printed to be added to a medical binder for organization.&lt;SEP&gt;Online patient portals are used to access medical records that can be downloaded or printed and added to a medical binder.</data>
  <data key="d9">digital access,information access,record organization</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250766</data>
  <data key="d13"></data>
</edge>
<edge source="Medical Binder" target="Imaging Tests">
  <data key="d7">1.0</data>
  <data key="d8">A medical binder is used to organize copies of imaging test results and reports for easy reference and second opinions.</data>
  <data key="d9">diagnostic support,record organization</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250887</data>
  <data key="d13"></data>
</edge>
<edge source="Abdominal Exam" target="Ascites">
  <data key="d7">1.0</data>
  <data key="d8">During an abdominal exam, a provider feels for ascites, which is a fluid buildup that can indicate advanced ovarian cancer.</data>
  <data key="d9">diagnostic sign,physical finding</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250262</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Treatment For NSCLC">
  <data key="d7">1.0</data>
  <data key="d8">The best treatment for NSCLC is decided by discussing recommendations with the care team to create a personalized plan.</data>
  <data key="d9">collaborative planning,patient care</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250280</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Gynecologic Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">The care team for ovarian cancer includes a gynecologic oncologist who works with other experts to plan treatment.</data>
  <data key="d9">collaborative care,treatment planning</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250342</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Medical Oncologist">
  <data key="d7">2.0</data>
  <data key="d8">A medical oncologist is a member of the multidisciplinary care team treating a patient with AML.&lt;SEP&gt;The care team for ovarian cancer includes a medical oncologist who collaborates on the treatment plan.</data>
  <data key="d9">collaborative care,team composition,treatment delivery,treatment planning</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250345</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">The care team will test suspicious lymph nodes to determine how far the disease has spread.</data>
  <data key="d9">diagnostic testing,disease staging</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250353</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Scans">
  <data key="d7">1.0</data>
  <data key="d8">Testing by the care team could include scans of the upper body, stomach, and pelvis to check for metastatic disease.</data>
  <data key="d9">diagnostic procedure,disease assessment</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250359</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Distress Screening">
  <data key="d7">1.0</data>
  <data key="d8">The care team conducts distress screening to assess and manage the patient's mental and emotional well-being as part of cancer care.</data>
  <data key="d9">patient care,psychological assessment</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250389</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Social Worker">
  <data key="d7">1.0</data>
  <data key="d8">The care team includes social workers who can provide support and counseling to the patient's family and loved ones.</data>
  <data key="d9">family counseling,support network</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250396</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Lung Nodule">
  <data key="d7">1.0</data>
  <data key="d8">A patient's care team assesses lung nodules, reviews images, and performs biopsies to determine if they are cancerous.</data>
  <data key="d9">diagnostic assessment,patient management</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250408</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Pulmonologist">
  <data key="d7">1.0</data>
  <data key="d8">A pulmonologist is a board-certified expert who is a member of a patient's care team.</data>
  <data key="d9">medical specialty,team composition</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250417</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Thoracic Radiologist">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic radiologist is a board-certified expert who is a member of a patient's care team.</data>
  <data key="d9">medical specialty,team composition</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250419</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Thoracic Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic surgeon is a board-certified expert who is a member of a patient's care team.</data>
  <data key="d9">medical specialty,team composition</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250421</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">The care team performs a biopsy if needed to decide if a lung nodule is cancer.</data>
  <data key="d9">decision-making,diagnostic procedure</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250423</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Medical History">
  <data key="d7">2.0</data>
  <data key="d8">A care team uses a patient's medical history to help determine which treatment is best for them.&lt;SEP&gt;A patient's medical history and physical exam inform the care team about the patient's overall health.</data>
  <data key="d9">assessment,information,patient assessment,treatment planning</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250429</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="AML">
  <data key="d7">1.0</data>
  <data key="d8">The Care Team manages the patient's AML treatment, recovery, and prescribes medicines based on test results.</data>
  <data key="d9">management,treatment</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250445</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Family History">
  <data key="d7">1.0</data>
  <data key="d8">The Care Team asks for a Family History to gather information about genetic risks and health issues of blood relatives.</data>
  <data key="d9">information gathering,risk assessment</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250448</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">The Doctor is part of the Care Team with whom the patient discusses test results.</data>
  <data key="d9">collaboration,communication</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250452</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Supplements">
  <data key="d7">1.0</data>
  <data key="d8">The Care Team needs to be informed about Supplements a patient takes as they can interact with prescribed medicines.</data>
  <data key="d9">interaction awareness,safety</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250455</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Patient">
  <data key="d7">9.0</data>
  <data key="d8">The relation (Care Team, Patient) describes the dynamic, collaborative partnership between a patient and their multidisciplinary healthcare providers. This relationship is fundamental to achieving optimal care outcomes, particularly in contexts like cancer treatment.

Effective communication is a central pillar of this relation. Patients are consistently encouraged to actively engage with their care team by asking questions, discussing concerns, and communicating openly about all aspects of their care, including diagnosis, treatment plans, and the understanding of test results. A key practical recommendation is for patients to maintain and utilize their care team's contact information to facilitate this ongoing dialogue.

Shared decision-making is another critical component. The patient's personal preferences, values, and wishes regarding treatment are considered vitally important and must be discussed with the care team to inform medical decisions. This collaborative approach extends to managing the treatment journey, including the shared effort required to monitor and address side effects. Ultimately, through proactive communication, mutual understanding, and joint decision-making, the patient and care team work in coordination to pursue the best possible care.</data>
  <data key="d9">collaboration,collaborative decision-making,communication,decision-making,healthcare communication,healthcare interaction,healthcare management,healthcare relationship,preferences,shared decision-making,side effect management,support,treatment coordination</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-8b44f0b4da13a804cd1dfb917ac7e981&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a&lt;SEP&gt;chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250479</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Smoking">
  <data key="d7">1.0</data>
  <data key="d8">The care team provides counseling and medicines to help patients quit smoking or vaping.</data>
  <data key="d9">cessation support,patient counseling</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Vaping">
  <data key="d7">1.0</data>
  <data key="d8">The care team provides counseling and medicines to help patients quit smoking or vaping.</data>
  <data key="d9">cessation support,patient counseling</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250485</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Bone Marrow Aspirate And Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A bone marrow sample is sometimes needed to get all the information the care team requires to help plan AML treatment.</data>
  <data key="d9">sample provision,treatment planning</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250657</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Sedative">
  <data key="d7">1.0</data>
  <data key="d8">The care team may administer a sedative to help a patient relax if they report nervousness in enclosed spaces.</data>
  <data key="d9">medication management,patient care</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250675</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Patient Advocacy">
  <data key="d7">1.0</data>
  <data key="d8">Patients are encouraged to ask questions and make shared decisions with their care team to get the best care.</data>
  <data key="d9">patient engagement,shared decision-making</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250723</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Primary Care Physician (PCP)">
  <data key="d7">1.0</data>
  <data key="d8">Patients should update their primary care physician regarding any changes, as part of coordinating with their care team.</data>
  <data key="d9">care coordination,information sharing</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250726</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Hematologist">
  <data key="d7">1.0</data>
  <data key="d8">A hematologist is a member of the multidisciplinary care team treating a patient with AML.</data>
  <data key="d9">specialized care,team composition</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250737</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Multidisciplinary Team">
  <data key="d7">1.0</data>
  <data key="d8">The care team for AML treatment should involve a Multidisciplinary Team (MDT).</data>
  <data key="d9">team structure,treatment planning</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250741</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Tracer">
  <data key="d7">1.0</data>
  <data key="d8">The care team uses the tracer from a PET scan to see how the patient's cells are using substances and to find abnormal usage.</data>
  <data key="d9">diagnostic tool,treatment monitoring</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250764</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Support System">
  <data key="d7">1.0</data>
  <data key="d8">A support system can help a patient by bringing someone to doctor visits and assisting with communication with the care team.</data>
  <data key="d9">assistance,coordination</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250769</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Primary Care Physician">
  <data key="d7">1.0</data>
  <data key="d8">Patients should keep their primary care physician informed of changes to their contact list and care team.</data>
  <data key="d9">coordination,information sharing</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250770</data>
  <data key="d13"></data>
</edge>
<edge source="Care Team" target="Contrast Material">
  <data key="d7">1.0</data>
  <data key="d8">Patients must inform their care team about past allergic reactions to contrast material to manage risks during imaging tests.</data>
  <data key="d9">allergy management,patient safety</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250891</data>
  <data key="d13"></data>
</edge>
<edge source="Pelvic Exam" target="Pap Test">
  <data key="d7">1.0</data>
  <data key="d8">A Pap test, which involves sampling cervical cells, is performed during a pelvic exam, though it is for cervical, not ovarian, cancer detection.</data>
  <data key="d9">cell sampling,diagnostic procedure</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250254</data>
  <data key="d13"></data>
</edge>
<edge source="Pelvic Exam" target="Endometrial Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">An endometrial biopsy may be performed as part of a pelvic exam to rule out uterine cancer during the evaluation for ovarian cancer.</data>
  <data key="d9">diagnostic procedure,tissue sampling</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250255</data>
  <data key="d13"></data>
</edge>
<edge source="Pelvic Exam" target="Rectovaginal Exam">
  <data key="d7">1.0</data>
  <data key="d8">A rectovaginal exam is a component of a pelvic exam used to check for cancer in the space between the rectum and vagina.</data>
  <data key="d9">diagnostic procedure,physical examination</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250257</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="Transabdominal Ultrasound">
  <data key="d7">1.0</data>
  <data key="d8">Transabdominal ultrasound is a specific type of ultrasound performed by moving a probe on the skin of the abdomen and pelvis.</data>
  <data key="d9">application method,imaging technique</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250255</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="Transvaginal Ultrasound">
  <data key="d7">1.0</data>
  <data key="d8">Transvaginal ultrasound is a specific type of ultrasound performed by inserting a probe into the vagina for clearer ovarian images.</data>
  <data key="d9">application method,imaging technique</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250257</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="Ultrasound Probe">
  <data key="d7">1.0</data>
  <data key="d8">An ultrasound probe is the hand-held device used to perform ultrasound exams and generate the sound wave images.</data>
  <data key="d9">diagnostic tool,image generation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250259</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">An ultrasound might be used to guide a lymph node biopsy.</data>
  <data key="d9">guidance,imaging assistance</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250500</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="Echocardiogram">
  <data key="d7">1.0</data>
  <data key="d8">An echocardiogram is a type of ultrasound that uses sound waves to make pictures.</data>
  <data key="d9">method classification,technology type</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250624</data>
  <data key="d13"></data>
</edge>
<edge source="Ultrasound" target="CT Scan">
  <data key="d7">1.0</data>
  <data key="d8">An ultrasound or CT scan can be used to guide a biopsy procedure for obtaining tissue samples.</data>
  <data key="d9">diagnostic guidance,procedural tool</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250889</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Contrast Agent">
  <data key="d7">1.0</data>
  <data key="d8">A contrast agent is used during a CT scan to make the images clearer and more detailed for diagnosis.</data>
  <data key="d9">diagnostic clarity,imaging enhancement</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250261</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="CT Scanner">
  <data key="d7">1.0</data>
  <data key="d8">A CT scanner is the large machine that performs CT scans by rotating an X-ray beam to take pictures from multiple angles.</data>
  <data key="d9">diagnostic tool,image generation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250263</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">A CT scan is used to check if lymph nodes are enlarged, which is a potential sign that ovarian cancer has metastasized.</data>
  <data key="d9">anatomical assessment,metastasis indicator</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250266</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Oral Contrast">
  <data key="d7">1.0</data>
  <data key="d8">Oral contrast is consumed by the patient before a CT scan to enhance the clarity of the images taken.</data>
  <data key="d9">diagnostic clarity,imaging preparation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250267</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="PET/MRI">
  <data key="d7">1.0</data>
  <data key="d8">CT scans are combined with PET/MRI to create a more accurate diagnostic method for locating cancer cells.</data>
  <data key="d9">diagnostic accuracy,medical imaging</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250297</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Regional CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Doctors may use regular CT scans to monitor patients with regional CSCC for signs of cancer in lymph nodes or other body parts.</data>
  <data key="d9">diagnostic imaging,disease monitoring</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250379</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A CT scan might be used to guide a lymph node biopsy.</data>
  <data key="d9">guidance,imaging assistance</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250502</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="PET Scan">
  <data key="d7">2.0</data>
  <data key="d8">PET scans are often combined with CT scans (PET/CT) to more accurately locate cancer cells in the body.&lt;SEP&gt;PET scans are sometimes combined with CT scans to provide detailed imaging for cancer diagnosis.</data>
  <data key="d9">combined imaging,diagnostic accuracy,diagnostic combination,imaging</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058&lt;SEP&gt;chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250670</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Radiologist">
  <data key="d7">1.0</data>
  <data key="d8">A radiologist interprets the images from a CT scan and writes a report for the patient's doctor.</data>
  <data key="d9">medical imaging,test interpretation</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250832</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Contrast">
  <data key="d7">1.0</data>
  <data key="d8">Contrast material is often used during a CT scan to make the internal pictures clearer and more detailed.</data>
  <data key="d9">diagnostic procedure,image enhancement</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="CT Scan" target="Contrast Material">
  <data key="d7">1.0</data>
  <data key="d8">A CT scan often uses contrast material to make the internal images clearer and more detailed for diagnosis.</data>
  <data key="d9">diagnostic tool,procedure enhancement</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250888</data>
  <data key="d13"></data>
</edge>
<edge source="MRI" target="Contrast Agent">
  <data key="d7">1.0</data>
  <data key="d8">A contrast agent may be used during an MRI to enhance the clarity of the pictures taken.</data>
  <data key="d9">diagnostic clarity,imaging enhancement</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250261</data>
  <data key="d13"></data>
</edge>
<edge source="MRI" target="Sedative">
  <data key="d7">1.0</data>
  <data key="d8">A sedative may be given to a patient undergoing an MRI to help them relax if they are nervous in the enclosed machine.</data>
  <data key="d9">patient comfort,procedure facilitation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250261</data>
  <data key="d13"></data>
</edge>
<edge source="MRI" target="MRI Machine">
  <data key="d7">1.0</data>
  <data key="d8">An MRI machine is the scanning device that uses radio waves and magnets to perform MRI scans.</data>
  <data key="d9">diagnostic tool,image generation</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250263</data>
  <data key="d13"></data>
</edge>
<edge source="MRI" target="PET Scan">
  <data key="d7">1.0</data>
  <data key="d8">PET scans are sometimes combined with MRI for comprehensive diagnostic imaging.</data>
  <data key="d9">diagnostic combination,imaging</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250673</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="PET CT">
  <data key="d7">1.0</data>
  <data key="d8">PET CT is a specific application where PET scan technology is combined with CT imaging for a more comprehensive diagnostic picture.</data>
  <data key="d9">diagnostic technique,imaging combination</data>
  <data key="d10">chunk-e5406c28b41e499fad4ae44f2c44fdd7</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250264</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="Cancer Cells">
  <data key="d7">1.0</data>
  <data key="d8">A PET scan uses a tracer to show where cancer cells are and how much sugar they are taking up.</data>
  <data key="d9">metabolic activity,tumor detection</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250609</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="FDG-PET/CT">
  <data key="d7">1.0</data>
  <data key="d8">An FDG-PET/CT is a type of PET scan combined with CT technology.</data>
  <data key="d9">advanced imaging,combined technology</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250611</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="Tracer">
  <data key="d7">2.0</data>
  <data key="d8">A PET scan uses a radioactive tracer injected into the patient to identify cancer cells in the body.&lt;SEP&gt;A PET scan uses a radioactive drug called a tracer injected into a vein.</data>
  <data key="d9">cancer detection,diagnostic agent,imaging component</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250619</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="Inflammation">
  <data key="d7">1.0</data>
  <data key="d8">Inflammation can show up as a bright spot on a PET scan and may be mistaken for cancer.</data>
  <data key="d9">differential diagnosis,imaging artifact</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250621</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="PET/CT Scan">
  <data key="d7">1.0</data>
  <data key="d8">A PET/CT scan is created when a PET scan is combined with a CT scan.</data>
  <data key="d9">hybrid imaging,technology combination</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250624</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="Sugar Radiotracer">
  <data key="d7">1.0</data>
  <data key="d8">A PET scan uses a sugar radiotracer injected into the body to show how cells are using sugar, which helps identify cancer.</data>
  <data key="d9">diagnostic agent,imaging enhancement</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250675</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="FDG-PET Scan">
  <data key="d7">1.0</data>
  <data key="d8">An FDG-PET scan is a specific type of PET scan that uses a radioactive sugar tracer to detect active cancer cells.</data>
  <data key="d9">cancer detection,specialized technique</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250833</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="MRI Scan">
  <data key="d7">1.0</data>
  <data key="d8">PET scans can be combined with MRI scans (PET/MRI) to improve the accuracy of locating cancer cells.</data>
  <data key="d9">combined imaging,diagnostic accuracy</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="PET Scan" target="FDG-PET/CT Scan">
  <data key="d7">1.0</data>
  <data key="d8">An FDG-PET/CT scan is a specific type of PET scan combined with CT imaging, using a specialized tracer for more precise cancer detection.</data>
  <data key="d9">diagnostic advancement,technological combination</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250888</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests are used to diagnose and guide treatment for Follicular Lymphoma.</data>
  <data key="d9">diagnostic procedure,disease management</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250541</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests produce results that contribute to the overall test findings.</data>
  <data key="d9">data generation,diagnostic procedure</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250585</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Leukemia">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests are performed to look for sites with leukemia outside the bone marrow.</data>
  <data key="d9">disease detection,monitoring</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250608</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Radiologist">
  <data key="d7">2.0</data>
  <data key="d8">A radiologist interprets the results of imaging tests and writes reports that are sent to healthcare providers and patients.&lt;SEP&gt;A radiologist interprets imaging tests and sends a report to the doctor.</data>
  <data key="d9">diagnostic interpretation,professional analysis,reporting,test interpretation</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250610</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Contrast Material">
  <data key="d7">2.0</data>
  <data key="d8">Contrast material is used in various imaging tests to improve the clarity and detail of the pictures taken inside the body.&lt;SEP&gt;Contrast material is used to improve the quality of pictures from imaging tests.</data>
  <data key="d9">diagnostic aid,diagnostic clarity,image enhancement</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f&lt;SEP&gt;chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250613</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Infection">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests can show areas of infection that may impact patient care.</data>
  <data key="d9">detection,diagnostic imaging</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250617</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Bleeding">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests can show areas of bleeding that may impact patient care.</data>
  <data key="d9">detection,diagnostic imaging</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250619</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Chapter 2: Testing For AML">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 2: Testing for AML lists imaging tests as a possible diagnostic procedure.</data>
  <data key="d9">chapter content,test overview</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250807</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Body">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests are used to take pictures of the inside of the body for diagnostic purposes.</data>
  <data key="d9">diagnosis,visualization</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250825</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Clinical Stage">
  <data key="d7">1.0</data>
  <data key="d8">Clinical stage is based on imaging tests and biopsy results conducted before treatment.</data>
  <data key="d9">basis,determination</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250830</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Patient Portal">
  <data key="d7">1.0</data>
  <data key="d8">Patients can use online patient portals to view and download the results of their imaging tests.</data>
  <data key="d9">digital communication,record access</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250889</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Tests" target="Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests such as ultrasound or CT are sometimes used to guide the precise location for a biopsy procedure.</data>
  <data key="d9">diagnostic accuracy,procedural guidance</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250891</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Stage" target="Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Clinical stage is based on imaging tests and biopsy results conducted before treatment.</data>
  <data key="d9">basis,determination</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250831</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Adrenal Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Blood tests are used to look for hormone secretion signs or to monitor treatment response in adrenal tumor cases.</data>
  <data key="d9">hormone detection,treatment monitoring</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250300</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="AML">
  <data key="d7">1.0</data>
  <data key="d8">Blood Tests are conducted during AML treatment and recovery to check treatment results and organ health.</data>
  <data key="d9">diagnosis,monitoring</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250454</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Blood tests are used to diagnose and guide treatment for Follicular Lymphoma.</data>
  <data key="d9">diagnostic procedure,disease management</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250543</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">The doctor orders blood tests as needed to monitor the patient during chemotherapy.</data>
  <data key="d9">diagnostic tool,treatment monitoring</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250710</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Treatment Plan">
  <data key="d7">1.0</data>
  <data key="d8">Results from blood tests are used to determine a patient's treatment plan.</data>
  <data key="d9">diagnosis,medical decision-making</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250768</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Test results are the output generated from procedures like blood tests.</data>
  <data key="d9">data source,diagnostic output</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250774</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Complete Blood Count">
  <data key="d7">1.0</data>
  <data key="d8">A complete blood count is a type of blood test used to assess general health by measuring blood cells.</data>
  <data key="d9">component,health assessment</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250815</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Blood Chemistry Profile">
  <data key="d7">1.0</data>
  <data key="d8">A blood chemistry profile is a type of blood test that measures chemical levels to assess organ function and nutrient intake.</data>
  <data key="d9">component,health assessment</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250817</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Tests" target="Liver Function Tests">
  <data key="d7">1.0</data>
  <data key="d8">Liver function tests are a type of blood test that measure liver chemicals to check for damage or cancer spread.</data>
  <data key="d9">component,health assessment</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250820</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Esophageal Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A biopsy is performed to obtain tissue samples for the definitive diagnosis of esophageal cancer.</data>
  <data key="d9">diagnostic confirmation,tissue analysis</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250331</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Metastasis">
  <data key="d7">1.0</data>
  <data key="d8">A biopsy of a metastasis may be performed to confirm the spread of cancer to areas like lymph nodes or lung.</data>
  <data key="d9">cancer confirmation,diagnostic procedure</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Imaging Studies">
  <data key="d7">1.0</data>
  <data key="d8">Results from imaging studies and biopsy may help determine a cancer treatment plan.</data>
  <data key="d9">diagnostic combination,treatment planning</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250488</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Treatment Plan">
  <data key="d7">2.0</data>
  <data key="d8">Results from a biopsy are used to determine a patient's treatment plan.&lt;SEP&gt;Results from a biopsy may help determine a treatment plan.</data>
  <data key="d9">diagnosis,information source,medical decision-making,planning basis</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250514</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A biopsy is a required test to diagnose basal cell skin cancer, forming part of the diagnostic process alongside medical history and physical exams.</data>
  <data key="d9">diagnosis,medical testing</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250522</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">A biopsy is an essential test for accurately diagnosing and treating Follicular Lymphoma.</data>
  <data key="d9">diagnostic procedure,disease management</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250538</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Test Results">
  <data key="d7">2.0</data>
  <data key="d8">Test results are the output generated from procedures like biopsies.&lt;SEP&gt;A biopsy produces results that contribute to the overall test findings.</data>
  <data key="d9">data generation,data source,diagnostic output,diagnostic procedure</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250587</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Diagnostic Laparoscopy">
  <data key="d7">1.0</data>
  <data key="d8">During a diagnostic laparoscopy, tissue samples are taken and tested via biopsy to check for cancer cells.</data>
  <data key="d9">diagnostic procedure,tissue sampling</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250672</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Tissue Fluid">
  <data key="d7">1.0</data>
  <data key="d8">A biopsy is performed to remove a sample of tissue or fluid from the body for testing.</data>
  <data key="d9">sampling,testing</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250825</data>
  <data key="d13"></data>
</edge>
<edge source="Biopsy" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">The assessment team utilizes a biopsy procedure to confirm a cancer diagnosis.</data>
  <data key="d9">confirmation,diagnostic procedure</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250886</data>
  <data key="d13"></data>
</edge>
<edge source="Airways Of The Lungs" target="Trachea">
  <data key="d7">1.0</data>
  <data key="d8">Air moves through the trachea as part of the airway system of the lungs.</data>
  <data key="d9">air passage,anatomical structure</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250264</data>
  <data key="d13"></data>
</edge>
<edge source="Trachea" target="Bronchi">
  <data key="d7">4.0</data>
  <data key="d8">The trachea splits into two airways called bronchi.&lt;SEP&gt;The trachea splits into two airways called the bronchi, which lead into the lungs.&lt;SEP&gt;The trachea (windpipe) splits into two airways called bronchi.</data>
  <data key="d9">air passage,airway division,airway pathway,anatomical branching,anatomical connection,anatomical division,anatomical structure,branching</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250266</data>
  <data key="d13"></data>
</edge>
<edge source="Trachea" target="Respiratory System">
  <data key="d7">1.0</data>
  <data key="d8">The trachea is part of the respiratory system through which air travels.</data>
  <data key="d9">air passage,system component</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250420</data>
  <data key="d13"></data>
</edge>
<edge source="Trachea" target="Windpipe">
  <data key="d7">1.0</data>
  <data key="d8">The windpipe is also referred to as the trachea, which is the airway that splits into the bronchi.</data>
  <data key="d9">airway identification,anatomical synonym</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250733</data>
  <data key="d13"></data>
</edge>
<edge source="Trachea" target="Airways">
  <data key="d7">1.0</data>
  <data key="d8">The trachea (windpipe) is part of the series of airways through which air moves.</data>
  <data key="d9">air passage,anatomical part</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250875</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Bronchioli">
  <data key="d7">2.0</data>
  <data key="d8">Inside the lung, each bronchus divides into smaller airways called the bronchioli.&lt;SEP&gt;The bronchi divide into smaller airways called the bronchioli.</data>
  <data key="d9">air passage,anatomical branching,anatomical division,branching</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250268</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Squamous Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma forms from cells that line the bronchi.</data>
  <data key="d9">cancer formation,cell origin</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250272</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Lungs">
  <data key="d7">1.0</data>
  <data key="d8">The bronchi are two large breathing tubes that connect the windpipe to the lungs.</data>
  <data key="d9">airway connection,anatomical structure</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250413</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Bronchioles">
  <data key="d7">1.0</data>
  <data key="d8">Inside the lungs, the bronchi divide into smaller airways called bronchioles.</data>
  <data key="d9">airway division,respiratory system</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250418</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Respiratory System">
  <data key="d7">1.0</data>
  <data key="d8">The bronchi are part of the respiratory system, branching from the trachea into the lungs.</data>
  <data key="d9">airway structure,system component</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250422</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Lung Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Lung carcinomas form from cells that line the airways, including the bronchi.</data>
  <data key="d9">anatomical location,cell lining</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250731</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchi" target="Lobes">
  <data key="d7">1.0</data>
  <data key="d8">Inside the lung, each bronchus branches off into the parts called lobes.</data>
  <data key="d9">anatomical connection,branching</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250875</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchioli" target="Alveoli">
  <data key="d7">2.0</data>
  <data key="d8">At the end of the bronchioli are sacs called alveoli, where oxygen transfer occurs.</data>
  <data key="d9">anatomical structure,anatomical termination,function,gas exchange</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250266</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchioli" target="Lung Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Lung carcinomas form from cells that line the airways, including the bronchioli.</data>
  <data key="d9">anatomical location,cell lining</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250735</data>
  <data key="d13"></data>
</edge>
<edge source="Alveoli" target="Adenocarcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Adenocarcinoma often forms from cells that line the alveoli.</data>
  <data key="d9">cancer formation,cell origin</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250268</data>
  <data key="d13"></data>
</edge>
<edge source="Alveoli" target="Lungs">
  <data key="d7">1.0</data>
  <data key="d8">The alveoli are airways that are part of the structure of the lungs.</data>
  <data key="d9">anatomical structure,part of</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250374</data>
  <data key="d13"></data>
</edge>
<edge source="Alveoli" target="Bronchioles">
  <data key="d7">1.0</data>
  <data key="d8">At the end of the bronchioles are sacs called alveoli, where oxygen is transferred into the blood.</data>
  <data key="d9">airway termination,gas exchange</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250415</data>
  <data key="d13"></data>
</edge>
<edge source="Alveoli" target="Respiratory System">
  <data key="d7">1.0</data>
  <data key="d8">The alveoli are air sacs at the end of the bronchioles in the respiratory system where gas exchange occurs.</data>
  <data key="d9">gas exchange,system component</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250428</data>
  <data key="d13"></data>
</edge>
<edge source="Alveoli" target="Lung Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Lung carcinomas form from cells that line the airways, including the alveoli.</data>
  <data key="d9">anatomical location,cell lining</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250737</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Large Cell Carcinoma">
  <data key="d7">3.0</data>
  <data key="d8">Large cell carcinoma is a type of Non-Small Cell Lung Cancer.&lt;SEP&gt;Large cell carcinoma is a subtype of non-small cell lung cancer that starts in large cells within the lungs.&lt;SEP&gt;Large cell carcinoma is a specific subtype of the broader category known as non-small cell lung cancer.</data>
  <data key="d9">cancer classification,cell origin,disease subtype,subtype</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250267</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Squamous Cell Carcinoma">
  <data key="d7">3.0</data>
  <data key="d8">Squamous cell carcinoma is a type of Non-Small Cell Lung Cancer.&lt;SEP&gt;Squamous cell carcinoma is a subtype of non-small cell lung cancer that starts in flat cells lining the bronchi.&lt;SEP&gt;Squamous cell carcinoma is a specific subtype of the broader category known as non-small cell lung cancer.</data>
  <data key="d9">cancer classification,cell origin,disease subtype,subtype</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250270</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Adenocarcinoma">
  <data key="d7">3.0</data>
  <data key="d8">Adenocarcinoma is a common type of Non-Small Cell Lung Cancer.&lt;SEP&gt;Adenocarcinoma is a subtype of non-small cell lung cancer that starts in mucus-making cells lining the alveoli.&lt;SEP&gt;Adenocarcinoma is a specific subtype of the broader category known as non-small cell lung cancer.</data>
  <data key="d9">cancer classification,cell origin,disease subtype,subtype</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250272</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="NCCN.org/patientguidelines">
  <data key="d7">1.0</data>
  <data key="d8">Information about NSCLC is available at the NCCN.org/patientguidelines website.</data>
  <data key="d9">information resource,patient guidance</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250276</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="NCCN Patient Guides For Cancer App">
  <data key="d7">1.0</data>
  <data key="d8">Information about NSCLC is available on the NCCN Patient Guides for Cancer app.</data>
  <data key="d9">information resource,patient guidance</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250278</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Stomach Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Cancers that spread to the lungs, like stomach cancer, are not classified as lung cancer.</data>
  <data key="d9">disease differentiation,metastasis</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250282</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Adenosquamous Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Adenosquamous carcinoma is a specific subtype of the broader category known as non-small cell lung cancer.</data>
  <data key="d9">cancer classification,subtype</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250366</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Sarcomatoid Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Sarcomatoid carcinoma is a specific subtype of the broader category known as non-small cell lung cancer.</data>
  <data key="d9">cancer classification,subtype</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250368</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Histology">
  <data key="d7">1.0</data>
  <data key="d8">Histology is the method of using a microscope to break down non-small cell lung cancer into its subtypes.</data>
  <data key="d9">diagnostic method,subtype identification</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250415</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Non-small cell lung cancer is the most common type of lung cancer.</data>
  <data key="d9">common type,disease classification</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250422</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Environmental Toxins">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to environmental toxins like tobacco smoke and arsenic can cause skin damage that leads to Squamous Cell Carcinoma.</data>
  <data key="d9">causation,risk factor</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250396</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Genetic Syndromes">
  <data key="d7">1.0</data>
  <data key="d8">Having genetic syndromes like Xeroderma Pigmentosum significantly increases the risk of developing Squamous Cell Carcinoma.</data>
  <data key="d9">hereditary risk,predisposition</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250400</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Xeroderma Pigmentosum">
  <data key="d7">1.0</data>
  <data key="d8">Xeroderma Pigmentosum prevents DNA repair from sun damage, leading to skin cells becoming cancerous.</data>
  <data key="d9">DNA repair deficiency,causation</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250401</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Recessive Dystrophic Epidermolysis Bullosa">
  <data key="d7">1.0</data>
  <data key="d8">The fragile skin and chronic blistering caused by RDEB create a high-risk environment for developing Squamous Cell Carcinoma.</data>
  <data key="d9">complication,skin fragility</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250403</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Weakened Immune System">
  <data key="d7">1.0</data>
  <data key="d8">A weakened immune system, from conditions like HIV or immunosuppressant drugs, increases the risk of developing Squamous Cell Carcinoma.</data>
  <data key="d9">immunodeficiency,risk factor</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250405</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Skin Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A skin biopsy is the definitive procedure to remove and test a skin lesion to confirm a diagnosis of Squamous Cell Carcinoma.</data>
  <data key="d9">confirmation,diagnostic procedure</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250406</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Scars">
  <data key="d7">1.0</data>
  <data key="d8">Squamous Cell Carcinoma can form within scars, making the cancer more difficult to treat.</data>
  <data key="d9">complication,site of development</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250409</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Chronic Wounds">
  <data key="d7">1.0</data>
  <data key="d8">Squamous Cell Carcinoma can develop in chronic, nonhealing wounds like ulcers and burns, a condition known as Marjolins ulcer.</data>
  <data key="d9">complication,site of development</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250411</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Mouth Cancer">
  <data key="d7">3.0</data>
  <data key="d8">Squamous Cell Carcinoma is the most common type of mouth cancer, originating in the squamous cells of the mouth's lining.&lt;SEP&gt;Squamous cell carcinoma is described as the most common type of mouth cancer.&lt;SEP&gt;Mouth cancer staging information is specifically used for squamous cell carcinoma (SCC) of the mouth.</data>
  <data key="d9">classification,common type,disease type,pathology,specific classification,type</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250425</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Oral Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">Squamous Cell Carcinoma starts in the squamous cells that form the surface epithelium of the oral mucosa.</data>
  <data key="d9">cell type,origin</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250429</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="NCCN Guidelines For Patients">
  <data key="d7">1.0</data>
  <data key="d8">Information for the treatment of cutaneous squamous cell carcinoma, a related condition, can be found in the NCCN Guidelines for Patients.</data>
  <data key="d9">resource,treatment information</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250432</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma" target="Epithelium">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma starts in the squamous cells of the epithelial layer that lines the inside of the mouth.</data>
  <data key="d9">cell origin,tissue layer</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250460</data>
  <data key="d13"></data>
</edge>
<edge source="Early And Locally Advanced NSCLC" target="Stage 1 Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Stage 1 cancer is classified as early NSCLC.</data>
  <data key="d9">disease classification,staging</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250268</data>
  <data key="d13"></data>
</edge>
<edge source="Early And Locally Advanced NSCLC" target="Stage 2 Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Stage 2 cancer is considered locally advanced NSCLC.</data>
  <data key="d9">disease classification,staging</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250271</data>
  <data key="d13"></data>
</edge>
<edge source="Early And Locally Advanced NSCLC" target="Stage 3 Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Stage 3 cancer is considered locally advanced NSCLC.</data>
  <data key="d9">disease classification,staging</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250274</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Stage" target="Metastatic Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Stage 4 cancer is metastatic cancer at the time of diagnosis.</data>
  <data key="d9">classification,disease progression</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250271</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Stage" target="Treatment Plan">
  <data key="d7">1.0</data>
  <data key="d8">The cancer stage is a key factor upon which the treatment plan is based.</data>
  <data key="d9">foundation,planning basis</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250632</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 1 Cancer" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">Some stage 1 cancers have spread to nearby lymph nodes.</data>
  <data key="d9">anatomical involvement,disease spread</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250277</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 2 Cancer" target="Lymph Nodes">
  <data key="d7">1.0</data>
  <data key="d8">Some stage 2 cancers have spread to nearby lymph nodes.</data>
  <data key="d9">anatomical involvement,disease spread</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250280</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Stage 3 Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Some stage 3 cancers have spread to nearby lymph nodes.</data>
  <data key="d9">anatomical involvement,disease spread</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250283</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Esophageal Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal cancer can spread to nearby lymph nodes as part of its progression.</data>
  <data key="d9">disease spread,metastasis</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250326</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Regional CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Regional CSCC is defined as squamous cell carcinoma that has spread to nearby lymph nodes.</data>
  <data key="d9">anatomical site,disease spread</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250371</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Physical Exam">
  <data key="d7">1.0</data>
  <data key="d8">A physical exam includes feeling for enlarged lymph nodes in the neck, underarm, and groin.</data>
  <data key="d9">medical examination,palpation</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250393</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Throat Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Cancer cells from throat cancer often spread to lymph nodes in the neck.</data>
  <data key="d9">disease metastasis,spreads to</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Surgical Staging">
  <data key="d7">1.0</data>
  <data key="d8">Lymph nodes are sampled or removed during surgical staging to check for cancer spread.</data>
  <data key="d9">metastasis detection,tissue sampling</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250667</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Needle Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A needle biopsy is used to take a sample from lymph nodes to test if cancer, such as CSCC, has spread to them.</data>
  <data key="d9">cancer detection,diagnostic sampling</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250761</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Lymphatic Fluid">
  <data key="d7">1.0</data>
  <data key="d8">Lymph nodes filter substances that travel through the lymphatic fluid as part of the body's immune system.</data>
  <data key="d9">filtration,immune function</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250766</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Lymph nodes contain lymphocytes, which are white blood cells that help the body fight infection and disease.</data>
  <data key="d9">component,immune defense</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250767</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Lymphatic System">
  <data key="d7">1.0</data>
  <data key="d8">Lymph Nodes are key components of the Lymphatic System that filter lymph fluid.</data>
  <data key="d9">filtration function,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250784</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Lymph">
  <data key="d7">1.0</data>
  <data key="d8">Lymph passes through Lymph Nodes, which filter out foreign particles and harmful cells from the fluid.</data>
  <data key="d9">filtration,fluid processing</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250794</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph Nodes" target="Mouth Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Most tumors, including mouth cancer, can spread to nearby lymph nodes in the head and neck.</data>
  <data key="d9">progression,spread</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250831</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Esophageal Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic cancer is an advanced stage where esophageal cancer has spread to distant body parts.</data>
  <data key="d9">disease progression,spread</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250322</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Liver">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic esophageal cancer commonly spreads to the liver.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250329</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Pancreas">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal cancer can spread to the pancreas.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250330</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Lung">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic esophageal cancer commonly spreads to the lung.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250332</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Spleen">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal cancer can spread to the spleen.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250334</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Bone">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic esophageal cancer can spread to bone.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250336</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Brain">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic esophageal cancer can spread to the brain.</data>
  <data key="d9">disease spread,metastasis site</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250338</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic cancer is a specific, advanced form of cancer that has spread from its original location.</data>
  <data key="d9">classification,disease progression</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250455</data>
  <data key="d13"></data>
</edge>
<edge source="Metastatic Cancer" target="Distant Metastasis">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic cancer involves the spread of cancer to distant parts of the body, which constitutes distant metastasis.</data>
  <data key="d9">advanced disease,disease spread</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250464</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment For NSCLC" target="Radiation Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Radiation therapy is a treatment option for early cancers if surgery is not possible.</data>
  <data key="d9">alternative treatment,therapeutic option</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250274</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment For NSCLC" target="Chemoradiation">
  <data key="d7">1.0</data>
  <data key="d8">Chemoradiation is a treatment option discussed for certain cancers.</data>
  <data key="d9">combination treatment,therapeutic option</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250277</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trials" target="Treatment Plan">
  <data key="d7">1.0</data>
  <data key="d8">Clinical trials are an option that may be included in an ovarian cancer treatment plan, studying investigational treatments.</data>
  <data key="d9">research,treatment options</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250342</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trials" target="Biomarker Testing">
  <data key="d7">1.0</data>
  <data key="d8">The results of biomarker testing can be used to determine if a patient is eligible to join certain clinical trials.</data>
  <data key="d9">eligibility determination,research participation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Nodules" target="Pulmonologist">
  <data key="d7">1.0</data>
  <data key="d8">A pulmonologist is part of the expert team that evaluates lung nodules.</data>
  <data key="d9">expert diagnosis,medical evaluation</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250274</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Nodules" target="Thoracic Radiologist">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic radiologist uses imaging to help decide if a lung nodule is cancer.</data>
  <data key="d9">expert diagnosis,medical imaging</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250277</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Nodules" target="Thoracic Surgeon">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic surgeon is part of the expert team involved in operations for lung nodules.</data>
  <data key="d9">expert diagnosis,surgical intervention</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250279</data>
  <data key="d13"></data>
</edge>
<edge source="Pulmonologist" target="Lung Diseases">
  <data key="d7">1.0</data>
  <data key="d8">A pulmonologist is a doctor who specializes in and is an expert in lung diseases.</data>
  <data key="d9">diagnosis,medical expertise</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250406</data>
  <data key="d13"></data>
</edge>
<edge source="Pulmonologist" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A pulmonologist is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250879</data>
  <data key="d13"></data>
</edge>
<edge source="Thoracic Radiologist" target="Imaging">
  <data key="d7">2.0</data>
  <data key="d8">A thoracic radiologist is an expert in imaging of the chest.&lt;SEP&gt;A thoracic radiologist is a doctor who specializes in imaging of the chest to diagnose conditions.</data>
  <data key="d9">diagnostic method,diagnostic procedure,expertise,medical imaging</data>
  <data key="d10">chunk-bd06bc83e13e7562ce65d6eee1b6024f&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250280</data>
  <data key="d13"></data>
</edge>
<edge source="Thoracic Radiologist" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic radiologist is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250877</data>
  <data key="d13"></data>
</edge>
<edge source="Thoracic Surgeon" target="Operations">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic surgeon is a doctor who specializes in performing operations within the chest.</data>
  <data key="d9">chest procedures,surgical expertise</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250408</data>
  <data key="d13"></data>
</edge>
<edge source="Thoracic Surgeon" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A thoracic surgeon is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250880</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN.org/patientguidelines" target="Lung Cancer Screening">
  <data key="d7">1.0</data>
  <data key="d8">Information on lung cancer screening is available at the NCCN.org/patientguidelines website.</data>
  <data key="d9">information resource,patient education</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250413</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN.org/patientguidelines" target="Immune-Related Adverse Events">
  <data key="d7">1.0</data>
  <data key="d8">Information on immune-related adverse events is available at NCCN.org/patientguidelines.</data>
  <data key="d9">information resource,side effect management</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250579</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN.org/patientguidelines" target="Lung Neuroendocrine Tumors">
  <data key="d7">1.0</data>
  <data key="d8">Information on lung neuroendocrine tumors can be found at the website NCCN.org/patientguidelines.</data>
  <data key="d9">information resource,online reference</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250731</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN.org/patientguidelines" target="NCCN Patient Guides For Cancer App">
  <data key="d7">1.0</data>
  <data key="d8">Both NCCN.org/patientguidelines and the NCCN Patient Guides for Cancer app provide information on Hodgkin lymphoma for children and adolescents.</data>
  <data key="d9">digital resources,information access</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250794</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging" target="Adrenal Tumors">
  <data key="d7">1.0</data>
  <data key="d8">Adrenal tumors are often found incidentally through imaging tests like CT or MRI scans performed for other reasons.</data>
  <data key="d9">diagnostic method,incidental finding</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250520</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">The doctor orders imaging tests as needed to monitor how well the chemotherapy is working.</data>
  <data key="d9">diagnostic tool,treatment monitoring</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250707</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Radiation Oncologist">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy treatments should be given by a practicing Radiation Oncologist.</data>
  <data key="d9">medical expertise,treatment administration</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250283</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="External Beam Radiation Therapy">
  <data key="d7">1.0</data>
  <data key="d8">External Beam Radiation Therapy is one of the two general types of Radiation Therapy used to treat cutaneous squamous cell carcinoma.</data>
  <data key="d9">cancer therapy,treatment modality</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250284</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Brachytherapy">
  <data key="d7">1.0</data>
  <data key="d8">Brachytherapy is one of the two general types of Radiation Therapy used to treat cutaneous squamous cell carcinoma.</data>
  <data key="d9">cancer therapy,treatment modality</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250286</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Adjuvant Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Radiation is sometimes used as an Adjuvant Therapy after surgery to kill remaining cancer cells or prevent recurrence.</data>
  <data key="d9">post-operative care,recurrence prevention</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250289</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Basal Cell Nevus Syndrome">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy should not be used in people with Basal Cell Nevus Syndrome due to a higher risk of radiation-induced skin cancer.</data>
  <data key="d9">contraindication,risk factor</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250291</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Xeroderma Pigmentosum">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy should not be used in people with Xeroderma Pigmentosum due to a higher risk of radiation-induced skin cancer.</data>
  <data key="d9">contraindication,risk factor</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250294</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Lupus">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy may not be appropriate for some people who have Lupus.</data>
  <data key="d9">contraindication,medical condition</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250295</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Scleroderma">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy may not be appropriate for some people who have Scleroderma.</data>
  <data key="d9">contraindication,medical condition</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250297</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Protons">
  <data key="d7">1.0</data>
  <data key="d8">Radiation Therapy can use beams of Protons (charged particles) as a source of intense energy to kill cancer cells.</data>
  <data key="d9">energy source,treatment modality</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250299</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Skin Redness">
  <data key="d7">1.0</data>
  <data key="d8">Skin Redness is a common short-term side effect of Radiation Therapy.</data>
  <data key="d9">patient symptom,side effect</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250301</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Non-Healing Ulcer">
  <data key="d7">1.0</data>
  <data key="d8">Non-Healing Ulcer is a potential serious long-term side effect of Radiation Therapy.</data>
  <data key="d9">medical complication,side effect</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250303</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Second Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A patient treated with Radiation Therapy could develop a Second Cancer in the treated area, though this is rare.</data>
  <data key="d9">long-term risk,treatment complication</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250306</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Systemic Therapy">
  <data key="d7">4.0</data>
  <data key="d8">Systemic therapy may be given in addition to radiation therapy for CSCC treatment.&lt;SEP&gt;Systemic therapy is used in addition to radiation therapy for squamous cell skin cancer when surgery cannot remove all the cancer.&lt;SEP&gt;Systemic therapy is sometimes used in addition to radiation therapy after surgery for regional CSCC.&lt;SEP&gt;Systemic therapy is sometimes used in addition to radiation therapy after surgery, especially in high-risk scenarios.</data>
  <data key="d9">adjuvant therapy,combination therapy,combination treatment,risk management</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250357</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Stereotactic Body Radiotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Stereotactic body radiotherapy is a special radiation technique that may be used in some cases.</data>
  <data key="d9">specialized treatment,technical application</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250360</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Distant Tumors">
  <data key="d7">1.0</data>
  <data key="d8">Radiation therapy may be used to treat distant tumors that are causing pain or other bothersome side effects.</data>
  <data key="d9">palliative care,symptom management</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250362</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Endocrine Tests">
  <data key="d7">1.0</data>
  <data key="d8">Endocrine tests are performed because radiation therapy to the head and neck can affect endocrine glands.</data>
  <data key="d9">side effect management,treatment monitoring</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250394</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Systemic Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Systemic therapy may be used in combination with radiation therapy to treat CSCC.</data>
  <data key="d9">combination treatment,therapeutic approach</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250570</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Therapy" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Radiation therapy can be used to treat basal cell skin cancer, but past radiation treatment for other conditions is also a risk factor for developing it.</data>
  <data key="d9">risk factor,treatment option</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250859</data>
  <data key="d13"></data>
</edge>
<edge source="Surgeon" target="Sentinel Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">The Surgeon injects a substance to locate and then identifies and removes the Sentinel Lymph Node(s).</data>
  <data key="d9">anatomical location,medical procedure</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250292</data>
  <data key="d13"></data>
</edge>
<edge source="Secondary Intention Healing" target="Wound">
  <data key="d7">1.0</data>
  <data key="d8">Secondary Intention Healing is a process where a Wound is left open to heal by itself.</data>
  <data key="d9">healing process,medical outcome</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250292</data>
  <data key="d13"></data>
</edge>
<edge source="Linear Closure" target="Wound">
  <data key="d7">1.0</data>
  <data key="d8">Linear Closure is a technique where a surgeon reshapes a Wound to stitch it together in a line.</data>
  <data key="d9">surgical technique,wound repair</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250294</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Graft" target="Wound">
  <data key="d7">1.0</data>
  <data key="d8">A Skin Graft may be needed for a Wound to heal well and lessen scarring.</data>
  <data key="d9">healing aid,surgical repair</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250296</data>
  <data key="d13"></data>
</edge>
<edge source="Radiation Oncologist" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A radiation oncologist is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250884</data>
  <data key="d13"></data>
</edge>
<edge source="External Beam Radiation Therapy" target="Electrons">
  <data key="d7">1.0</data>
  <data key="d8">Electrons are one of the two most common types of beams used in External Beam Radiation Therapy for superficial tumors.</data>
  <data key="d9">energy source,treatment modality</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250294</data>
  <data key="d13"></data>
</edge>
<edge source="External Beam Radiation Therapy" target="Photons">
  <data key="d7">1.0</data>
  <data key="d8">Photons are one of the two most common types of beams used in External Beam Radiation Therapy for deeper tumors.</data>
  <data key="d9">energy source,treatment modality</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250296</data>
  <data key="d13"></data>
</edge>
<edge source="Adjuvant Therapy" target="Recurrence">
  <data key="d7">1.0</data>
  <data key="d8">Adjuvant Therapy is given after primary treatment to lower the risk that cancer will come back (Recurrence).</data>
  <data key="d9">risk reduction,treatment goal</data>
  <data key="d10">chunk-e9cc65c1c26b9e24bfb2c8c966f734a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250295</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Patient Guides For Cancer App" target="NCCN">
  <data key="d7">3.0</data>
  <data key="d8">NCCN provides its patient guidelines, including those for NSCLC, through the NCCN Patient Guides for Cancer app.&lt;SEP&gt;The NCCN makes its patient guidelines available through a dedicated mobile application.&lt;SEP&gt;NCCN provides its patient guidelines through the NCCN Patient Guides for Cancer app.</data>
  <data key="d9">digital distribution,publication,resource access,resource provision</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250374</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Patient Guides For Cancer App" target="Lung Cancer Screening">
  <data key="d7">1.0</data>
  <data key="d8">Information on lung cancer screening is available on the NCCN Patient Guides for Cancer mobile app.</data>
  <data key="d9">digital resource,patient support</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250415</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Patient Guides For Cancer App" target="NCCN Guidelines For Patients: Adolescent And Young Adult Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Information from the NCCN Guidelines for Patients is also available on the NCCN Patient Guides for Cancer app.</data>
  <data key="d9">digital access,information resource</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250687</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Patient Guides For Cancer App" target="National Comprehensive Cancer Network">
  <data key="d7">1.0</data>
  <data key="d8">Information on Hodgkin Lymphoma is available through the NCCN Patient Guides for Cancer app provided by the National Comprehensive Cancer Network.</data>
  <data key="d9">digital resource,publication</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250774</data>
  <data key="d13"></data>
</edge>
<edge source="Recurrence" target="Biomarkers">
  <data key="d7">1.0</data>
  <data key="d8">The presence of specific biomarkers helps guide treatment decisions for recurrent ovarian cancer.</data>
  <data key="d9">testing,treatment guidance</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250848</data>
  <data key="d13"></data>
</edge>
<edge source="Recurrence" target="Clinical Trial">
  <data key="d7">1.0</data>
  <data key="d8">Individuals with recurrent ovarian cancer are encouraged to consider enrolling in a clinical trial for treatment.</data>
  <data key="d9">research,treatment consideration</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250855</data>
  <data key="d13"></data>
</edge>
<edge source="Recurrence" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Recurrence is a potential outcome where basal cell skin cancer returns to its original site or spreads to other parts of the body.</data>
  <data key="d9">disease progression,outcome</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250860</data>
  <data key="d13"></data>
</edge>
<edge source="FDG-PET Scan" target="Adrenal Tumor">
  <data key="d7">1.0</data>
  <data key="d8">FDG-PET scans are used to evaluate adrenal tumors, though many such tumors are not very bright on this scan.</data>
  <data key="d9">imaging technique,tumor evaluation</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250298</data>
  <data key="d13"></data>
</edge>
<edge source="FDG-PET Scan" target="Neuroendocrine Tumor">
  <data key="d7">1.0</data>
  <data key="d8">FDG-PET scans help determine if neuroendocrine tumors are becoming more aggressive.</data>
  <data key="d9">aggressiveness assessment,diagnostic tool</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250300</data>
  <data key="d13"></data>
</edge>
<edge source="FDG-PET Scan" target="18-Fluorodeoxyglucose">
  <data key="d7">1.0</data>
  <data key="d8">An FDG-PET scan uses 18-fluorodeoxyglucose as its radioactive tracer to identify active cancer cells.</data>
  <data key="d9">diagnostic tracer,imaging component</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250309</data>
  <data key="d13"></data>
</edge>
<edge source="FDG-PET Scan" target="Adrenal Tumors">
  <data key="d7">1.0</data>
  <data key="d8">FDG-PET scans are noted as being helpful for patients with adrenal tumors.</data>
  <data key="d9">diagnostic application,disease management</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="SSTR-PET Scan" target="Somatostatin Receptor">
  <data key="d7">1.0</data>
  <data key="d8">SSTR-PET scans use a tracer that specifically binds to somatostatin receptors on cells.</data>
  <data key="d9">imaging method,molecular targeting</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250299</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Tumor" target="Biochemical Tests">
  <data key="d7">1.0</data>
  <data key="d8">Biochemical tests measure hormones in bodily fluids to help diagnose adrenal tumors or related syndromes.</data>
  <data key="d9">diagnostic testing,hormone measurement</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250302</data>
  <data key="d13"></data>
</edge>
<edge source="Somatostatin Receptor" target="Somatostatin">
  <data key="d7">1.0</data>
  <data key="d8">Somatostatin receptors are proteins on cell surfaces that bind to the hormone somatostatin.</data>
  <data key="d9">hormone binding,molecular interaction</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250310</data>
  <data key="d13"></data>
</edge>
<edge source="Biochemical Tests" target="Guide 1 Biochemical Tests">
  <data key="d7">1.0</data>
  <data key="d8">More information on biochemical tests can be found in a reference document called Guide 1 Biochemical Tests.</data>
  <data key="d9">diagnostic guidance,information reference</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250311</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Cancer Doctors">
  <data key="d7">1.0</data>
  <data key="d8">A discussion between cancer doctors is recommended to consider systemic therapy as a treatment option.</data>
  <data key="d9">clinical consultation,treatment planning</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250349</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Metastatic Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic squamous cell skin cancer that cannot be removed surgically is treated with systemic therapy.</data>
  <data key="d9">disease management,primary treatment</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250354</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Clinical Trial">
  <data key="d7">1.0</data>
  <data key="d8">Enrolling in a clinical trial is an option for systemic therapy.</data>
  <data key="d9">experimental treatment,research option</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250363</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Extracapsular Extension">
  <data key="d7">1.0</data>
  <data key="d8">Systemic therapy may be used after surgery if cancer was found to have extracapsular extension in removed lymph nodes.</data>
  <data key="d9">pathological finding,treatment indication</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250366</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Immunotherapy">
  <data key="d7">3.0</data>
  <data key="d8">Immunotherapy with an immune checkpoint inhibitor is a preferred type of systemic therapy used alone for squamous cell skin cancer.&lt;SEP&gt;Immunotherapy is a type of systemic therapy used for CSCC.&lt;SEP&gt;Immunotherapy is a type of systemic therapy used in cancer treatment.</data>
  <data key="d9">drug class,inclusion,therapeutic option,treatment type</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250552</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Targeted Therapy">
  <data key="d7">2.0</data>
  <data key="d8">Targeted therapy is a type of systemic therapy used for CSCC.&lt;SEP&gt;Targeted therapy is a type of systemic therapy used in cancer treatment.</data>
  <data key="d9">inclusion,therapeutic option,treatment type</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38&lt;SEP&gt;chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250602</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Catheter">
  <data key="d7">1.0</data>
  <data key="d8">A catheter is used to deliver systemic therapy into the body during AML treatment.</data>
  <data key="d9">medical device,treatment delivery</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250737</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Oncology Nurse">
  <data key="d7">1.0</data>
  <data key="d8">An oncology nurse provides hands-on care, including the administration of systemic therapy to patients.</data>
  <data key="d9">administration,care</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250760</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapy" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Systemic therapy is one of the methods that might be used to treat basal cell skin cancer.</data>
  <data key="d9">treatment option</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250860</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Squamous Cells">
  <data key="d7">2.0</data>
  <data key="d8">The epidermis contains squamous cells in its upper part.&lt;SEP&gt;Squamous cells are a main type of cell found in the epidermis, the outermost layer of the skin.</data>
  <data key="d9">cellular composition,cellular layer,composition,skin structure</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250302</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Basal Cells">
  <data key="d7">2.0</data>
  <data key="d8">The epidermis contains basal cells in its lower part, which are responsible for forming new skin cells.&lt;SEP&gt;Basal cells are located in the lower part of the epidermis and divide to form new skin cells.</data>
  <data key="d9">cell regeneration,cellular layer,composition,skin layer function</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250305</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Dermis">
  <data key="d7">1.0</data>
  <data key="d8">The epidermis is the outermost layer of skin, and the dermis is the middle layer beneath it.</data>
  <data key="d9">skin anatomy,structural layers</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250307</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer originates from abnormal basal cells located in the epidermis, the top layer of the skin.</data>
  <data key="d9">location,origin</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250855</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Melanocytes">
  <data key="d7">1.0</data>
  <data key="d8">The epidermis contains melanocytes in its lower part, which produce melanin.</data>
  <data key="d9">cellular layer,composition</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250857</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermis" target="Skin">
  <data key="d7">1.0</data>
  <data key="d8">The skin is composed of layers, with the epidermis being its top layer.</data>
  <data key="d9">composition,layer</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250861</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cells" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer occurs when basal cells in the epidermis become abnormal and grow out of control.</data>
  <data key="d9">abnormality,cellular origin</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250857</data>
  <data key="d13"></data>
</edge>
<edge source="Melanocytes" target="Ultraviolet Rays">
  <data key="d7">1.0</data>
  <data key="d8">Melanocytes produce melanin, which protects the skin from the harmful effects of ultraviolet rays.</data>
  <data key="d9">pigment function,skin protection</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250303</data>
  <data key="d13"></data>
</edge>
<edge source="Melanocytes" target="Melanin">
  <data key="d7">2.0</data>
  <data key="d8">Melanocytes are the cells that produce melanin, the pigment responsible for skin, hair, and eye color and UV protection.&lt;SEP&gt;Melanocytes are the cells that produce the pigment melanin.</data>
  <data key="d9">cellular function,function,pigment production,production</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb&lt;SEP&gt;chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250307</data>
  <data key="d13"></data>
</edge>
<edge source="Environmental Toxins" target="Arsenic">
  <data key="d7">1.0</data>
  <data key="d8">Arsenic is one of the specific environmental toxins, found in soil, water, and air, that contributes to skin damage.</data>
  <data key="d9">component,pollutant</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250403</data>
  <data key="d13"></data>
</edge>
<edge source="Dermis" target="Hypodermis">
  <data key="d7">1.0</data>
  <data key="d8">The dermis is the middle layer of skin, and the hypodermis is the deepest layer beneath it.</data>
  <data key="d9">skin anatomy,structural layers</data>
  <data key="d10">chunk-f1379433bc205cdec8af2edc77613acb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250309</data>
  <data key="d13"></data>
</edge>
<edge source="Dermis" target="Skin">
  <data key="d7">1.0</data>
  <data key="d8">The skin is composed of layers, with the dermis being its middle layer.</data>
  <data key="d9">composition,layer</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250862</data>
  <data key="d13"></data>
</edge>
<edge source="Hypodermis" target="Skin">
  <data key="d7">1.0</data>
  <data key="d8">The skin is composed of layers, with the hypodermis being its deepest layer.</data>
  <data key="d9">composition,layer</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250863</data>
  <data key="d13"></data>
</edge>
<edge source="Melanin" target="Fair Skin">
  <data key="d7">1.0</data>
  <data key="d8">Fair skin has less melanin, which reduces protection against UV rays and increases skin cancer risk.</data>
  <data key="d9">pigmentation,risk factor</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250864</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Tunica Adventitia">
  <data key="d7">2.0</data>
  <data key="d8">The tunica adventitia is the outermost connective tissue layer that forms part of the esophagus wall.&lt;SEP&gt;The tunica adventitia is the outermost connective tissue layer of the esophagus wall.</data>
  <data key="d9">anatomical layer,anatomical structure,tissue layer,wall structure</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250312</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Striated Muscle">
  <data key="d7">2.0</data>
  <data key="d8">The upper part of the esophagus is composed of striated muscle, which is under voluntary control.&lt;SEP&gt;The upper part of the esophagus is made of striated (voluntary) muscle.</data>
  <data key="d9">anatomical composition,anatomical region,muscle type,tissue composition</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250313</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Smooth Muscle">
  <data key="d7">2.0</data>
  <data key="d8">The lower part of the esophagus is composed of smooth muscle, which is involuntary.&lt;SEP&gt;The lower part of the esophagus consists of smooth (involuntary) muscle.</data>
  <data key="d9">anatomical composition,anatomical region,muscle type,tissue composition</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250315</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Esophagogastric Junction">
  <data key="d7">1.0</data>
  <data key="d8">The esophagus connects to the stomach at the esophagogastric junction.</data>
  <data key="d9">anatomical connection,junction</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250317</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Mucosa">
  <data key="d7">2.0</data>
  <data key="d8">The mucosa is the innermost layer of the esophagus wall where cells line the inside.&lt;SEP&gt;The mucosa is one of the four layers that make up the wall of the esophagus.</data>
  <data key="d9">anatomical layer,anatomical structure,tissue layer,wall structure</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250318</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Submucosa">
  <data key="d7">2.0</data>
  <data key="d8">The submucosa is a layer of the esophagus wall located beneath the mucosa.&lt;SEP&gt;The submucosa is a layer of connective tissue just below the mucosa in the esophagus wall.</data>
  <data key="d9">anatomical layer,anatomical structure,tissue layer,wall structure</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250320</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Muscularis Propria">
  <data key="d7">2.0</data>
  <data key="d8">The muscularis propria is a muscle layer within the wall of the esophagus.&lt;SEP&gt;The muscularis propria is a thick muscle layer under the submucosa in the esophagus wall.</data>
  <data key="d9">anatomical layer,anatomical structure,tissue layer,wall structure</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab&lt;SEP&gt;chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250322</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Esophageal Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal cancer starts in the inner lining of the esophagus.</data>
  <data key="d9">anatomical location,disease origin</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250878</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Digestive System">
  <data key="d7">1.0</data>
  <data key="d8">The esophagus is a part of the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250879</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Peristalsis">
  <data key="d7">1.0</data>
  <data key="d8">Peristalsis is the process that moves food down the esophagus during swallowing.</data>
  <data key="d9">movement mechanism,physiological function</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250880</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Sphincters">
  <data key="d7">1.0</data>
  <data key="d8">The esophagus contains two sphincters, circular muscles that control passage.</data>
  <data key="d9">anatomical component,muscle structure</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250881</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Spine">
  <data key="d7">1.0</data>
  <data key="d8">The esophagus is located in front of the spine.</data>
  <data key="d9">anatomical position,spatial relation</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250884</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagus" target="Stomach">
  <data key="d7">1.0</data>
  <data key="d8">The esophagus transports food and drink into the stomach.</data>
  <data key="d9">anatomical connection,function</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250886</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagogastric Junction" target="Gastroesophageal Junction">
  <data key="d7">1.0</data>
  <data key="d8">The esophagogastric junction is also called the gastroesophageal junction.</data>
  <data key="d9">anatomical terminology,synonym</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250323</data>
  <data key="d13"></data>
</edge>
<edge source="Esophagogastric Junction" target="Diaphragm">
  <data key="d7">1.0</data>
  <data key="d8">The esophagogastric junction is located just beneath the diaphragm.</data>
  <data key="d9">anatomical location,proximity</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250324</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Esophageal Squamous Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal squamous cell carcinoma is one of the two main types of esophageal cancer.</data>
  <data key="d9">cancer type,disease classification</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250315</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Esophageal Adenocarcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal adenocarcinoma is one of the two main types of esophageal cancer, common in Western regions.</data>
  <data key="d9">cancer type,disease classification</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250317</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Barrett Esophagus">
  <data key="d7">1.0</data>
  <data key="d8">Barrett esophagus is a condition that increases the risk of developing esophageal adenocarcinoma.</data>
  <data key="d9">disease risk factor,precancerous condition</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250318</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">Esophageal cancer typically starts in the mucosa, the innermost lining of the esophagus.</data>
  <data key="d9">disease origin,tissue layer</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250320</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Early-Stage Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Early-stage cancer is a category where esophageal cancer is confined to the inner esophagus.</data>
  <data key="d9">disease staging,progression</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250323</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Locoregional Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Locoregional cancer is a category where esophageal cancer has invaded the esophageal wall or spread locally.</data>
  <data key="d9">disease staging,progression</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250324</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Siewert Types">
  <data key="d7">1.0</data>
  <data key="d8">Siewert types are used in the staging of esophageal cancer to describe tumor location.</data>
  <data key="d9">disease classification,staging system</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250328</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Endoscopy">
  <data key="d7">1.0</data>
  <data key="d8">Endoscopy is a key diagnostic procedure used to detect and evaluate esophageal cancer.</data>
  <data key="d9">diagnostic procedure,examination</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250330</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Cancer" target="Biomarker Testing">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing is used to identify specific markers associated with esophageal cancer for treatment planning.</data>
  <data key="d9">diagnostic analysis,molecular profiling</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250333</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Squamous Cell Carcinoma" target="Eastern Europe">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma is a more common type of esophageal cancer in Eastern Europe.</data>
  <data key="d9">disease epidemiology,regional prevalence</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250327</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Squamous Cell Carcinoma" target="Asia">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma is a more common type of esophageal cancer in Asia.</data>
  <data key="d9">disease epidemiology,regional prevalence</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250329</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Squamous Cell Carcinoma" target="Africa">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma is a more common type of esophageal cancer in Africa.</data>
  <data key="d9">disease epidemiology,regional prevalence</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250330</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Adenocarcinoma" target="Barrett Esophagus">
  <data key="d7">1.0</data>
  <data key="d8">Individuals with Barrett esophagus are at an increased risk of developing esophageal adenocarcinoma.</data>
  <data key="d9">disease development,risk factor</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250320</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Adenocarcinoma" target="North America">
  <data key="d7">1.0</data>
  <data key="d8">Adenocarcinoma is the most common type of esophageal cancer in North America.</data>
  <data key="d9">disease epidemiology,regional prevalence</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250325</data>
  <data key="d13"></data>
</edge>
<edge source="Esophageal Adenocarcinoma" target="Western Europe">
  <data key="d7">1.0</data>
  <data key="d8">Adenocarcinoma is the most common type of esophageal cancer in Western Europe.</data>
  <data key="d9">disease epidemiology,regional prevalence</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250327</data>
  <data key="d13"></data>
</edge>
<edge source="Mucosa" target="Epithelium">
  <data key="d7">1.0</data>
  <data key="d8">The epithelium is the innermost part of the mucosa layer.</data>
  <data key="d9">anatomical sublayer,tissue composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250880</data>
  <data key="d13"></data>
</edge>
<edge source="Mucosa" target="Lamina Propria">
  <data key="d7">1.0</data>
  <data key="d8">The lamina propria is a connective tissue layer under the epithelium in the mucosa.</data>
  <data key="d9">anatomical sublayer,tissue composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250881</data>
  <data key="d13"></data>
</edge>
<edge source="Mucosa" target="Muscularis Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">The muscularis mucosa is a thin muscle layer under the lamina propria in the mucosa.</data>
  <data key="d9">anatomical sublayer,tissue composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250884</data>
  <data key="d13"></data>
</edge>
<edge source="Liver" target="Bile Ducts">
  <data key="d7">1.0</data>
  <data key="d8">Abnormal chemical levels made or processed by the liver can signal that the bile ducts might be blocked.</data>
  <data key="d9">blockage indicator,organ function</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250678</data>
  <data key="d13"></data>
</edge>
<edge source="Liver" target="Coagulation Factors">
  <data key="d7">1.0</data>
  <data key="d8">Coagulation factors, proteins needed for blood clotting, are made by the liver.</data>
  <data key="d9">organ function,protein synthesis</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250681</data>
  <data key="d13"></data>
</edge>
<edge source="Liver" target="Digestive System">
  <data key="d7">1.0</data>
  <data key="d8">The liver is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250886</data>
  <data key="d13"></data>
</edge>
<edge source="Pancreas" target="Digestive System">
  <data key="d7">1.0</data>
  <data key="d8">The pancreas is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250886</data>
  <data key="d13"></data>
</edge>
<edge source="Lung" target="Metastasis">
  <data key="d7">1.0</data>
  <data key="d8">Metastasis is the spread of cancer to an area such as the lung.</data>
  <data key="d9">disease progression,spread site</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250501</data>
  <data key="d13"></data>
</edge>
<edge source="Spleen" target="Lymphatic System">
  <data key="d7">1.0</data>
  <data key="d8">The Spleen is the largest organ within the Lymphatic System, involved in lymphocyte production and blood filtration.</data>
  <data key="d9">immune function,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250786</data>
  <data key="d13"></data>
</edge>
<edge source="Metric System" target="Cancer Care Team">
  <data key="d7">1.0</data>
  <data key="d8">Healthcare teams use the metric system to measure treatment aspects in cancer care.</data>
  <data key="d9">measurement standard,medical practice</data>
  <data key="d10">chunk-cb36cedd3f66584d65304e58b668eeab</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250332</data>
  <data key="d13"></data>
</edge>
<edge source="Performance Status" target="Eastern Cooperative Oncology Group">
  <data key="d7">1.0</data>
  <data key="d8">The Eastern Cooperative Oncology Group (ECOG) provides the scale used to measure a patient's performance status.</data>
  <data key="d9">health assessment,rating system</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250391</data>
  <data key="d13"></data>
</edge>
<edge source="Performance Status" target="Eastern Cooperative Oncology Group Score">
  <data key="d7">1.0</data>
  <data key="d8">Performance status is rated using the Eastern Cooperative Oncology Group score.</data>
  <data key="d9">health assessment,rating scale</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250684</data>
  <data key="d13"></data>
</edge>
<edge source="Performance Status" target="Karnofsky Performance Status">
  <data key="d7">1.0</data>
  <data key="d8">Performance status is rated using the Karnofsky Performance Status scale.</data>
  <data key="d9">health assessment,rating scale</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250686</data>
  <data key="d13"></data>
</edge>
<edge source="Online Patient Portals" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Online patient portals are a method for patients to access their test results.</data>
  <data key="d9">access,information management</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250769</data>
  <data key="d13"></data>
</edge>
<edge source="Online Patient Portals" target="MyChart">
  <data key="d7">1.0</data>
  <data key="d8">MyChart is given as an example of an online patient portal that can help track appointments.</data>
  <data key="d9">digital tool,example</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250770</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Epithelium">
  <data key="d7">1.0</data>
  <data key="d8">The epithelium is the surface layer of tissue surrounding the ovaries, and most ovarian cancers are found in this layer.</data>
  <data key="d9">anatomical structure,cancer origin</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250332</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Fallopian Tube">
  <data key="d7">1.0</data>
  <data key="d8">Each ovary is surrounded by a fallopian tube, which catches eggs released by the ovary and transports them to the uterus.</data>
  <data key="d9">anatomical connection,reproductive function</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250334</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Uterus">
  <data key="d7">2.0</data>
  <data key="d8">The ovaries are part of the female reproductive system which includes the uterus.&lt;SEP&gt;Eggs released from the ovaries travel via the fallopian tubes to the uterus, where a fetus develops or menstruation occurs.</data>
  <data key="d9">anatomical connection,egg transport,reproductive system</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72&lt;SEP&gt;chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250336</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Female Reproductive System">
  <data key="d7">1.0</data>
  <data key="d8">The ovaries are a key part of the female reproductive system, which also includes the fallopian tubes, uterus, cervix, and vagina.</data>
  <data key="d9">organ function,system composition</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250338</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Symptoms">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer originating in the ovaries can cause symptoms like bloating, pelvic pain, and urinary urgency.</data>
  <data key="d9">disease manifestation,health impact</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250344</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Cervix">
  <data key="d7">1.0</data>
  <data key="d8">The ovaries are part of the female reproductive system which includes the cervix.</data>
  <data key="d9">anatomical connection,reproductive system</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250844</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Vagina">
  <data key="d7">1.0</data>
  <data key="d8">The ovaries are part of the female reproductive system which includes the vagina.</data>
  <data key="d9">anatomical connection,reproductive system</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250846</data>
  <data key="d13"></data>
</edge>
<edge source="Ovaries" target="Fallopian Tubes">
  <data key="d7">1.0</data>
  <data key="d8">The ovaries are connected to the fallopian tubes as part of the female reproductive system.</data>
  <data key="d9">anatomical connection,reproductive system</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250848</data>
  <data key="d13"></data>
</edge>
<edge source="Epithelium" target="High-Grade Serous Carcinoma (HGSC)">
  <data key="d7">1.0</data>
  <data key="d8">High-grade serous carcinoma is a common form of epithelial ovarian cancer that originates in the epithelium.</data>
  <data key="d9">cancer type,tissue origin</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250335</data>
  <data key="d13"></data>
</edge>
<edge source="Epithelium" target="High-Grade Endometrioid Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">High-grade endometrioid carcinoma is a common form of epithelial ovarian cancer that originates in the epithelium.</data>
  <data key="d9">cancer type,tissue origin</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250337</data>
  <data key="d13"></data>
</edge>
<edge source="Epithelium" target="Less Common Ovarian Cancers (LCOCs)">
  <data key="d7">1.0</data>
  <data key="d8">Less common ovarian cancers can start in the epithelium of the ovaries.</data>
  <data key="d9">cancer classification,origin site</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250340</data>
  <data key="d13"></data>
</edge>
<edge source="Epithelium" target="Oral Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">The oral mucosa is composed of layers, with the epithelium being its surface layer containing squamous cells.</data>
  <data key="d9">anatomical composition,layer</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250435</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Mutation">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing identifies the presence or absence of genetic mutations to help choose the best cancer treatment.</data>
  <data key="d9">genetic analysis,treatment guidance</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Molecular Testing">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing is sometimes called molecular testing, tumor profiling, sequencing, gene expression profiling, or genomic testing.</data>
  <data key="d9">diagnostic methods,synonymous terms</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250484</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Advanced Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker tests are generally used in advanced cancers.</data>
  <data key="d9">application context,disease stage</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250504</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Metastatic Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker tests are generally used in metastatic cancers.</data>
  <data key="d9">application context,disease stage</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250506</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="P16 (HPV) Testing">
  <data key="d7">1.0</data>
  <data key="d8">P16 (HPV) testing is a specific type of biomarker testing.</data>
  <data key="d9">category,specific test</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250584</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="BRCA Genes">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing involves analyzing the tumor for BRCA mutations to guide ovarian cancer treatment decisions.</data>
  <data key="d9">mutation analysis,treatment planning</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Microsatellite Instability">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for microsatellite instability, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Mismatch Repair">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for mismatch repair, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="HER2 Expression">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for HER2 expression, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Tumor Mutational Burden">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for tumor mutational burden, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="BRAF V600E Mutation">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for the BRAF V600E mutation, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Folate Receptor Alpha Expression">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for folate receptor alpha expression, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="RET Mutations">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for RET mutations, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="NTRK Gene Fusion">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing can include testing tumor tissue for NTRK gene fusion, often for recurrent ovarian cancer.</data>
  <data key="d9">recurrent cancer,tumor analysis</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Precision Oncology">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing is also known as precision oncology, among other names like molecular testing and tumor profiling.</data>
  <data key="d9">synonym,treatment approach</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Biomarker Testing" target="Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Biomarker testing is performed on cancer to look for genes or mutations that might suggest treatment.</data>
  <data key="d9">analysis,guidance</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250830</data>
  <data key="d13"></data>
</edge>
<edge source="Uterus" target="Ovarian Cancer Surgery">
  <data key="d7">1.0</data>
  <data key="d8">The uterus is removed during surgery for ovarian cancer as part of the standard procedure.</data>
  <data key="d9">surgical removal,treatment procedure</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250901</data>
  <data key="d13"></data>
</edge>
<edge source="Medical Oncologist" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A medical oncologist is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250881</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment Plan" target="Primary Care Provider">
  <data key="d7">1.0</data>
  <data key="d8">A patient's primary care provider can be involved in the cancer treatment plan to help manage other health conditions affected by treatment.</data>
  <data key="d9">care coordination,health management</data>
  <data key="d10">chunk-b4da30dee72e228147daa825e4f5be72</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250345</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment Plan" target="Imaging Studies">
  <data key="d7">2.0</data>
  <data key="d8">Results from imaging studies are used to determine a patient's treatment plan.&lt;SEP&gt;Results from imaging studies may help determine a treatment plan.</data>
  <data key="d9">diagnosis,information source,medical decision-making,planning basis</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250512</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment Plan" target="Diagnosis">
  <data key="d7">1.0</data>
  <data key="d8">The diagnosis of basal cell skin cancer determines the subsequent treatment plan for the patient.</data>
  <data key="d9">care planning,medical process</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250525</data>
  <data key="d13"></data>
</edge>
<edge source="Primary Care Provider" target="Assessment Team">
  <data key="d7">1.0</data>
  <data key="d8">A primary care provider may refer a patient to a specialist assessment team for cancer diagnosis.</data>
  <data key="d9">care coordination,referral</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250875</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer" target="Extracapsular Extension">
  <data key="d7">1.0</data>
  <data key="d8">Cancer found to have grown through the outer layer of a lymph node is called extracapsular extension, influencing treatment.</data>
  <data key="d9">disease progression,pathological finding</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250347</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer" target="Skin Exams">
  <data key="d7">1.0</data>
  <data key="d8">After finishing treatment, regular skin exams are very important to monitor for the return of squamous cell skin cancer.</data>
  <data key="d9">post-treatment monitoring,recurrence detection</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250354</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer" target="Metastasis">
  <data key="d7">1.0</data>
  <data key="d8">Cancer cells can spread through blood and lymph in a process called metastasis to form tumors in other areas.</data>
  <data key="d9">disease process,spread mechanism</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250358</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer" target="Stage 4 Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Stage 4 cancer represents the most advanced stage of cancer within the numbered staging system.</data>
  <data key="d9">disease severity,staging</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250458</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Lymph">
  <data key="d7">1.0</data>
  <data key="d8">Cancer cells from a tumor can spread to other body parts by entering the lymph fluid.</data>
  <data key="d9">disease progression,metastasis</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250373</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Depth Of Invasion">
  <data key="d7">1.0</data>
  <data key="d8">The depth of invasion (DOI) is a key measurement for a tumor, indicating how deeply it has grown and correlating with metastasis risk.</data>
  <data key="d9">risk factor,tumor measurement</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250457</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Regional Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">Cancer from a tumor can spread to regional lymph nodes, resulting in lymph node metastasis.</data>
  <data key="d9">disease spread,metastasis</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250459</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Location And Size">
  <data key="d7">1.0</data>
  <data key="d8">The location and size of a tumor are factors used to determine its risk level for squamous cell skin cancer.</data>
  <data key="d9">classification,risk determinant</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250596</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Tumor Shape">
  <data key="d7">1.0</data>
  <data key="d8">The shape and definition of a tumor's border are factors used to determine its risk level.</data>
  <data key="d9">classification,risk determinant</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250599</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Perineural Invasion">
  <data key="d7">1.0</data>
  <data key="d8">If a tumor exhibits perineural invasion, it is considered a high- or very high-risk cancer.</data>
  <data key="d9">complication,risk indicator</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250601</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Tumor Grade">
  <data key="d7">1.0</data>
  <data key="d8">The tumor grade is assessed to predict how fast the cancer will grow and spread.</data>
  <data key="d9">evaluation,prognostic factor</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250605</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Risk Assessment">
  <data key="d7">1.0</data>
  <data key="d8">Risk assessment is performed by considering several features of the confirmed tumor.</data>
  <data key="d9">evaluation basis,feature analysis</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250608</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Intrahepatic Bile Duct Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Intrahepatic bile duct cancer is staged based on the size (T) and spread of the primary tumor.</data>
  <data key="d9">cancer staging,disease progression</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250710</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="DNA Mutations">
  <data key="d7">1.0</data>
  <data key="d8">A sample of a tumor may be tested to look for specific DNA mutations, protein levels, or other molecular features.</data>
  <data key="d9">characterization,testing</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250826</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor" target="Cancer Staging">
  <data key="d7">1.0</data>
  <data key="d8">Cancer staging describes the size and location of the tumor and if cancer has spread.</data>
  <data key="d9">classification,description</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250828</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Clinical Trial">
  <data key="d7">1.0</data>
  <data key="d8">Immunotherapy or enrollment in a clinical trial are preferred systemic therapy options for eligible patients.</data>
  <data key="d9">research option,treatment alternative</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250349</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Immune Checkpoint Inhibitor">
  <data key="d7">3.0</data>
  <data key="d8">Immunotherapy with an immune checkpoint inhibitor is a recommended treatment option.&lt;SEP&gt;An immune checkpoint inhibitor is the specific type of drug used in the preferred immunotherapy for CSCC.&lt;SEP&gt;Immunotherapy with an immune checkpoint inhibitor is the preferred form of systemic therapy for eligible patients.</data>
  <data key="d9">drug type,specific agent,specific method,treatment modality,treatment type</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37&lt;SEP&gt;chunk-50c5e5d6c7a62da56b73abb9a3384301&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250355</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Systemic Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Immunotherapy is a category of systemic therapy that stimulates the immune system to fight cancer.</data>
  <data key="d9">immune stimulation,treatment category</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250568</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Programmed Death Ligand 1 Inhibitors">
  <data key="d7">1.0</data>
  <data key="d8">Immunotherapy for CSCC uses PD-1 inhibitors, a type of immune checkpoint inhibitor.</data>
  <data key="d9">immune checkpoint inhibition,treatment mechanism</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250572</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Immune-Related Adverse Events">
  <data key="d7">1.0</data>
  <data key="d8">Immunotherapy can cause immune-related adverse events as side effects.</data>
  <data key="d9">specific side effects,treatment risk</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250574</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="Biomarkers">
  <data key="d7">1.0</data>
  <data key="d8">Immunotherapy may be a treatment option for ovarian cancer based on the presence of specific biomarkers.</data>
  <data key="d9">targeted approach,treatment eligibility</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250852</data>
  <data key="d13"></data>
</edge>
<edge source="Immunotherapy" target="NCCN Guidelines">
  <data key="d7">1.0</data>
  <data key="d8">Information on the side effects of immunotherapy is available in the NCCN Guidelines for Patients.</data>
  <data key="d9">patient information,side effect management</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250854</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Chemopreventive Agents">
  <data key="d7">1.0</data>
  <data key="d8">Patients can ask their care team about joining a clinical trial for chemopreventive agents to prevent lung cancer.</data>
  <data key="d9">preventive treatment,research study</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250419</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="U.S. Food and Drug Administration">
  <data key="d7">1.0</data>
  <data key="d8">Clinical trials test treatments that may be approved by the FDA if found safe and effective.</data>
  <data key="d9">regulatory approval,research outcome</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250570</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Phase 1 Trial">
  <data key="d7">1.0</data>
  <data key="d8">Phase 1 trials are an initial phase of clinical trials focusing on dose and safety.</data>
  <data key="d9">research phase,safety study</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250572</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Phase 2 Trial">
  <data key="d7">1.0</data>
  <data key="d8">Phase 2 trials are a phase of clinical trials that study a treatment's effectiveness against a specific cancer.</data>
  <data key="d9">efficacy study,research phase</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250574</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Phase 3 Trial">
  <data key="d7">1.0</data>
  <data key="d8">Phase 3 trials are a phase of clinical trials that test a treatment against a standard therapy.</data>
  <data key="d9">comparative study,research phase</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250575</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Phase 4 Trial">
  <data key="d7">1.0</data>
  <data key="d8">Phase 4 trials are a phase of clinical trials that study the long-term safety of an approved treatment.</data>
  <data key="d9">long-term study,research phase</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250577</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Eligibility Criteria">
  <data key="d7">1.0</data>
  <data key="d8">Clinical trials have eligibility criteria that define who can enroll to ensure participant safety.</data>
  <data key="d9">participation rules,safety protocol</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250579</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Informed Consent">
  <data key="d7">1.0</data>
  <data key="d8">Informed consent is a required process for participants in a clinical trial.</data>
  <data key="d9">ethical process,participant information</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250580</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Placebo">
  <data key="d7">2.0</data>
  <data key="d8">Placebos are rarely used alone in cancer clinical trials as a control element.&lt;SEP&gt;A placebo may be part of a clinical trial, typically combined with a standard treatment rather than used alone.</data>
  <data key="d9">research control,research methodology,treatment comparison,treatment component</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250582</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Research Team">
  <data key="d7">1.0</data>
  <data key="d8">Clinical trials are managed by a research team that explains the study to participants.</data>
  <data key="d9">expert oversight,trial management</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250584</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Standard Treatment">
  <data key="d7">2.0</data>
  <data key="d8">Clinical trials often test new treatments against standard treatments.&lt;SEP&gt;If a patient has already started standard treatment, they may not be eligible for certain clinical trials.</data>
  <data key="d9">eligibility conflict,research design,treatment comparison,treatment sequence</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0&lt;SEP&gt;chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250587</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Patient">
  <data key="d7">1.0</data>
  <data key="d8">Enrolling in a clinical trial is presented as another treatment option for a patient.</data>
  <data key="d9">enrollment,treatment option</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250590</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="National Cancer Institute (NCI)">
  <data key="d7">1.0</data>
  <data key="d8">The NCI provides tools and services to help patients find clinical trials.</data>
  <data key="d9">resource provision,search facilitation</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250591</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="U.S. National Library of Medicine (NLM)">
  <data key="d7">1.0</data>
  <data key="d8">The NLM maintains ClinicalTrials.gov, a resource for finding clinical trials worldwide.</data>
  <data key="d9">database management,information access</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250593</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="NCIs Cancer Information Service (CIS)">
  <data key="d7">1.0</data>
  <data key="d8">The CIS provides help to individuals who need assistance finding a clinical trial.</data>
  <data key="d9">guidance,support service</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250595</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Study Sponsor">
  <data key="d7">1.0</data>
  <data key="d8">The study sponsor pays for the research-related costs of a clinical trial.</data>
  <data key="d9">cost coverage,funding</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250598</data>
  <data key="d13"></data>
</edge>
<edge source="Clinical Trial" target="Insurance">
  <data key="d7">1.0</data>
  <data key="d8">Standard care received during a clinical trial is billed to insurance, while trial-related costs are covered by the sponsor.</data>
  <data key="d9">cost structure,financial coverage</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250599</data>
  <data key="d13"></data>
</edge>
<edge source="Targeted Therapy" target="Systemic Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Targeted therapy is a category of systemic therapy that attacks specific receptors on cancer cells.</data>
  <data key="d9">receptor targeting,treatment category</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250566</data>
  <data key="d13"></data>
</edge>
<edge source="Targeted Therapy" target="Epidermal Growth Factor Receptor">
  <data key="d7">1.0</data>
  <data key="d8">Targeted therapies for CSCC include EGFR inhibitors that block the EGFR protein.</data>
  <data key="d9">inhibition mechanism,receptor targeting</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250568</data>
  <data key="d13"></data>
</edge>
<edge source="Targeted Therapy" target="Gemtuzumab Ozogamicin">
  <data key="d7">1.0</data>
  <data key="d8">Gemtuzumab ozogamicin is an example of a targeted therapy, which focuses on specific features like the CD33 protein on cancer cells.</data>
  <data key="d9">drug type,molecular targeting</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250836</data>
  <data key="d13"></data>
</edge>
<edge source="Targeted Therapy" target="FLT3">
  <data key="d7">1.0</data>
  <data key="d8">Targeted therapies such as Gilteritinib and Sorafenib are used specifically to treat AML with mutations in the FLT3 gene.</data>
  <data key="d9">drug targeting,genetic mutation</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250838</data>
  <data key="d13"></data>
</edge>
<edge source="Regional Squamous Cell Skin Cancer" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Regional Squamous Cell Skin Cancer is a classification of CSCC that describes cancer which has spread to the lymph nodes.</data>
  <data key="d9">disease classification,staging</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250766</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exams" target="NCCN Experts">
  <data key="d7">1.0</data>
  <data key="d8">NCCN experts recommend having a skin exam once a year for life after the initial post-treatment monitoring period.</data>
  <data key="d9">long-term care,medical guideline</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250357</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exams" target="High-Risk Patients">
  <data key="d7">1.0</data>
  <data key="d8">The frequency of skin exams depends on patient risk, with high-risk patients requiring exams every 3 to 6 months initially.</data>
  <data key="d9">monitoring frequency,risk stratification</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250360</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exams" target="Paper Gown">
  <data key="d7">1.0</data>
  <data key="d8">During a skin exam, the patient wears a paper gown to allow the doctor to perform a complete check of the skin.</data>
  <data key="d9">clinical procedure,patient attire</data>
  <data key="d10">chunk-64895edc4d35c98b293c555e32022a37</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250362</data>
  <data key="d13"></data>
</edge>
<edge source="Metastasis" target="Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">Metastasis is the spread of cancer to an area such as lymph nodes.</data>
  <data key="d9">disease progression,spread site</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250504</data>
  <data key="d13"></data>
</edge>
<edge source="Metastasis" target="Very High-Risk CSCC">
  <data key="d7">1.0</data>
  <data key="d8">A very high-risk CSCC has an increased risk of metastasis.</data>
  <data key="d9">prognosis,risk factor</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250596</data>
  <data key="d13"></data>
</edge>
<edge source="High-Risk CSCC" target="Risk Assessment">
  <data key="d7">1.0</data>
  <data key="d8">Risk assessment determines if a cancer is classified as high-risk CSCC.</data>
  <data key="d9">categorization,outcome</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250598</data>
  <data key="d13"></data>
</edge>
<edge source="High-Risk CSCC" target="Local Recurrence">
  <data key="d7">1.0</data>
  <data key="d8">A high-risk CSCC has an increased risk of local recurrence.</data>
  <data key="d9">prognosis,risk factor</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250600</data>
  <data key="d13"></data>
</edge>
<edge source="High-Risk CSCC" target="Recurrent Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Any tumor that has returned after treatment is considered a high-risk squamous cell skin cancer.</data>
  <data key="d9">classification,outcome</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250604</data>
  <data key="d13"></data>
</edge>
<edge source="Very High-Risk CSCC" target="Risk Assessment">
  <data key="d7">1.0</data>
  <data key="d8">Risk assessment determines if a cancer is classified as very high-risk CSCC.</data>
  <data key="d9">categorization,outcome</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250599</data>
  <data key="d13"></data>
</edge>
<edge source="Low-Risk CSCC" target="Shave Excision">
  <data key="d7">1.0</data>
  <data key="d8">Shave excision is a recommended treatment option for low-risk, local CSCC.</data>
  <data key="d9">surgery,treatment option</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250558</data>
  <data key="d13"></data>
</edge>
<edge source="Low-Risk CSCC" target="Risk Assessment">
  <data key="d7">1.0</data>
  <data key="d8">Risk assessment determines if a cancer is classified as low-risk CSCC.</data>
  <data key="d9">categorization,outcome</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250596</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="Computed Tomography Scan">
  <data key="d7">1.0</data>
  <data key="d8">A CT scan is recommended to assess cancerous lymph nodes in regional CSCC.</data>
  <data key="d9">diagnostic imaging,lymph node assessment</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250363</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="PET/CT">
  <data key="d7">1.0</data>
  <data key="d8">A PET/CT may be needed to see if regional CSCC has spread beyond lymph nodes.</data>
  <data key="d9">advanced imaging,metastasis detection</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250365</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="Fine-Needle Aspiration">
  <data key="d7">1.0</data>
  <data key="d8">Fine-needle aspiration is a biopsy type used for squamous cell skin cancer in lymph nodes for regional CSCC.</data>
  <data key="d9">diagnostic procedure,lymph node biopsy</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250366</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="Core Needle Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Core needle biopsy is a biopsy type used for squamous cell skin cancer in lymph nodes for regional CSCC.</data>
  <data key="d9">diagnostic procedure,lymph node biopsy</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250367</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="Cemiplimab-Rwlc">
  <data key="d7">1.0</data>
  <data key="d8">Cemiplimab-rwlc may be used to shrink tumors before surgery for regional CSCC.</data>
  <data key="d9">neoadjuvant therapy,tumor reduction</data>
  <data key="d10">chunk-50c5e5d6c7a62da56b73abb9a3384301</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250369</data>
  <data key="d13"></data>
</edge>
<edge source="Regional CSCC" target="Skin Exam">
  <data key="d7">1.0</data>
  <data key="d8">Patients with regional CSCC require more frequent skin exams (e.g., every 2-3 months initially) as part of their follow-up care.</data>
  <data key="d9">disease management,monitoring protocol</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250377</data>
  <data key="d13"></data>
</edge>
<edge source="Fine-Needle Aspiration" target="Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">A fine-needle aspiration (FNA) can be used to remove a sample from a lymph node.</data>
  <data key="d9">diagnostic target,sampling procedure</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250496</data>
  <data key="d13"></data>
</edge>
<edge source="Core Needle Biopsy" target="Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">A core needle biopsy (CNB) can be used to remove a sample from a lymph node.</data>
  <data key="d9">diagnostic target,sampling procedure</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250501</data>
  <data key="d13"></data>
</edge>
<edge source="Core Needle Biopsy" target="Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">A Core Needle Biopsy may be used as an alternative method to diagnose Hodgkin Lymphoma in some cases.</data>
  <data key="d9">alternative test,diagnostic method</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250794</data>
  <data key="d13"></data>
</edge>
<edge source="Local CSCC" target="Skin Exam">
  <data key="d7">1.0</data>
  <data key="d8">Patients with local CSCC require skin exams at specific intervals (e.g., every 3-12 months) to monitor for cancer recurrence.</data>
  <data key="d9">disease management,monitoring protocol</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250375</data>
  <data key="d13"></data>
</edge>
<edge source="Local CSCC" target="Imaging Test">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests may be used to monitor some people who have local CSCC for signs of cancer spread.</data>
  <data key="d9">diagnostic procedure,disease monitoring</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250378</data>
  <data key="d13"></data>
</edge>
<edge source="Risk Assessment" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">A doctor performs a risk assessment on confirmed squamous cell skin cancer to determine its risk level.</data>
  <data key="d9">diagnostic process,evaluation</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250594</data>
  <data key="d13"></data>
</edge>
<edge source="Lungs" target="Small Cell Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Small cell lung cancer originates from cells that line the inner airways of the lungs.</data>
  <data key="d9">disease origin,organ system</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250367</data>
  <data key="d13"></data>
</edge>
<edge source="Lungs" target="Bronchus">
  <data key="d7">1.0</data>
  <data key="d8">The bronchus is an airway that is part of the structure of the lungs.</data>
  <data key="d9">anatomical structure,part of</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250371</data>
  <data key="d13"></data>
</edge>
<edge source="Lungs" target="Bronchioles">
  <data key="d7">1.0</data>
  <data key="d8">The bronchioles are airways that are part of the structure of the lungs.</data>
  <data key="d9">anatomical structure,part of</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250372</data>
  <data key="d13"></data>
</edge>
<edge source="Lungs" target="Respiration">
  <data key="d7">1.0</data>
  <data key="d8">The lungs perform the biological function of respiration, facilitating gas exchange.</data>
  <data key="d9">biological function,gas exchange</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250377</data>
  <data key="d13"></data>
</edge>
<edge source="Small Cell Lung Cancer" target="Smoking Cigarettes">
  <data key="d7">1.0</data>
  <data key="d8">Smoking cigarettes is identified as the main cause of small cell lung cancer.</data>
  <data key="d9">causation,primary risk factor</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250369</data>
  <data key="d13"></data>
</edge>
<edge source="Small Cell Lung Cancer" target="Second-Hand Smoke">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to second-hand smoke is a known risk factor that increases the likelihood of developing small cell lung cancer.</data>
  <data key="d9">environmental exposure,risk factor</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250371</data>
  <data key="d13"></data>
</edge>
<edge source="Small Cell Lung Cancer" target="Combined Cell Lung Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Combined cell lung carcinoma, which contains small cell cancer cells, is typically treated according to protocols for small cell lung cancer.</data>
  <data key="d9">cancer classification,treatment protocol</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250373</data>
  <data key="d13"></data>
</edge>
<edge source="Small Cell Lung Cancer" target="Neuroendocrine Cells">
  <data key="d7">2.0</data>
  <data key="d8">Small cell lung cancer is a fast-dividing cancer that originates from neuroendocrine cells in the lungs.&lt;SEP&gt;Small cell lung cancer originates from neuroendocrine cells in the lungs.</data>
  <data key="d9">cell origin,disease pathology,disease type</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9&lt;SEP&gt;chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250375</data>
  <data key="d13"></data>
</edge>
<edge source="Small Cell Lung Cancer" target="Small Cell Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">Small cell carcinoma is a specific subtype of the broader category known as small cell lung cancer.</data>
  <data key="d9">cancer classification,subtype</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250377</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Cancer Screening" target="Health Care Provider">
  <data key="d7">1.0</data>
  <data key="d8">Lung cancer screening involves discussions with a health care provider to determine if an individual qualifies based on their risk.</data>
  <data key="d9">eligibility assessment,medical consultation</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250367</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Cancer Screening" target="Risk Factors">
  <data key="d7">1.0</data>
  <data key="d8">Lung cancer screening programs are designed and recommended based on an individual's specific risk factors for developing the disease.</data>
  <data key="d9">risk assessment,screening criteria</data>
  <data key="d10">chunk-08475506372bb4ce9ec1bd326caf0fe9</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250369</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Cancer Screening" target="Lung Nodule">
  <data key="d7">1.0</data>
  <data key="d8">If a lung nodule is unlikely to be cancer, the care team may refer the patient for lung cancer screening.</data>
  <data key="d9">early detection,risk assessment</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250410</data>
  <data key="d13"></data>
</edge>
<edge source="Health Care Provider" target="Medical History And Physical Exam">
  <data key="d7">1.0</data>
  <data key="d8">A Health Care Provider performs the Physical Exam component of the Medical History and Physical Exam.</data>
  <data key="d9">assessment,performance</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="Health Care Provider" target="Patient">
  <data key="d7">1.0</data>
  <data key="d8">Patients are instructed to discuss their test results with their health care provider.</data>
  <data key="d9">consultation,discussion</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Health Care Provider" target="Radiologist">
  <data key="d7">1.0</data>
  <data key="d8">A radiologist sends the report of imaging test interpretations to the patient's health care provider.</data>
  <data key="d9">professional communication,report delivery</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250891</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking Cigarettes" target="SCLC">
  <data key="d7">1.0</data>
  <data key="d8">Smoking cigarettes is identified as the main cause of Small Cell Lung Cancer.</data>
  <data key="d9">causation,primary risk factor</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250868</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking Cigarettes" target="Nicotine Addiction">
  <data key="d7">1.0</data>
  <data key="d8">Nicotine addiction makes it difficult for people who smoke to quit.</data>
  <data key="d9">cessation barrier,complication</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250871</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking Cigarettes" target="Lung Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Quitting smoking makes new lung tumors less likely to develop.</data>
  <data key="d9">prevention,risk reduction</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250873</data>
  <data key="d13"></data>
</edge>
<edge source="Second-Hand Smoke" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to second-hand smoke increases a person's risk of developing lung cancer.</data>
  <data key="d9">environmental exposure,increased risk</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250413</data>
  <data key="d13"></data>
</edge>
<edge source="Second-Hand Smoke" target="SCLC">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to second-hand smoke increases a person's risk of developing SCLC.</data>
  <data key="d9">exposure,risk factor</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250869</data>
  <data key="d13"></data>
</edge>
<edge source="Bronchioles" target="Respiratory System">
  <data key="d7">1.0</data>
  <data key="d8">The bronchioles are smaller airways within the respiratory system, branching from the bronchi.</data>
  <data key="d9">airway subdivision,system component</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250424</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph" target="Lymphatic Vessels">
  <data key="d7">1.0</data>
  <data key="d8">Lymph is transported throughout the body by the Lymphatic Vessels.</data>
  <data key="d9">fluid transport,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250789</data>
  <data key="d13"></data>
</edge>
<edge source="Lymph" target="Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Lymph carries lymphocytes, which are infection-fighting white blood cells.</data>
  <data key="d9">cell transport,fluid composition</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250791</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exam" target="NCCN">
  <data key="d7">1.0</data>
  <data key="d8">NCCN experts recommend specific schedules for skin exams as part of follow-up care after skin cancer treatment.</data>
  <data key="d9">follow-up care,medical recommendation</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250379</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exam" target="Low-Risk Patient">
  <data key="d7">1.0</data>
  <data key="d8">Low-risk patients are advised to have skin exams every 3 to 12 months as part of their follow-up care after skin cancer treatment.</data>
  <data key="d9">monitoring frequency,patient care</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250381</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exam" target="High-Risk Patient">
  <data key="d7">1.0</data>
  <data key="d8">High-risk patients are advised to have skin exams every 3 to 6 months as part of their follow-up care after skin cancer treatment.</data>
  <data key="d9">monitoring frequency,patient care</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250383</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exam" target="Very High-Risk Local CSCC">
  <data key="d7">1.0</data>
  <data key="d8">Patients with very high-risk local CSCC should have skin exams every 3 to 6 months during the first 2 years of follow-up.</data>
  <data key="d9">disease management,monitoring protocol</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250385</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Exam" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A skin exam is conducted as part of the process to diagnose basal cell skin cancer.</data>
  <data key="d9">clinical assessment,diagnosis</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250529</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Test" target="Gastrointestinal Tract">
  <data key="d7">1.0</data>
  <data key="d8">Imaging tests are used to check the gastrointestinal tract for issues related to ovarian cancer symptoms.</data>
  <data key="d9">diagnostic examination,procedure</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250813</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Test" target="Scope">
  <data key="d7">1.0</data>
  <data key="d8">A scope is an imaging tool used in procedures like colonoscopy and upper endoscopy to examine the GI tract.</data>
  <data key="d9">diagnostic tool,utilization</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250815</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="BCR::ABL1 Gene">
  <data key="d7">2.0</data>
  <data key="d8">Chronic Myeloid Leukemia is caused by the presence of the abnormal BCR::ABL1 fused gene.&lt;SEP&gt;The cause of CML is traced to the abnormal BCR::ABL1 gene, which is created by a translocation and is not found in normal cells.</data>
  <data key="d9">disease hallmark,disease pathology,genetic cause</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250378</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="Philadelphia (Ph) Chromosome">
  <data key="d7">1.0</data>
  <data key="d8">The presence of the Philadelphia Chromosome, which carries the BCR::ABL1 gene, is a diagnostic marker for CML.</data>
  <data key="d9">diagnostic marker,genetic abnormality</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250380</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="Myeloid Progenitor Cell">
  <data key="d7">1.0</data>
  <data key="d8">CML arises from blood stem cells that produce an increased amount of myeloid progenitor cells.</data>
  <data key="d9">cell overproduction,disease mechanism</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250383</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="Blast Phase CML (BP-CML)">
  <data key="d7">2.0</data>
  <data key="d8">Blast Phase CML is an advanced and more aggressive form of Chronic Myeloid Leukemia.&lt;SEP&gt;Blast Phase CML is an advanced form of CML that can cause an increased amount of lymphoid or myeloid progenitor cells.</data>
  <data key="d9">advanced stage,disease progression</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb&lt;SEP&gt;chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250385</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="Myeloid Progenitor Cells">
  <data key="d7">1.0</data>
  <data key="d8">CML is thought to arise from blood stem cells that make an increased amount of myeloid progenitor cells.</data>
  <data key="d9">cell production,disease origin</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250715</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="Blasts">
  <data key="d7">1.0</data>
  <data key="d8">In CML, the very immature cells (myeloblasts or lymphoblasts) are often referred to simply as blasts.</data>
  <data key="d9">cell identification,disease terminology</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250717</data>
  <data key="d13"></data>
</edge>
<edge source="Chronic Myeloid Leukemia (CML)" target="BCR::ABL1 Protein">
  <data key="d7">1.0</data>
  <data key="d8">The BCR::ABL1 protein leads to uncontrolled blood cell growth, which ultimately causes CML.</data>
  <data key="d9">cell growth,disease mechanism</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250722</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Gene" target="Philadelphia (Ph) Chromosome">
  <data key="d7">1.0</data>
  <data key="d8">The BCR::ABL1 gene is located on the Philadelphia Chromosome, which is a shortened chromosome 22.</data>
  <data key="d9">chromosomal abnormality,genetic association</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250382</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Gene" target="Chromosome 9">
  <data key="d7">1.0</data>
  <data key="d8">The BCR::ABL1 gene is formed when a piece of chromosome 9 breaks off and switches places with a piece of chromosome 22.</data>
  <data key="d9">chromosome involvement,genetic translocation</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250718</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Gene" target="Chromosome 22">
  <data key="d7">1.0</data>
  <data key="d8">The BCR::ABL1 gene is formed when a piece of chromosome 22 breaks off and switches places with a piece of chromosome 9.</data>
  <data key="d9">chromosome involvement,genetic translocation</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250723</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Gene" target="Philadelphia Chromosome (Ph)">
  <data key="d7">1.0</data>
  <data key="d8">The Philadelphia chromosome contains the BCR::ABL1 gene, and its presence is required for a CML diagnosis.</data>
  <data key="d9">disease definition,genetic content</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250725</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Gene" target="BCR::ABL1 Protein">
  <data key="d7">1.0</data>
  <data key="d8">The BCR::ABL1 gene makes the BCR::ABL1 protein, which leads to uncontrolled blood cell growth.</data>
  <data key="d9">gene expression,protein production</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250729</data>
  <data key="d13"></data>
</edge>
<edge source="Blood" target="Plasma">
  <data key="d7">2.0</data>
  <data key="d8">Plasma is the liquid component of blood in which blood cells are suspended.&lt;SEP&gt;Blood contains plasma as its liquid component, in which blood cells are suspended.</data>
  <data key="d9">biological composition,composition,fluid component</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250458</data>
  <data key="d13"></data>
</edge>
<edge source="Blood" target="Red Blood Cells">
  <data key="d7">2.0</data>
  <data key="d8">Red blood cells are a primary cellular component of blood responsible for carrying oxygen.&lt;SEP&gt;Blood contains red blood cells, which are responsible for carrying oxygen throughout the body.</data>
  <data key="d9">biological function,composition,oxygen transport</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250460</data>
  <data key="d13"></data>
</edge>
<edge source="Blood" target="White Blood Cells">
  <data key="d7">2.0</data>
  <data key="d8">White blood cells are a cellular component of blood that play a crucial role in the immune system.&lt;SEP&gt;Blood contains white blood cells, which are responsible for fighting infections.</data>
  <data key="d9">biological function,composition,immune defense,immune function</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250462</data>
  <data key="d13"></data>
</edge>
<edge source="Blood" target="Platelets">
  <data key="d7">2.0</data>
  <data key="d8">Platelets are a cellular component of blood essential for clotting and preventing bleeding.&lt;SEP&gt;Blood contains platelets, which are responsible for helping to control bleeding.</data>
  <data key="d9">biological function,composition,hemostasis</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250464</data>
  <data key="d13"></data>
</edge>
<edge source="Blood" target="Tumor Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Tumor mutation testing can use a sample of blood to see if cancer cells have DNA mutations.</data>
  <data key="d9">diagnostic material,sample source</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250509</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow" target="Blood Stem Cell">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells are located within the bone marrow and are responsible for producing all blood cells.</data>
  <data key="d9">biological location,cell production</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250379</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow" target="Lymphatic System">
  <data key="d7">1.0</data>
  <data key="d8">Bone Marrow is part of the Lymphatic System where new blood cells, including lymphocytes, are made.</data>
  <data key="d9">cell production,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250788</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow" target="Blood Stem Cells">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow contains and is the site where blood stem cells are located and multiply.</data>
  <data key="d9">cellular origin,production site</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250795</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Stem Cell" target="Myeloid Progenitor Cell">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells give rise to myeloid progenitor cells, which are overproduced in Chronic Myeloid Leukemia.</data>
  <data key="d9">blood cell formation,cell differentiation</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250381</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Stem Cell" target="Red Blood Cell (RBC)">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells give rise to red blood cells as part of the normal blood cell formation process in the bone marrow.</data>
  <data key="d9">blood cell formation,cell differentiation</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250383</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Stem Cell" target="White Blood Cell (WBC)">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells give rise to white blood cells as part of the normal blood cell formation process in the bone marrow.</data>
  <data key="d9">blood cell formation,cell differentiation</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250387</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Stem Cell" target="Platelet (PLT)">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells give rise to platelets as part of the normal blood cell formation process in the bone marrow.</data>
  <data key="d9">blood cell formation,cell differentiation</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250389</data>
  <data key="d13"></data>
</edge>
<edge source="Myeloid Progenitor Cell" target="Blast">
  <data key="d7">1.0</data>
  <data key="d8">Myeloid progenitor cells form into myeloblasts, which are a type of immature blast cell.</data>
  <data key="d9">cell development,maturation stage</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250389</data>
  <data key="d13"></data>
</edge>
<edge source="Blast Phase CML (BP-CML)" target="Blasts">
  <data key="d7">1.0</data>
  <data key="d8">The type of blast phase cell (lymphoid or myeloid progenitor) will affect treatment in BP-CML.</data>
  <data key="d9">cell type,disease phase</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250720</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines for Patients" target="NCCN">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN organization creates the NCCN Guidelines for Patients to provide trusted, expert-based information on cancer care.</data>
  <data key="d9">patient education,publication</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250381</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines for Patients" target="Patient Advocacy">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients help patients understand cancer care, preparing them to discuss care with their team.</data>
  <data key="d9">care preparation,patient education</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250729</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="Fertility Preservation">
  <data key="d7">1.0</data>
  <data key="d8">NCCN provides guidelines and resources on fertility preservation for young cancer patients.</data>
  <data key="d9">information resource,patient guidance</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250394</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="Genetic Syndromes">
  <data key="d7">1.0</data>
  <data key="d8">NCCN recommends that individuals with genetic syndromes predisposing them to CSCC be referred to specialized cancer centers.</data>
  <data key="d9">medical guideline,recommendation</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250401</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="NCCN Patient Guides for Cancer App">
  <data key="d7">1.0</data>
  <data key="d8">NCCN provides patient guidelines for cancer through its digital application, the NCCN Patient Guides for Cancer app.</data>
  <data key="d9">digital tool,resource provision</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250467</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="Immune Checkpoint Inhibitors">
  <data key="d7">1.0</data>
  <data key="d8">NCCN provides guidelines for patients regarding the side effects of immunotherapy treatments like Immune Checkpoint Inhibitors.</data>
  <data key="d9">guidelines provision,treatment information</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250472</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="Side Effects">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN provides guidelines and an app with information on managing side effects like nausea and vomiting.</data>
  <data key="d9">information resource,patient support</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250695</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="National Comprehensive Cancer Network">
  <data key="d7">1.0</data>
  <data key="d8">NCCN is the abbreviation for the National Comprehensive Cancer Network.</data>
  <data key="d9">abbreviation,organizational identity</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250801</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN" target="NSCLC">
  <data key="d7">1.0</data>
  <data key="d8">Patient guidelines for NSCLC are provided by the NCCN organization.</data>
  <data key="d9">information source,medical guidelines</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250867</data>
  <data key="d13"></data>
</edge>
<edge source="White Blood Cell (WBC)" target="Granulocyte">
  <data key="d7">1.0</data>
  <data key="d8">Granulocytes are a specific type of white blood cell involved in fighting infections.</data>
  <data key="d9">cell classification,component</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250385</data>
  <data key="d13"></data>
</edge>
<edge source="Lymphoid Progenitor Cell" target="Blast">
  <data key="d7">1.0</data>
  <data key="d8">Lymphoid progenitor cells form into lymphoblasts, which are a type of immature blast cell.</data>
  <data key="d9">cell development,maturation stage</data>
  <data key="d10">chunk-8b66e38931f28ed6ac9b231faaf202fb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250386</data>
  <data key="d13"></data>
</edge>
<edge source="Physical Exam" target="Head And Neck Exam">
  <data key="d7">1.0</data>
  <data key="d8">A head and neck exam is a specific component included as part of a comprehensive physical exam.</data>
  <data key="d9">component,medical procedure</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250386</data>
  <data key="d13"></data>
</edge>
<edge source="Physical Exam" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A physical exam is conducted as part of the process to diagnose basal cell skin cancer.</data>
  <data key="d9">clinical assessment,diagnosis</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250528</data>
  <data key="d13"></data>
</edge>
<edge source="Physical Exam" target="Complete Head And Neck Exam">
  <data key="d7">1.0</data>
  <data key="d8">A complete head and neck exam is a specific part of the physical exam for patients with mouth cancer.</data>
  <data key="d9">focused examination,specialized assessment</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250627</data>
  <data key="d13"></data>
</edge>
<edge source="Dental Exam" target="Head And Neck Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Patients with head and neck cancer are advised to have regular dental exams because the disease and its treatment can affect oral health.</data>
  <data key="d9">disease management,preventive care</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250387</data>
  <data key="d13"></data>
</edge>
<edge source="Distress Screening" target="Distress">
  <data key="d7">1.0</data>
  <data key="d8">Distress screening is conducted to assess a patient's level of distress, which includes feelings of sadness, fear, and anxiety.</data>
  <data key="d9">assessment,psychological state</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250393</data>
  <data key="d13"></data>
</edge>
<edge source="Endocrine Tests" target="Head And Neck Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Endocrine tests are performed for head and neck cancer patients because radiation therapy to the area can affect endocrine glands like the thyroid.</data>
  <data key="d9">monitoring,treatment side effect</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250389</data>
  <data key="d13"></data>
</edge>
<edge source="Hearing Test" target="Head And Neck Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Hearing tests are conducted because head and neck tumors and their treatment can affect a patient's hearing.</data>
  <data key="d9">disease complication,treatment impact</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250393</data>
  <data key="d13"></data>
</edge>
<edge source="Hearing Test" target="Audiogram">
  <data key="d7">1.0</data>
  <data key="d8">A hearing test can produce an audiogram, which is a graph visualizing the test results.</data>
  <data key="d9">diagnostic tool,result visualization</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250395</data>
  <data key="d13"></data>
</edge>
<edge source="Nutrition Assessment" target="Nutritionist">
  <data key="d7">1.0</data>
  <data key="d8">A nutritionist conducts a nutrition assessment to provide dietary recommendations to a patient before cancer treatment.</data>
  <data key="d9">dietary planning,professional service</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250389</data>
  <data key="d13"></data>
</edge>
<edge source="Speech And Swallowing Assessment" target="Speech Or Swallowing Therapist">
  <data key="d7">1.0</data>
  <data key="d8">A speech or swallowing therapist performs a speech and swallowing assessment to evaluate a patient's abilities before and after treatment.</data>
  <data key="d9">functional evaluation,professional service</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250390</data>
  <data key="d13"></data>
</edge>
<edge source="Fertility Preservation" target="Fertility Specialist">
  <data key="d7">1.0</data>
  <data key="d8">A fertility specialist consults with patients to discuss fertility preservation options before they begin cancer treatment.</data>
  <data key="d9">medical consultation,reproductive planning</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250392</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Mouth Cancer">
  <data key="d7">2.0</data>
  <data key="d8">Mouth cancer is one of several types of cancers grouped into the broader category called head and neck cancers.&lt;SEP&gt;Mouth cancer is specifically identified as a type of head and neck cancer.</data>
  <data key="d9">categorization,grouping,type</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250429</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="High-Volume Center">
  <data key="d7">1.0</data>
  <data key="d8">It is strongly recommended for patients with head and neck cancers to be treated at a high-volume center experienced in their type of cancer.</data>
  <data key="d9">specialized care,treatment recommendation</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250433</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Smoking">
  <data key="d7">1.0</data>
  <data key="d8">Stopping smoking is essential for patients with head and neck cancer to maximize the chance for cure and minimize side effects.</data>
  <data key="d9">risk factor,treatment necessity</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250485</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Vaping">
  <data key="d7">1.0</data>
  <data key="d8">Stopping vaping is essential for patients with head and neck cancer to maximize the chance for cure and minimize side effects.</data>
  <data key="d9">risk factor,treatment necessity</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250487</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Dentist">
  <data key="d7">1.0</data>
  <data key="d8">Patients should tell their dentist about their head and neck cancer and maintain regular dental checkups.</data>
  <data key="d9">dental care,patient communication</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250490</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Jaw">
  <data key="d7">1.0</data>
  <data key="d8">Head and neck cancer and its treatment can affect the health of the jaw.</data>
  <data key="d9">anatomical impact,health effect</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250513</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Teeth">
  <data key="d7">1.0</data>
  <data key="d8">Head and neck cancer and its treatment can affect the health of the teeth.</data>
  <data key="d9">anatomical impact,health effect</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250516</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Gums">
  <data key="d7">1.0</data>
  <data key="d8">Head and neck cancer and its treatment can affect the health of the gums.</data>
  <data key="d9">anatomical impact,health effect</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250518</data>
  <data key="d13"></data>
</edge>
<edge source="Head And Neck Cancer" target="Jaw Teeth Gums">
  <data key="d7">1.0</data>
  <data key="d8">Head and neck cancer and its treatment can affect the health of a patient's jaw, teeth, and gums.</data>
  <data key="d9">health impact,side effect</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Barrier Methods" target="Preventing Pregnancy">
  <data key="d7">1.0</data>
  <data key="d8">Barrier methods are recommended as a form of contraception to prevent pregnancy during cancer treatment.</data>
  <data key="d9">contraception,reproductive safety</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250395</data>
  <data key="d13"></data>
</edge>
<edge source="Intrauterine Devices" target="Preventing Pregnancy">
  <data key="d7">1.0</data>
  <data key="d8">Intrauterine devices (IUDs) are a birth control option to prevent pregnancy during cancer treatment.</data>
  <data key="d9">contraception,reproductive safety</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250398</data>
  <data key="d13"></data>
</edge>
<edge source="Pregnancy Test" target="Preventing Pregnancy">
  <data key="d7">1.0</data>
  <data key="d8">A pregnancy test is required before treatment to ensure pregnancy is prevented, as cancer treatment can harm a fetus.</data>
  <data key="d9">safety protocol,treatment planning</data>
  <data key="d10">chunk-7bdde77ad1be3ee9308db3c7703674b0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250399</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Cancer" target="Tanning Beds">
  <data key="d7">1.0</data>
  <data key="d8">Using tanning beds, which emit UV radiation, increases the risk of getting any type of skin cancer.</data>
  <data key="d9">UV exposure,risk factor</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250403</data>
  <data key="d13"></data>
</edge>
<edge source="Marjolins Ulcer" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Marjolins Ulcer is a specific form of Cutaneous Squamous Cell Carcinoma that develops in old wounds, burns, or scars.</data>
  <data key="d9">cancer subtype,clinical presentation</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250763</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Syndromes" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Certain genetic syndromes increase a person's likelihood of developing squamous cell skin cancer.</data>
  <data key="d9">disease susceptibility,risk factor</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250774</data>
  <data key="d13"></data>
</edge>
<edge source="Weakened Immune System" target="Immunosuppressants">
  <data key="d7">1.0</data>
  <data key="d8">Immunosuppressant drugs taken after organ transplantation intentionally weaken the immune system to prevent organ rejection.</data>
  <data key="d9">drug effect,side effect</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250399</data>
  <data key="d13"></data>
</edge>
<edge source="Weakened Immune System" target="Corticosteroid Use">
  <data key="d7">1.0</data>
  <data key="d8">Long-term corticosteroid use is a condition that can lead to a weakened immune system.</data>
  <data key="d9">cause,risk factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250560</data>
  <data key="d13"></data>
</edge>
<edge source="Weakened Immune System" target="HIV">
  <data key="d7">1.0</data>
  <data key="d8">HIV is a condition that weakens the immune system.</data>
  <data key="d9">cause,risk factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250563</data>
  <data key="d13"></data>
</edge>
<edge source="Weakened Immune System" target="AIDS">
  <data key="d7">1.0</data>
  <data key="d8">AIDS is a condition that weakens the immune system.</data>
  <data key="d9">cause,risk factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250565</data>
  <data key="d13"></data>
</edge>
<edge source="Weakened Immune System" target="Organ Transplant">
  <data key="d7">1.0</data>
  <data key="d8">Having received an organ transplant is a condition that weakens the immune system.</data>
  <data key="d9">cause,risk factor</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250567</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Biopsy" target="Doctor">
  <data key="d7">1.0</data>
  <data key="d8">A doctor performs a skin biopsy on a patient to obtain a sample for cancer testing.</data>
  <data key="d9">healthcare,procedure performance</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250411</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Biopsy" target="Local Anesthetic">
  <data key="d7">1.0</data>
  <data key="d8">A local anesthetic is used during a skin biopsy to numb the area and prevent patient pain during the procedure.</data>
  <data key="d9">pain management,procedure component</data>
  <data key="d10">chunk-3821a6febf2d21784059ac62a6e659c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250413</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Punch Biopsy" target="Leukemia Predisposition Syndromes">
  <data key="d7">1.0</data>
  <data key="d8">A skin punch biopsy is used to test for leukemia predisposition syndromes by obtaining DNA unaltered by AML to check for inherited risks.</data>
  <data key="d9">hereditary testing,risk assessment</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250643</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Punch Biopsy" target="Excision Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Both are biopsy methods used to remove tissue samples for testing and diagnosis of skin conditions like cancer.</data>
  <data key="d9">diagnostic procedures,tissue sampling</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250758</data>
  <data key="d13"></data>
</edge>
<edge source="Skin Punch Biopsy" target="Shave Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Both Shave Biopsy and Skin Punch Biopsy are methods for removing skin tissue samples for diagnostic testing.</data>
  <data key="d9">diagnostic procedures,tissue sampling</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250763</data>
  <data key="d13"></data>
</edge>
<edge source="Doctor" target="Smoking">
  <data key="d7">1.0</data>
  <data key="d8">A doctor should be asked by patients for help to quit smoking, as it impacts cancer treatment.</data>
  <data key="d9">health advice,patient counseling</data>
  <data key="d10">chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250566</data>
  <data key="d13"></data>
</edge>
<edge source="Doctor" target="Pelvic And Rectovaginal Exam">
  <data key="d7">1.0</data>
  <data key="d8">The doctor may perform a pelvic and rectovaginal exam to monitor the patient during chemotherapy.</data>
  <data key="d9">monitoring procedure,physical assessment</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250704</data>
  <data key="d13"></data>
</edge>
<edge source="Doctor" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">A doctor makes the diagnosis of CSCC and follows up with a complete skin exam and lymph node assessment.</data>
  <data key="d9">diagnosis,management</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250769</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Counselor" target="Genetic Testing">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing may involve a genetic counselor who helps patients understand the results and implications of gene changes.</data>
  <data key="d9">patient guidance,test interpretation</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250675</data>
  <data key="d13"></data>
</edge>
<edge source="Tanning Beds" target="Ultraviolet (UV) Radiation">
  <data key="d7">1.0</data>
  <data key="d8">Ultraviolet (UV) radiation, a cause of basal cell skin cancer, can come from sources like tanning beds.</data>
  <data key="d9">risk factor,source</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250863</data>
  <data key="d13"></data>
</edge>
<edge source="Tobacco Smoke" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Tobacco smoke is the biggest risk factor for lung cancer, containing over 50 cancer-causing compounds.</data>
  <data key="d9">causative agent,risk factor</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250411</data>
  <data key="d13"></data>
</edge>
<edge source="Chemopreventive Agents" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Chemopreventive agents are treatments studied to prevent lung cancer, particularly that caused by smoking.</data>
  <data key="d9">clinical research,preventive treatment</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250415</data>
  <data key="d13"></data>
</edge>
<edge source="Radon" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to radon increases the likelihood of getting lung cancer, especially for smokers.</data>
  <data key="d9">carcinogen,environmental hazard</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250418</data>
  <data key="d13"></data>
</edge>
<edge source="Radon" target="Carcinogens">
  <data key="d7">1.0</data>
  <data key="d8">Radon is listed as an example of a cancer-causing chemical (carcinogen).</data>
  <data key="d9">category inclusion,example</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250872</data>
  <data key="d13"></data>
</edge>
<edge source="Asbestos" target="Lung Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to asbestos increases the likelihood of getting lung cancer, especially for smokers.</data>
  <data key="d9">carcinogen,occupational hazard</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250419</data>
  <data key="d13"></data>
</edge>
<edge source="Asbestos" target="Carcinogens">
  <data key="d7">1.0</data>
  <data key="d8">Asbestos is listed as an example of a cancer-causing chemical (carcinogen).</data>
  <data key="d9">category inclusion,example</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250874</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Cancer" target="Risk Factor">
  <data key="d7">1.0</data>
  <data key="d8">Risk factors are elements that increase a person's chance of developing lung cancer.</data>
  <data key="d9">disease causation,probability increase</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250424</data>
  <data key="d13"></data>
</edge>
<edge source="Lung Cancer" target="Carcinomas">
  <data key="d7">1.0</data>
  <data key="d8">Almost all lung cancers are a subtype called carcinomas, which start in cells lining the airways.</data>
  <data key="d9">cell origin,disease classification</data>
  <data key="d10">chunk-7843955573cdc294b34e74019195fafb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250427</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Oral Cavity">
  <data key="d7">2.0</data>
  <data key="d8">Mouth cancer develops within the oral cavity, which is composed of various structures like the lips, tongue, and gums.&lt;SEP&gt;Mouth cancer is defined as cancer that develops in the oral cavity.</data>
  <data key="d9">development,development site,location</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250423</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Tongue">
  <data key="d7">1.0</data>
  <data key="d8">The front two-thirds of the tongue is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250432</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Lips">
  <data key="d7">1.0</data>
  <data key="d8">The mucosal lip is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250435</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Gums">
  <data key="d7">1.0</data>
  <data key="d8">The gums (gingiva) are one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250436</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Hard Palate">
  <data key="d7">1.0</data>
  <data key="d8">The hard palate is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250437</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Buccal Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">The buccal mucosa is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250439</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Alveolar Ridge">
  <data key="d7">1.0</data>
  <data key="d8">The alveolar ridge is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250441</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Floor Of The Mouth">
  <data key="d7">1.0</data>
  <data key="d8">The floor of the mouth is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250442</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="Retromolar Trigone">
  <data key="d7">1.0</data>
  <data key="d8">The retromolar trigone is one of the specific parts of the mouth where mouth cancer can develop.</data>
  <data key="d9">anatomical site,cancer development</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250444</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="TNM Staging">
  <data key="d7">1.0</data>
  <data key="d8">TNM staging information is specifically used for classifying and staging mouth cancer, such as squamous cell carcinoma.</data>
  <data key="d9">diagnostic criteria,disease classification</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250458</data>
  <data key="d13"></data>
</edge>
<edge source="Mouth Cancer" target="TNM System">
  <data key="d7">1.0</data>
  <data key="d8">The TNM system is used to stage mouth cancer by describing different areas of cancer growth.</data>
  <data key="d9">classification,staging</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250828</data>
  <data key="d13"></data>
</edge>
<edge source="Oral Cavity" target="Oral Mucosa">
  <data key="d7">1.0</data>
  <data key="d8">The inside of the oral cavity is lined by the oral mucosa, a mucous membrane composed of epithelial and connective tissue layers.</data>
  <data key="d9">anatomical lining,structure</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250425</data>
  <data key="d13"></data>
</edge>
<edge source="Oral Mucosa" target="Depth Of Invasion">
  <data key="d7">1.0</data>
  <data key="d8">The Depth of Invasion is a measure of how deep a tumor has grown through the layers of the oral mucosa.</data>
  <data key="d9">progression,tumor measurement</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250432</data>
  <data key="d13"></data>
</edge>
<edge source="Oral Mucosa" target="Lamina Propria">
  <data key="d7">1.0</data>
  <data key="d8">The oral mucosa is composed of layers, with the lamina propria being its bottom layer of connective tissue.</data>
  <data key="d9">anatomical composition,layer</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250436</data>
  <data key="d13"></data>
</edge>
<edge source="Oral Mucosa" target="Nonkeratinized Squamous Epithelium">
  <data key="d7">1.0</data>
  <data key="d8">Parts of the oral mucosa, such as the soft palate and inner cheeks, are covered by nonkeratinized squamous epithelium.</data>
  <data key="d9">coverage,tissue type</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250437</data>
  <data key="d13"></data>
</edge>
<edge source="Oral Mucosa" target="Keratinized Squamous Epithelium">
  <data key="d7">1.0</data>
  <data key="d8">Parts of the oral mucosa, such as the gums and hard palate, are covered by keratinized squamous epithelium.</data>
  <data key="d9">coverage,tissue type</data>
  <data key="d10">chunk-f43f96815f23658d5b24fe95ed4bd5ed</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250439</data>
  <data key="d13"></data>
</edge>
<edge source="Medical History" target="Medicines">
  <data key="d7">1.0</data>
  <data key="d8">A patient's Medical History includes a list of all Medicines they have taken or are currently taking.</data>
  <data key="d9">record,review</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250456</data>
  <data key="d13"></data>
</edge>
<edge source="Medical History" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">A patient's medical history is used to help determine the best treatment for Follicular Lymphoma.</data>
  <data key="d9">patient assessment,treatment planning</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250545</data>
  <data key="d13"></data>
</edge>
<edge source="Medical History" target="Primary Care Physician">
  <data key="d7">1.0</data>
  <data key="d8">A patient's medical history is shared with their primary care physician to help determine the best treatment options.</data>
  <data key="d9">information sharing,treatment planning</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250831</data>
  <data key="d13"></data>
</edge>
<edge source="Medical History" target="Family History">
  <data key="d7">1.0</data>
  <data key="d8">Family history is a component of a person's overall medical history used to assess the risk of hereditary diseases.</data>
  <data key="d9">genetic information,risk assessment</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250832</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Acute Myeloid Leukemia">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients provide expert recommendations and information for making decisions about care for conditions like AML.</data>
  <data key="d9">patient education,treatment guidance</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250460</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Patient">
  <data key="d7">1.0</data>
  <data key="d8">Patients use the NCCN Guidelines for Patients to understand cancer care, ask informed questions, and play an active role in their treatment decisions.</data>
  <data key="d9">education,self-advocacy</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250517</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Questions To Ask">
  <data key="d7">3.0</data>
  <data key="d8">The NCCN Guidelines for Patients includes a 'Questions to ask' section at the end of each chapter to help patients gather information from their care team.&lt;SEP&gt;The NCCN Guidelines for Patients book includes a section called Questions to Ask at the end of each chapter to help patients engage with their care team.&lt;SEP&gt;The NCCN Guidelines for Patients includes a "Questions to ask" section at the end of each chapter to aid patient communication.</data>
  <data key="d9">content feature,patient engagement,patient engagement tool,resource structure</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250520</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="National Comprehensive Cancer Network">
  <data key="d7">2.0</data>
  <data key="d8">The National Comprehensive Cancer Network develops the NCCN Guidelines for Patients.&lt;SEP&gt;The National Comprehensive Cancer Network (NCCN) holds the copyright for and publishes the NCCN Guidelines for Patients.</data>
  <data key="d9">copyright ownership,development,publication</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250770</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="NCCN Foundation">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Foundation provides funding and distributes the NCCN Guidelines for Patients.</data>
  <data key="d9">distribution,funding</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250772</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Pfizer Inc.">
  <data key="d7">1.0</data>
  <data key="d8">Pfizer Inc. is a corporate supporter that provides funding to help make the NCCN Guidelines for Patients available.</data>
  <data key="d9">corporate support,funding</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250774</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Hodgkin Lymphoma">
  <data key="d7">2.0</data>
  <data key="d8">The NCCN Guidelines for Patients provide information and recommendations specifically for Hodgkin Lymphoma.&lt;SEP&gt;The NCCN Guidelines for Patients provide information and recommendations to help patients understand and manage care for Hodgkin Lymphoma.</data>
  <data key="d9">care guidance,guidance,patient education,resource</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250776</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="NCCN Clinical Practice Guidelines In Oncology">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients are based on and plainly explain the expert recommendations from the NCCN Clinical Practice Guidelines in Oncology.</data>
  <data key="d9">adaptation,patient education</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250777</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 2: Testing For AML">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 2: Testing for AML as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250802</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 3: Types Of Treatment">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 3: Types of treatment as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250803</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 4: AML">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 4: AML as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250804</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 5: APL">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 5: APL as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250804</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="AML">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients provides information and guidance for understanding and managing AML care.</data>
  <data key="d9">information resource,patient education</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250805</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 6: BPDCN">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 6: BPDCN as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250807</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Guidelines For Patients" target="Chapter 7: Other Resources">
  <data key="d7">1.0</data>
  <data key="d8">The NCCN Guidelines for Patients contains Chapter 7: Other resources as one of its sections.</data>
  <data key="d9">content structure,informational chapter</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250808</data>
  <data key="d13"></data>
</edge>
<edge source="High-Volume Center" target="Head and Neck Cancers">
  <data key="d7">1.0</data>
  <data key="d8">It is recommended that patients with head and neck cancer be treated at a high-volume center experienced in this cancer type.</data>
  <data key="d9">specialized care,treatment recommendation</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250472</data>
  <data key="d13"></data>
</edge>
<edge source="Tongue" target="Ear Nose And Throat Doctor">
  <data key="d7">1.0</data>
  <data key="d8">One should see an ENT doctor if feeling something different around the tongue.</data>
  <data key="d9">consultation reason,symptom location</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250514</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Medical History And Physical Exam">
  <data key="d7">1.0</data>
  <data key="d8">A Medical History and Physical Exam is a procedure used to help determine the best treatment for AML.</data>
  <data key="d9">assessment,diagnosis</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250437</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Complete Blood Count And Differential">
  <data key="d7">1.0</data>
  <data key="d8">A Complete Blood Count and Differential is a key test that provides a picture of overall health and can detect signs of AML.</data>
  <data key="d9">diagnosis,monitoring</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250439</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Comprehensive Metabolic Panel">
  <data key="d7">1.0</data>
  <data key="d8">A Comprehensive Metabolic Panel is used during AML treatment to assess how well organs like the kidneys and liver are working.</data>
  <data key="d9">diagnosis,organ function</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250441</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Bone Marrow Aspirate And Biopsy">
  <data key="d7">2.0</data>
  <data key="d8">A bone marrow aspirate and biopsy is a procedure used to obtain samples for diagnosing and testing AML.&lt;SEP&gt;A Bone Marrow Aspirate and Biopsy with biomarker and genetic testing is a procedure for diagnosing and analyzing AML.</data>
  <data key="d9">diagnosis,diagnostic procedure,genetic analysis,sample collection</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57&lt;SEP&gt;chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250443</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Lactate Dehydrogenase Test">
  <data key="d7">1.0</data>
  <data key="d8">The Lactate Dehydrogenase Test is part of the initial diagnostic panel for AML, as fast-growing tumor cells release LDH.</data>
  <data key="d9">diagnosis,monitoring</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250447</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="B12 And Folic Acid Test">
  <data key="d7">1.0</data>
  <data key="d8">B12 and Folic Acid levels are monitored during AML care as they are needed for normal red and white blood cell formation.</data>
  <data key="d9">monitoring,nutrition</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250449</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Guide 1">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 is a resource that lists possible tests and procedures related to AML.</data>
  <data key="d9">diagnosis,information resource</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Blood Stem Cells">
  <data key="d7">1.0</data>
  <data key="d8">AML starts in and affects blood stem cells.</data>
  <data key="d9">cellular pathology,disease origin</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250802</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Blasts">
  <data key="d7">1.0</data>
  <data key="d8">AML causes the production of abnormal blasts (myeloblasts) in the bone marrow and blood.</data>
  <data key="d9">abnormal production,disease manifestation</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250803</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="Complete Blood Count">
  <data key="d7">1.0</data>
  <data key="d8">A Complete Blood Count (CBC) is a test used in the diagnosis and management of AML.</data>
  <data key="d9">diagnostic testing,disease monitoring</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250807</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="APL">
  <data key="d7">1.0</data>
  <data key="d8">APL is a rare subtype of Acute Myeloid Leukemia (AML).</data>
  <data key="d9">disease classification,subtype</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250808</data>
  <data key="d13"></data>
</edge>
<edge source="AML" target="BPDCN">
  <data key="d7">1.0</data>
  <data key="d8">BPDCN is an aggressive subtype of Acute Myeloid Leukemia (AML).</data>
  <data key="d9">disease classification,subtype</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250811</data>
  <data key="d13"></data>
</edge>
<edge source="Medical History And Physical Exam" target="Guide 1">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 lists a medical history and physical exam as a possible test or procedure for AML.</data>
  <data key="d9">guide content,listed procedure</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250809</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Red Blood Cells">
  <data key="d7">1.0</data>
  <data key="d8">The Complete Blood Count measures the levels of Red Blood Cells in the blood.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250441</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="White Blood Cells">
  <data key="d7">1.0</data>
  <data key="d8">The Complete Blood Count and its differential component measure and count the types of White Blood Cells.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250443</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Platelets">
  <data key="d7">1.0</data>
  <data key="d8">The Complete Blood Count measures the level of Platelets in the blood.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250445</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Hemoglobin">
  <data key="d7">1.0</data>
  <data key="d8">Hemoglobin level is a key measurement taken as part of the Complete Blood Count.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250447</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Absolute Neutrophil Count">
  <data key="d7">1.0</data>
  <data key="d8">The Absolute Neutrophil Count is a measurement derived from the Complete Blood Count differential.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250448</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Blasts">
  <data key="d7">1.0</data>
  <data key="d8">Blasts or leukemia cells can be detected and reported as a percentage in the Complete Blood Count and Differential.</data>
  <data key="d9">analysis,detection</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="Complete Blood Count And Differential" target="Red Blood Cell Transfusion">
  <data key="d7">1.0</data>
  <data key="d8">Hemoglobin measurement from the Complete Blood Count helps determine if a Red Blood Cell Transfusion might be needed.</data>
  <data key="d9">assessment,indication</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250453</data>
  <data key="d13"></data>
</edge>
<edge source="Comprehensive Metabolic Panel" target="Creatinine">
  <data key="d7">1.0</data>
  <data key="d8">The Comprehensive Metabolic Panel measures Creatinine levels to assess how well the kidneys are working.</data>
  <data key="d9">kidney function,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250445</data>
  <data key="d13"></data>
</edge>
<edge source="Comprehensive Metabolic Panel" target="Blood Urea Nitrogen">
  <data key="d7">1.0</data>
  <data key="d8">The Comprehensive Metabolic Panel measures Blood Urea Nitrogen levels as an indicator of kidney function.</data>
  <data key="d9">kidney function,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250447</data>
  <data key="d13"></data>
</edge>
<edge source="Comprehensive Metabolic Panel" target="Electrolytes">
  <data key="d7">1.0</data>
  <data key="d8">The Comprehensive Metabolic Panel measures Electrolyte levels to ensure proper nerve, muscle, heart, and brain function.</data>
  <data key="d9">body function,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250448</data>
  <data key="d13"></data>
</edge>
<edge source="Comprehensive Metabolic Panel" target="Liver Function Tests">
  <data key="d7">1.0</data>
  <data key="d8">Liver Function Tests are part of the Comprehensive Metabolic Panel, assessing the health of the liver.</data>
  <data key="d9">assessment,inclusion</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="Comprehensive Metabolic Panel" target="Guide 1">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 lists a Comprehensive Metabolic Panel (CMP) as a possible test for AML.</data>
  <data key="d9">guide content,listed test</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250813</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow Aspirate And Biopsy" target="AML Biomarker And Genetic Tests">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow aspirate and biopsy provide samples used in AML biomarker and genetic tests to analyze leukemia cells.</data>
  <data key="d9">diagnostic testing,sample collection</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250638</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow Aspirate And Biopsy" target="Guide 1">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 lists a bone marrow aspirate and biopsy as a possible procedure for AML.</data>
  <data key="d9">guide content,listed procedure</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250817</data>
  <data key="d13"></data>
</edge>
<edge source="FDG-PET/CT" target="Fluorodeoxyglucose">
  <data key="d7">1.0</data>
  <data key="d8">An FDG-PET/CT uses a radiotracer called fluorodeoxyglucose (FDG).</data>
  <data key="d9">specific procedure,tracer use</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250621</data>
  <data key="d13"></data>
</edge>
<edge source="Lumbar Puncture" target="Leukemia">
  <data key="d7">1.0</data>
  <data key="d8">A lumbar puncture is performed to detect if leukemia cells are present in the spinal fluid.</data>
  <data key="d9">diagnostic procedure,disease detection</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250735</data>
  <data key="d13"></data>
</edge>
<edge source="Lumbar Puncture" target="Chapter 2: Testing For AML">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 2: Testing for AML lists lumbar puncture as a possible diagnostic procedure.</data>
  <data key="d9">chapter content,test overview</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250811</data>
  <data key="d13"></data>
</edge>
<edge source="Heart Tests" target="Cardiologist">
  <data key="d7">1.0</data>
  <data key="d8">A patient might be referred to a cardiologist for heart tests.</data>
  <data key="d9">cardiac care,specialist referral</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250612</data>
  <data key="d13"></data>
</edge>
<edge source="Heart Tests" target="Treatment Side Effects">
  <data key="d7">1.0</data>
  <data key="d8">Heart tests might be used to monitor treatment side effects.</data>
  <data key="d9">monitoring,patient management</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250622</data>
  <data key="d13"></data>
</edge>
<edge source="Heart Tests" target="Chapter 2: Testing For AML">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 2: Testing for AML lists heart tests as a possible diagnostic procedure.</data>
  <data key="d9">chapter content,test overview</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250808</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Clotting Tests" target="Coagulation Factors">
  <data key="d7">1.0</data>
  <data key="d8">Blood clotting tests assess the proteins called coagulation factors.</data>
  <data key="d9">diagnostic assessment,protein measurement</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250683</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Clotting Tests" target="Disseminated Intravascular Coagulation Panel">
  <data key="d7">1.0</data>
  <data key="d8">Blood clotting tests are known together as a coagulation panel or disseminated intravascular coagulation (DIC) panel.</data>
  <data key="d9">diagnostic synonym,test grouping</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250687</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Clotting Tests" target="Guide 1">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 lists blood clotting tests as possible tests for AML.</data>
  <data key="d9">guide content,listed test</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250815</data>
  <data key="d13"></data>
</edge>
<edge source="Uric Acid Test" target="Uric Acid">
  <data key="d7">1.0</data>
  <data key="d8">The Uric Acid Test measures the level of Uric Acid in the blood.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250449</data>
  <data key="d13"></data>
</edge>
<edge source="Lactate Dehydrogenase Test" target="Lactate Dehydrogenase">
  <data key="d7">1.0</data>
  <data key="d8">The Lactate Dehydrogenase Test measures the level of the Lactate Dehydrogenase enzyme in the blood.</data>
  <data key="d9">analysis,measurement</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="B12 And Folic Acid Test" target="B12">
  <data key="d7">1.0</data>
  <data key="d8">The B12 and Folic Acid Test measures the level of Vitamin B12 in the blood.</data>
  <data key="d9">measurement,monitoring</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250451</data>
  <data key="d13"></data>
</edge>
<edge source="B12 And Folic Acid Test" target="Folic Acid">
  <data key="d7">1.0</data>
  <data key="d8">The B12 and Folic Acid Test measures the level of Folic Acid in the blood.</data>
  <data key="d9">measurement,monitoring</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250453</data>
  <data key="d13"></data>
</edge>
<edge source="Red Blood Cells" target="Myeloid Progenitor Cells">
  <data key="d7">1.0</data>
  <data key="d8">Myeloid progenitor cells develop into red blood cells.</data>
  <data key="d9">cellular maturation,development</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250798</data>
  <data key="d13"></data>
</edge>
<edge source="White Blood Cells" target="Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Lymphocytes are a specific type of white blood cell.</data>
  <data key="d9">cell type,subcategory</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250784</data>
  <data key="d13"></data>
</edge>
<edge source="Platelets" target="Myeloid Progenitor Cells">
  <data key="d7">1.0</data>
  <data key="d8">Myeloid progenitor cells develop into platelets.</data>
  <data key="d9">cellular maturation,development</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250799</data>
  <data key="d13"></data>
</edge>
<edge source="Blasts" target="Granulocytes">
  <data key="d7">1.0</data>
  <data key="d8">Blasts (myeloblasts) normally mature into granulocytes (neutrophils).</data>
  <data key="d9">cellular development,normal maturation</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250799</data>
  <data key="d13"></data>
</edge>
<edge source="Hemoglobin" target="Iron">
  <data key="d7">1.0</data>
  <data key="d8">Iron is important for producing hemoglobin, the oxygen-carrying molecule in blood.</data>
  <data key="d9">mineral function,molecule production</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250679</data>
  <data key="d13"></data>
</edge>
<edge source="Liver Function Tests" target="Bile Ducts">
  <data key="d7">1.0</data>
  <data key="d8">Abnormal results in Liver Function Tests can signal that the Bile Ducts might be blocked.</data>
  <data key="d9">blockage detection,health indicator</data>
  <data key="d10">chunk-69e63736c94b8b08a565c3d8679d3b57</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250455</data>
  <data key="d13"></data>
</edge>
<edge source="Guide 1" target="Complete Blood Count">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 lists a Complete Blood Count (CBC) as a possible test for AML.</data>
  <data key="d9">guide content,listed test</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250811</data>
  <data key="d13"></data>
</edge>
<edge source="Lactate Dehydrogenase" target="Tumor Markers">
  <data key="d7">1.0</data>
  <data key="d8">Lactate dehydrogenase is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Folic Acid" target="Red Blood Cell">
  <data key="d7">1.0</data>
  <data key="d8">Folic acid is needed for the normal formation of red blood cells.</data>
  <data key="d9">cell formation,nutrient requirement</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250679</data>
  <data key="d13"></data>
</edge>
<edge source="Folic Acid" target="White Blood Cell">
  <data key="d7">1.0</data>
  <data key="d8">Folic acid is needed for the normal formation of white blood cells.</data>
  <data key="d9">cell formation,nutrient requirement</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250681</data>
  <data key="d13"></data>
</edge>
<edge source="Stage 4 Cancer" target="TNM Staging">
  <data key="d7">1.0</data>
  <data key="d8">The TNM staging system is used to define numbered cancer stages, with stage 4 being the most advanced.</data>
  <data key="d9">classification system,disease assessment</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250457</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="Carcinoma In Situ">
  <data key="d7">1.0</data>
  <data key="d8">Within the TNM staging system, Tis designates carcinoma in situ, the earliest stage where cancer is confined to the cell layer of origin.</data>
  <data key="d9">early disease,staging category</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250461</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="T1 Tumor">
  <data key="d7">1.0</data>
  <data key="d8">T1 is a category within the TNM staging system defined by specific tumor size and depth of invasion criteria.</data>
  <data key="d9">staging category,tumor size</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250463</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="T2 Tumor">
  <data key="d7">1.0</data>
  <data key="d8">T2 is a category within the TNM staging system defined by specific tumor size and depth of invasion criteria.</data>
  <data key="d9">staging category,tumor size</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250464</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="T3 Tumor">
  <data key="d7">1.0</data>
  <data key="d8">T3 is a category within the TNM staging system defined by specific tumor size and depth of invasion criteria.</data>
  <data key="d9">staging category,tumor size</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250467</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="T4a Tumor">
  <data key="d7">1.0</data>
  <data key="d8">T4a is a category within the TNM staging system indicating moderately advanced local disease with specific invasion criteria.</data>
  <data key="d9">local invasion,staging category</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250470</data>
  <data key="d13"></data>
</edge>
<edge source="TNM Staging" target="T4b Tumor">
  <data key="d7">1.0</data>
  <data key="d8">T4b is a category within the TNM staging system indicating very advanced local disease with invasion of critical structures.</data>
  <data key="d9">extensive invasion,staging category</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250471</data>
  <data key="d13"></data>
</edge>
<edge source="Regional Lymph Node" target="Extranodal Extension">
  <data key="d7">1.0</data>
  <data key="d8">Extranodal extension describes the condition where cancer has spread beyond the confines of a regional lymph node.</data>
  <data key="d9">disease progression,metastasis characteristic</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250461</data>
  <data key="d13"></data>
</edge>
<edge source="Regional Lymph Node" target="Lymph Node Metastasis">
  <data key="d7">1.0</data>
  <data key="d8">Cancer found in a regional lymph node is specifically classified as a lymph node metastasis.</data>
  <data key="d9">diagnostic finding,disease spread</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250463</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Myeloid Blasts">
  <data key="d7">1.0</data>
  <data key="d8">In Acute Myeloid Leukemia (AML), the disease is characterized by the abnormal accumulation of immature myeloid blasts.</data>
  <data key="d9">cell abnormality,disease mechanism</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250458</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Acute Promyelocytic Leukemia">
  <data key="d7">1.0</data>
  <data key="d8">Acute promyelocytic leukemia (APL) is identified as a specific subtype of acute myeloid leukemia (AML).</data>
  <data key="d9">classification,disease subtype</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250465</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Blastic Plasmacytoid Dendritic Cell Neoplasm">
  <data key="d7">2.0</data>
  <data key="d8">Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is included alongside AML in the informational book's scope.&lt;SEP&gt;Blastic plasmacytoid dendritic cell neoplasm is a suspected subtype of Acute Myeloid Leukemia.</data>
  <data key="d9">diagnostic suspicion,disease subtype,informational scope,related condition</data>
  <data key="d10">chunk-d9882c04dd7676c6433074e5e393c72e&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250468</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Coagulopathy">
  <data key="d7">1.0</data>
  <data key="d8">Coagulopathy, an impaired clotting process, is common in leukemia.</data>
  <data key="d9">common condition,disease complication</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250681</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Bone Marrow Tests">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow tests are used to diagnose Acute Myeloid Leukemia by sampling and analyzing bone marrow.</data>
  <data key="d9">disease diagnosis,sample analysis</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250684</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Myeloblast">
  <data key="d7">1.0</data>
  <data key="d8">In AML, abnormal changes cause an accumulation of myeloblasts in the bone marrow and blood.</data>
  <data key="d9">cell abnormality,disease mechanism</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250735</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Bone Marrow Aspirate">
  <data key="d7">1.0</data>
  <data key="d8">A bone marrow aspirate is used to confirm a diagnosis of Acute Myeloid Leukemia.</data>
  <data key="d9">diagnostic confirmation,testing</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250737</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Bone Marrow Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">A bone marrow biopsy is used to confirm a diagnosis of Acute Myeloid Leukemia.</data>
  <data key="d9">diagnostic confirmation,testing</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250739</data>
  <data key="d13"></data>
</edge>
<edge source="Acute Myeloid Leukemia" target="Genetic And Biomarker Tests">
  <data key="d7">1.0</data>
  <data key="d8">Genetic and biomarker tests are used to learn more about the AML subtype, target treatment, and determine prognosis.</data>
  <data key="d9">subtype classification,treatment planning</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250741</data>
  <data key="d13"></data>
</edge>
<edge source="Carcinoma In Situ" target="Intrahepatic Bile Duct Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Carcinoma in situ (Tis) is defined as a specific, early stage of intrahepatic bile duct cancer.</data>
  <data key="d9">disease stage,early detection</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250712</data>
  <data key="d13"></data>
</edge>
<edge source="Distant Metastasis" target="TNM System">
  <data key="d7">1.0</data>
  <data key="d8">The M in the TNM system describes if cancer has spread to distant parts of the body.</data>
  <data key="d9">assessment,component</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250831</data>
  <data key="d13"></data>
</edge>
<edge source="Blastic Plasmacytoid Dendritic Cell Neoplasm" target="Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">If the BPDCN subtype of AML is suspected, a lymph node biopsy might be performed.</data>
  <data key="d9">diagnostic procedure,subtype suspicion</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250690</data>
  <data key="d13"></data>
</edge>
<edge source="Blastic Plasmacytoid Dendritic Cell Neoplasm" target="Skin Lesion Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">If the BPDCN subtype of AML is suspected, a skin lesion biopsy might be performed.</data>
  <data key="d9">diagnostic procedure,subtype suspicion</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250693</data>
  <data key="d13"></data>
</edge>
<edge source="NCCN Patient Guides for Cancer App" target="Immune-Related Adverse Events">
  <data key="d7">1.0</data>
  <data key="d8">Information on immune-related adverse events is available on the NCCN Patient Guides for Cancer app.</data>
  <data key="d9">information resource,side effect management</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250580</data>
  <data key="d13"></data>
</edge>
<edge source="Throat" target="Oropharynx">
  <data key="d7">2.0</data>
  <data key="d8">The oropharynx is a part of the throat where cancer can form.&lt;SEP&gt;The throat includes the oropharynx as a specific anatomical region, which is the focus for throat cancer.</data>
  <data key="d9">anatomical part,cancer site,includes</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250467</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Pharynx">
  <data key="d7">1.0</data>
  <data key="d8">The oropharynx is one of the three parts of the pharynx, along with the nasopharynx and hypopharynx.</data>
  <data key="d9">anatomical division,part of</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250470</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Soft Palate">
  <data key="d7">3.0</data>
  <data key="d8">The oropharynx includes the soft palate as one of its constituent anatomical structures.&lt;SEP&gt;The oropharynx includes the soft palate, which is the back of the roof of the mouth.&lt;SEP&gt;The oropharynx includes the soft palate.</data>
  <data key="d9">anatomical inclusion,part of</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a&lt;SEP&gt;chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250472</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Tonsils">
  <data key="d7">2.0</data>
  <data key="d8">The oropharynx includes the tonsils as one of its constituent anatomical structures.&lt;SEP&gt;The oropharynx includes the tonsils.</data>
  <data key="d9">anatomical inclusion,part of</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b&lt;SEP&gt;chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250475</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Base of the Tongue">
  <data key="d7">1.0</data>
  <data key="d8">The oropharynx includes the base of the tongue as one of its constituent anatomical structures.</data>
  <data key="d9">anatomical inclusion,part of</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250476</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Throat Cancer">
  <data key="d7">1.0</data>
  <data key="d8">The oropharynx is the anatomical focus for the discussion of throat cancer testing and treatment.</data>
  <data key="d9">anatomical focus,disease location</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250581</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="Base Of The Tongue">
  <data key="d7">1.0</data>
  <data key="d8">The oropharynx includes the base of the tongue.</data>
  <data key="d9">anatomical inclusion,part of</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250585</data>
  <data key="d13"></data>
</edge>
<edge source="Oropharynx" target="This Book">
  <data key="d7">1.0</data>
  <data key="d8">This book has the oropharynx as its focus.</data>
  <data key="d9">content focus,subject matter</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250587</data>
  <data key="d13"></data>
</edge>
<edge source="Head and Neck Cancers" target="Throat Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Throat cancer is a type of head and neck cancer that specifically starts in the oropharynx.</data>
  <data key="d9">cancer classification,includes</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250470</data>
  <data key="d13"></data>
</edge>
<edge source="Squamous Cell Carcinoma of the Head and Neck" target="Throat Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Squamous cell carcinoma is the most common type of throat cancer, which is a subset of head and neck cancers.</data>
  <data key="d9">cancer type,common form</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250471</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="Primary Tumor">
  <data key="d7">1.0</data>
  <data key="d8">Throat cancer involves the formation of a primary tumor within the oropharynx.</data>
  <data key="d9">disease manifestation,forms</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250475</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="Testing for Throat Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Diagnosing and planning treatment for throat cancer involves a series of tests, including imaging, biopsy, and biomarker analysis.</data>
  <data key="d9">involves,medical diagnosis</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250476</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="Larynx">
  <data key="d7">1.0</data>
  <data key="d8">Tumors from throat cancer can grow into nearby tissues and organs, such as the larynx (voice box).</data>
  <data key="d9">affects,disease progression</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250477</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="Treatment Planning">
  <data key="d7">1.0</data>
  <data key="d8">Treatment planning for throat cancer is initiated based on diagnostic testing.</data>
  <data key="d9">care process,diagnosis</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250584</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="This Chapter">
  <data key="d7">1.0</data>
  <data key="d8">This chapter provides an overview of tests for throat cancer.</data>
  <data key="d9">content focus,subject matter</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250587</data>
  <data key="d13"></data>
</edge>
<edge source="Throat Cancer" target="Head And Neck Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Throat cancer is a type of head and neck cancer.</data>
  <data key="d9">anatomical location,cancer category</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250857</data>
  <data key="d13"></data>
</edge>
<edge source="Testing for Throat Cancer" target="p16 (HPV) Testing">
  <data key="d7">1.0</data>
  <data key="d8">p16 (HPV) testing is one of the specific tests included in the broader testing process for throat cancer.</data>
  <data key="d9">diagnostic procedure,includes</data>
  <data key="d10">chunk-5a84075aaac61b0ad85e5f811fc4f24b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250477</data>
  <data key="d13"></data>
</edge>
<edge source="Tonsils" target="Lymphatic System">
  <data key="d7">1.0</data>
  <data key="d8">The Tonsils are lymph tissue that is part of the Lymphatic System, helping to trap germs.</data>
  <data key="d9">immune defense,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250793</data>
  <data key="d13"></data>
</edge>
<edge source="Dentists" target="Oral Surgeons">
  <data key="d7">1.0</data>
  <data key="d8">Dentists and oral surgeons are both professionals who commonly perform dental procedures in everyday practice.</data>
  <data key="d9">dental procedures,professional practice</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250476</data>
  <data key="d13"></data>
</edge>
<edge source="Ear Nose And Throat Doctor" target="Neck">
  <data key="d7">1.0</data>
  <data key="d8">One should see an ENT doctor if feeling something different around the neck.</data>
  <data key="d9">consultation reason,symptom location</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250510</data>
  <data key="d13"></data>
</edge>
<edge source="Ear Nose And Throat Doctor" target="Glands">
  <data key="d7">1.0</data>
  <data key="d8">One should see an ENT doctor if feeling something different around the glands.</data>
  <data key="d9">consultation reason,symptom location</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250512</data>
  <data key="d13"></data>
</edge>
<edge source="Ear Nose And Throat Doctor" target="Mouth Area">
  <data key="d7">1.0</data>
  <data key="d8">One should see an ENT doctor if feeling something different around the mouth area.</data>
  <data key="d9">consultation reason,symptom location</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250517</data>
  <data key="d13"></data>
</edge>
<edge source="Dentist" target="Regular Dental Cleanings">
  <data key="d7">1.0</data>
  <data key="d8">Patients should keep up with regular dental cleanings performed by their dentist.</data>
  <data key="d9">maintenance care,professional service</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250515</data>
  <data key="d13"></data>
</edge>
<edge source="Dentist" target="Regular Dental Checkups">
  <data key="d7">1.0</data>
  <data key="d8">Patients should keep up with regular dental checkups performed by their dentist.</data>
  <data key="d9">maintenance care,professional service</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250517</data>
  <data key="d13"></data>
</edge>
<edge source="Dentist" target="Patient">
  <data key="d7">1.0</data>
  <data key="d8">Patients should tell their dentist about their head and neck cancer and keep up with regular dental cleanings and checkups.</data>
  <data key="d9">communication,maintenance</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Fine Needle Biopsy" target="Lymph Node">
  <data key="d7">1.0</data>
  <data key="d8">A fine needle biopsy (FNB) can be used to remove a sample from a lymph node.</data>
  <data key="d9">diagnostic target,sampling procedure</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250498</data>
  <data key="d13"></data>
</edge>
<edge source="Deoxyribonucleic Acid" target="Chromosome">
  <data key="d7">1.0</data>
  <data key="d8">DNA molecules are tightly packaged into structures called chromosomes.</data>
  <data key="d9">packaging,structural organization</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250501</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome" target="Gene">
  <data key="d7">2.0</data>
  <data key="d8">Chromosomes contain thousands of genes, which are coded instructions for the proteins cells make.&lt;SEP&gt;Each chromosome contains thousands of genes.</data>
  <data key="d9">containment,genetic organization,genetic structure,protein coding</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250506</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome" target="DNA">
  <data key="d7">1.0</data>
  <data key="d8">DNA molecules are tightly packaged into chromosomes, which contain most of the genetic information in a cell.</data>
  <data key="d9">genetic packaging,information storage</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250640</data>
  <data key="d13"></data>
</edge>
<edge source="Gene" target="Protein">
  <data key="d7">1.0</data>
  <data key="d8">Genes are coded instructions for the proteins your cells make.</data>
  <data key="d9">instruction,production basis</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250503</data>
  <data key="d13"></data>
</edge>
<edge source="Gene" target="Next-Generation Sequencing">
  <data key="d7">1.0</data>
  <data key="d8">Next-Generation Sequencing looks at a gene in a detailed way to find mutations.</data>
  <data key="d9">detailed analysis,mutation screening</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250614</data>
  <data key="d13"></data>
</edge>
<edge source="Gene" target="Mutation">
  <data key="d7">1.0</data>
  <data key="d8">Genes can undergo mutations, which are changes in the genetic code, as examined in AML testing.</data>
  <data key="d9">code change,genetic alteration</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250640</data>
  <data key="d13"></data>
</edge>
<edge source="Gene" target="Proteins">
  <data key="d7">1.0</data>
  <data key="d8">Genes are coded instructions for the proteins that cells make.</data>
  <data key="d9">genetic instruction,molecule production</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250650</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Tumor Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Tumor mutation testing identifies specific DNA mutations in cancer cells that can be targeted with specific therapies.</data>
  <data key="d9">DNA analysis,targeted therapy</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250485</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Next-Generation Sequencing">
  <data key="d7">1.0</data>
  <data key="d8">NGS shows if a gene has any mutations that might affect how it works.</data>
  <data key="d9">detection,genetic variation</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250617</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Amplification">
  <data key="d7">1.0</data>
  <data key="d8">Amplification is a type of mutation where a chromosome or gene part is increased, identified in AML cells.</data>
  <data key="d9">duplication,genetic change</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250642</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Deletion">
  <data key="d7">1.0</data>
  <data key="d8">Deletion is a type of mutation where part of a chromosome or gene is missing, detected in AML mutation testing.</data>
  <data key="d9">genetic change,loss</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250643</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Insertion">
  <data key="d7">1.0</data>
  <data key="d8">Insertion is a type of mutation where a new part of a chromosome or gene is included, found in AML cells.</data>
  <data key="d9">addition,genetic change</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250645</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Inversion">
  <data key="d7">1.0</data>
  <data key="d8">Inversion is a type of mutation involving switching parts within a chromosome, such as inv(16), in AML.</data>
  <data key="d9">genetic change,rearrangement</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250646</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Point Mutation">
  <data key="d7">1.0</data>
  <data key="d8">Point mutation is a type of mutation where part of a gene is changed, assessed in AML testing.</data>
  <data key="d9">alteration,genetic change</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250650</data>
  <data key="d13"></data>
</edge>
<edge source="Mutation" target="Chromosome Translocation And Gene Rearrangement">
  <data key="d7">1.0</data>
  <data key="d8">Chromosome translocation and gene rearrangement are types of mutations involving switching parts between chromosomes, analyzed in AML.</data>
  <data key="d9">genetic change,switching</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250653</data>
  <data key="d13"></data>
</edge>
<edge source="Molecular Testing" target="Mouth Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Molecular testing has limited value in treating mouth cancers due to few drugs targeting the specific genetic mutations.</data>
  <data key="d9">limited utility,treatment context</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="Molecular Testing" target="Drugs">
  <data key="d7">1.0</data>
  <data key="d8">Molecular testing has limited value for mouth cancers since there are few drugs targeting the specific mutations.</data>
  <data key="d9">limited utility,treatment context</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250504</data>
  <data key="d13"></data>
</edge>
<edge source="MSI-H/dMMR Mutation" target="Microsatellite Instability-High">
  <data key="d7">1.0</data>
  <data key="d8">MSI-H/dMMR mutation refers to the condition of microsatellite instability-high, often due to dMMR.</data>
  <data key="d9">genetic defect,synonymous condition</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250504</data>
  <data key="d13"></data>
</edge>
<edge source="MSI-H/dMMR Mutation" target="Deficient Mismatch Repair">
  <data key="d7">1.0</data>
  <data key="d8">MSI-H/dMMR mutation refers to the condition of deficient mismatch repair, leading to MSI-H.</data>
  <data key="d9">genetic defect,synonymous condition</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250507</data>
  <data key="d13"></data>
</edge>
<edge source="PD-L1 Testing" target="Programmed Death Ligand 1">
  <data key="d7">1.0</data>
  <data key="d8">PD-L1 testing measures the expression of the PD-L1 protein on cancer cells to guide the use of immune checkpoint inhibitors.</data>
  <data key="d9">protein measurement,treatment indication</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250482</data>
  <data key="d13"></data>
</edge>
<edge source="PD-L1 Testing" target="Combined Positive Score">
  <data key="d7">1.0</data>
  <data key="d8">PD-L1 expression is measured using a combined positive score (CPS) to determine eligibility for certain therapies.</data>
  <data key="d9">assessment metric,scoring system</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250485</data>
  <data key="d13"></data>
</edge>
<edge source="Programmed Death Ligand 1" target="Immune Protein">
  <data key="d7">1.0</data>
  <data key="d8">Programmed death ligand 1 (PD-L1) is an immune protein.</data>
  <data key="d9">categorization,molecular type</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250506</data>
  <data key="d13"></data>
</edge>
<edge source="Programmed Death Ligand 1" target="Immune Cells">
  <data key="d7">1.0</data>
  <data key="d8">The PD-L1 protein on cancer cells can cause immune cells to ignore the cancer.</data>
  <data key="d9">immune suppression,interaction</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250509</data>
  <data key="d13"></data>
</edge>
<edge source="Programmed Death Ligand 1" target="Anti-Tumor Immune Response">
  <data key="d7">1.0</data>
  <data key="d8">The PD-L1 protein can suppress the anti-tumor immune response.</data>
  <data key="d9">immune evasion,suppression</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250511</data>
  <data key="d13"></data>
</edge>
<edge source="Combined Positive Score" target="Immune System">
  <data key="d7">1.0</data>
  <data key="d8">The combined positive score (CPS) measures immune proteins in the tumor and the immune system.</data>
  <data key="d9">measurement,system assessment</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250507</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutational Burden" target="Immune Checkpoint Inhibitor Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic or unresectable TMB-H cancers are often treated using immune checkpoint inhibitors targeting PD-1 and PD-L1.</data>
  <data key="d9">mutation threshold,treatment indication</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250484</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutational Burden" target="Unresectable Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Unresectable TMB-H cancers are often treated using immune checkpoint inhibitors.</data>
  <data key="d9">disease stage,treatment context</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250509</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutational Burden" target="Metastatic Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Metastatic TMB-H cancers are often treated using immune checkpoint inhibitors.</data>
  <data key="d9">disease stage,treatment context</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250511</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutational Burden" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker tumor mutational burden is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutation Testing" target="Genetic Testing">
  <data key="d7">1.0</data>
  <data key="d8">Tumor mutation testing is a different type of DNA testing than genetic testing for inherited mutations.</data>
  <data key="d9">distinction,testing type</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250511</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Mutation Testing" target="Specific Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Tumor mutation testing identifies mutations that can be targeted with specific therapies.</data>
  <data key="d9">application,treatment guidance</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250513</data>
  <data key="d13"></data>
</edge>
<edge source="Imaging Studies" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Test results are the output generated from procedures like imaging studies.</data>
  <data key="d9">data source,diagnostic output</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250776</data>
  <data key="d13"></data>
</edge>
<edge source="Online Portals" target="Patient">
  <data key="d7">1.0</data>
  <data key="d8">Patients use online portals to access their medical test results.</data>
  <data key="d9">access,results</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Nicotine" target="Smoking">
  <data key="d7">2.0</data>
  <data key="d8">Nicotine is the addictive chemical in tobacco that makes quitting smoking difficult.&lt;SEP&gt;Nicotine is the chemical in tobacco that makes people want to keep smoking and vaping.</data>
  <data key="d9">addiction,chemical component</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d&lt;SEP&gt;chunk-a9d0006f1c78fe4fa7bb74b756033104</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250487</data>
  <data key="d13"></data>
</edge>
<edge source="Nicotine" target="Vaping">
  <data key="d7">1.0</data>
  <data key="d8">Nicotine is the chemical in tobacco that makes people want to keep smoking and vaping.</data>
  <data key="d9">addiction,chemical component</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250490</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Nicotine Withdrawal">
  <data key="d7">1.0</data>
  <data key="d8">Nicotine withdrawal is challenging for people who smoke, and the stress of cancer may make quitting harder.</data>
  <data key="d9">cessation challenge,stress interaction</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250489</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Head And Neck Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of smoking increases the chances of developing head and neck cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250492</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Lung Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of smoking increases the chances of developing lung cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250493</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Other Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of smoking increases the chances of developing other cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250494</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Cancer Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Smoking can limit how well cancer treatment works.</data>
  <data key="d9">negative effect,treatment limitation</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250495</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Wound Healing">
  <data key="d7">1.0</data>
  <data key="d8">Smoking can prevent wound healing.</data>
  <data key="d9">negative effect,prevention</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250496</data>
  <data key="d13"></data>
</edge>
<edge source="Smoking" target="Treatment Outcomes">
  <data key="d7">1.0</data>
  <data key="d8">Smoking or heavy alcohol use negatively affects cancer treatment outcomes and increases treatment toxicity.</data>
  <data key="d9">negative impact,toxicity</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250827</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Nicotine Withdrawal">
  <data key="d7">1.0</data>
  <data key="d8">Nicotine withdrawal is challenging for people who vape, and the stress of cancer may make quitting harder.</data>
  <data key="d9">cessation challenge,stress interaction</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250492</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Head And Neck Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of vaping increases the chances of developing head and neck cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250493</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Lung Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of vaping increases the chances of developing lung cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250494</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Wound Healing">
  <data key="d7">1.0</data>
  <data key="d8">Vaping can prevent wound healing.</data>
  <data key="d9">negative effect,prevention</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250495</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Other Cancers">
  <data key="d7">1.0</data>
  <data key="d8">A history of vaping increases the chances of developing other cancers.</data>
  <data key="d9">disease association,risk factor</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250496</data>
  <data key="d13"></data>
</edge>
<edge source="Vaping" target="Cancer Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Vaping can limit how well cancer treatment works.</data>
  <data key="d9">negative effect,treatment limitation</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250500</data>
  <data key="d13"></data>
</edge>
<edge source="Cannabis Use" target="Anesthesia">
  <data key="d7">1.0</data>
  <data key="d8">Cannabis use might affect the amount of anesthesia used during surgery.</data>
  <data key="d9">dosage effect,surgical consideration</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250487</data>
  <data key="d13"></data>
</edge>
<edge source="Dentures" target="Dental Procedures">
  <data key="d7">1.0</data>
  <data key="d8">Dental procedures may be used to plan treatment for dentures.</data>
  <data key="d9">prosthetic care,treatment planning</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250490</data>
  <data key="d13"></data>
</edge>
<edge source="Braces" target="Dental Procedures">
  <data key="d7">1.0</data>
  <data key="d8">Dental procedures may be used to plan treatment for braces.</data>
  <data key="d9">orthodontic care,treatment planning</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250492</data>
  <data key="d13"></data>
</edge>
<edge source="Implants" target="Dental Procedures">
  <data key="d7">1.0</data>
  <data key="d8">Dental procedures may be used to plan treatment for implants.</data>
  <data key="d9">prosthetic care,treatment planning</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250493</data>
  <data key="d13"></data>
</edge>
<edge source="Fertility" target="Head And Neck Cancer Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Treatment for head and neck cancer can affect fertility, and patients should discuss this with their care team.</data>
  <data key="d9">patient concern,side effect</data>
  <data key="d10">chunk-3d609bd1a55d409470c55ad55e2d125d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250491</data>
  <data key="d13"></data>
</edge>
<edge source="Fertility" target="Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Cancer treatment can affect a patient's fertility.</data>
  <data key="d9">impact,side effect</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Treatment" target="Contraception">
  <data key="d7">1.0</data>
  <data key="d8">Contraception is recommended during and after cancer treatment to prevent pregnancy due to potential sperm damage from the treatment.</data>
  <data key="d9">fertility management,risk prevention</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250887</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Treatment" target="Smoking And Vaping">
  <data key="d7">1.0</data>
  <data key="d8">Smoking or vaping can limit the effectiveness of cancer treatment and increase the likelihood of side effects and poor healing.</data>
  <data key="d9">risk factor,treatment efficacy</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250889</data>
  <data key="d13"></data>
</edge>
<edge source="Immune System" target="Cutaneous Squamous Cell Carcinoma (CSCC)">
  <data key="d7">1.0</data>
  <data key="d8">Having a weakened immune system increases a person's likelihood of getting squamous cell skin cancer.</data>
  <data key="d9">disease susceptibility,risk factor</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250772</data>
  <data key="d13"></data>
</edge>
<edge source="Immune System" target="Lymphatic System">
  <data key="d7">1.0</data>
  <data key="d8">The lymphatic system is a part of the immune system that helps fight infection and disease.</data>
  <data key="d9">biological function,component</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250782</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="BRCA1 Gene">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing can identify mutations in the BRCA1 gene to assess hereditary cancer risk.</data>
  <data key="d9">mutation detection,risk assessment</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250674</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="Somatic Tumor Mutations">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing includes testing the tumor itself for somatic mutations in BRCA and related genes.</data>
  <data key="d9">mutation detection,tumor analysis</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250678</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="BRCA2 Gene">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing can identify mutations in the BRCA2 gene to assess hereditary cancer risk.</data>
  <data key="d9">mutation detection,risk assessment</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250679</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="Gynecology Care Team">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing for ovarian cancer may be done through a patient's gynecology care team.</data>
  <data key="d9">care coordination,test administration</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250681</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="Oncology Care Team">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing for ovarian cancer may be done through a patient's oncology care team.</data>
  <data key="d9">care coordination,test administration</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250683</data>
  <data key="d13"></data>
</edge>
<edge source="Genetic Testing" target="Commercial Genetic Tests">
  <data key="d7">1.0</data>
  <data key="d8">Commercial genetic tests are available for common mutations but are not comprehensive for all hereditary cancer syndromes.</data>
  <data key="d9">limitations,test availability</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250686</data>
  <data key="d13"></data>
</edge>
<edge source="Specific Therapies" target="DNA Mutations">
  <data key="d7">1.0</data>
  <data key="d8">Specific DNA mutations and proteins found in a tumor might be targeted with specific therapies.</data>
  <data key="d9">targeting,treatment</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250827</data>
  <data key="d13"></data>
</edge>
<edge source="Neck" target="Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the neck, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250865</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Treatment By Risk And Recurrence">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 4: Treatment by risk and recurrence provides specific information on how to treat basal cell skin cancer, especially regarding its recurrence.</data>
  <data key="d9">medical information,treatment guidance</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250516</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Types Of Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 3: Types of treatment provides information on the various treatment options available for basal cell skin cancer.</data>
  <data key="d9">medical information,treatment options</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250519</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Medical And Family History">
  <data key="d7">1.0</data>
  <data key="d8">Medical and family history is used as part of the basis for diagnosing basal cell skin cancer.</data>
  <data key="d9">diagnosis,risk assessment</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250525</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Ultraviolet (UV) Radiation">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to ultraviolet (UV) radiation from the sun or tanning beds is the primary cause of basal cell skin cancer, as it damages cellular DNA.</data>
  <data key="d9">causation,risk factor</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250858</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Basal Cell Carcinoma (BCC)">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer is also known as basal cell carcinoma (BCC).</data>
  <data key="d9">synonym,terminology</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250861</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="United States">
  <data key="d7">1.0</data>
  <data key="d8">About 3 million cases of basal cell skin cancer are diagnosed every year in the United States.</data>
  <data key="d9">diagnosis location,prevalence</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250861</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Face">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the face, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250862</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Head">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the head, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250863</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Arms">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the arms, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250866</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Legs">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the legs, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250866</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Trunk">
  <data key="d7">1.0</data>
  <data key="d8">Basal cell skin cancer usually develops on the trunk, an area frequently exposed to the sun.</data>
  <data key="d9">common location,development site</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250866</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Fair Skin">
  <data key="d7">1.0</data>
  <data key="d8">People with fair skin are at a higher risk of developing basal cell skin cancer.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250866</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Red Or Blond Hair">
  <data key="d7">1.0</data>
  <data key="d8">People with red or blond hair are at a higher risk of developing basal cell skin cancer.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250867</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Light Eye Color">
  <data key="d7">1.0</data>
  <data key="d8">People with light eye color are at a higher risk of developing basal cell skin cancer.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250867</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Age">
  <data key="d7">1.0</data>
  <data key="d8">The risk of developing basal cell skin cancer increases with age due to cumulative sun exposure.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250867</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="History Of Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">A personal or family history of skin cancer increases the likelihood of developing basal cell skin cancer.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250868</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Immune Suppression">
  <data key="d7">1.0</data>
  <data key="d8">People with immune suppression from conditions like organ transplants have a higher risk for basal cell skin cancer.</data>
  <data key="d9">risk factor,susceptibility</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250869</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Full Skin Exams">
  <data key="d7">1.0</data>
  <data key="d8">Following treatment for basal cell skin cancer, patients undergo full skin exams with a doctor at least once a year for monitoring.</data>
  <data key="d9">monitoring,post-treatment care</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250870</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Chapter 2: Testing For Basal Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 2: Testing for Basal Cell Skin Cancer provides information on how basal cell skin cancer is diagnosed.</data>
  <data key="d9">diagnostic information,resource</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250871</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Chapter 4: Treatment By Risk And Recurrence">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 4: Treatment by Risk and Recurrence provides detailed information on treating basal cell skin cancer based on risk and recurrence.</data>
  <data key="d9">resource,treatment information</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250872</data>
  <data key="d13"></data>
</edge>
<edge source="Basal Cell Skin Cancer" target="Chapter 3: Types Of Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 3: Types of Treatment provides information on the various methods used to treat basal cell skin cancer.</data>
  <data key="d9">resource,treatment information</data>
  <data key="d10">chunk-66dd071b6c2be50e36cee1a1c1bd3b33</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250874</data>
  <data key="d13"></data>
</edge>
<edge source="Cushing Syndrome" target="Adrenal Adenoma">
  <data key="d7">1.0</data>
  <data key="d8">An adrenal adenoma that produces too much cortisol causes the condition known as Cushing syndrome.</data>
  <data key="d9">cause,hormonal disorder</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250521</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Primary Care Physician">
  <data key="d7">2.0</data>
  <data key="d8">Patients are encouraged to keep their primary care physician informed of changes and involved in their care.&lt;SEP&gt;A patient should update their Primary Care Physician regarding any changes in their cancer treatment.</data>
  <data key="d9">healthcare coordination,healthcare partnership,information sharing</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250542</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Caregiver">
  <data key="d7">1.0</data>
  <data key="d8">A caregiver provides transportation, meals, emotional support, and helps ask questions for the patient.</data>
  <data key="d9">assistance provision,support role</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250544</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Treatment Team">
  <data key="d7">1.0</data>
  <data key="d8">A patient is instructed to ask their treatment team if they meet the requirements for clinical trials.</data>
  <data key="d9">eligibility assessment,medical consultation</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250587</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Insurance">
  <data key="d7">1.0</data>
  <data key="d8">During a clinical trial, a patient's standard care is billed to their insurance, and they are responsible for uncovered costs.</data>
  <data key="d9">care coverage,financial responsibility</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250591</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Patient Portals">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to use online patient portals to access test results and communicate with their care team.</data>
  <data key="d9">information access,tool usage</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250628</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Support Groups">
  <data key="d7">1.0</data>
  <data key="d8">Patients are encouraged to seek out support groups for emotional support during diagnosis and treatment.</data>
  <data key="d9">emotional support,resource utilization</data>
  <data key="d10">chunk-d47a420aa2acde1175ad95bf6dc2e664</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250629</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to ask questions about and keep copies of their test results.</data>
  <data key="d9">health management,information access</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250777</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Insurance Forms">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to create files to organize their insurance forms.</data>
  <data key="d9">documentation,organization</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250779</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Medical Records">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to create files to organize their medical records.</data>
  <data key="d9">documentation,organization</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250782</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="Contact List">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to keep a contact list for their care team and make it accessible in an emergency.</data>
  <data key="d9">emergency planning,preparedness</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250784</data>
  <data key="d13"></data>
</edge>
<edge source="Patient" target="AML Specialist">
  <data key="d7">1.0</data>
  <data key="d8">A patient is advised to consider seeking the opinion of an AML specialist for optimal care.</data>
  <data key="d9">expert consultation,healthcare seeking</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250804</data>
  <data key="d13"></data>
</edge>
<edge source="Adrenal Adenoma" target="Aldosteronoma">
  <data key="d7">1.0</data>
  <data key="d8">An aldosteronoma is a specific type of adrenal adenoma characterized by the overproduction of the hormone aldosterone.</data>
  <data key="d9">hormonal disorder,subtype</data>
  <data key="d10">chunk-f8eae4d6dadf6a6fbd339efa4dec2172</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250525</data>
  <data key="d13"></data>
</edge>
<edge source="Health Organization Classification" target="Classic Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">The Health Organization Classification (WHO5) terms grades 1, 2, and 3A of follicular lymphoma as classic FL.</data>
  <data key="d9">disease classification,medical terminology</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250525</data>
  <data key="d13"></data>
</edge>
<edge source="International Consensus Classification" target="This Book">
  <data key="d7">1.0</data>
  <data key="d8">This book follows the ICC classification system for follicular lymphoma.</data>
  <data key="d9">content adherence,reference standard</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250528</data>
  <data key="d13"></data>
</edge>
<edge source="International Consensus Classification" target="Classic Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">The International Consensus Classification (ICC) groups follicular lymphoma grades 1 and 2 as classic FL.</data>
  <data key="d9">disease classification,medical terminology</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250529</data>
  <data key="d13"></data>
</edge>
<edge source="International Consensus Classification" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">The ICC classification system groups follicular lymphoma grades, such as treating grades 1 and 2 as classic FL.</data>
  <data key="d9">disease categorization,treatment guideline</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250715</data>
  <data key="d13"></data>
</edge>
<edge source="Classic Follicular Lymphoma" target="Follicular Lymphoma Grade 1">
  <data key="d7">1.0</data>
  <data key="d8">Classic Follicular Lymphoma includes grade 1 FL according to the ICC classification followed in the book.</data>
  <data key="d9">classification inclusion,disease subtype</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250532</data>
  <data key="d13"></data>
</edge>
<edge source="Classic Follicular Lymphoma" target="Follicular Lymphoma Grade 2">
  <data key="d7">1.0</data>
  <data key="d8">Classic Follicular Lymphoma includes grade 2 FL according to the ICC classification followed in the book.</data>
  <data key="d9">classification inclusion,disease subtype</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250535</data>
  <data key="d13"></data>
</edge>
<edge source="Classic Follicular Lymphoma" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Classic follicular lymphoma is a treatment category for specific grades of FL as defined by classification systems like ICC and WHO.</data>
  <data key="d9">disease classification,treatment category</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250722</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma Grade 3A" target="Diffuse Large B-Cell Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Follicular Lymphoma Grade 3A might be treated as DLBCL depending on the cancer center and cell testing results.</data>
  <data key="d9">diagnostic ambiguity,treatment protocol</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250529</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma Grade 3A" target="WHO5">
  <data key="d7">1.0</data>
  <data key="d8">WHO5 classifies Follicular Lymphoma Grade 3A as part of classic FL.</data>
  <data key="d9">disease classification,medical terminology</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250536</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma Grade 3B" target="Diffuse Large B-Cell Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Follicular Lymphoma Grade 3B is treated as DLBCL.</data>
  <data key="d9">disease rarity,treatment equivalence</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250530</data>
  <data key="d13"></data>
</edge>
<edge source="Diffuse Large B-Cell Lymphoma" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Follicular Lymphoma can transform into the more aggressive Diffuse Large B-Cell Lymphoma.</data>
  <data key="d9">disease progression,transformation</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250535</data>
  <data key="d13"></data>
</edge>
<edge source="Diffuse Large B-Cell Lymphoma" target="Transformed Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Transformed Follicular Lymphoma is the state where FL has turned into DLBCL.</data>
  <data key="d9">disease identity,progression outcome</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250536</data>
  <data key="d13"></data>
</edge>
<edge source="Diffuse Large B-Cell Lymphoma" target="Germinal Center">
  <data key="d7">1.0</data>
  <data key="d8">The text states that the germinal centers in follicular lymphoma are different from those found in some subtypes of diffuse large B-cell lymphoma.</data>
  <data key="d9">disease comparison,structural difference</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250715</data>
  <data key="d13"></data>
</edge>
<edge source="Diffuse Large B-Cell Lymphoma" target="Nodular Lymphocyte-Predominant Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Nodular Lymphocyte-Predominant Hodgkin Lymphoma can transform into Diffuse Large B-Cell Lymphoma, a fast-growing cancer.</data>
  <data key="d9">disease progression,transformation risk</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250786</data>
  <data key="d13"></data>
</edge>
<edge source="Uncommon Follicular Lymphoma" target="t(14;18)-Negative">
  <data key="d7">1.0</data>
  <data key="d8">Uncommon Follicular Lymphoma might be characterized by being t(14;18)-negative.</data>
  <data key="d9">diagnostic criteria,genetic feature</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250540</data>
  <data key="d13"></data>
</edge>
<edge source="Transformed Follicular Lymphoma" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">The stage of follicular lymphoma helps determine if it should be treated as classic FL, DLBCL, or transformed FL.</data>
  <data key="d9">disease progression,treatment determination</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250725</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Hodgkin Lymphoma" target="Follicular Lymphoma">
  <data key="d7">2.0</data>
  <data key="d8">Follicular lymphoma is a specific, slow-growing type of non-Hodgkin lymphoma.&lt;SEP&gt;Follicular Lymphoma is a type of Non-Hodgkin Lymphoma.</data>
  <data key="d9">classification,disease category,disease subtype,subtype relationship</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250530</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Hodgkin Lymphoma" target="Lymphatic System">
  <data key="d7">2.0</data>
  <data key="d8">Non-Hodgkin lymphoma begins in the lymphatic system, which is part of the body's immune network.&lt;SEP&gt;Non-Hodgkin Lymphoma is a cancer that develops from lymphocytes within the lymphatic system.</data>
  <data key="d9">biological system,disease origin</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1&lt;SEP&gt;chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250533</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Hodgkin Lymphoma" target="Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Non-Hodgkin Lymphoma develops from lymphocytes, a type of white blood cell.</data>
  <data key="d9">cell of origin,disease development</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250539</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Hodgkin Lymphoma" target="Lymphocyte">
  <data key="d7">1.0</data>
  <data key="d8">Non-Hodgkin lymphoma is a cancer that originates from lymphocytes, a type of white blood cell.</data>
  <data key="d9">cancer development,cell origin</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250707</data>
  <data key="d13"></data>
</edge>
<edge source="Lymphatic System" target="Hodgkin Lymphoma">
  <data key="d7">2.0</data>
  <data key="d8">Hodgkin Lymphoma usually starts in the lymph nodes, which are part of the lymphatic system.&lt;SEP&gt;Hodgkin Lymphoma is a cancer that affects the Lymphatic System.</data>
  <data key="d9">biological system,disease location,origin,system involvement</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85&lt;SEP&gt;chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250779</data>
  <data key="d13"></data>
</edge>
<edge source="Lymphatic System" target="Thymus">
  <data key="d7">1.0</data>
  <data key="d8">The Thymus is an organ of the Lymphatic System where lymphocytes mature into T cells.</data>
  <data key="d9">cell development,system component</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250790</data>
  <data key="d13"></data>
</edge>
<edge source="BCL2 Protein" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Almost everyone with Follicular Lymphoma has excess levels of the BCL2 protein in their tumor.</data>
  <data key="d9">biomarker association,disease characteristic</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250533</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome Translocation" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Almost everyone with Follicular Lymphoma has a chromosome translocation in their lymphoma cells.</data>
  <data key="d9">disease characteristic,genetic abnormality</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250536</data>
  <data key="d13"></data>
</edge>
<edge source="Immunophenotyping" target="Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Immunophenotyping is a test used in the diagnosis and treatment planning for Follicular Lymphoma.</data>
  <data key="d9">diagnostic procedure,disease management</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250539</data>
  <data key="d13"></data>
</edge>
<edge source="Immunophenotyping" target="Flow Cytometry">
  <data key="d7">2.0</data>
  <data key="d8">Flow cytometry is the most common method used for immunophenotyping, the identification of markers on cells.&lt;SEP&gt;Flow cytometry is commonly used in immunophenotyping to identify markers on cells, particularly in the immune system.</data>
  <data key="d9">cell analysis,cell marker identification,diagnostic method,laboratory method</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4&lt;SEP&gt;chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250635</data>
  <data key="d13"></data>
</edge>
<edge source="Immunophenotyping" target="White Blood Cell Antigens">
  <data key="d7">1.0</data>
  <data key="d8">Immunophenotyping uses antibodies to detect the presence or absence of white blood cell antigens (biomarkers) for AML diagnosis.</data>
  <data key="d9">antibody detection,biomarker identification</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250637</data>
  <data key="d13"></data>
</edge>
<edge source="Immunophenotyping" target="Immunohistochemistry">
  <data key="d7">1.0</data>
  <data key="d8">Immunohistochemistry (IHC) looks for the immunophenotype of cells from a biopsy or tissue sample using a chemical marker and microscope.</data>
  <data key="d9">cell study,staining process</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250638</data>
  <data key="d13"></data>
</edge>
<edge source="Immunophenotyping" target="Biomarker">
  <data key="d7">1.0</data>
  <data key="d8">Immunophenotyping detects biomarkers (white blood cell antigens), and certain biomarkers are targeted in AML treatment.</data>
  <data key="d9">antigen detection,diagnostic targeting</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250649</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="B Symptoms">
  <data key="d7">1.0</data>
  <data key="d8">Symptoms of Follicular Lymphoma can include B symptoms such as fever, night sweats, fatigue, and weight loss.</data>
  <data key="d9">disease presentation,symptom association</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250547</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="Germinal Centers">
  <data key="d7">1.0</data>
  <data key="d8">In Follicular Lymphoma, excess abnormal B lymphocytes form clusters in the germinal centers of lymph nodes.</data>
  <data key="d9">cellular location,disease pathology</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250548</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="B Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Follicular Lymphoma involves excess amounts of abnormal B lymphocytes forming clusters.</data>
  <data key="d9">cell of origin,disease pathology</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250550</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="B Lymphocyte">
  <data key="d7">1.0</data>
  <data key="d8">Follicular lymphoma develops from abnormal B lymphocytes that form clusters in lymph nodes.</data>
  <data key="d9">abnormal growth,cell origin</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250708</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="Germinal Center">
  <data key="d7">1.0</data>
  <data key="d8">Follicular lymphoma starts in the temporary germinal centers of lymph nodes where B cells grow out of control.</data>
  <data key="d9">biological structure,disease origin</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250713</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="World Health Organization Classification">
  <data key="d7">1.0</data>
  <data key="d8">The WHO classification system categorizes follicular lymphoma grades, such as terming grades 1, 2, and 3A as classic FL.</data>
  <data key="d9">disease categorization,medical standard</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250713</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="Centroblast">
  <data key="d7">1.0</data>
  <data key="d8">The presence and quantity of centroblasts help determine the grade of follicular lymphoma, with more centroblasts indicating a higher grade.</data>
  <data key="d9">cellular indicator,disease grading</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250717</data>
  <data key="d13"></data>
</edge>
<edge source="Follicular Lymphoma" target="Grade 3B Follicular Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Grade 3B is a specific, high-grade subtype of follicular lymphoma characterized by containing only centroblasts.</data>
  <data key="d9">disease grading,subtype</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250720</data>
  <data key="d13"></data>
</edge>
<edge source="Lymphocytes" target="Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Lymphoma is a cancer that begins when white blood cells called lymphocytes grow out of control.</data>
  <data key="d9">cellular pathology,origin</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250781</data>
  <data key="d13"></data>
</edge>
<edge source="Patient Portal" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Online patient portals are one way for patients to access their test results.</data>
  <data key="d9">information access,patient communication</data>
  <data key="d10">chunk-829d6b7840e9f2c8d97d22d2ce2c43c1</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250542</data>
  <data key="d13"></data>
</edge>
<edge source="Systemic Therapies" target="Side Effects">
  <data key="d7">1.0</data>
  <data key="d8">Systemic therapies can cause various side effects depending on the medicine used.</data>
  <data key="d9">adverse reactions,treatment risk</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250574</data>
  <data key="d13"></data>
</edge>
<edge source="Epidermal Growth Factor Receptor" target="Cetuximab">
  <data key="d7">1.0</data>
  <data key="d8">Cetuximab is an EGFR inhibitor that blocks the EGFR protein to treat cancer.</data>
  <data key="d9">drug action,protein inhibition</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250570</data>
  <data key="d13"></data>
</edge>
<edge source="Cetuximab" target="Erbitux">
  <data key="d7">1.0</data>
  <data key="d8">Cetuximab is also known by the brand name Erbitux.</data>
  <data key="d9">brand name,drug identification</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250575</data>
  <data key="d13"></data>
</edge>
<edge source="Programmed Death Ligand 1 Inhibitors" target="Cemiplimab">
  <data key="d7">1.0</data>
  <data key="d8">Cemiplimab is a PD-1 inhibitor used in immunotherapy for squamous cell skin cancer.</data>
  <data key="d9">drug type,treatment application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250568</data>
  <data key="d13"></data>
</edge>
<edge source="Programmed Death Ligand 1 Inhibitors" target="Pembrolizumab">
  <data key="d7">1.0</data>
  <data key="d8">Pembrolizumab is a PD-1 inhibitor used in immunotherapy for squamous cell skin cancer.</data>
  <data key="d9">drug type,treatment application</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250570</data>
  <data key="d13"></data>
</edge>
<edge source="Cemiplimab" target="Libtayo">
  <data key="d7">1.0</data>
  <data key="d8">Cemiplimab is also known by the brand name Libtayo.</data>
  <data key="d9">brand name,drug identification</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250575</data>
  <data key="d13"></data>
</edge>
<edge source="Pembrolizumab" target="Keytruda">
  <data key="d7">1.0</data>
  <data key="d8">Pembrolizumab is also known by the brand name Keytruda.</data>
  <data key="d9">brand name,drug identification</data>
  <data key="d10">chunk-f6fd03791661f76f6c1a246b2074b2a0</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250576</data>
  <data key="d13"></data>
</edge>
<edge source="Side Effects" target="Neuropathy">
  <data key="d7">1.0</data>
  <data key="d8">Neuropathy, or nerve damage, is listed as a common side effect of chemotherapy.</data>
  <data key="d9">nerve damage,specific symptom</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250706</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment Planning" target="Test Results">
  <data key="d7">1.0</data>
  <data key="d8">Test results from imaging and biopsy are used to determine the treatment plan.</data>
  <data key="d9">data utilization,decision making</data>
  <data key="d10">chunk-3c0380786c40dd9eac36a8c529c63d9a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250583</data>
  <data key="d13"></data>
</edge>
<edge source="Treatment Team" target="Ovarian Cancer Surgery">
  <data key="d7">1.0</data>
  <data key="d8">The treatment team provides instructions to prepare the patient for ovarian cancer surgery.</data>
  <data key="d9">care coordination,patient preparation</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250904</data>
  <data key="d13"></data>
</edge>
<edge source="Photodynamic Therapy" target="Actinic Keratoses">
  <data key="d7">1.0</data>
  <data key="d8">Photodynamic therapy is a treatment option for actinic keratoses.</data>
  <data key="d9">management,treatment</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250590</data>
  <data key="d13"></data>
</edge>
<edge source="Photodynamic Therapy" target="Superficial Treatments">
  <data key="d7">1.0</data>
  <data key="d8">Photodynamic therapy is a specific type of superficial treatment that uses light-activated drugs to kill cancer cells.</data>
  <data key="d9">method,treatment type</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250749</data>
  <data key="d13"></data>
</edge>
<edge source="Topical Therapy" target="Actinic Keratoses">
  <data key="d7">1.0</data>
  <data key="d8">Topical therapy is a treatment option for actinic keratoses.</data>
  <data key="d9">management,treatment</data>
  <data key="d10">chunk-60426652ddf8265bf75caba550026d38</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250593</data>
  <data key="d13"></data>
</edge>
<edge source="Actinic Keratoses" target="Superficial Treatments">
  <data key="d7">1.0</data>
  <data key="d8">Superficial treatments are applied to treat actinic keratoses, which are pre-cancerous lesions.</data>
  <data key="d9">treatment application</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250748</data>
  <data key="d13"></data>
</edge>
<edge source="Actinic Keratoses" target="Bowens Lesion">
  <data key="d7">1.0</data>
  <data key="d8">Actinic keratoses, which are pre-cancerous lesions, can be found in the same general area as a Bowen's lesion.</data>
  <data key="d9">co-location,pre-cancerous association</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250753</data>
  <data key="d13"></data>
</edge>
<edge source="Karyotype" target="Bone Marrow Or Blood Sample">
  <data key="d7">1.0</data>
  <data key="d8">A karyotype requires a sample of bone marrow or blood to grow cells for analysis.</data>
  <data key="d9">cell growth,sample requirement</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250605</data>
  <data key="d13"></data>
</edge>
<edge source="Karyotype" target="Chromosomes">
  <data key="d7">1.0</data>
  <data key="d8">A karyotype is a picture of chromosomes used to analyze their structure.</data>
  <data key="d9">analysis,visualization</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250613</data>
  <data key="d13"></data>
</edge>
<edge source="Karyotype" target="AML Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Karyotype is a method used in AML mutation testing to provide a picture of chromosomes showing abnormalities.</data>
  <data key="d9">chromosome analysis,diagnostic method</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250646</data>
  <data key="d13"></data>
</edge>
<edge source="Karyotype" target="Cytogenetics">
  <data key="d7">1.0</data>
  <data key="d8">Karyotype is also referred to as cytogenetics, a method used to analyze chromosomes in AML mutation testing.</data>
  <data key="d9">chromosome analysis,synonymous method</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250655</data>
  <data key="d13"></data>
</edge>
<edge source="Next-Generation Sequencing" target="DNA Sequence">
  <data key="d7">1.0</data>
  <data key="d8">Next-Generation Sequencing is used to determine a portion of a person's DNA sequence to find mutations.</data>
  <data key="d9">genetic analysis,mutation detection</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250605</data>
  <data key="d13"></data>
</edge>
<edge source="Next-Generation Sequencing" target="Polymerase Chain Reaction">
  <data key="d7">1.0</data>
  <data key="d8">PCR is very sensitive and can produce material for NGS, important for testing treatment response.</data>
  <data key="d9">sensitivity,testing support</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250608</data>
  <data key="d13"></data>
</edge>
<edge source="Next-Generation Sequencing" target="AML Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Next-generation sequencing (NGS) is a method used in AML mutation testing to determine DNA sequence and identify gene mutations.</data>
  <data key="d9">DNA sequencing,diagnostic method</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250649</data>
  <data key="d13"></data>
</edge>
<edge source="Polymerase Chain Reaction" target="PCR Products">
  <data key="d7">1.0</data>
  <data key="d8">PCR creates copies called PCR products, which might be used for Next-Generation Sequencing.</data>
  <data key="d9">amplification,material production</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250604</data>
  <data key="d13"></data>
</edge>
<edge source="Polymerase Chain Reaction" target="DNA">
  <data key="d7">1.0</data>
  <data key="d8">PCR is a technique that can make millions or billions of copies of DNA.</data>
  <data key="d9">amplification,genetic material</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250615</data>
  <data key="d13"></data>
</edge>
<edge source="Polymerase Chain Reaction" target="RNA">
  <data key="d7">1.0</data>
  <data key="d8">PCR is a technique that can make millions or billions of copies of RNA.</data>
  <data key="d9">amplification,genetic material</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250617</data>
  <data key="d13"></data>
</edge>
<edge source="Polymerase Chain Reaction" target="AML Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Polymerase chain reaction (PCR) is a method used in AML mutation testing to look for changes in genes and chromosomes.</data>
  <data key="d9">diagnostic method,genetic detection</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250652</data>
  <data key="d13"></data>
</edge>
<edge source="Real-Time Or Reverse Transcriptase PCR" target="PML::RARA">
  <data key="d7">1.0</data>
  <data key="d8">Real-Time or Reverse Transcriptase PCR is used to look for the PML::RARA gene rearrangement.</data>
  <data key="d9">diagnostic tool,gene analysis</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250607</data>
  <data key="d13"></data>
</edge>
<edge source="Real-Time Or Reverse Transcriptase PCR" target="Targeted Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Real-Time or Reverse Transcriptase PCR aids in monitoring response to targeted therapies.</data>
  <data key="d9">diagnostic aid,monitoring</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250616</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast Material" target="Brain CT Scan">
  <data key="d7">1.0</data>
  <data key="d8">Contrast may or may not be used during a Brain CT scan.</data>
  <data key="d9">optional use,procedure detail</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250616</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast Material" target="Brain MRI Scan">
  <data key="d7">1.0</data>
  <data key="d8">Contrast may or may not be used during a Brain MRI scan.</data>
  <data key="d9">optional use,procedure detail</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250618</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast Material" target="Allergic Reaction">
  <data key="d7">1.0</data>
  <data key="d8">Patients should tell their care team if they have had allergic reactions to contrast material in the past.</data>
  <data key="d9">patient safety,risk factor</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250620</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast Material" target="Kidneys">
  <data key="d7">1.0</data>
  <data key="d8">Contrast might not be used if a patient's kidneys are not working well.</data>
  <data key="d9">contraindication,safety protocol</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250622</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast Material" target="MRI Scan">
  <data key="d7">1.0</data>
  <data key="d8">An MRI scan frequently uses contrast material to enhance the images of the body's internal structures.</data>
  <data key="d9">diagnostic tool,procedure enhancement</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250888</data>
  <data key="d13"></data>
</edge>
<edge source="Brain MRI Scan" target="Leukemic Meningitis">
  <data key="d7">1.0</data>
  <data key="d8">An MRI can show if the outer layer of the brain is swollen from leukemia, known as leukemic meningitis.</data>
  <data key="d9">condition detection,diagnosis</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250620</data>
  <data key="d13"></data>
</edge>
<edge source="Brain MRI Scan" target="Claustrophobia">
  <data key="d7">1.0</data>
  <data key="d8">Patients with claustrophobia should talk to their care team about MRI options.</data>
  <data key="d9">patient consideration,procedure planning</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250622</data>
  <data key="d13"></data>
</edge>
<edge source="Electrocardiogram" target="Heart">
  <data key="d7">1.0</data>
  <data key="d8">An electrocardiogram shows electrical changes in the heart to reveal information about heart rate and rhythm.</data>
  <data key="d9">electrical monitoring,rhythm analysis</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250611</data>
  <data key="d13"></data>
</edge>
<edge source="Electrocardiogram" target="Prolonged Corrected QT Interval">
  <data key="d7">1.0</data>
  <data key="d8">An electrocardiogram can reveal a prolonged corrected QT interval (QTc).</data>
  <data key="d9">cardiac risk,detection</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250622</data>
  <data key="d13"></data>
</edge>
<edge source="Echocardiogram" target="Heart">
  <data key="d7">1.0</data>
  <data key="d8">An echocardiogram uses sound waves to make pictures of the beating heart.</data>
  <data key="d9">sound wave analysis,structural imaging</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250614</data>
  <data key="d13"></data>
</edge>
<edge source="Echocardiogram" target="Ejection Fraction">
  <data key="d7">1.0</data>
  <data key="d8">An echocardiogram measures the ejection fraction to assess the heart's pumping function.</data>
  <data key="d9">diagnostic measurement,heart function</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250733</data>
  <data key="d13"></data>
</edge>
<edge source="Radiologist" target="Positron Emission Tomography (PET) Scan">
  <data key="d7">1.0</data>
  <data key="d8">A radiologist interprets PET scan images to see how cells are using substances and identify abnormal activity.</data>
  <data key="d9">diagnostic analysis,image interpretation</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250763</data>
  <data key="d13"></data>
</edge>
<edge source="Claustrophobia" target="MRI Scan">
  <data key="d7">1.0</data>
  <data key="d8">Patients with claustrophobia should discuss this with their care team before an MRI, as the machine is an enclosed space.</data>
  <data key="d9">patient consideration,procedural adaptation</data>
  <data key="d10">chunk-705ff2bd04b2b58b98187f60f23a659e</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250891</data>
  <data key="d13"></data>
</edge>
<edge source="Tracer" target="Positron Emission Tomography (PET) Scan">
  <data key="d7">1.0</data>
  <data key="d8">A PET scan uses a radioactive tracer injected into the body to highlight areas of abnormal metabolic activity, such as cancer cells.</data>
  <data key="d9">diagnostic imaging,radioactive tracking</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250759</data>
  <data key="d13"></data>
</edge>
<edge source="PET/CT Scan" target="Positron Emission Tomography (PET) Scan">
  <data key="d7">1.0</data>
  <data key="d8">A PET/CT scan combines the metabolic imaging of a PET scan with the anatomical detail of a CT scan for more comprehensive diagnostics.</data>
  <data key="d9">diagnostic integration,imaging combination</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250761</data>
  <data key="d13"></data>
</edge>
<edge source="Prolonged Corrected QT Interval" target="Dangerous Heart Rhythms">
  <data key="d7">1.0</data>
  <data key="d8">If the QTc becomes too prolonged, it can cause dangerous heart rhythms.</data>
  <data key="d9">cardiac complication,risk factor</data>
  <data key="d10">chunk-4724f6acaaa7931560b29614efc2927f</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250625</data>
  <data key="d13"></data>
</edge>
<edge source="Dangerous Heart Rhythms" target="QTc">
  <data key="d7">1.0</data>
  <data key="d8">A prolonged QTc interval can cause dangerous heart rhythms.</data>
  <data key="d9">cardiac condition,medical risk</data>
  <data key="d10">chunk-97836a515d346931beb424ae40a89877</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250733</data>
  <data key="d13"></data>
</edge>
<edge source="Flow Cytometry" target="Blood Test">
  <data key="d7">1.0</data>
  <data key="d8">A blood test counts white blood cells but cannot detect subtle differences, whereas flow cytometry can detect these differences for blood cancers.</data>
  <data key="d9">cell analysis,diagnostic comparison</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250646</data>
  <data key="d13"></data>
</edge>
<edge source="Flow Cytometry" target="Peripheral Blood">
  <data key="d7">1.0</data>
  <data key="d8">Flow cytometry may be used on cells from circulating (peripheral) blood.</data>
  <data key="d9">cell analysis,sample source</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250691</data>
  <data key="d13"></data>
</edge>
<edge source="AML Biomarker And Genetic Tests" target="Prognosis">
  <data key="d7">1.0</data>
  <data key="d8">AML biomarker and genetic tests are used to learn about AML subtype, target treatment, and determine prognosis.</data>
  <data key="d9">subtype identification,treatment targeting</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250640</data>
  <data key="d13"></data>
</edge>
<edge source="Deletion" target="Del(5q)">
  <data key="d7">1.0</data>
  <data key="d8">Del(5q) is a specific example of a deletion, where part of a chromosome is missing, as described in AML genetic changes.</data>
  <data key="d9">genetic abnormality,specific example</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250650</data>
  <data key="d13"></data>
</edge>
<edge source="Inversion" target="Inv(16)">
  <data key="d7">1.0</data>
  <data key="d8">Inv(16) is a specific example of a chromosome inversion, a type of genetic change in AML.</data>
  <data key="d9">genetic abnormality,specific example</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250653</data>
  <data key="d13"></data>
</edge>
<edge source="Inversion" target="Inv(3)">
  <data key="d7">1.0</data>
  <data key="d8">Inv(3) is a specific example of a chromosome inversion, a type of genetic change in AML.</data>
  <data key="d9">genetic abnormality,specific example</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250655</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome Translocation And Gene Rearrangement" target="T(8;21)(q22;q1)">
  <data key="d7">1.0</data>
  <data key="d8">T(8;21)(q22;q1) is a specific example of a chromosome translocation described at the chromosome level.</data>
  <data key="d9">genetic abnormality,specific example</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250655</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome Translocation And Gene Rearrangement" target="RUNX1::RUNX1T1">
  <data key="d7">1.0</data>
  <data key="d8">RUNX1::RUNX1T1 is a specific example of a gene rearrangement described at the gene level, corresponding to a translocation.</data>
  <data key="d9">genetic abnormality,specific example</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250659</data>
  <data key="d13"></data>
</edge>
<edge source="Leukemia Predisposition Syndromes" target="Hematopoietic Cell Donors">
  <data key="d7">1.0</data>
  <data key="d8">Biological family members who are possible hematopoietic cell donors might be tested for leukemia predisposition syndrome.</data>
  <data key="d9">donor screening,family testing</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250655</data>
  <data key="d13"></data>
</edge>
<edge source="AML Mutation Testing" target="FISH">
  <data key="d7">1.0</data>
  <data key="d8">FISH is a method used in AML mutation testing to detect genetic abnormalities too small for other techniques.</data>
  <data key="d9">abnormality detection,diagnostic method</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250645</data>
  <data key="d13"></data>
</edge>
<edge source="FISH" target="Probes">
  <data key="d7">1.0</data>
  <data key="d8">FISH involves special dyes called probes that attach to pieces of DNA to detect genetic abnormalities.</data>
  <data key="d9">DNA attachment,diagnostic tool</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250657</data>
  <data key="d13"></data>
</edge>
<edge source="Prognosis" target="Cancer Staging">
  <data key="d7">1.0</data>
  <data key="d8">Cancer staging is used to reflect a patient's prognosis and to guide treatment decisions.</data>
  <data key="d9">evaluation,guidance</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250827</data>
  <data key="d13"></data>
</edge>
<edge source="Proteins" target="FLT3">
  <data key="d7">1.0</data>
  <data key="d8">Proteins are given names such as FLT3, which is also an example of a gene identified in the text.</data>
  <data key="d9">gene association,molecule naming</data>
  <data key="d10">chunk-b63f0a9aec8d42c8426ded05a9bf92b4</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250653</data>
  <data key="d13"></data>
</edge>
<edge source="FLT3" target="Gilteritinib">
  <data key="d7">1.0</data>
  <data key="d8">Gilteritinib is a targeted therapy used to treat AML with mutations in the FLT3 gene.</data>
  <data key="d9">drug targeting,genetic mutation</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250842</data>
  <data key="d13"></data>
</edge>
<edge source="FLT3" target="Quizartinib">
  <data key="d7">1.0</data>
  <data key="d8">Quizartinib is a targeted therapy used to treat AML with mutations in the FLT3 gene, specifically FLT3-ITD.</data>
  <data key="d9">drug targeting,genetic mutation</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250844</data>
  <data key="d13"></data>
</edge>
<edge source="FLT3" target="Midostaurin">
  <data key="d7">1.0</data>
  <data key="d8">Midostaurin is a targeted therapy used to treat AML with mutations in the FLT3 gene.</data>
  <data key="d9">drug targeting,genetic mutation</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250846</data>
  <data key="d13"></data>
</edge>
<edge source="FLT3" target="Sorafenib">
  <data key="d7">1.0</data>
  <data key="d8">Sorafenib is a targeted therapy used to treat AML with mutations in the FLT3 gene, specifically FLT3-ITD.</data>
  <data key="d9">drug targeting,genetic mutation</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250848</data>
  <data key="d13"></data>
</edge>
<edge source="Fertility-Sparing Surgery" target="Unilateral Salpingooophorectomy (USO)">
  <data key="d7">1.0</data>
  <data key="d8">USO is a type of fertility-sparing surgery for cancer confined to one ovary.</data>
  <data key="d9">fertility preservation,organ removal</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250665</data>
  <data key="d13"></data>
</edge>
<edge source="Fertility-Sparing Surgery" target="In Vitro Fertilization (IVF)">
  <data key="d7">1.0</data>
  <data key="d8">IVF can be used to achieve pregnancy after fertility-sparing surgery for ovarian cancer.</data>
  <data key="d9">pregnancy option,reproductive assistance</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250667</data>
  <data key="d13"></data>
</edge>
<edge source="In Vitro Fertilization (IVF)" target="Donor Eggs">
  <data key="d7">1.0</data>
  <data key="d8">Donor eggs can be used in IVF procedures for pregnancy after ovarian cancer treatment.</data>
  <data key="d9">assisted reproduction,reproductive material</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250669</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Staging" target="Omentum">
  <data key="d7">1.0</data>
  <data key="d8">The omentum is removed during surgical staging to check for cancer spread.</data>
  <data key="d9">cancer detection,tissue removal</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250665</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Staging" target="Microscopic Metastases">
  <data key="d7">1.0</data>
  <data key="d8">Surgical staging is performed to check for microscopic metastases of ovarian cancer.</data>
  <data key="d9">cancer spread,detection method</data>
  <data key="d10">chunk-77ac570b4029abb181150e0d0975aefb</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250672</data>
  <data key="d13"></data>
</edge>
<edge source="BRCA Genes" target="Homologous Recombination Deficiency">
  <data key="d7">1.0</data>
  <data key="d8">A mutation in the BRCA genes is a form of homologous recombination deficiency, making the tumor HRD positive.</data>
  <data key="d9">DNA repair deficiency,genetic mutation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="BRCA Genes" target="Somatic Mutations">
  <data key="d7">1.0</data>
  <data key="d8">Mutations in the BRCA genes found in the tumor itself are known as somatic or tumor mutations.</data>
  <data key="d9">mutation type,tumor testing</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="BRCA Genes" target="Germline Mutations">
  <data key="d7">1.0</data>
  <data key="d8">Genetic testing of the blood for inherited BRCA mutations checks for germline mutations.</data>
  <data key="d9">inherited testing,mutation type</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="HER2 Expression" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker HER2 expression is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="BRAF V600E Mutation" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker BRAF V600E mutation is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="RET Mutations" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker RET mutations is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250827</data>
  <data key="d13"></data>
</edge>
<edge source="NTRK Gene Fusion" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker NTRK gene fusion is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250829</data>
  <data key="d13"></data>
</edge>
<edge source="Hereditary Ovarian Cancer" target="BRCA1 Gene">
  <data key="d7">1.0</data>
  <data key="d8">Hereditary ovarian cancer is most often caused by mutations in the BRCA1 gene.</data>
  <data key="d9">genetic cause,risk factor</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250672</data>
  <data key="d13"></data>
</edge>
<edge source="Hereditary Ovarian Cancer" target="BRCA2 Gene">
  <data key="d7">1.0</data>
  <data key="d8">Hereditary ovarian cancer is most often caused by mutations in the BRCA2 gene.</data>
  <data key="d9">genetic cause,risk factor</data>
  <data key="d10">chunk-ae40f53e9d867c255e1e6901f5cfb058</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250674</data>
  <data key="d13"></data>
</edge>
<edge source="Nutritional And Digestive Tract Health" target="Registered Dietitian Or Nutritionist">
  <data key="d7">1.0</data>
  <data key="d8">Patients with questions about diet or meal planning for ovarian cancer may be referred to a registered dietitian or nutritionist.</data>
  <data key="d9">dietary guidance,referral</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250815</data>
  <data key="d13"></data>
</edge>
<edge source="Nutritional And Digestive Tract Health" target="Provider">
  <data key="d7">1.0</data>
  <data key="d8">A provider may ask a patient about their diet and eating habits as part of assessing nutritional and digestive tract health.</data>
  <data key="d9">inquiry,patient assessment</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Vitamin B12" target="Red Blood Cell">
  <data key="d7">1.0</data>
  <data key="d8">Vitamin B12 is needed for the normal formation of red blood cells.</data>
  <data key="d9">cell formation,nutrient requirement</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250678</data>
  <data key="d13"></data>
</edge>
<edge source="Vitamin B12" target="White Blood Cell">
  <data key="d7">1.0</data>
  <data key="d8">Vitamin B12 is needed for the normal formation of white blood cells.</data>
  <data key="d9">cell formation,nutrient requirement</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250679</data>
  <data key="d13"></data>
</edge>
<edge source="Human Leukocyte Antigen" target="HLA Typing">
  <data key="d7">1.0</data>
  <data key="d8">HLA typing is a test that detects a person's unique Human Leukocyte Antigen proteins.</data>
  <data key="d9">protein detection,test target</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250684</data>
  <data key="d13"></data>
</edge>
<edge source="HLA Typing" target="Allogeneic Hematopoietic Cell Transplant">
  <data key="d7">1.0</data>
  <data key="d8">HLA typing is a blood test done before an allogeneic hematopoietic cell transplant to find a suitable donor match.</data>
  <data key="d9">donor matching,pre-transplant testing</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250682</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow Aspirate" target="Bone Marrow Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow aspirate and biopsy are two types of bone marrow tests often done at the same time.</data>
  <data key="d9">diagnostic procedures,sample collection</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250686</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow Aspirate" target="Pelvis">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow aspirate samples are usually taken from the back of the hip bone (pelvis).</data>
  <data key="d9">procedure site,sample location</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250693</data>
  <data key="d13"></data>
</edge>
<edge source="Bone Marrow Biopsy" target="Pelvis">
  <data key="d7">1.0</data>
  <data key="d8">Bone marrow biopsy samples are usually taken from the back of the hip bone (pelvis).</data>
  <data key="d9">procedure site,sample location</data>
  <data key="d10">chunk-d73843c009e523101e1464a2b28bc144</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250690</data>
  <data key="d13"></data>
</edge>
<edge source="Bevacizumab" target="Olaparib">
  <data key="d7">1.0</data>
  <data key="d8">For HR deficient and BRCA-mutated cancers, maintenance therapy with both bevacizumab and olaparib is a recommended option.</data>
  <data key="d9">combination therapy,maintenance regimen</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250699</data>
  <data key="d13"></data>
</edge>
<edge source="Bevacizumab" target="Avastin">
  <data key="d7">1.0</data>
  <data key="d8">Avastin is the brand name for the medication bevacizumab.</data>
  <data key="d9">brand name,medication identity</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250702</data>
  <data key="d13"></data>
</edge>
<edge source="Bevacizumab" target="Platinum-Resistant Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Bevacizumab is a preferred treatment option for platinum-resistant recurrent ovarian cancer.</data>
  <data key="d9">targeted therapy,treatment option</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250848</data>
  <data key="d13"></data>
</edge>
<edge source="Intraperitoneal Chemotherapy" target="Catheter">
  <data key="d7">1.0</data>
  <data key="d8">Intraperitoneal chemotherapy is given through a catheter connected to a port in the abdomen.</data>
  <data key="d9">drug delivery,medical device</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250694</data>
  <data key="d13"></data>
</edge>
<edge source="PARP Inhibitors" target="Olaparib">
  <data key="d7">1.0</data>
  <data key="d8">Olaparib is a PARP inhibitor used for maintenance therapy.</data>
  <data key="d9">drug class,specific medication</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250697</data>
  <data key="d13"></data>
</edge>
<edge source="PARP Inhibitors" target="Niraparib">
  <data key="d7">1.0</data>
  <data key="d8">Niraparib is a PARP inhibitor used for maintenance therapy.</data>
  <data key="d9">drug class,specific medication</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250698</data>
  <data key="d13"></data>
</edge>
<edge source="PARP Inhibitors" target="Rucaparib">
  <data key="d7">1.0</data>
  <data key="d8">Rucaparib is a PARP inhibitor used for maintenance therapy.</data>
  <data key="d9">drug class,specific medication</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250699</data>
  <data key="d13"></data>
</edge>
<edge source="PARP Inhibitors" target="Homologous Recombination Deficiency">
  <data key="d7">1.0</data>
  <data key="d8">PARP inhibitors work best in cancers with homologous recombination deficiency.</data>
  <data key="d9">genetic biomarker,treatment efficacy</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250702</data>
  <data key="d13"></data>
</edge>
<edge source="Olaparib" target="Lynparza">
  <data key="d7">1.0</data>
  <data key="d8">Lynparza is the brand name for the PARP inhibitor olaparib.</data>
  <data key="d9">brand name,medication identity</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250702</data>
  <data key="d13"></data>
</edge>
<edge source="Niraparib" target="Zejula">
  <data key="d7">1.0</data>
  <data key="d8">Zejula is the brand name for the PARP inhibitor niraparib.</data>
  <data key="d9">brand name,medication identity</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250702</data>
  <data key="d13"></data>
</edge>
<edge source="Rucaparib" target="Rubraca">
  <data key="d7">1.0</data>
  <data key="d8">Rubraca is the brand name for the PARP inhibitor rucaparib.</data>
  <data key="d9">brand name,medication identity</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250703</data>
  <data key="d13"></data>
</edge>
<edge source="Homologous Recombination Deficiency" target="BRCA Mutation">
  <data key="d7">1.0</data>
  <data key="d8">Homologous recombination deficiency includes cancers caused by a BRCA mutation.</data>
  <data key="d9">biomarker association,genetic cause</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250705</data>
  <data key="d13"></data>
</edge>
<edge source="Observation" target="Complete Response">
  <data key="d7">1.0</data>
  <data key="d8">Observation is an option for maintenance therapy if there was a complete response to chemotherapy.</data>
  <data key="d9">eligibility criterion,treatment outcome</data>
  <data key="d10">chunk-8b44f0b4da13a804cd1dfb917ac7e981</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250706</data>
  <data key="d13"></data>
</edge>
<edge source="Serosa" target="Bile Duct">
  <data key="d7">1.0</data>
  <data key="d8">The serosa is described as a membrane, similar to the inner and outer membranes that make up the layers of a bile duct.</data>
  <data key="d9">anatomical structure,membrane layer</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250706</data>
  <data key="d13"></data>
</edge>
<edge source="Germinal Center" target="Centrocyte">
  <data key="d7">1.0</data>
  <data key="d8">Germinal centers contain a light zone where smaller B cells called centrocytes are found.</data>
  <data key="d9">cellular composition,structural zone</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250709</data>
  <data key="d13"></data>
</edge>
<edge source="Germinal Center" target="Centroblast">
  <data key="d7">1.0</data>
  <data key="d8">Germinal centers contain a dark zone where larger, frequently dividing B cells called centroblasts are found.</data>
  <data key="d9">cellular composition,structural zone</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250711</data>
  <data key="d13"></data>
</edge>
<edge source="Germinal Center" target="Burkitt Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">The text states that the germinal centers in follicular lymphoma are different from those found in some subtypes of Burkitt lymphoma.</data>
  <data key="d9">disease comparison,structural difference</data>
  <data key="d10">chunk-b00f93aa3d24d0275d4290db3fb2cca3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250713</data>
  <data key="d13"></data>
</edge>
<edge source="Myeloid Progenitor Cells" target="Myeloblasts">
  <data key="d7">1.0</data>
  <data key="d8">Myeloid progenitor cells form into myeloblasts and other non-lymphoid blood cells.</data>
  <data key="d9">blood cell formation,cell differentiation</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250717</data>
  <data key="d13"></data>
</edge>
<edge source="Myeloid Progenitor Cells" target="Granulocytes">
  <data key="d7">1.0</data>
  <data key="d8">Myeloid progenitor cells develop into granulocytes, a type of white blood cell.</data>
  <data key="d9">cellular maturation,development</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250798</data>
  <data key="d13"></data>
</edge>
<edge source="Myeloid Progenitor Cells" target="Blood Stem Cells">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells develop into myeloid progenitor cells.</data>
  <data key="d9">cellular development,lineage commitment</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250801</data>
  <data key="d13"></data>
</edge>
<edge source="Blood Stem Cells" target="Differentiation">
  <data key="d7">1.0</data>
  <data key="d8">Blood stem cells develop into mature blood cells through the process of differentiation.</data>
  <data key="d9">development process,maturation</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250798</data>
  <data key="d13"></data>
</edge>
<edge source="Chromosome 22" target="Philadelphia Chromosome (Ph)">
  <data key="d7">1.0</data>
  <data key="d8">The translocation creates a new, abnormal chromosome 22 called the Philadelphia chromosome, which is the hallmark of CML.</data>
  <data key="d9">chromosomal abnormality,disease marker</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250721</data>
  <data key="d13"></data>
</edge>
<edge source="BCR::ABL1 Protein" target="CML Treatment">
  <data key="d7">1.0</data>
  <data key="d8">Treatment for CML aims to stop the activity of the BCR::ABL1 protein.</data>
  <data key="d9">therapeutic target,treatment goal</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250725</data>
  <data key="d13"></data>
</edge>
<edge source="Patient Advocacy" target="CML Specialist">
  <data key="d7">1.0</data>
  <data key="d8">Patients are advised to consider seeking the opinion of a CML specialist as part of advocating for their care.</data>
  <data key="d9">care optimization,specialist consultation</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250726</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer (NSCLC)" target="Lung Carcinoma">
  <data key="d7">1.0</data>
  <data key="d8">NSCLC is a type of lung carcinoma, which forms from cells that line the airways of the lungs.</data>
  <data key="d9">cancer classification,cell origin</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250729</data>
  <data key="d13"></data>
</edge>
<edge source="Non-Small Cell Lung Cancer (NSCLC)" target="Early and Locally Advanced NSCLC">
  <data key="d7">1.0</data>
  <data key="d8">The chapter discusses what it means if NSCLC is early or locally advanced, which are stages of the disease.</data>
  <data key="d9">cancer classification,disease staging</data>
  <data key="d10">chunk-ef6586b896c47b361bf4f6aabb4c35d5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250731</data>
  <data key="d13"></data>
</edge>
<edge source="Oncologist" target="CA-125 Level">
  <data key="d7">1.0</data>
  <data key="d8">An oncologist may order regular checks of the CA-125 level as part of post-treatment surveillance for ovarian cancer.</data>
  <data key="d9">monitoring,surveillance</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250847</data>
  <data key="d13"></data>
</edge>
<edge source="Oncologist" target="Survivorship">
  <data key="d7">1.0</data>
  <data key="d8">Survivorship involves regular visits to an oncologist for physical and pelvic exams after cancer treatment.</data>
  <data key="d9">post-treatment care,regular exams</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250853</data>
  <data key="d13"></data>
</edge>
<edge source="Oncology Nurse" target="Nurse Navigator">
  <data key="d7">1.0</data>
  <data key="d8">An oncology nurse is sometimes referred to as a nurse navigator, indicating the same professional role in cancer care.</data>
  <data key="d9">role,synonym</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250763</data>
  <data key="d13"></data>
</edge>
<edge source="Superficial Treatments" target="Bowens Disease">
  <data key="d7">1.0</data>
  <data key="d8">Superficial treatments are used specifically to treat Bowen's disease, the earliest form of squamous cell skin cancer.</data>
  <data key="d9">treatment application</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250747</data>
  <data key="d13"></data>
</edge>
<edge source="Superficial Treatments" target="Topical Therapies">
  <data key="d7">1.0</data>
  <data key="d8">Topical therapies, such as creams, are a category of superficial treatments applied directly to the skin.</data>
  <data key="d9">method,treatment type</data>
  <data key="d10">chunk-e8ac9bf8f198bc5ad54fd1a7b843e810</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250755</data>
  <data key="d13"></data>
</edge>
<edge source="Computed Tomography (CT) Scan" target="Contrast Dye">
  <data key="d7">1.0</data>
  <data key="d8">Contrast dye is often used during a CT scan to improve the clarity of the images of tissues and organs.</data>
  <data key="d9">diagnostic tool,imaging enhancement</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250759</data>
  <data key="d13"></data>
</edge>
<edge source="Magnetic Resonance Imaging (MRI)" target="Contrast Dye">
  <data key="d7">1.0</data>
  <data key="d8">Contrast dye is often used during an MRI to help tissues and organs show up more clearly in the pictures.</data>
  <data key="d9">diagnostic tool,imaging enhancement</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250761</data>
  <data key="d13"></data>
</edge>
<edge source="Cutaneous Squamous Cell Carcinoma (CSCC)" target="Local Squamous Cell Skin Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Local Squamous Cell Skin Cancer is a classification of CSCC that describes cancer which has not spread to nearby lymph nodes.</data>
  <data key="d9">disease classification,staging</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250765</data>
  <data key="d13"></data>
</edge>
<edge source="Cutaneous Squamous Cell Carcinoma (CSCC)" target="Sun">
  <data key="d7">1.0</data>
  <data key="d8">Excessive exposure to the sun over many years is a most common cause of Cutaneous Squamous Cell Carcinoma.</data>
  <data key="d9">causative factor,disease risk</data>
  <data key="d10">chunk-6eafb110f88c7af38808f77f59ed155d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250770</data>
  <data key="d13"></data>
</edge>
<edge source="National Comprehensive Cancer Network" target="NCCN Clinical Practice Guidelines In Oncology">
  <data key="d7">1.0</data>
  <data key="d8">The National Comprehensive Cancer Network develops the NCCN Clinical Practice Guidelines in Oncology.</data>
  <data key="d9">development,publication</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250772</data>
  <data key="d13"></data>
</edge>
<edge source="Hodgkin Lymphoma" target="Reed-Sternberg Cells">
  <data key="d7">1.0</data>
  <data key="d8">Hodgkin Lymphoma is characterized by the presence of abnormal lymphocytes called Reed-Sternberg cells.</data>
  <data key="d9">characteristic,pathology</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250777</data>
  <data key="d13"></data>
</edge>
<edge source="Hodgkin Lymphoma" target="Non-Hodgkin Lymphomas">
  <data key="d7">1.0</data>
  <data key="d8">Lymphomas are classified as either Hodgkin or the distinct group of Non-Hodgkin lymphomas.</data>
  <data key="d9">classification,distinction</data>
  <data key="d10">chunk-64f36a4a5be80c8fa51631db16e52b85</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250782</data>
  <data key="d13"></data>
</edge>
<edge source="Hodgkin Lymphoma" target="Classic Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Classic Hodgkin Lymphoma is the most common type of Hodgkin Lymphoma.</data>
  <data key="d9">common type,disease classification</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250785</data>
  <data key="d13"></data>
</edge>
<edge source="Hodgkin Lymphoma" target="Nodular Lymphocyte-Predominant Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Nodular Lymphocyte-Predominant Hodgkin Lymphoma is a rare type of Hodgkin Lymphoma.</data>
  <data key="d9">disease classification,rare type</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250789</data>
  <data key="d13"></data>
</edge>
<edge source="Hodgkin Lymphoma" target="Excisional Lymph Node Biopsy">
  <data key="d7">1.0</data>
  <data key="d8">Hodgkin Lymphoma is best diagnosed using an Excisional Lymph Node Biopsy.</data>
  <data key="d9">diagnostic method,preferred test</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250791</data>
  <data key="d13"></data>
</edge>
<edge source="Reed-Sternberg Cells" target="Classic Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Classic Hodgkin Lymphoma is recognized by the presence of Reed-Sternberg cells.</data>
  <data key="d9">cellular characteristic,disease marker</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250786</data>
  <data key="d13"></data>
</edge>
<edge source="Thymus" target="T Lymphocytes">
  <data key="d7">1.0</data>
  <data key="d8">Lymphocytes travel to the Thymus to develop into T Lymphocytes (T cells).</data>
  <data key="d9">cell development,organ function</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250793</data>
  <data key="d13"></data>
</edge>
<edge source="Nodular Lymphocyte-Predominant Hodgkin Lymphoma" target="Popcorn-Shaped Cells">
  <data key="d7">1.0</data>
  <data key="d8">Nodular Lymphocyte-Predominant Hodgkin Lymphoma is known for the presence of Popcorn-Shaped Cells.</data>
  <data key="d9">cellular characteristic,disease marker</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250791</data>
  <data key="d13"></data>
</edge>
<edge source="Excisional Lymph Node Biopsy" target="Guide 1 Testing For Hodgkin Lymphoma">
  <data key="d7">1.0</data>
  <data key="d8">Guide 1 Testing for Hodgkin Lymphoma explains that an Excisional Lymph Node Biopsy is the best way to diagnose the disease.</data>
  <data key="d9">chapter content,diagnostic explanation</data>
  <data key="d10">chunk-d67bee20d5e5400994f8c8f03052dd06</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250794</data>
  <data key="d13"></data>
</edge>
<edge source="PML::RARA Fusion Gene" target="APL">
  <data key="d7">1.0</data>
  <data key="d8">APL, a subtype of AML, is characterized by the presence of the abnormal PML::RARA fusion gene.</data>
  <data key="d9">disease characterization,genetic marker</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250799</data>
  <data key="d13"></data>
</edge>
<edge source="Chapter 2: Testing For AML" target="Genetic And Biomarker Mutation Testing">
  <data key="d7">1.0</data>
  <data key="d8">Chapter 2: Testing for AML provides an overview of genetic and biomarker mutation testing.</data>
  <data key="d9">chapter content,test overview</data>
  <data key="d10">chunk-bd7ea43a74059d6781866faec437f19a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250805</data>
  <data key="d13"></data>
</edge>
<edge source="Registered Dietitian Or Nutritionist" target="Provider">
  <data key="d7">1.0</data>
  <data key="d8">A provider can give a referral to a registered dietitian or nutritionist for dietary help.</data>
  <data key="d9">healthcare coordination,professional referral</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Gastrointestinal Tract" target="Digestive System">
  <data key="d7">1.0</data>
  <data key="d8">The gastrointestinal tract is part of the digestive system.</data>
  <data key="d9">pathway,system component</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250880</data>
  <data key="d13"></data>
</edge>
<edge source="Gastrointestinal Tract" target="Small Intestine">
  <data key="d7">1.0</data>
  <data key="d8">After the stomach, food enters the small intestine as part of the GI tract.</data>
  <data key="d9">anatomical sequence,pathway</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250886</data>
  <data key="d13"></data>
</edge>
<edge source="Gastrointestinal Tract" target="Large Intestine">
  <data key="d7">1.0</data>
  <data key="d8">The large intestine is the final part of the GI tract that prepares waste for expulsion.</data>
  <data key="d9">anatomical sequence,pathway</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250887</data>
  <data key="d13"></data>
</edge>
<edge source="Scope" target="Colonoscopy">
  <data key="d7">1.0</data>
  <data key="d8">A scope is the instrument inserted during a colonoscopy to examine the large bowel.</data>
  <data key="d9">instrument,procedure</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250813</data>
  <data key="d13"></data>
</edge>
<edge source="Scope" target="Upper Endoscopy">
  <data key="d7">1.0</data>
  <data key="d8">A scope is the instrument guided down the throat during an upper endoscopy to examine the upper GI tract.</data>
  <data key="d9">instrument,procedure</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250818</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Cancer Antigen-125">
  <data key="d7">1.0</data>
  <data key="d8">Cancer antigen-125 is a common tumor marker test used to help diagnose and monitor ovarian cancer.</data>
  <data key="d9">diagnostic indicator,protein</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250817</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Inhibin">
  <data key="d7">1.0</data>
  <data key="d8">Inhibin is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250820</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Beta-Human Chorionic Gonadotropin">
  <data key="d7">1.0</data>
  <data key="d8">Beta-human chorionic gonadotropin is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Alpha-Fetoprotein">
  <data key="d7">1.0</data>
  <data key="d8">Alpha-fetoprotein is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250821</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Carcinoembryonic Antigen">
  <data key="d7">1.0</data>
  <data key="d8">Carcinoembryonic antigen is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="CA 19-9">
  <data key="d7">1.0</data>
  <data key="d8">CA 19-9 is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="HE4">
  <data key="d7">1.0</data>
  <data key="d8">HE4 is a tumor marker that may be elevated in less common ovarian cancers.</data>
  <data key="d9">diagnostic indicator,less common cancer</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Tumor Markers" target="Less Common Ovarian Cancers">
  <data key="d7">1.0</data>
  <data key="d8">Tumor markers like inhibin, -hCG, AFP, LDH, CEA, CA 19-9, and HE4 may be found in higher amounts in people with less common ovarian cancers.</data>
  <data key="d9">diagnostic association,specific cancer type</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Antigen-125" target="Endometriosis">
  <data key="d7">1.0</data>
  <data key="d8">Endometriosis, a non-cancerous health problem, can cause elevated CA-125 levels.</data>
  <data key="d9">false positive,non-cancerous condition</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250822</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Antigen-125" target="Diverticulitis">
  <data key="d7">1.0</data>
  <data key="d8">Diverticulitis, a non-cancerous health problem, can cause elevated CA-125 levels.</data>
  <data key="d9">false positive,non-cancerous condition</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Microsatellite Instability" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker microsatellite instability is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250823</data>
  <data key="d13"></data>
</edge>
<edge source="Mismatch Repair" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker mismatch repair is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250824</data>
  <data key="d13"></data>
</edge>
<edge source="Folate Receptor Alpha Expression" target="Recurrent Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">Testing for the biomarker folate receptor alpha expression is generally recommended for recurrent ovarian cancer.</data>
  <data key="d9">biomarker testing,recommendation</data>
  <data key="d10">chunk-96238b4b361e393ff452a09d1ce26154</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250826</data>
  <data key="d13"></data>
</edge>
<edge source="Heavy Alcohol Use" target="Treatment Outcomes">
  <data key="d7">1.0</data>
  <data key="d8">Smoking or heavy alcohol use negatively affects cancer treatment outcomes and increases treatment toxicity.</data>
  <data key="d9">negative impact,toxicity</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250828</data>
  <data key="d13"></data>
</edge>
<edge source="Cancer Staging" target="American Joint Committee On Cancer">
  <data key="d7">1.0</data>
  <data key="d8">The American Joint Committee on Cancer (AJCC) created a staging system to determine the extent of cancer in the body.</data>
  <data key="d9">creation,standardization</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250829</data>
  <data key="d13"></data>
</edge>
<edge source="American Joint Committee On Cancer" target="FIGO Staging System">
  <data key="d7">1.0</data>
  <data key="d8">The American Joint Committee on Cancer developed an alternative staging system for ovarian cancer, similar to but less used than the FIGO system.</data>
  <data key="d9">alternative system,staging methodology</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250900</data>
  <data key="d13"></data>
</edge>
<edge source="TNM System" target="Tumor Size">
  <data key="d7">1.0</data>
  <data key="d8">The T in the TNM system describes the depth and size of the primary tumor.</data>
  <data key="d9">component,measurement</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250829</data>
  <data key="d13"></data>
</edge>
<edge source="TNM System" target="Lymph Node Status">
  <data key="d7">1.0</data>
  <data key="d8">The N in the TNM system describes if cancer has spread to nearby lymph nodes.</data>
  <data key="d9">assessment,component</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250830</data>
  <data key="d13"></data>
</edge>
<edge source="TNM System" target="Anatomic Stage">
  <data key="d7">1.0</data>
  <data key="d8">Anatomic staging is based on the extent of cancer as defined by the TNM factors: tumor size, lymph node status, and distant metastasis.</data>
  <data key="d9">basis,definition</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250832</data>
  <data key="d13"></data>
</edge>
<edge source="TNM System" target="Numbered Stages">
  <data key="d7">1.0</data>
  <data key="d8">Numbered stages for cancer are derived from the combined scores of the TNM system.</data>
  <data key="d9">classification,derivation</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="Anatomic Stage" target="Prognostic Stage">
  <data key="d7">1.0</data>
  <data key="d8">The prognostic stage includes the anatomic TNM information and assumes standard-of-care treatment.</data>
  <data key="d9">enhancement,inclusion</data>
  <data key="d10">chunk-28e4e845dfd1390f7f94cfb11bee1526</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250834</data>
  <data key="d13"></data>
</edge>
<edge source="Pathologic Stage" target="FIGO Staging System">
  <data key="d7">1.0</data>
  <data key="d8">The pathologic stage of ovarian cancer is described using the FIGO staging system.</data>
  <data key="d9">classification system,standard description</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250897</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast" target="MRI Scan">
  <data key="d7">1.0</data>
  <data key="d8">Contrast might be used during an MRI scan to improve the quality of the images taken.</data>
  <data key="d9">diagnostic tool,image enhancement</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250832</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast" target="Diphenhydramine (Benadryl)">
  <data key="d7">1.0</data>
  <data key="d8">Diphenhydramine may be given to patients to prevent allergic reactions to contrast material used in imaging tests.</data>
  <data key="d9">allergy management,medical precaution</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250835</data>
  <data key="d13"></data>
</edge>
<edge source="Contrast" target="Prednisone (Steroids)">
  <data key="d7">1.0</data>
  <data key="d8">Prednisone may be given to patients to prevent allergic reactions to contrast material used in imaging tests.</data>
  <data key="d9">allergy management,medical precaution</data>
  <data key="d10">chunk-aa14ecd19e2d721cb99ea9590f0ede3a</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250837</data>
  <data key="d13"></data>
</edge>
<edge source="Multi-Agent Chemotherapy" target="Antimetabolites">
  <data key="d7">1.0</data>
  <data key="d8">Antimetabolites, such as Cytarabine, are one type of chemotherapy that can be used in multi-agent regimens for AML.</data>
  <data key="d9">combination therapy,drug class</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250835</data>
  <data key="d13"></data>
</edge>
<edge source="Multi-Agent Chemotherapy" target="Anthracyclines">
  <data key="d7">1.0</data>
  <data key="d8">Anthracyclines, such as daunorubicin, are one type of chemotherapy that can be used in multi-agent regimens for AML.</data>
  <data key="d9">combination therapy,drug class</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250837</data>
  <data key="d13"></data>
</edge>
<edge source="Antimetabolites" target="Cytarabine">
  <data key="d7">1.0</data>
  <data key="d8">Cytarabine is classified as an antimetabolite, a type of chemotherapy that prevents DNA building blocks from being used.</data>
  <data key="d9">drug classification,mechanism of action</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250838</data>
  <data key="d13"></data>
</edge>
<edge source="Antimetabolites" target="Cladribine">
  <data key="d7">1.0</data>
  <data key="d8">Cladribine is provided as an example of an antimetabolite chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250839</data>
  <data key="d13"></data>
</edge>
<edge source="Antimetabolites" target="Clofarabine">
  <data key="d7">1.0</data>
  <data key="d8">Clofarabine is provided as an example of an antimetabolite chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250840</data>
  <data key="d13"></data>
</edge>
<edge source="Antimetabolites" target="Fludarabine">
  <data key="d7">1.0</data>
  <data key="d8">Fludarabine is provided as an example of an antimetabolite chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250841</data>
  <data key="d13"></data>
</edge>
<edge source="Antimetabolites" target="Methotrexate">
  <data key="d7">1.0</data>
  <data key="d8">Methotrexate is provided as an example of an antimetabolite chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250843</data>
  <data key="d13"></data>
</edge>
<edge source="Anthracyclines" target="Daunorubicin">
  <data key="d7">1.0</data>
  <data key="d8">Daunorubicin is provided as an example of an anthracycline chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250839</data>
  <data key="d13"></data>
</edge>
<edge source="Anthracyclines" target="Idarubicin">
  <data key="d7">1.0</data>
  <data key="d8">Idarubicin is provided as an example of an anthracycline chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250840</data>
  <data key="d13"></data>
</edge>
<edge source="Anthracyclines" target="Mitoxantrone">
  <data key="d7">1.0</data>
  <data key="d8">Mitoxantrone is provided as an example of an anthracycline chemotherapy drug.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250841</data>
  <data key="d13"></data>
</edge>
<edge source="Cytarabine" target="Intrathecal Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Cytarabine can be administered via intrathecal chemotherapy, where it is injected into the spinal fluid to treat AML in the central nervous system.</data>
  <data key="d9">administration method,specific treatment</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250836</data>
  <data key="d13"></data>
</edge>
<edge source="Cytarabine" target="CPX-351">
  <data key="d7">1.0</data>
  <data key="d8">CPX-351 contains the drug cytarabine as part of its dual-drug liposome formulation.</data>
  <data key="d9">combination therapy,drug composition</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250840</data>
  <data key="d13"></data>
</edge>
<edge source="Hypomethylating Agents" target="Azacitidine">
  <data key="d7">1.0</data>
  <data key="d8">Azacitidine is provided as an example of a hypomethylating agent.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250840</data>
  <data key="d13"></data>
</edge>
<edge source="Hypomethylating Agents" target="Decitabine">
  <data key="d7">1.0</data>
  <data key="d8">Decitabine is provided as an example of a hypomethylating agent.</data>
  <data key="d9">drug classification,example</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250841</data>
  <data key="d13"></data>
</edge>
<edge source="Gemtuzumab Ozogamicin" target="Core Binding Factor">
  <data key="d7">1.0</data>
  <data key="d8">Gemtuzumab ozogamicin might be used in combination with other drugs to treat AML associated with Core Binding Factor abnormalities.</data>
  <data key="d9">genetic abnormality,treatment application</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250838</data>
  <data key="d13"></data>
</edge>
<edge source="Gemtuzumab Ozogamicin" target="CD33">
  <data key="d7">1.0</data>
  <data key="d8">Gemtuzumab ozogamicin attaches to the CD33 protein on the surface of leukemic blasts.</data>
  <data key="d9">drug mechanism,molecular targeting</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250841</data>
  <data key="d13"></data>
</edge>
<edge source="Daunorubicin" target="CPX-351">
  <data key="d7">1.0</data>
  <data key="d8">CPX-351 contains the drug daunorubicin as part of its dual-drug liposome formulation.</data>
  <data key="d9">combination therapy,drug composition</data>
  <data key="d10">chunk-53afdc6713818c4177b64a712ecce11b</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250841</data>
  <data key="d13"></data>
</edge>
<edge source="Fallopian Tubes" target="Ovarian Cancer Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Fallopian tubes are removed during surgery for ovarian cancer as part of the standard procedure.</data>
  <data key="d9">surgical removal,treatment procedure</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250899</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Resistant Cancer" target="Mirvetuximab Soravtansine-Gynx">
  <data key="d7">1.0</data>
  <data key="d8">Mirvetuximab soravtansine-gynx is the preferred targeted therapy for platinum-resistant recurrent ovarian cancer with the FR biomarker.</data>
  <data key="d9">biomarker-based treatment,targeted therapy</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250851</data>
  <data key="d13"></data>
</edge>
<edge source="Platinum-Sensitive Cancer" target="Secondary Cytoreductive Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Secondary cytoreductive surgery may be suggested before starting recurrence treatment for platinum-sensitive ovarian cancer.</data>
  <data key="d9">recurrence treatment,surgical intervention</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250850</data>
  <data key="d13"></data>
</edge>
<edge source="PARP Inhibitor" target="Stage 2 Ovarian Cancer">
  <data key="d7">1.0</data>
  <data key="d8">There is limited research on the use of PARP inhibitors as maintenance therapy for stage 2 ovarian cancer.</data>
  <data key="d9">research gap,treatment eligibility</data>
  <data key="d10">chunk-c622c677deca24391324ecd5f16ce4a3</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250852</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="Radiation Therapy To The Chest">
  <data key="d7">1.0</data>
  <data key="d8">Prior radiation therapy to the chest increases a person's chances of getting SCLC.</data>
  <data key="d9">medical history,risk factor</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250870</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="Carcinogens">
  <data key="d7">1.0</data>
  <data key="d8">Exposure to carcinogens like radon and asbestos increases the risk of SCLC.</data>
  <data key="d9">chemical exposure,risk factor</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250871</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="Paraneoplastic Syndromes">
  <data key="d7">1.0</data>
  <data key="d8">SCLC can cause symptoms through paraneoplastic syndromes, an abnormal body response.</data>
  <data key="d9">indirect effect,symptom causation</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250872</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="X-Rays">
  <data key="d7">1.0</data>
  <data key="d8">SCLC can sometimes be found using X-ray imaging before symptoms start.</data>
  <data key="d9">detection method,diagnostic imaging</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250875</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="CT Scans">
  <data key="d7">1.0</data>
  <data key="d8">SCLC can sometimes be found using CT scan imaging before symptoms start.</data>
  <data key="d9">detection method,diagnostic imaging</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250877</data>
  <data key="d13"></data>
</edge>
<edge source="SCLC" target="Guide SCLC">
  <data key="d7">1.0</data>
  <data key="d8">Symptoms caused by SCLC are listed in a specific guide referred to as Guide SCLC.</data>
  <data key="d9">reference material,symptom documentation</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250882</data>
  <data key="d13"></data>
</edge>
<edge source="Assessment Team" target="Interventional Radiologist">
  <data key="d7">1.0</data>
  <data key="d8">An interventional radiologist is one of the board-certified experts that may be part of the assessment team.</data>
  <data key="d9">specialist inclusion,team composition</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250878</data>
  <data key="d13"></data>
</edge>
<edge source="Digestive System" target="Stomach">
  <data key="d7">1.0</data>
  <data key="d8">The stomach is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250885</data>
  <data key="d13"></data>
</edge>
<edge source="Digestive System" target="Small Intestine">
  <data key="d7">1.0</data>
  <data key="d8">The small intestine is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250887</data>
  <data key="d13"></data>
</edge>
<edge source="Digestive System" target="Colon">
  <data key="d7">1.0</data>
  <data key="d8">The colon is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250888</data>
  <data key="d13"></data>
</edge>
<edge source="Digestive System" target="Rectum">
  <data key="d7">1.0</data>
  <data key="d8">The rectum is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250891</data>
  <data key="d13"></data>
</edge>
<edge source="Digestive System" target="Anus">
  <data key="d7">1.0</data>
  <data key="d8">The anus is an organ included in the digestive system.</data>
  <data key="d9">anatomical part,system inclusion</data>
  <data key="d10">chunk-ecc6c4bcd3cab65fa05ab5f3c55e528d</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250894</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Menopause" target="Hormone Replacement Therapy">
  <data key="d7">1.0</data>
  <data key="d8">Hormone Replacement Therapy may be suggested by a doctor to manage the symptoms of surgical menopause.</data>
  <data key="d9">symptom management,treatment option</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250894</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Menopause" target="Estrogen">
  <data key="d7">1.0</data>
  <data key="d8">Surgical menopause is caused by the sudden drop in estrogen levels following ovary removal.</data>
  <data key="d9">hormonal cause,physiological change</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250903</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Menopause" target="Cardiovascular Disease">
  <data key="d7">1.0</data>
  <data key="d8">Cardiovascular disease is a long-term health risk associated with surgical menopause due to low estrogen.</data>
  <data key="d9">health complication,long-term risk</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250905</data>
  <data key="d13"></data>
</edge>
<edge source="Surgical Menopause" target="Osteoporosis">
  <data key="d7">1.0</data>
  <data key="d8">Osteoporosis is a long-term health risk associated with surgical menopause due to low estrogen.</data>
  <data key="d9">health complication,long-term risk</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250906</data>
  <data key="d13"></data>
</edge>
<edge source="Hormone Replacement Therapy" target="Menopausal Symptom Team">
  <data key="d7">1.0</data>
  <data key="d8">A menopausal symptom team is consulted to help determine if Hormone Replacement Therapy is appropriate.</data>
  <data key="d9">decision support,treatment consultation</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250904</data>
  <data key="d13"></data>
</edge>
<edge source="Deep Vein Thrombosis" target="Ovarian Cancer Surgery">
  <data key="d7">1.0</data>
  <data key="d8">Ovarian cancer surgery is a risk factor for developing Deep Vein Thrombosis, leading to preventive use of blood thinners.</data>
  <data key="d9">complication,surgical risk</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250896</data>
  <data key="d13"></data>
</edge>
<edge source="Deep Vein Thrombosis" target="Blood Thinners">
  <data key="d7">1.0</data>
  <data key="d8">Blood thinners are used to prevent Deep Vein Thrombosis after ovarian cancer surgery.</data>
  <data key="d9">post-surgical care,prevention</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250901</data>
  <data key="d13"></data>
</edge>
<edge source="Interval Cytoreductive Surgery" target="Hyperthermic Intraperitoneal Chemotherapy">
  <data key="d7">1.0</data>
  <data key="d8">Hyperthermic Intraperitoneal Chemotherapy may be used during Interval Cytoreductive Surgery for stage 3 ovarian cancer.</data>
  <data key="d9">combined treatment,surgical technique</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250897</data>
  <data key="d13"></data>
</edge>
<edge source="FIGO Staging System" target="International Federation Of Gynecology And Obstetrics">
  <data key="d7">1.0</data>
  <data key="d8">The FIGO staging system was developed by the International Federation of Gynecology and Obstetrics.</data>
  <data key="d9">organizational standard,system development</data>
  <data key="d10">chunk-cf2d987135a5936876bc819136e3a5b5</data>
  <data key="d11">unknown_source</data>
  <data key="d12">1767250899</data>
  <data key="d13"></data>
</edge>
</graph></graphml>